<?xml version="1.0" encoding="utf-8"?>
<documents>
  <document>
    <id>293405</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=293405]]&gt;</url>
    <title>2008-August. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-August. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Patient Safety Guidance&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293193&amp;amp;tabID=288" target="_blank"&gt;Technical patient safety solutions for ventilator-associated pneumonia in adults. NICE Patient Safety Guidance 2. Published 27 August 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=30132&amp;amp;tabID=288" target="_blank"&gt;Updated national guidance on the safe administration of intrathecal chemotherapy, Published 11th August 2008.&lt;BR&gt;(This guideline updates and replaces the October 2003 guideline of the same title).&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;American Society of Clinical Oncology&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291856&amp;amp;tabID=288" target="_blank"&gt;2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. Published 21 May 2007.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Mayo Clinic College of Medicine (USA)&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291862&amp;amp;tabID=288" target="_blank"&gt;Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Published August 2006.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;UKCCSG-PONF Mouth Care Group&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292413&amp;amp;tabID=288" target="_blank"&gt;Mouth care for children and young people with cancer : evidence-based guidelines. Published February 2006.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NHS Quality Improvement Scotland&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292551&amp;amp;tabID=288" target="_blank"&gt;Best practice statement : working with dependent older people to achieve good oral health. Published May 2005.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292953&amp;amp;tabID=289" target="_blank"&gt;A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292956&amp;amp;tabID=289" target="_blank"&gt;A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292908&amp;amp;tabID=289" target="_blank"&gt;Clinical effects of reminiscence therapy in older adults: a meta-analysis of controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292901&amp;amp;tabID=289" target="_blank"&gt;Do the benefits of anti-dementia drugs extend to caregivers?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292875&amp;amp;tabID=289" target="_blank"&gt;Does religious activity improve health outcomes: a critical review of the recent literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292958&amp;amp;tabID=289" target="_blank"&gt;Does this patient have dementia?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292969&amp;amp;tabID=289" target="_blank"&gt;Effects of music listening on adult patients' pre-procedural state anxiety in hospital&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292935&amp;amp;tabID=289" target="_blank"&gt;Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292929&amp;amp;tabID=289" target="_blank"&gt;Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292880&amp;amp;tabID=289" target="_blank"&gt;Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292879&amp;amp;tabID=289" target="_blank"&gt;Survival in cancer patients undergoing in-hospital cardiopulmonary resuscitation: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292934&amp;amp;tabID=289" target="_blank"&gt;Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292965&amp;amp;tabID=289" target="_blank"&gt;Systematic review: the evidence that publishing patient care performance data improves quality of care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292869&amp;amp;tabID=289" target="_blank"&gt;The effectiveness of Web-based vs. non-Web-based interventions: a meta-analysis of behavioral change outcomes.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=292968&amp;amp;tabID=289" target="_blank"&gt;The role of intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a clinical practice guideline&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;OTHER&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293236&amp;amp;tabID=292" target="_blank"&gt;Bereavement Advice Centre&lt;/A&gt;&amp;nbsp;[website]&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=281915&amp;amp;tabID=290" target="_blank"&gt;Mapping global health inequalities: challenges and opportunities&lt;/A&gt;&amp;nbsp;[Public Health SL]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>305740</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=305740]]&gt;</url>
    <title>2008-Dec and 2009-Jan. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-Dec and 2009-Jan. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=300628&amp;amp;tabID=288" target="_blank"&gt;Rapid response report - resuscitation in mental health and learning disability settings. Published by the National Patient Safety Agency on 26 November 2008&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;CLINICAL KNOWLEDGE SUMMARIES (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300553&amp;amp;tabID=288" target="_blank"&gt;Migraine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300554&amp;amp;tabID=288" target="_blank"&gt;Migraine: Migraine in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300555&amp;amp;tabID=288" target="_blank"&gt;Migraine: Migraine in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300571&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Capsaicin for neuropathic pain - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300572&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Carbamazepine for neuropathic pain - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300573&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Duloxetine for neuropathic pain - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300574&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Gabapentin for neuropathic pain - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300575&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Lidocaine 5% medicated plaster - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300576&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - adjunct drugs: Tricyclic antidepressants for neuropathic pain - prescribing information&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300570&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain - prescribing information for adjunct drugs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=272437&amp;amp;tabID=288" target="_blank"&gt;Palliative care - pain: Managing neuropathic pain&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303927&amp;amp;tabID=289" target="_blank"&gt;A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303968&amp;amp;tabID=289" target="_blank"&gt;Comparative effectiveness of therapies for clinically localized prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303940&amp;amp;tabID=289" target="_blank"&gt;Effectiveness of cognitive behavioral and supportive-expressive group therapy for women diagnosed with breast cancer: a review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303923&amp;amp;tabID=289" target="_blank"&gt;Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303931&amp;amp;tabID=289" target="_blank"&gt;Implementing a hospital guideline on pneumonia: a semi-quantitative review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303959&amp;amp;tabID=289" target="_blank"&gt;Nursing interventions to improve the health of men with prostate cancer undergoing radiotherapy: a review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303904&amp;amp;tabID=289" target="_blank"&gt;Pharmacological treatment of dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303971&amp;amp;tabID=289" target="_blank"&gt;Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304001&amp;amp;tabID=289" target="_blank"&gt;A cost-utility analysis of pregabalin in the management of peripheral neuropathic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303980&amp;amp;tabID=289" target="_blank"&gt;Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303977&amp;amp;tabID=289" target="_blank"&gt;Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>291339</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=291339]]&gt;</url>
    <title>2008-July. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-July. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=290712&amp;amp;tabID=288" target="_blank"&gt;Interventional Procedure Guidance: Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision. NICE Interventional Procedure Guidance 268.&amp;nbsp; Published 23 July 2008.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289031&amp;amp;tabID=288" target="_blank"&gt;Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck. NICE Technology Appraisal Guidance 145. Published 25 June 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;SIGN:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289369&amp;amp;tabID=288" target="_blank"&gt;Diagnosis and management of chronic kidney disease. Published June 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Nursing and Midwifery Council:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=126943&amp;amp;tabID=288" target="_blank"&gt;Record keeping.&amp;nbsp; Published July 2007.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287909&amp;amp;tabID=288" target="_blank"&gt;The Code : standards of conduct, performance and ethics for nurses and midwives. Published May 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291260&amp;amp;tabID=288" target="_blank"&gt;Confidence in caring : a framework for best practice. Published 21 July 2008.&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291261&amp;amp;tabID=288" target="_blank"&gt;End of Life Care Strategy - promoting high quality care for all adults at the end of life. Published 16 July 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;National Osteoporosis Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289630&amp;amp;tabID=288" target="_blank"&gt;Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK expert group. Published in July 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;American College of Radiology:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289642&amp;amp;tabID=288" target="_blank"&gt;Practice guideline for the management of ductal carcinoma in-situ of the breast. (DCIS). Published in January 2006.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British HIV Association:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289819&amp;amp;tabID=288" target="_blank"&gt;British HIV Association guidelines for HIV-associated malignancies 2008. Published in July 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;National Patient Safety Agency:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289847&amp;amp;tabID=288" target="_blank"&gt;Rapid response report : reducing dosing errors with opioid medicines. Published 04 July 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;World Gastroenterology Organisation:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289582&amp;amp;tabID=288" target="_blank"&gt;(Global Guidelines) Constipation, Published in 2007.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289597&amp;amp;tabID=288" target="_blank"&gt;(Global Guidelines) Dysphagia, Published in 2007.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British Society for Antimicrobial Chemotherapy:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289999&amp;amp;tabID=288" target="_blank"&gt;Guidelines for the management of hospital-acquired pneumonia in the UK. Published on 29 April 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Association of Paediatric Anaesthetists of Great Britain and Ireland:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=290188&amp;amp;tabID=288" target="_blank"&gt;Good practice in postoperative and procedural pain. Published in 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NHS Primary Care Contracting:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291259&amp;amp;tabID=288" target="_blank"&gt;Providing care for patients with urological conditions : guidance and resources for commissioners. Published on 15 July 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;COCHRANE&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260040&amp;amp;tabID=289" target="_blank"&gt;Lamotrigine for acute and chronic pain&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=268926&amp;amp;tabID=289" target="_blank"&gt;A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>289548</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=289548]]&gt;</url>
    <title>2008-June. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-June. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287827&amp;amp;tabID=289" target="_blank"&gt;Non-Hodgkin's lymphoma: meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287796&amp;amp;tabID=289" target="_blank"&gt;Systematic review of the clinical effectiveness of self care support networks in health and social care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287839&amp;amp;tabID=289" target="_blank"&gt;The criterion validity of the Geriatric Depression Scale: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287822&amp;amp;tabID=289" target="_blank"&gt;The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=287788&amp;amp;tabID=289" target="_blank"&gt;Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients: a systematic review&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;/STRONG&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278893&amp;amp;tabID=289" target="_blank"&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278893&amp;amp;tabID=289" target="_blank"&gt;A cost-effectiveness analysis of chemotherapy for patients with recurrent platinum-sensitive epithelial ovarian cancer&lt;/A&gt;&lt;/LI&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283892&amp;amp;tabID=289" target="_blank"&gt;A cost-utility analysis of treatments for malignant liver tumours: a pilot project&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=277949&amp;amp;tabID=289" target="_blank"&gt;A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=277944&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis comparing chemotherapy regimens in the treatment of AIDS-related Kaposi's sarcoma in Brazil&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>288406</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=288406]]&gt;</url>
    <title>2008-May. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-May. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;COCHRANE&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283720&amp;amp;tabID=289" target="_blank"&gt;Clinical pathways for chronic cough in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283729&amp;amp;tabID=289" target="_blank"&gt;Dopamine agonist therapy in early Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283709&amp;amp;tabID=289" target="_blank"&gt;Exercise for the management of cancer-related fatigue in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283690&amp;amp;tabID=289" target="_blank"&gt;Huperzine A for Alzheimer's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283706&amp;amp;tabID=289" target="_blank"&gt;Medically assisted hydration for palliative care patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283666&amp;amp;tabID=289" target="_blank"&gt;Mistletoe therapy in oncology&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283698&amp;amp;tabID=289" target="_blank"&gt;Mu-opioid antagonists for opioid-induced bowel dysfunction&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283692&amp;amp;tabID=289" target="_blank"&gt;Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283670&amp;amp;tabID=289" target="_blank"&gt;Palliative endobronchial brachytherapy for non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283688&amp;amp;tabID=289" target="_blank"&gt;Psychotherapy for depression among incurable cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283711&amp;amp;tabID=289" target="_blank"&gt;Targeted therapy for advanced renal cell carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283681&amp;amp;tabID=289" target="_blank"&gt;Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283689&amp;amp;tabID=289" target="_blank"&gt;Topotecan for ovarian cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE) &lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283814&amp;amp;tabID=289" target="_blank"&gt;A systematic review of intervention studies about anxiety in caregivers of people with dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283747&amp;amp;tabID=289" target="_blank"&gt;Alzheimer disease: operating characteristics of PET. A meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283777&amp;amp;tabID=289" target="_blank"&gt;Autogenic training for tension type headaches: a systematic review of controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283849&amp;amp;tabID=289" target="_blank"&gt;Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000-2004&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283761&amp;amp;tabID=289" target="_blank"&gt;Does successful treatment of constipation or faecal impaction resolve lower urinary tract symptoms: a structured review of the literature. Systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283767&amp;amp;tabID=289" target="_blank"&gt;Evidence-based practice recommendations for working with individuals with dementia: simulated presence therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283845&amp;amp;tabID=289" target="_blank"&gt;Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=277896&amp;amp;tabID=289" target="_blank"&gt;Follow-up care of patients treated for breast cancer: a structured review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283839&amp;amp;tabID=289" target="_blank"&gt;Interactive technologies and videotapes for patient education in cancer care: systematic review and meta-analysis of randomised trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283756&amp;amp;tabID=289" target="_blank"&gt;Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283818&amp;amp;tabID=289" target="_blank"&gt;Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283857&amp;amp;tabID=289" target="_blank"&gt;Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278844&amp;amp;tabID=289" target="_blank"&gt;Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278873&amp;amp;tabID=289" target="_blank"&gt;Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278883&amp;amp;tabID=289" target="_blank"&gt;Minimising undernutrition in the older inpatient&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278855&amp;amp;tabID=289" target="_blank"&gt;The WHO analgesic ladder for cancer pain control, twenty years of use: how much pain relief does one get from using it?&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=277896&amp;amp;tabID=289" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;CLINICAL KNOWLEDGE SUMMARIES&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283608&amp;amp;tabID=288" target="_blank"&gt;Anaemia - iron deficiency&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283609&amp;amp;tabID=288" target="_blank"&gt;Anaemia - iron deficiency: Iron deficiency anaemia - assessment of cause and complications&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283610&amp;amp;tabID=288" target="_blank"&gt;Anaemia - iron deficiency: Iron deficiency anaemia – management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283623&amp;amp;tabID=288" target="_blank"&gt;Constipation: Constipation in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283622&amp;amp;tabID=288" target="_blank"&gt;Constipation: Constipation in infants and children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283614&amp;amp;tabID=288" target="_blank"&gt;Palliative cancer care – constipation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283615&amp;amp;tabID=288" target="_blank"&gt;Palliative cancer care - constipation: Constipation in palliative care&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;HEALTH TECHNOLOGY ASSESSMENT&amp;nbsp; (HTA) &lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283927&amp;amp;tabID=290" target="_blank"&gt;Follow-up visits from nurses after discharge from multidisciplinary pain centre - a health technology assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283948&amp;amp;tabID=289" target="_blank"&gt;Genetic counselling in breast cancer and colon cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283923&amp;amp;tabID=289" target="_blank"&gt;Impact of gene expression profiling tests on breast cancer outcomes&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283949&amp;amp;tabID=289" target="_blank"&gt;Interval cancers in the early breast cancer detection programme&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278941&amp;amp;tabID=289" target="_blank"&gt;Positron Emission Tomography (PET) for Alzheimer's disease (AD)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278954&amp;amp;tabID=290" target="_blank"&gt;Technology and Ageing: The maintenance of independency and self-determination of aged people&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=252400&amp;amp;tabID=290" target="_blank"&gt;Transnational analysis of the socio-economic impact of Alzheimer's disease (AD) in the European Union&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=261869&amp;amp;tabID=290" target="_blank"&gt;Transurethral prostatectomy vs laparoscopy vs brachytherapy vs IMRT in the treatment of prostate cancer (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278690&amp;amp;tabID=290" target="_blank"&gt;A randomised controlled trial in the palliative setting regarding off-label medication: investigating the efficiency of amitriptyline versus pregabalin from a societal perspective (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278609&amp;amp;tabID=290" target="_blank"&gt;Aging in the community (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278588&amp;amp;tabID=290" target="_blank"&gt;Alzheimer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278509&amp;amp;tabID=290" target="_blank"&gt;Bortezomib monotherapy for relapsed multiple myeloma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278518&amp;amp;tabID=290" target="_blank"&gt;Home telemonitoring for chronic diseases (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278578&amp;amp;tabID=290" target="_blank"&gt;Life-saving treatment - only for the rich? Examining the factors affecting the staff while presenting information and consulting women with local breast cancer regarding preventive treatment with Herceptin (the drug was not included in the NLHS at the time). (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278442&amp;amp;tabID=290" target="_blank"&gt;Lymphoedema therapy in breast cancer patients. Effectiveness, current practice and costs.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278680&amp;amp;tabID=290" target="_blank"&gt;Medically unexplained symptoms-systematic review (Project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=257518&amp;amp;tabID=290" target="_blank"&gt;Service improvement tools for the prevention, diagnosis and management of chronic diseases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278666&amp;amp;tabID=290" target="_blank"&gt;Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin, HTA ref 39295, Technology Assessment Report for NICE (Project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260567&amp;amp;tabID=289" target="_blank"&gt;Therapeutic conversation: expectations and results with regard to intensified physician-patient communication (project)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>299881</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=299881]]&gt;</url>
    <title>2008-November. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,SERVICE PROVISION,ETHICS &amp; LAW,RESEARCH,HUMANITIES,POLICY,POPULATIONS AND SETTINGS,FAMILIES &amp; CARERS,DEATH,SYMPTOM MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-November. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299757&amp;amp;tabID=288" target="_blank"&gt;Clinical Guidelines: Metastatic spinal cord compression: diagnosis and management of adults at risk of and with metastatic spinal cord compression. NICE Clinical Guideline 75. Published 26 November 2008.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299720&amp;amp;tabID=288" target="_blank"&gt;Technology Appraisal Guidance: Erlotinib for the treatment of non-small-cell lung cancer. NICE Technology Appraisal Guidance 162. Published 26 November 2008.&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299787&amp;amp;tabID=288" target="_blank"&gt;Interventional Procedure Guidance: Electrically-stimulated intravesical chemotherapy for superficial bladder cancer. NICE Interventional Procedure Guidance 277. Published 26 November 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;SIGN&lt;/EM&gt;:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=298074&amp;amp;tabID=288" target="_blank"&gt;Control of pain in adults with cancer. Published November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299693&amp;amp;tabID=288" target="_blank"&gt;Diagnosis and management of headache in adults. Published November 2008 &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=298275&amp;amp;tabID=288" target="_blank"&gt;Guidance on nominating a consultee for research involving adults who lack capacity to consent. Published 22 February 2008.&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299706&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: breast measures. Published 18 November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299697&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: gynaecology measures. Published 07 November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299708&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: lung measures. Published 18 November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299673&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: skin measures. Published 07 November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299710&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: upper GI measures. Published 18 November 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299703&amp;amp;tabID=288" target="_blank"&gt;Manual for Cancer Services 2008: urology measures. Published 18 November 2008. &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Royal College of Paediatrics and Child Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=298393&amp;amp;tabID=288" target="_blank"&gt;Witholding or withdrawing life sustaining treatment in children : a framework for practice. Published May 2004.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;Diabetes UK:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=298482&amp;amp;tabID=288" target="_blank"&gt;Care recommendation : fasting during Yom Kippur (Day of Atonement) and Tisha B’Av (9th of Av) Published June 2008. &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Cancer Care Ontario (CCO), Canada:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299463&amp;amp;tabID=288" target="_blank"&gt;The management of thymoma: guideline recommendations. Published September 2008. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299466&amp;amp;tabID=288" target="_blank"&gt;Postoperative adjuvant chemotherapy in completely resected non-small cell lung cancer: guidance for nurses. Published December 2007. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299466&amp;amp;tabID=288" target="_blank"&gt;Postoperative adjuvant chemotherapy, with or without radiotherapy, in completely resected non-small cell lung cancer: a clinical practice guideline. Published December 2005. &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299481&amp;amp;tabID=288" target="_blank"&gt;Postoperative adjuvant radiation therapy in stage II or IIIA completely resected non-small cell lung cancer. Published February 2005. &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Royal College of Physicians of Edinburgh:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299668&amp;amp;tabID=288" target="_blank"&gt;Think transition: developing the essential link between paediatric and adult care. Published November 2008. &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Department for Children, Schools and Families:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299833&amp;amp;tabID=288" target="_blank"&gt;Children's Trusts: statutory guidance on inter-agency cooperation to improve well-being of children, young people and their families. Published 18 November 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Royal College of Physicians:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=30205&amp;amp;tabID=288" target="_blank"&gt;Non-invasive ventilation in chronic obstructive pulmonary disease : management of acute type 2 respiratory failure. Published October 2008. (This document updates and replaces the 2002 British Thoracic Society guidance entitled: 'Non-invasive ventilation in acute respiratory failure').&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British HIV Association:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=30221&amp;amp;tabID=288" target="_blank"&gt;British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy (2008), Published September 2008. (This document updates and replaces the previous guidelines published in 2006 entitled: BHIVA guidelines for the treatment of HIV-infected adults with antiretroviral therapy 2006).&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297284&amp;amp;tabID=289" target="_blank"&gt;A literature review of randomized controlled trials of the organization of care at the end of life&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297335&amp;amp;tabID=289" target="_blank"&gt;A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297309&amp;amp;tabID=289" target="_blank"&gt;A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297364&amp;amp;tabID=289" target="_blank"&gt;A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297306&amp;amp;tabID=289" target="_blank"&gt;A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297388&amp;amp;tabID=289" target="_blank"&gt;Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297307&amp;amp;tabID=289" target="_blank"&gt;Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297338&amp;amp;tabID=289" target="_blank"&gt;Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297394&amp;amp;tabID=289" target="_blank"&gt;Effectiveness of specialized palliative care: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297409&amp;amp;tabID=289" target="_blank"&gt;Evidence for the impact of quality improvement collaboratives: systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297257&amp;amp;tabID=289" target="_blank"&gt;Evidence-based practice recommendations for working with individuals with dementia: Montessori-based interventions&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297308&amp;amp;tabID=289" target="_blank"&gt;Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297401&amp;amp;tabID=289" target="_blank"&gt;Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297407&amp;amp;tabID=289" target="_blank"&gt;Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297273&amp;amp;tabID=289" target="_blank"&gt;Short-burst oxygen therapy in chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297392&amp;amp;tabID=289" target="_blank"&gt;Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297269&amp;amp;tabID=289" target="_blank"&gt;The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297375&amp;amp;tabID=289" target="_blank"&gt;The impact of residential respite care on the behaviour of older people with dementia: literature review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297362&amp;amp;tabID=289" target="_blank"&gt;The treatment of depression in cancer patients: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297287&amp;amp;tabID=289" target="_blank"&gt;Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;HEALTH TECHNOLOGY ASSESSMENTS (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297671&amp;amp;tabID=290" target="_blank"&gt;Dementia - etiology and epidemiology (Vol 1)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297672&amp;amp;tabID=290" target="_blank"&gt;Dementia - diagnostic and therapeutic interventions (Vol 2) &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297657&amp;amp;tabID=290" target="_blank"&gt;Efficacy and safety of new therapies for metastatic clear cell renal-cell carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=278453&amp;amp;tabID=290" target="_blank"&gt;Exercise training in pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297676&amp;amp;tabID=289" target="_blank"&gt;External review and validation of methodological instruments for the critical reading and summary of scientific evidence&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297665&amp;amp;tabID=290" target="_blank"&gt;Intensity modulated radiation therapy (IMRT) for localized prostate cancer &lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297686&amp;amp;tabID=289" target="_blank"&gt;Intraoperative radiotherapy in pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297687&amp;amp;tabID=289" target="_blank"&gt;Intraoperative radiotherapy in soft tissues sarcomas&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297678&amp;amp;tabID=289" target="_blank"&gt;Literature bibliographic search protocols adapting them to the different search outputs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297603&amp;amp;tabID=290" target="_blank"&gt;Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297629&amp;amp;tabID=290" target="_blank"&gt;Psychosocial interventions for non-professional carers of people with Parkinson's Disease: a scoping review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297606&amp;amp;tabID=290" target="_blank"&gt;Stepped treatment of older adults on laxatives. The STOOL trial&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297651&amp;amp;tabID=290" target="_blank"&gt;The efficacy of acupuncture in the treatment of cephalalgia/ migraine and different conditions&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297608&amp;amp;tabID=290" target="_blank"&gt;The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297660&amp;amp;tabID=290" target="_blank"&gt;Utility of PET-FDG in assessing lymphoma. Systematic review of results after chemo and immunotherapy&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297742&amp;amp;tabID=289" target="_blank"&gt;A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297749&amp;amp;tabID=289" target="_blank"&gt;A Markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297728&amp;amp;tabID=289" target="_blank"&gt;Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297726&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297743&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297740&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297717&amp;amp;tabID=289" target="_blank"&gt;Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297722&amp;amp;tabID=289" target="_blank"&gt;Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>297183</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=297183]]&gt;</url>
    <title>2008-October. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SERVICE PROVISION,ETHICS &amp; LAW,HUMANITIES,RESEARCH,POLICY,SYMPTOM MANAGEMENT,DEATH,FAMILIES &amp; CARERS,POPULATIONS AND SETTINGS,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-October. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=294680&amp;amp;tabID=288" target="_blank"&gt;Clinical Guidelines:Chronic kidney disease : early identification and management of chronic kidney disease in adults in primary and secondary care. NICE Clinical Guideline 73. (Published 24 September 2008)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;European Society of Cardiology: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293429&amp;amp;tabID=288" target="_blank"&gt;ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. (Published in 2008)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Multinational Association of Supportive Care in Cancer, International Society for Oral Oncology:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293529&amp;amp;tabID=288" target="_blank"&gt;Updated clinical practice guidelines for the prevention and treatment of mucositis. (Published 05 February 2007)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;European Federation of Neurological Societies (EFNS):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=294992&amp;amp;tabID=288" target="_blank"&gt;EFNS guideline on the drug treatment of migraine - report of an EFNS task force. (Published 06 April 2006).&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295060&amp;amp;tabID=288" target="_blank"&gt;EFNS guidelines on diagnosis and treatment of brain metastases : report of an EFNS Task Force. (Published July 2006)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295101&amp;amp;tabID=288" target="_blank"&gt;Review of the therapeutic management of Parkinson's disease. Part I: early (uncomplicated) Parkinson's disease. (Published November 2006)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295081&amp;amp;tabID=288" target="_blank"&gt;Review of the therapeutic management of Parkinson’s disease. Part II: late (complicated) Parkinson’s disease. (Published November 2006)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;COCHRANE&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=279173&amp;amp;tabID=289" target="_blank"&gt;Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295708&amp;amp;tabID=289" target="_blank"&gt;Antimotility agents for chronic diarrhoea in people with HIV/AIDS&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=237390&amp;amp;tabID=289" target="_blank"&gt;Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295687&amp;amp;tabID=289" target="_blank"&gt;Antipsychotics for acute and chronic pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295717&amp;amp;tabID=289" target="_blank"&gt;Medically assisted nutrition for palliative care in adult patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295704&amp;amp;tabID=289" target="_blank"&gt;Procaine treatments for cognition and dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=270967&amp;amp;tabID=289" target="_blank"&gt;Protein restriction for children with chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295738&amp;amp;tabID=289" target="_blank"&gt;Smart home technologies for health and social care support&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295734&amp;amp;tabID=289" target="_blank"&gt;Touch therapies for pain relief in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295852&amp;amp;tabID=289" target="_blank"&gt;A critical review of complementary therapies for cancer-related fatigue&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295797&amp;amp;tabID=289" target="_blank"&gt;A meta-analysis of the effects of psychological interventions in pediatric oncology on outcomes of psychological distress and adjustment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295915&amp;amp;tabID=289" target="_blank"&gt;A review of the benefits of whole body exercise during and after treatment for breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295840&amp;amp;tabID=289" target="_blank"&gt;A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295918&amp;amp;tabID=289" target="_blank"&gt;Does the patient-held record improve continuity and related outcomes in cancer care: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295793&amp;amp;tabID=289" target="_blank"&gt;Metaanalysis of acustimulation effects on postoperative nausea and vomiting in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295850&amp;amp;tabID=289" target="_blank"&gt;Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295771&amp;amp;tabID=289" target="_blank"&gt;Prophylactic treatment of migraine in children - Part 1: a systematic review of non-pharmacological trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295937&amp;amp;tabID=289" target="_blank"&gt;The use of bisphosphonates in men with hormone-refractory prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295817&amp;amp;tabID=289" target="_blank"&gt;Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295992&amp;amp;tabID=289" target="_blank"&gt;Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295977&amp;amp;tabID=289" target="_blank"&gt;Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=295961&amp;amp;tabID=289" target="_blank"&gt;Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>293902</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=293902]]&gt;</url>
    <title>2008-September. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2008-September. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;COCHRANE&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293685&amp;amp;tabID=289" target="_blank"&gt;Adjunctive therapies for AIDS dementia complex&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293640&amp;amp;tabID=289" target="_blank"&gt;Adjuvant therapy for completely resected Stage II Colon Cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293642&amp;amp;tabID=289" target="_blank"&gt;Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293639&amp;amp;tabID=289" target="_blank"&gt;Oxygen therapy for dyspnoea in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283743&amp;amp;tabID=289" target="_blank"&gt;Personal assistance for adults (19-64) with physical impairments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293703&amp;amp;tabID=289" target="_blank"&gt;Personal assistance for children and adolescents (0-18) with both physical and intellectual impairments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293702&amp;amp;tabID=289" target="_blank"&gt;Personal assistance for children and adolescents (0-18) with intellectual impairments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293675&amp;amp;tabID=289" target="_blank"&gt;Personal assistance for children and adolescents (0-18) with physical impairments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293651&amp;amp;tabID=289" target="_blank"&gt;Physical activity programs for persons with dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293657&amp;amp;tabID=289" target="_blank"&gt;Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238275&amp;amp;tabID=289" target="_blank"&gt;Transcutaneous electric nerve stimulation (TENS) for dementia&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;OTHER SYSTEMATIC REVIEWS&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;HARRIS FM,&amp;nbsp;KENDALL M, BENTLEY A,&amp;nbsp;MAGUIRE R,&amp;nbsp;WORTH A,&amp;nbsp; MURRAY S,&amp;nbsp;BOYD K,&amp;nbsp;BROWN D,&amp;nbsp;KEARNEY N,&amp;nbsp;SHEIKH A. Researching experiences of terminal cancer: a systematic review of methodological issues and approaches. European Journal of Cancer Care&amp;nbsp; 2008 v 17 no 4, p 377-386. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18485015" target="_blank"&gt;Get Pubmed abstract&lt;/A&gt;] &lt;/LI&gt;
&lt;LI&gt;BALLANTYNE JC,&amp;nbsp;SHIN NS.&amp;nbsp;Efficacy of opioids for chronic pain: A review of the evidence.&amp;nbsp;ClinJPain 08 v24 no 6 p469-478. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18574357" target="_blank"&gt;Get Pubmed abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;OTHER RESOURCES&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Brunnhuber K, Nash S, Meier DE, Weissman DE, Woodcock J. Putting evidence into practice: palliative care. [An 88-page report from Clinical Evidence]. Spring 2008&amp;nbsp;[&lt;A href="http://clinicalevidence.bmj.com/downloads/end-of-life.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>313873</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=313873]]&gt;</url>
    <title>2009-Apr. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-Apr. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/H2&gt;
&lt;P&gt;Dept of Health:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=313196&amp;amp;tabID=288" target="_blank"&gt;Your health, your way: a guide to long term conditions and self care. Information for healthcare professionals. Published 07 April 2009&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=313009&amp;amp;tabID=288" target="_blank"&gt;NHS Emergency Planning Guidance 2009: Planning for the evacuation and sheltering of people in health sector settings - interim strategic national guidance. Published 21 April 2009&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Nursing and Midwifery Council:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=311031&amp;amp;tabID=288" target="_blank"&gt;Guidance for the care of older people. Published March 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Royal College of Radiologists:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=311636&amp;amp;tabID=288" target="_blank"&gt;Implementing image-guided brachytherapy for cervix cancer in the UK. Published in 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Medendium Group Publishing Ltd:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312052&amp;amp;tabID=288" target="_blank"&gt;Consensus guideline on the medication management of adults with swallowing difficulties. Published in 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;British National Formulary (BNF): March 2009&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312454&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313414&amp;amp;tabID=288" target="_blank"&gt;Acute diarrhoea&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313415&amp;amp;tabID=288" target="_blank"&gt;Chronic bowel disorders&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313417&amp;amp;tabID=288" target="_blank"&gt;Laxatives&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313418&amp;amp;tabID=288" target="_blank"&gt;Stoma care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313425&amp;amp;tabID=288" target="_blank"&gt;Intravenous nutrition&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=313440&amp;amp;tabID=288" target="_blank"&gt;Oral nutrition&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;British National Formulary for Children: Latest – July 2008&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312532&amp;amp;tabID=288" target="_blank"&gt;Antiplatelet drugs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312546&amp;amp;tabID=288" target="_blank"&gt;Neuropathic pain &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Journal of Neurology, Neurosurgery and Pyschiatry (JNNP) Online:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=313172&amp;amp;tabID=288" target="_blank"&gt;A UK consensus on the management of the bladder in multiple sclerosis. Published Online (ahead of print) May 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;University of Warwick/ JRCALC:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=261535&amp;amp;tabID=288" target="_blank"&gt;Sickle cell crisis – update. Published 21 April 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;COCHRANE&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312223&amp;amp;tabID=289" target="_blank"&gt;Cannabinoids for the treatment of dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312223&amp;amp;tabID=289" target="_blank"&gt;Enteral tube feeding for older people with advanced dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312184&amp;amp;tabID=289" target="_blank"&gt;Haloperidol for the treatment of nausea and vomiting in palliative care patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312247&amp;amp;tabID=289" target="_blank"&gt;HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312171&amp;amp;tabID=289" target="_blank"&gt;Homeopathic medicines for adverse effects of cancer treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312244&amp;amp;tabID=289" target="_blank"&gt;Honey and lozenges for children with non-specific cough&lt;BR&gt;&amp;nbsp;Huperzine A for vascular dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312205&amp;amp;tabID=289" target="_blank"&gt;Influenza vaccination in children being treated with chemotherapy for cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312191&amp;amp;tabID=289" target="_blank"&gt;Interventions for improving the psychosocial well-being of children affected by HIV and AIDS&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312175&amp;amp;tabID=289" target="_blank"&gt;Interventions for psychosexual dysfunction in women treated for gynaecological malignancy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312200&amp;amp;tabID=289" target="_blank"&gt;Music for stress and anxiety reduction in coronary heart disease patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312202&amp;amp;tabID=289" target="_blank"&gt;Polymer-based oral rehydration solution for treating acute watery diarrhoea&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312242&amp;amp;tabID=289" target="_blank"&gt;Psychological therapies for the management of chronic pain (excluding headache) in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312204&amp;amp;tabID=289" target="_blank"&gt;Rituximab as maintenance therapy for patients with follicular lymphoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312167&amp;amp;tabID=289" target="_blank"&gt;Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312210&amp;amp;tabID=289" target="_blank"&gt;Second-line chemotherapy in advanced and metastatic CRC&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312186&amp;amp;tabID=289" target="_blank"&gt;Transcutaneous electrical nerve stimulation for acute pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312161&amp;amp;tabID=289" target="_blank"&gt;Written information about individual medicines for consumers&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312314&amp;amp;tabID=289" target="_blank"&gt;Acupuncture and related techniques for postoperative pain: a systematic review of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312348&amp;amp;tabID=289" target="_blank"&gt;Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=312264&amp;amp;tabID=289" target="_blank"&gt;Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312278&amp;amp;tabID=289" target="_blank"&gt;Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312334&amp;amp;tabID=289" target="_blank"&gt;Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312353&amp;amp;tabID=289" target="_blank"&gt;Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312308&amp;amp;tabID=289" target="_blank"&gt;Massage therapy as a supportive care intervention for children with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312316&amp;amp;tabID=289" target="_blank"&gt;Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312304&amp;amp;tabID=289" target="_blank"&gt;Multidimensional preventive home visit programs for community-dwelling older adults: a systematic review and meta-analysis of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312302&amp;amp;tabID=289" target="_blank"&gt;Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312335&amp;amp;tabID=289" target="_blank"&gt;Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312300&amp;amp;tabID=289" target="_blank"&gt;Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312403&amp;amp;tabID=289" target="_blank"&gt;A new GP with special interest headache service: observational study&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312409&amp;amp;tabID=289" target="_blank"&gt;A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy for advanced breast cancer in postmenopausal patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312396&amp;amp;tabID=289" target="_blank"&gt;Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312364&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312397&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312379&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312408&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312357&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312380&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=312377&amp;amp;tabID=289" target="_blank"&gt;Risk-stratified intensive follow up for treated colorectal cancer: realistic and cost saving?&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>324344</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=324344]]&gt;</url>
    <title>2009-August. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-August. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: (All Guidance Published 26 August 2009)&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:323757:1" name=internalLink&gt;Cetuximab for the first-line treatment of metastatic colorectal cancer. NICE Technology Appraisal Guidance 176&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323783:0" name=internalLink&gt;Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE Technology Appraisal Guidance 178&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:323145:1" name=internalLink&gt;Chemotherapy Services in England: ensuring quality and safety. Published 21 August 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;American College of Cardiology&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:323010:1" name=internalLink&gt;2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. Published 14 April 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Australian and New Zealand College of Anaesthetists &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322712:1" name=internalLink&gt;Guidelines on acute pain management. Published February 2007&lt;/A&gt;&lt;A href="nelh:322712:1" name=internalLink&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;/A&gt;&lt;EM&gt;British Heart Foundation&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322658:1" name=internalLink&gt;Implantable cardioverter defibrillators in patients who are reaching the end of life. Published July 2007&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;National Council for Palliative Care&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322584:1" name=internalLink&gt;A guide to involving patients, carers and the public in palliative care and end of life care services. Published July 2009.&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322665:1" name=internalLink&gt;Planning for your future care – a guide. Published March 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;NHS End of Life Care&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322576:1" name=internalLink&gt;End of life care in advanced kidney disease: a framework for implementation. Published March 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Association of Dermatologists&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:30536:1" name=internalLink&gt;Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Updated 12 August 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;CLINICAL KNOWLEDGE SUMMARIES (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:321750:1" name=internalLink&gt;&lt;A href="nelh:321750:1" name=internalLink&gt;Bone cancer and sarcoma - suspected&lt;/A&gt;&lt;A href="nelh:321750:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321751:1" name=internalLink&gt;Bone cancer and sarcoma - suspected: Bone cancer and sarcoma - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321748:1" name=internalLink&gt;Brain tumour - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321749:1" name=internalLink&gt;Brain tumour - suspected: Brain tumour - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321728:1" name=internalLink&gt;&lt;A href="nelh:321728:0" name=internalLink&gt;Breast cancer - suspected&lt;/A&gt;&lt;A href="nelh:321728:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321729:1" name=internalLink&gt;Breast cancer - suspected: Breast cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321746:1" name=internalLink&gt;&lt;A href="nelh:321746:1" name=internalLink&gt;Children's tumours - suspected&lt;/A&gt;&lt;A href="nelh:321746:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321747:1" name=internalLink&gt;Children's tumours - suspected: Children's tumours - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321767:1" name=internalLink&gt;Chronic kidney disease - not diabetic&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321769:1" name=internalLink&gt;Chronic kidney disease - not diabetic: Management of stage 1 and 2 chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321770:1" name=internalLink&gt;Chronic kidney disease - not diabetic: Management of stage 3 chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321771:1" name=internalLink&gt;Chronic kidney disease - not diabetic: Management of stage 4 and 5 chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321768:1" name=internalLink&gt;Chronic kidney disease - not diabetic: Testing for chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321744:1" name=internalLink&gt;GI (lower) cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321745:1" name=internalLink&gt;GI (lower) cancer - suspected: GI (lower) cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321742:1" name=internalLink&gt;GI (upper) cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321743:1" name=internalLink&gt;GI (upper) cancer - suspected: GI (upper) cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321740:1" name=internalLink&gt;Gynaecological cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321741:1" name=internalLink&gt;Gynaecological cancer - suspected: Gynaecological cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321738:1" name=internalLink&gt;Haematological malignancy - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321739:1" name=internalLink&gt;Haematological malignancy - suspected: Haematological malignancy - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321736:1" name=internalLink&gt;Head/neck cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321737:1" name=internalLink&gt;Head/neck cancer - suspected: Head/neck cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321754:1" name=internalLink&gt;Insomnia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321755:0" name=internalLink&gt;Insomnia: Insomnia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321734:1" name=internalLink&gt;Lung cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321735:1" name=internalLink&gt;Lung cancer - suspected: Lung cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321758:1" name=internalLink&gt;&lt;A href="nelh:321758:0" name=internalLink&gt;Palliative cancer care - malignant ulcer of the skin&lt;/A&gt;&lt;A href="nelh:321758:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321759:1" name=internalLink&gt;&lt;A href="nelh:321759:0" name=internalLink&gt;Palliative cancer care - malignant ulcer: Palliative cancer care - malignant ulcer of the skin&lt;/A&gt;&lt;A href="nelh:321759:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321732:1" name=internalLink&gt;Skin cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321733:1" name=internalLink&gt;Skin cancer - suspected: Skin cancer - suspected&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321730:1" name=internalLink&gt;&lt;A href="nelh:321730:0" name=internalLink&gt;Urological cancer - suspected&lt;/A&gt;&lt;A href="nelh:321730:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321731:1" name=internalLink&gt;Urological cancer - suspected: Urological cancer - suspected&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322379:1" name=internalLink&gt;A review of functional outcomes related to prosthetic treatment after maxillary and mandibular reconstruction in patients with head and neck cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322313:1" name=internalLink&gt;A systematic review of nonpharmacologic adjunctive therapies for symptom management in children with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322424:1" name=internalLink&gt;A systematic review of the effects of acupuncture in treating insomnia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322377:1" name=internalLink&gt;Acute migraine therapy: recent evidence from randomized comparative trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322432:1" name=internalLink&gt;Are migraineurs at increased risk of adverse drug responses: a meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322418:1" name=internalLink&gt;Biphosphonates for the therapy of complex regional pain syndrome I: systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322335:1" name=internalLink&gt;CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322259:1" name=internalLink&gt;Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322403:1" name=internalLink&gt;Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department: a meta-analysis and systematic review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322400:1" name=internalLink&gt;Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322381:1" name=internalLink&gt;Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322354:1" name=internalLink&gt;Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322317:1" name=internalLink&gt;Evidence-based practice recommendations for dementia: educating caregivers on Alzheimer's disease and training communication strategies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322317:1" name=internalLink&gt;External qigong for pain conditions: a systematic review of randomized clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322317:1" name=internalLink&gt;Herbal medicines for the treatment of COPD: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322353:1" name=internalLink&gt;Home-based exercise increases exercise capacity but not quality of life in people with chronic heart failure: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322407:1" name=internalLink&gt;Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322430:1" name=internalLink&gt;Metastatic renal cell cancer treatments: an indirect comparison meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322429:1" name=internalLink&gt;Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322263:1" name=internalLink&gt;Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322320:1" name=internalLink&gt;Role of acupuncture in the treatment of insomnia: a comprehensive review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322333:1" name=internalLink&gt;The anxiety- and pain-reducing effects of music interventions: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322297:1" name=internalLink&gt;The effect of music therapy on patients' perception and manifestation of pain, anxiety, and patient satisfaction&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322479:1" name=internalLink&gt;An economic evaluation of cetuximab combined with radiotherapy for patients with locally advanced head and neck cancer in Belgium, France, Italy, Switzerland, and the United Kingdom&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322469:1" name=internalLink&gt;Cost-effectiveness analyses of natalizumab (Tysabri) compared with other disease-modifying therapies for people with highly active relapsing-remitting multiple sclerosis in the UK&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322475:1" name=internalLink&gt;Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322478:1" name=internalLink&gt;Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322482:1" name=internalLink&gt;Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>333826</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=333826]]&gt;</url>
    <title>2009-December. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-December. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: Interventional Procedure Guidance (Published 16th December 2009) &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:333295:1" name=internalLink&gt;Radiofrequency ablation for colorectal liver metastases. IPG 327&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;CLINICAL KNOWLEDGE SUMMARIES (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:331729:1" name=internalLink&gt;Breast cancer - managing family history&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331730:1" name=internalLink&gt;Breast cancer - managing FH: Breast cancer - managing family history&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:331839:1" name=internalLink&gt;Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331840:1" name=internalLink&gt;Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331866:1" name=internalLink&gt;Behavioral treatments of chronic tension-type headache in adults: are they beneficial?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331847:1" name=internalLink&gt;Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331743:1" name=internalLink&gt;Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331783:1" name=internalLink&gt;Dysphagia treatment post stroke: a systematic review of randomised controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331750:1" name=internalLink&gt;Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331809:1" name=internalLink&gt;Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331741:1" name=internalLink&gt;Improving participant comprehension in the informed consent process&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331744:1" name=internalLink&gt;Music for pain and anxiety in children undergoing medical procedures: a systematic review of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331796:1" name=internalLink&gt;Nebulized furosemide for the management of dyspnea: does the evidence support its use?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331752:1" name=internalLink&gt;Systematic review of peer-support programs for people with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331882:1" name=internalLink&gt;The effectiveness of hypnosis for reducing procedure-related pain in children and adolescents: a comprehensive methodological review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331832:1" name=internalLink&gt;Traditional Chinese medicinal herbs in the treatment of patients with esophageal cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:331843:1" name=internalLink&gt;Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;HEALTH TECHNOLOGY ASSESSMENTS (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:331981:1" name=internalLink&gt;Microsurgical treatment of postmastectomy lymphedema&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:332001:1" name=internalLink&gt;Percutaneous cryoablation for treatment of renal cell cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:332023:1" name=internalLink&gt;Radiofrequency ablation (RFA) of malignant pulmonary tumors in nonsurgical candidates&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:332021:1" name=internalLink&gt;Radiofrequency ablation for renal tumors&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:332043:1" name=internalLink&gt;Spinal manipulation under anesthesia for the treatment of pain&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>307439</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=307439]]&gt;</url>
    <title>2009-Feb. New records added to the Supportive and Palliative Care Library</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-Feb. New records added to the Supportive and Palliative Care Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Clinical Guidelines: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307063&amp;amp;tabID=288" target="_blank"&gt;Early and locally advanced breast cancer: diagnosis and treatment. NICE Clinical Guideline 80. Published 25 February 2009&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=30021&amp;amp;tabID=288" target="_blank"&gt;Advanced breast cancer: diagnosis and treatment. NICE Clinical Guideline 81. Published 25 February 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="https://rmsadmin.library.nhs.uk/admin/wizards/articles/•http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=306183&amp;amp;tabID=288" target="_blank"&gt;Living well with dementia: A National Dementia Strategy. Published 03 February 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Medical Education Partnership:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=306086&amp;amp;tabID=288" target="_blank"&gt;Best practice for the management of lymphoedema: International consensus. Published 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Association of Paediatric Anaesthetists of GB &amp;amp; Ireland:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=306746&amp;amp;tabID=288" target="_blank"&gt;Guidelines on the prevention of post-operative vomiting in children. Published Spring 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Intensive Care Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=306859&amp;amp;tabID=288" target="_blank"&gt;Statement on the use of unlicensed medicines or licensed medicines for unlicensed uses in critically ill patients. Published January 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;United Kingdom Clinical Pharmacy Association:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=306897&amp;amp;tabID=288" target="_blank"&gt;Detection, prevention and treatment of delirium in critically ill patients. Published June 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Royal College of Physicians:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=306973&amp;amp;tabID=288" target="_blank"&gt;Advance care planning. Published February 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;COCHRANE&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304979&amp;amp;tabID=289" target="_blank"&gt;Acupuncture for tension-type headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304884&amp;amp;tabID=289" target="_blank"&gt;Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304898&amp;amp;tabID=289" target="_blank"&gt;Advance treatment directives for people with severe mental illness&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304881&amp;amp;tabID=289" target="_blank"&gt;Anticholinergics for urinary symptoms in multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304942&amp;amp;tabID=289" target="_blank"&gt;Donepezil for dementia in people with Down syndrome&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304919&amp;amp;tabID=289" target="_blank"&gt;Driving assessment for maintaining mobility and safety in drivers with dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="https://rmsadmin.library.nhs.uk/admin/wizards/articles/Early%20discharge%20hospital%20at%20home" target="_blank"&gt;Early discharge hospital at home&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304945&amp;amp;tabID=289" target="_blank"&gt;Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304950&amp;amp;tabID=289" target="_blank"&gt;First line chemotherapy in low risk gestational trophoblastic neoplasia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304972&amp;amp;tabID=289" target="_blank"&gt;Galantamine for dementia in people with Down syndrome&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304928&amp;amp;tabID=289" target="_blank"&gt;Interferon Beta for Primary Progressive Multiple Sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304973&amp;amp;tabID=289" target="_blank"&gt;Memantine for dementia in people with Down syndrome&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304953&amp;amp;tabID=289" target="_blank"&gt;Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304871&amp;amp;tabID=289" target="_blank"&gt;Post-operative radiotherapy for ductal carcinoma in situ of the breast&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304951&amp;amp;tabID=289" target="_blank"&gt;Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304958&amp;amp;tabID=289" target="_blank"&gt;Psychosocial interventions for reducing fatigue during cancer treatment in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304888&amp;amp;tabID=289" target="_blank"&gt;Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304878&amp;amp;tabID=289" target="_blank"&gt;Rehabilitation for older people in long-term care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238918&amp;amp;tabID=289" target="_blank"&gt;Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304915&amp;amp;tabID=289" target="_blank"&gt;Treatment for familial amyotrophic lateral sclerosis/motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304915&amp;amp;tabID=289" target="_blank"&gt;Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=279169&amp;amp;tabID=289" target="_blank"&gt;Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;CLINICAL KNOWLEDGE SUMMARIES (CKS)&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=306406&amp;amp;tabID=288" target="_blank"&gt;Tamoxifen - managing adverse effects&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=306407&amp;amp;tabID=288" target="_blank"&gt;Tamoxifen - managing adverse effects: Tamoxifen - managing adverse effects&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=306402&amp;amp;tabID=288" target="_blank"&gt;Tuberculosis (including people with HIV) assessment &amp;amp; referral&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=306403&amp;amp;tabID=288" target="_blank"&gt;Tuberculosis: Tuberculosis (including people with HIV) assessment &amp;amp; referral&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>321667</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=321667]]&gt;</url>
    <title>2009-July. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-July. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt;&lt;/SPAN&gt; &lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;EM&gt;NICE:&lt;/EM&gt; (All Guidance Published 22 July 2009)&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:320976:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Rituximab for the first-line treatment of chronic lymphocytic leukaemia. NICE Technical Appraisal Guidance 174.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:321011:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Gefitinib for the second-line treatment of locally advanced or metastatic non-small-cell lung cancer (terminated appraisal). NICE Technical Appraisal 175.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:273445:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Delivering better oral health: an evidence-based toolkit for prevention - second edition. Published 13 Jul 2009.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:321190:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Living well with dementia: a National Dementia Strategy implementation plan. Published 22 July 2009.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;EM&gt;American College of Gastroenterology:&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:320711:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Published October 2007.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;EM&gt;Eastern Association for the Surgery of Trauma:&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:321184:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Practice management guidelines for small bowel obstruction. Published June 2008.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;EM&gt;European Respiratory Society:&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:320403:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Published July 2009.&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/SPAN&gt; 
&lt;H3&gt;&lt;/H3&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319439:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Acupuncture for tension-type headache: a meta-analysis of randomized controlled trials&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319422:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319430:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Exercise in migraine therapy. Is there any evidence for efficacy: a critical review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319395:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Music therapy in the treatment of multiple sclerosis: a comprehensive literature review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319488:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: a systematic review with meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319457:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319483:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Self-help therapy for insomnia: a meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319500:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319470:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319486:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319407:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;o:p&gt;&lt;/o:p&gt;&lt;/STRONG&gt;&lt;/SPAN&gt; 
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319534:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Cost effectiveness of chest pain unit care in the NHS&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319523:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319504:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319530:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319535:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Post-acute care for older people in community hospitals: a cost-effectiveness analysis within a multi-centre randomised controlled trial&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319512:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;A href="nelh:319526:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>318834</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=318834]]&gt;</url>
    <title>2009-Jun. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-Jun. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;EM&gt;NICE:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:318267:0" name=internalLink&gt;Lenalomide for the treatment of multiple myeloma in people who have received at least one prior therapy. NICE Technology Appraisal 171&lt;/A&gt;&lt;A href="nelh:318267:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:318239:0" name=internalLink&gt;Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck. NICE Technology Appraisal 172&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:317635:0" name=internalLink&gt;Living well with dementia: the National Dementia Strategy Joint commissioning framework for dementia. Published 15 June 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&amp;nbsp;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Others:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British Association for Sexual Health and HIV:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:317724:0" name=internalLink&gt;&lt;A href="nelh:317724:0" name=internalLink&gt;2007 UK guidelines for the management of sexual &lt;/A&gt;&lt;A href="nelh:317724:0" name=internalLink&gt;and reproductive health (SRH) of people living with HIV infection. Published May 2007&lt;/A&gt;&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&amp;nbsp;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British Psychological Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:317300:0" name=internalLink&gt;Psychological services for people with Parkinson’s disease. Published February 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;Multiple Sclerosis Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:52010:0" name=internalLink&gt;Translating the NICE and NSF guidance into practice: a guide for physiotherapists. Published May 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;Royal College of Physicians&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:317414:0" name=internalLink&gt;The prevention, diagnosis and management of delirium in older people. Published June 2006&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:316771:0" name=internalLink&gt;Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients&lt;/A&gt;&lt;A href="nelh:316771:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:316766:0" name=internalLink&gt;Adverse effects of medical cannabinoids: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316823:0" name=internalLink&gt;Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316819:0" name=internalLink&gt;Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: meta-analysis&lt;/A&gt;&lt;A href="nelh:316819:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:316720:0" name=internalLink&gt;Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316752:0" name=internalLink&gt;Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316722:0" name=internalLink&gt;Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316753:0" name=internalLink&gt;Evidence-based psychosocial treatments for ethnic minority youth&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316729:0" name=internalLink&gt;Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316823:0" name=internalLink&gt;Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316756:0" name=internalLink&gt;Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316759:0" name=internalLink&gt;Interventions for alleviating cancer-related dyspnea: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316783:0" name=internalLink&gt;Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316764:0" name=internalLink&gt;Safety of long-acting beta-agonists in stable COPD: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316758:0" name=internalLink&gt;Self-care and quality of life outcomes in heart failure patients&lt;/A&gt;&lt;A href="nelh:316758:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:316784:0" name=internalLink&gt;Systematic review of multidisciplinary teams in the management of lung cancer&lt;/A&gt;&lt;A href="nelh:316758:0" name=internalLink&gt;&lt;/LI&gt;&lt;/A&gt;
&lt;LI&gt;&lt;A href="nelh:316768:0" name=internalLink&gt;Treatment of children with migraine in the emergency department: a qualitative systematic review&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:316861:0" name=internalLink&gt;Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC)&lt;/A&gt;&lt;A href="nelh:316861:0" name=internalLink&gt;&lt;/LI&gt;&lt;/A&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>310906</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=310906]]&gt;</url>
    <title>2009-Mar. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-Mar. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/H2&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;All Published 25th March 2009&lt;/P&gt;
&lt;P&gt;Technology Appraisal Guidance:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=310198&amp;amp;tabID=288" target="_blank"&gt;Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE Technology Appraisal Guidance 169&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Clinical Guidelines:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310226&amp;amp;tabID=288" target="_blank"&gt;Rehabilitation after critical illness. NICE Clinical Guideline 83&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Public Health Guidance:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310240&amp;amp;tabID=288" target="_blank"&gt;Managing long-term sickness absence and incapacity for work. NICE Public Health Guidance 19&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Interventional Procedures Guidance:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310315&amp;amp;tabID=288" target="_blank"&gt;Photodynamic therapy for brain tumours. NICE Interventional Procedure Guidance 290&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dept of Health:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310639&amp;amp;tabID=288" target="_blank"&gt;National Service Framework for older people. Published 24 May 2001&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307687&amp;amp;tabID=288" target="_blank"&gt;The Medicines (Pharmacies)(Responsible Pharmacist) Regulations 2008: Guidance. Published 27 February 2009&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=309109&amp;amp;tabID=288" target="_blank"&gt;Impact assessment for implementing personalised care planning for people with long-term conditions (including guidance to NHS and social care). Published 02 March 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Society of Obstetricians &amp;amp; Gynaecologists of Canada:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308607&amp;amp;tabID=288" target="_blank"&gt;Guideline for the management of postoperative nausea and vomiting. Published July 2008&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;British Lymphology Society:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308683&amp;amp;tabID=288" target="_blank"&gt;Consensus document on the management of cellulitis in lymphoedema. Published February 2007&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;British Thoracic Society:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308870&amp;amp;tabID=288" target="_blank"&gt;BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease. Published March 2008&lt;BR&gt;&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308012&amp;amp;tabID=289" target="_blank"&gt;A systematic review of honey uses and its potential value within oncology care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307969&amp;amp;tabID=289" target="_blank"&gt;Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307973&amp;amp;tabID=289" target="_blank"&gt;The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307998&amp;amp;tabID=289" target="_blank"&gt;The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;HEALTH TECHNOLOGY ASSESSMENTS (HTA)&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308146&amp;amp;tabID=290" target="_blank"&gt;Assessment of a model for cross-sectorial collaboration in pain assessment among individuals with chronic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308346&amp;amp;tabID=290" target="_blank"&gt;Capecitabine (Xeloda) for colorectal cancer - metastatic, first and second line (in combination with oxiplatin with or without bevacizumab): horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308300&amp;amp;tabID=290" target="_blank"&gt;Cetuximab for metastatic first line colorectal cancer (project)&lt;BR&gt;Chemoprevention of colorectal cancer: systematic review and economic model (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308274&amp;amp;tabID=290" target="_blank"&gt;Chronic fatigue syndrome: diagnosis, treatment and management of CFS patients (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308368&amp;amp;tabID=290" target="_blank"&gt;Clofarabine (Evoltra) for acute myeloid leukaemia - older adults with additional risk factors: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308387&amp;amp;tabID=290" target="_blank"&gt;Cryotherapy for recurrent prostate and renal cancer (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308293&amp;amp;tabID=290" target="_blank"&gt;Cryotherapy for Recurrent Prostate Cancer and Renal Cancer (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308407&amp;amp;tabID=290" target="_blank"&gt;Development of indicators and standards, based on clinical practice guidelines, to improve process and outcomes in oncological care (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308205&amp;amp;tabID=290" target="_blank"&gt;Home care nursing&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308411&amp;amp;tabID=289" target="_blank"&gt;Home telehealth for chronic disease management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308202&amp;amp;tabID=290" target="_blank"&gt;Home visiting&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308351&amp;amp;tabID=290" target="_blank"&gt;INGN201 contusugene Iadenovec, Advexin for head and neck cancer - recurrent unresectable: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308122&amp;amp;tabID=290" target="_blank"&gt;Intraoperative radiotherapy in pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308370&amp;amp;tabID=290" target="_blank"&gt;Medically unexplained symptoms - systematic review (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308383&amp;amp;tabID=290" target="_blank"&gt;Myalgic encephalomyelitis / Chronic fatigue syndrome -&amp;nbsp; non-systematic review (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308252&amp;amp;tabID=290" target="_blank"&gt;Patient-Reported Outcomes (PRO) as parameters for the benefit by the example of a chronic disease?s therapy (asthma) (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308329&amp;amp;tabID=290" target="_blank"&gt;Pemetrexed (Alimta) for non small cell lung cancer - first line, locally advanced or metastatic: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308099&amp;amp;tabID=290" target="_blank"&gt;Pemetrexed for the treatment of malignant pleural mesothelioma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308354&amp;amp;tabID=290" target="_blank"&gt;Plerixafor (Mozobil) for multiple myeloma - stem cell mobilisation: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308355&amp;amp;tabID=290" target="_blank"&gt;Plerixafor (Mozobil) for non Hodgkins lymphoma - stem cell mobilisation: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308402&amp;amp;tabID=290" target="_blank"&gt;Pulmonary rehabilitation for COPD (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308304&amp;amp;tabID=290" target="_blank"&gt;Reminiscence groups for people with dementia and their family care-givers: pragmatic 8-centre trial of joint reminiscence and maintenance versus usual treatment (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308335&amp;amp;tabID=290" target="_blank"&gt;Rituximab (MabThera) for chronic lymphocytic leukaemia - first line and relapsed: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308357&amp;amp;tabID=290" target="_blank"&gt;Rituximab (Mabthera) for non Hodgkins lymphoma - first line maintenance therapy: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=308101&amp;amp;tabID=290" target="_blank"&gt;Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308133&amp;amp;tabID=290" target="_blank"&gt;Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308348&amp;amp;tabID=290" target="_blank"&gt;Sorafenib (BAY 43-9006) for non small cell lung cancer - advanced: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308345&amp;amp;tabID=290" target="_blank"&gt;Sunitinib (Sutent) for breast cancer - advanced and/or metastatic, first or second line: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308366&amp;amp;tabID=290" target="_blank"&gt;Tarenflurbil (Flurizan, R-Flurbiprofen) for Alzheimer's disease - mild: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308231&amp;amp;tabID=290" target="_blank"&gt;Telerehabilitation in neurological disability. Analysis of the current status of telemedicine services to evaluate the viability of a telerehabilitation programme in patients with a major acquired neurological disability (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308369&amp;amp;tabID=290" target="_blank"&gt;Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308309&amp;amp;tabID=290" target="_blank"&gt;The measurement of patients' expectations for health care (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308359&amp;amp;tabID=290" target="_blank"&gt;Trabectedin (Yondelis) for ovarian cancer - relapsed, second line: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308330&amp;amp;tabID=290" target="_blank"&gt;Trastuzumab (Herceptin) for gastric cancer - metastatic HER2 positive, first line: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308360&amp;amp;tabID=290" target="_blank"&gt;Vandetanib ( Zactima, - 6474, AZD-6474, ZD6474) for medullary thyroid cancer - locally advanced or metastatic: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308350&amp;amp;tabID=290" target="_blank"&gt;Vandetanib ( Zactima, - 6474, AZD-6474, ZD6474) for non small cell lung cancer - advanced or metastatic , second line therapy: horizon scanning technology briefing (project)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308033&amp;amp;tabID=289" target="_blank"&gt;Outcomes and costs of community living: semi-independent living and fully staffed group homes&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=308026&amp;amp;tabID=289" target="_blank"&gt;Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303988&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness analysis of enfuvirtide (ENF) added to an optimized therapy compared with an optimized therapy in patients with HIV/AIDS&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303980&amp;amp;tabID=289" target="_blank"&gt;Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303977&amp;amp;tabID=289" target="_blank"&gt;Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: a Slovenian perspective&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=300293&amp;amp;tabID=289" target="_blank"&gt;Cost-effectiveness of acupuncture treatment in patients with headache&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316207</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=316207]]&gt;</url>
    <title>2009-May. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-May. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;NATIONAL LIBRARY OF GUIDELINES&lt;/H2&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:315686:0" name=internalLink&gt;Understanding what matters: a guide to using patient feedback to transform services. Published 21 May 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British National Formulary (BNF): March 2009:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:313810:0" name=internalLink&gt;Treatment of dry mouth&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Thoracic Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:313790:1" name=internalLink&gt;Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Published May 2009&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Resuscitation Council (UK):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:315695:1" name=internalLink&gt;&lt;A href="nelh:315695:1" name=internalLink&gt;Recommended standards for recording &lt;/A&gt;&lt;A href="nelh:315695:1" name=internalLink&gt;‘Do not attempt resuscitation’ (DNAR) decisions. Published May 2009&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;CLINICAL KNOWLEDGE SUMMARIES (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:272856:0" name=internalLink&gt;Palliative cancer care – cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272857:0" name=internalLink&gt;Palliative cancer care – cough: Assessment of cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272858:0" name=internalLink&gt;Palliative cancer care – cough: Known cause of cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272859:0" name=internalLink&gt;Palliative cancer care – cough: Symptomatic treatment of cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272777:0" name=internalLink&gt;Palliative cancer care – dyspnoea&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272778:0" name=internalLink&gt;Palliative cancer care – dyspnoea: Assessment of dyspnoea in palliative cancer care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272780:0" name=internalLink&gt;Palliative cancer care – dyspnoea: Management of dyspnoea of known cause in palliative cancer care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272779:0" name=internalLink&gt;Palliative cancer care – dyspnoea: Symptomatic treatment of dyspnoea in palliative cancer care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272846:0" name=internalLink&gt;Palliative cancer care – oral problems&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272848:0" name=internalLink&gt;Palliative cancer care – oral: Dry mouth&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272851:0" name=internalLink&gt;Palliative cancer care – oral: Halitosis, excessive salivation, and altered taste&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272850:0" name=internalLink&gt;Palliative cancer care – oral: Mouth ulcers&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272849:0" name=internalLink&gt;Palliative cancer care – oral: Oral Candida infection&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272847:0" name=internalLink&gt;Palliative cancer care – oral: Self care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314176:0" name=internalLink&gt;Palliative cancer care -&amp;nbsp; Palliative cancer care - pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314177:0" name=internalLink&gt;Palliative cancer care - pain: Acute severe pain&lt;/A&gt;&lt;A href="nelh:314177:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314178:0" name=internalLink&gt;Palliative cancer care - pain: Assessment of pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314183:0" name=internalLink&gt;Palliative cancer care - pain: Managing bone pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314182:0" name=internalLink&gt;Palliative cancer care - pain: Managing colic&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314181:0" name=internalLink&gt;Palliative cancer care - pain: Managing intracranial pressure pain&lt;/A&gt;&lt;A href="nelh:314181:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314184:0" name=internalLink&gt;Palliative cancer care - pain: Managing muscle spasm pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314180:0" name=internalLink&gt;Palliative cancer care - pain: Managing neuropathic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314179:0" name=internalLink&gt;Palliative cancer care - pain: Managing pain - non-emergency&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314185:0" name=internalLink&gt;Palliative cancer care - pain: Spinal cord compression&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272839:0" name=internalLink&gt;Palliative cancer care – respiratory secretions at the end of life&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272840:0" name=internalLink&gt;Palliative cancer care – secretions: Noisy respiratory secretions at the end of life&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:272841:0" name=internalLink&gt;Palliative cancer care – secretions: Terminal phase – overview of management &lt;/A&gt;&lt;A href="nelh:272841:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:272431:0" name=internalLink&gt;Palliative care – malignant ulcer of the skin&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:314269:0" name=internalLink&gt;A meta-analysis and systematic review of thalidomide for patients with previously untreated multiple myeloma&lt;/A&gt;&lt;A href="nelh:314269:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314216:0" name=internalLink&gt;Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314274:0" name=internalLink&gt;Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis&lt;/A&gt;&lt;A href="nelh:314274:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314249:0" name=internalLink&gt;&lt;A href="nelh:314274:0" name=internalLink&gt;Gemcitabine in the management of metastatic breast cancer: a systematic review&lt;/A&gt;&lt;A href="nelh:314274:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:292925:0" name=internalLink&gt;Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:244020:0" name=internalLink&gt;Meta-analysis of inoperable pancreatic cancer: gemcitabine combined with cisplatin versus gemcitabine alone&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:300153:0" name=internalLink&gt;Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:243892:0" name=internalLink&gt;Use of gemcitabine in non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:259054:0" name=internalLink&gt;Use of gemcitabine in the treatment of advanced pancreatic adenocarcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314254:0" name=internalLink&gt;Hydroxyurea treatment of sickle cell disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314205:0" name=internalLink&gt;Information giving and decision-making in patients with advanced cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314284:0" name=internalLink&gt;Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis&lt;/A&gt;&lt;A href="nelh:314284:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314230:0" name=internalLink&gt;Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314282:0" name=internalLink&gt;Patients' knowledge of patient controlled analgesia (PCA) and their experience of postoperative pain relief: a review of the impact of structured preoperative education&lt;/A&gt;&lt;A href="nelh:314282:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314211:0" name=internalLink&gt;Psychological treatment of recurrent headache in children and adolescents: a meta-analysis&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:314240:0" name=internalLink&gt;Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314251:0" name=internalLink&gt;Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314215:0" name=internalLink&gt;The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS ECONOMIC EVALUATION DATABASE (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:314329:0" name=internalLink&gt;Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314303:0" name=internalLink&gt;Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for stage III ovarian cancer: a cost-effectiveness analysis&lt;/A&gt;&lt;A href="nelh:314303:0" name=internalLink&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314332:0" name=internalLink&gt;Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>331459</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=331459]]&gt;</url>
    <title>2009-November. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-November. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: all guidance published 25 November 2009&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:331109:1" name=internalLink&gt;Topotecan for the treatment of relapsed small-cell lung cancer. NICE Technology Appraisal Guidance 184. Published 25 November 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;British National Formulary for Children – all published 10 July 2009:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:328797:0" name=internalLink&gt;Acute diarrhoea&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:156448:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328801:0" name=internalLink&gt;Laxatives&lt;/A&gt;&lt;A href="nelh:313417:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:313417:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:313417:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:313417:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:313417:1" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328811:1" name=internalLink&gt;Stoma and enteral feeding tubes&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Clinical Knowledge Summaries (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:328941:0" name=internalLink&gt;Tiredness/fatigue in adults: Tiredness/fatigue in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328940:0" name=internalLink&gt;Tiredness/fatigue in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:329515:1" name=internalLink&gt;Aromatherapy for pain relief and psychological problems. Systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329370:1" name=internalLink&gt;Avastin (bevacizumab) (Genentech Inc.) for metastatic breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329369:1" name=internalLink&gt;Avastin (bevacizumab) for the treatment of ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329516:1" name=internalLink&gt;Bach flower remedies for pain relief and psychological problems. Systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329235:1" name=internalLink&gt;Bevacizumab for the treatment of patients with advanced colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329373:1" name=internalLink&gt;Bexxar (tositumomab and iodine-131 tositumomab) (GlaxoSmithKline) for treatment of refractory or relapsed non-Hodgkin's lymphoma (NHL)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329381:1" name=internalLink&gt;Calypso 4D localization system (Calypso Medical Technologies Inc.) for guidance of prostate cancer radiation therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329382:1" name=internalLink&gt;Cancer antigen 15-3 (CA 15-3) for breast cancer prognosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329383:1" name=internalLink&gt;Cancer antigen 27.29 (CA 27.29) for diagnosis, staging, and treatment monitoring of breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329386:1" name=internalLink&gt;CellSearch circulating tumor cell kit (Veridex LLC) for monitoring breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329236:1" name=internalLink&gt;Cetuximab for the management of advanced colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329387:1" name=internalLink&gt;ChemoFX assay (Precision Therapeutics Inc.) for prediction of response to chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329529:1" name=internalLink&gt;Colon hydrotherapy for defecation disorders. Systematic Review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329413:1" name=internalLink&gt;Deep brain stimulation for treatment of movement disorders of multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329324:1" name=internalLink&gt;Drug therapies in Alzheimer's disease patients: state of knowledge&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329267:1" name=internalLink&gt;Effectiveness of dasatinib in chronic myeloid leukemia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329233:1" name=internalLink&gt;Effectiveness of lenalidomide in multiple myeloma patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329326:1" name=internalLink&gt;Efficacy and safety of respiratory rehabilitation in natural water spas for patients with chronic respiratory diseases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329422:1" name=internalLink&gt;Electrical stimulation of the occipital nerve for the treatment of occipital neuralgia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329215:1" name=internalLink&gt;Guidelines for surgical pain management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329440:1" name=internalLink&gt;Helical tomotherapy (TomoTherapy Hi-Art System) for non-small cell lung cancer (NSCLC)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329132:1" name=internalLink&gt;HER2 testing to manage patients with breast or other solid tumors&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329441:1" name=internalLink&gt;Histamine desensitization therapy for prophylaxis against intractable migraine or chronic cluster headaches&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329344:1" name=internalLink&gt;IHE Ambassador Program, Headache Guidelines (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329525:1" name=internalLink&gt;Image guided radiotherapy using cone-beam computed tomography. Systematic Review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329169:1" name=internalLink&gt;Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329257:0" name=internalLink&gt;Intensity modulated radiotherapy (IMRT) for prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329454:1" name=internalLink&gt;Intradialytic parenteral nutrition (IDPN) for end-stage renal disease in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329522:1" name=internalLink&gt;Intraoperative radiotherapy for primary breast cancer. Systematic Review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329534:1" name=internalLink&gt;Intraoperative radiotherapy in breast and colorectal cancer (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329234:0" name=internalLink&gt;Lapatinib in breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329264:1" name=internalLink&gt;Motor cortex stimulation in the treatment of central and neuropathic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329210:1" name=internalLink&gt;Non-drug therapies in Alzheimer's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329463:1" name=internalLink&gt;Optimal management of lymphedema secondary to breast cancer treatment (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329230:1" name=internalLink&gt;Prevention and management of delirium&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329229:1" name=internalLink&gt;Prevention of ventilator-associated pneumonia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329471:1" name=internalLink&gt;Renal replacement therapy in advanced chronic kidney disease. Review of the starting criteria in dialysis programs&amp;nbsp;and assessment of the efficacy and effectiveness of an early start&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329466:1" name=internalLink&gt;Sentinel lymph node biopsy in breast cancer management (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329174:0" name=internalLink&gt;Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329317:1" name=internalLink&gt;Sunitinib for the management of renal cell carcinoma&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329333:1" name=internalLink&gt;Sunitinib in metastatic renal-cell cancer: efficacy and safety&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329205:1" name=internalLink&gt;Systematic guideline search and appraisal for the DMP "Asthma/COPD"&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329206:1" name=internalLink&gt;Systematic guideline search and appraisal for the DMP "Breast cancer"&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329177:1" name=internalLink&gt;Systematic review of respite care in the frail elderly&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329239:1" name=internalLink&gt;T-cell vaccines for the treatment of multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329137:1" name=internalLink&gt;Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329467:1" name=internalLink&gt;Towards accreditation of teams fighting cancer. Lessons learned from the international literature (project)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329242:1" name=internalLink&gt;Usefulness of high-intensity focused ultrasound in prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329238:1" name=internalLink&gt;Usefulness of multislice computed tomography for the assessment of liver metastases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329249:1" name=internalLink&gt;Usefulness of real-time PCR for the monitoring of chronic myeloid leukemia patient&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329250:1" name=internalLink&gt;Usefulness of real-time PCR in acute promyelocytic leukemia patient monitoring&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:329081:1" name=internalLink&gt;A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328953:1" name=internalLink&gt;A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329049:1" name=internalLink&gt;A systematic review of the role of immunonutrition in patients undergoing surgery for head and neck cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:308902:0" name=internalLink&gt;Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: guideline recommendations&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328987:1" name=internalLink&gt;Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329050:1" name=internalLink&gt;An evidence-based medicine review of lymphadenectomy extent for gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328951:1" name=internalLink&gt;Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329084:1" name=internalLink&gt;How effective are patient-based educational interventions in the management of cancer pain: systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329057:1" name=internalLink&gt;Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329032:1" name=internalLink&gt;Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329048:1" name=internalLink&gt;Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328968:1" name=internalLink&gt;Staging investigations for oesophageal cancer: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328985:1" name=internalLink&gt;The use of aromatherapy to treat behavioural problems in dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329079:1" name=internalLink&gt;UK self-care support initiatives for older patients with long-term conditions: a review&lt;BR&gt;&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;A href="nelh:329250:1" name=internalLink&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;UK DUETs (Database of Uncertainties of the Effects of Treatments)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:303273:1" name=internalLink&gt;Chinese medicinal herbs for alleviating chemotherapy-induced short term side effects in breast cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328651:1" name=internalLink&gt;Covered versus uncovered metal palliative biliary stents for obstructing pancreatic carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327245:0" name=internalLink&gt;Cryotherapy for hepatocellular carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:303276:1" name=internalLink&gt;Decision aids and the effect on choice for surgery and knowledge of treatment options for breast cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:302436:1" name=internalLink&gt;Management of lymphoedema following surgery for breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328649:1" name=internalLink&gt;Metal versus plastic palliative biliary stents for obstructing pancreatic carcinoma in patients with a life expectancy of less than six months&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:283670:0" name=internalLink&gt;Palliative endobronchial brachytherapy for non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328653:1" name=internalLink&gt;Perflouro alkoxy plastic versus metal palliative biliary stents for obstructing pancreatic carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:313129:1" name=internalLink&gt;Polymer-based oral rehydration solution versus ORS &amp;amp;#8804; 270 for acute watery diarrhoea&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:302437:1" name=internalLink&gt;Prevention of lymphoedema following surgery for breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327724:1" name=internalLink&gt;Selective internal radiation therapy in combination with chemotherapy as front-line therapy for liver metastases from colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327686:1" name=internalLink&gt;Self-expanding metal stent insertion versus non-stent therapy or combination non-stent and stent therapy for dysphagia in oesophageal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328652:1" name=internalLink&gt;Stainless-steel alloy versus nickel-titanium alloy endoscopic palliative biliary stents for obstructing pancreatic carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:303290:1" name=internalLink&gt;Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:303450:1" name=internalLink&gt;Treatment of constipation on the number of urinary incontinence episodes in frail elderly people&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316501:1" name=internalLink&gt;What clinical and patient characteristics determine the effectiveness and acceptability of treatment and management strategies for neurogenic bladder dysfunction in multiple sclerosis?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:316507:1" name=internalLink&gt;What therapy can reduce neurological pain triggered by urinary incontinence in multiple sclerosis?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:313130:1" name=internalLink&gt;Wheat-based oral rehydration solution for acute watery diarrhoea&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED)&lt;BR&gt;&lt;/P&gt;&lt;/STRONG&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:329095:1" name=internalLink&gt;A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329101:1" name=internalLink&gt;A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329116:1" name=internalLink&gt;Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329103:1" name=internalLink&gt;Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan: a Belgian analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329119:1" name=internalLink&gt;Economic analysis of esophageal stenting for management of malignant dysphagia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329096:1" name=internalLink&gt;Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329106:1" name=internalLink&gt;Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Recent items of evidence news from the collection's RSS feed&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;?xml:namespace prefix = v ns = "urn:schemas-microsoft-com:vml" /&gt;&lt;v:f eqn="if lineDrawn pixelLineWidth 0"&gt;&lt;v:f eqn="sum @0 1 0"&gt;&lt;v:f eqn="sum 0 0 @1"&gt;&lt;v:f eqn="prod @2 1 2"&gt;&lt;v:f eqn="prod @3 21600 pixelWidth"&gt;&lt;v:f eqn="prod @3 21600 pixelHeight"&gt;&lt;v:f eqn="sum @0 0 1"&gt;&lt;v:f eqn="prod @6 1 2"&gt;&lt;v:f eqn="prod @7 21600 pixelWidth"&gt;&lt;v:f eqn="sum @8 21600 0"&gt;&lt;v:f eqn="prod @7 21600 pixelHeight"&gt;&lt;v:f eqn="sum @10 21600 0"&gt;&lt;v:path gradientshapeok="t" u1:extrusionok="f" u1:connecttype="rect"&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri"&gt;&lt;/SPAN&gt;&lt;/v:path&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;v:f eqn="if lineDrawn pixelLineWidth 0"&gt;&lt;v:f eqn="sum @0 1 0"&gt;&lt;v:f eqn="sum 0 0 @1"&gt;&lt;v:f eqn="prod @2 1 2"&gt;&lt;v:f eqn="prod @3 21600 pixelWidth"&gt;&lt;v:f eqn="prod @3 21600 pixelHeight"&gt;&lt;v:f eqn="sum @0 0 1"&gt;&lt;v:f eqn="prod @6 1 2"&gt;&lt;v:f eqn="prod @7 21600 pixelWidth"&gt;&lt;v:f eqn="sum @8 21600 0"&gt;&lt;v:f eqn="prod @7 21600 pixelHeight"&gt;&lt;v:f eqn="sum @10 21600 0"&gt;&lt;v:path gradientshapeok="t" u1:extrusionok="f" u1:connecttype="rect"&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-ascii-font-family: Calibri; mso-hansi-font-family: Calibri"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8367301.stm" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Morphine 'might spread cancer'&lt;/FONT&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;25 November 2009, 15:15:21 | BBC&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;v:f eqn="if lineDrawn pixelLineWidth 0"&gt;&lt;v:f eqn="sum @0 1 0"&gt;&lt;v:f eqn="sum 0 0 @1"&gt;&lt;v:f eqn="prod @2 1 2"&gt;&lt;v:f eqn="prod @3 21600 pixelWidth"&gt;&lt;v:f eqn="prod @3 21600 pixelHeight"&gt;&lt;v:f eqn="sum @0 0 1"&gt;&lt;v:f eqn="prod @6 1 2"&gt;&lt;v:f eqn="prod @7 21600 pixelWidth"&gt;&lt;v:f eqn="sum @8 21600 0"&gt;&lt;v:f eqn="prod @7 21600 pixelHeight"&gt;&lt;v:f eqn="sum @10 21600 0"&gt;&lt;/SPAN&gt;&lt;v:path gradientshapeok="t" u1:extrusionok="f" u1:connecttype="rect"&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"Laboratory tests suggest morphine could in fact encourage the spread of cancer, for which it is routinely prescribed to relieve pain from surgery and tumours. US scientists say the opiate promotes the growth of new blood vessels which deliver tumours oxygen and nutrients."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;?xml:namespace prefix = u1 /&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330785" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Annual Evidence Update - Supportive and pallaitive care in chronic lung disease&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;23 November 2009, 13:31:24 | Richard Stevens, NHS Evidence&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"The Annual Evidence Update on supportive and palliative care in chronic lung disease collects together the best new knowledge covering two key symptoms which affect most patients - cough and dyspnoea (breathlessness). Our review of the literature encompasses recent advances in our understanding of the mechanisms of these symptoms as well as their management using drugs, physical, nursing and other non-pharmacological methods."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://www.guardian.co.uk/lifeandstyle/2009/oct/21/women-denied-cancer-drug" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Women denied cancer drug that could extend life&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;20 November 2009, 11:34:54 | Sarah Boseley, Guardian&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"A drug which can give women with advanced breast cancer extra weeks or months of life has been turned down by a government watchdog body for use in the NHS...The National Institute for Health and Clinical Excellence (Nice) says it proposes to reject Tyverb (lapatinib) in spite of changes in the rules brought in specifically to allow people at the end of their lives to have the chance of new and often expensive treatments."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://www.telegraph.co.uk/science/science-news/6583913/Ketamine-causes-memory-loss-research-finds.html" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Ketamine causes memory loss research finds&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;20 November 2009, 11:30:47 | Telegraph&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"A study of frequent users found the drug had a ''profound'' impact on short and long-term memory...Users became ''dissociated'' in their day-to-day lives and struggled to remember names and conversations."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8359836.stm" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Dementia patient care criticised&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;20 November 2009, 11:29:37 | BBC&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"Half of all dementia patients leave hospital in a worse state than when they arrive, it is claimed."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://www.dh.gov.uk/en/News/Recentstories/DH_107836" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;National CJD Surveillance Unit publishes 17th Annual Report for 2008&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;13 November 2009, 13:48:54 | Dept of Health&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"The report looks back over the period from May 1990 (when the Unit was set up) to 31 December 2008. The report outlines the Unit’s work in the clinical surveillance of variant (vCJD), sporadic and iatrogenic CJD."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://www.dh.gov.uk/en/News/Recentstories/DH_108330" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Government takes action on antipsychotic drugs and dementia&lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;13 November 2009, 13:46:06 | Dept of Health&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"A tough new action plan to tackle the over prescribing of antipsychotic drugs to people with dementia was today announced by Care Services Minister Phil Hope...The action plan responds to an independent review by Professor Sube Banerjee, commissioned by the Department of Health. Professor Banerjee’s review shows that too many people with dementia are routinely prescribed antipsychotic drugs to treat aggression and agitation, contrary to National Institute of Health and Clinical Excellence (NICE) guidance."&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8350220.stm" target="_blank"&gt;&lt;FONT color=#800080 face=Calibri&gt;Drug 'shrinks lung cancer tumour' &lt;/FONT&gt;&lt;/A&gt;&lt;u1:p&gt;&lt;/u1:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;13 November 2009, 13:25:47 | BBC&lt;u1:p&gt;&lt;/u1:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Calibri&gt;"Scientists have identified a drug which may offer hope to patients with a particularly lethal form of lung cancer...The drug eliminated small cell lung cancer tumours in 50% of mice, and blocked the cells' ability to resist standard chemotherapy treatment."&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/v:path&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/SPAN&gt;&lt;/v:path&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326763</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326763]]&gt;</url>
    <title>2009-October. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-October. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:328277:1" name=internalLink&gt;Topotecan for the treatment of recurrent and stage IVB cervical cancer. NICE Technology Appraisal 183. Published 28 October 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:327446:1" name=internalLink&gt;Manual for Cancer Services 2008: complementary therapy (safeguarding practice) measures. Published 9 October 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Royal College of Radiologists:&amp;nbsp; &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:328025:1" name=internalLink&gt;Consensus guidelines for the prescription and administration of oral bowel cleansing agents. Published September 2009&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:327252:1" name=internalLink&gt;Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:321439:0" name=internalLink&gt;Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327245:1" name=internalLink&gt;Cryotherapy for hepatocellular carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327231:1" name=internalLink&gt;Interventions for HIV-associated nephropathy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327230:1" name=internalLink&gt;Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327165:1" name=internalLink&gt;Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327203:1" name=internalLink&gt;Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327237:1" name=internalLink&gt;Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327235:1" name=internalLink&gt;Selective internal radiation therapy for liver metastases from colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327249:1" name=internalLink&gt;Single dose oral fenbufen for acute postoperative pain in adults&lt;/A&gt;&lt;A href="nelh:327249:1" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:327223:1" name=internalLink&gt;Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327258:1" name=internalLink&gt;Single dose oral lornoxicam for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327251:1" name=internalLink&gt;Single dose oral meloxicam for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327250:1" name=internalLink&gt;Single dose oral nabumetone for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327247:1" name=internalLink&gt;Single dose oral sulindac for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327248:1" name=internalLink&gt;Single dose oral tiaprofenic acid for acute postoperative pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327214:1" name=internalLink&gt;Topical capsaicin for chronic neuropathic pain in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327191:1" name=internalLink&gt;Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327183:1" name=internalLink&gt;Ultrasound guidance for peripheral nerve blockade&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:326907:1" name=internalLink&gt;A meta-analysis on the efficacy of oral theophylline in patients with stable COPD&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327017:1" name=internalLink&gt;A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326928:1" name=internalLink&gt;Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326942:1" name=internalLink&gt;Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326913:1" name=internalLink&gt;Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326932:1" name=internalLink&gt;Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326932:1" name=internalLink&gt;Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326935:1" name=internalLink&gt;Home-based telehealth: a review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326940:1" name=internalLink&gt;Management of brain metastases: role of radiotherapy alone or in combination with other treatment modalities&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326940:1" name=internalLink&gt;Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326973:1" name=internalLink&gt;Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer&lt;/A&gt;&lt;A href="nelh:326973:1" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:326910:1" name=internalLink&gt;Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326902:1" name=internalLink&gt;Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326976:1" name=internalLink&gt;The functional effects of physical exercise training in frail older people: a systematic review&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:327060:1" name=internalLink&gt;Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327075:1" name=internalLink&gt;The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:327039:1" name=internalLink&gt;Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DUETs (Database of Uncertainties of the Effects of Treatments)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:322102:1" name=internalLink&gt;Acupuncture vs routine care for tension-type headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322103:1" name=internalLink&gt;Acupuncture vs sham treatments for tension-type headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322091:1" name=internalLink&gt;Different types of practitioners and treatment response to acupuncture for migraine prophylaxis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322090:1" name=internalLink&gt;Effectiveness of a second acupuncture treatment in improving migraine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322093:1" name=internalLink&gt;Effectiveness of different types of acupuncture for migraine prophylaxis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:302524:1" name=internalLink&gt;Epidural blood patching for preventing and treating post–dural puncture headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322092:1" name=internalLink&gt;Importance of correct point location in acupuncture for migraine prophylaxis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322089:1" name=internalLink&gt;Length of duration of improvements associated with acupuncture treatment for migraine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:322099:1" name=internalLink&gt;Optimal frequency and duration of acupuncture sessions for migraine prophylaxis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:303268:0" name=internalLink&gt;Palliative care for heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314656:1" name=internalLink&gt;Targeted drug therapies for the management of metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:314137:1" name=internalLink&gt;The impact of targeted drug therapies on current management of metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:303370:1" name=internalLink&gt;Whole brain radiotherapy for the treatment of multiple brain metastases&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Recent items of evidence news from the collection's RSS feed&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.timesonline.co.uk/tol/comment/letters/article6857395.ece" target="_blank"&gt;A 'care' pathway that effectively leads to the vast majority of terminal patients not being hydrated stands to be seen as inhumane&lt;BR&gt;30 October 2009, 15:30:52 | Prof Sam Hjelmeland Ahmedzai (letter), Times&lt;/A&gt;&lt;BR&gt;"Sir, The debate about end of life care will have, if nothing else, brought the medical management of dying people into the consciousness of lay people who are usually better at avoiding the subject..." &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncpc.org.uk/newsroom/lcp.html" target="_blank"&gt;The Liverpool Care Pathway&lt;BR&gt;22 October 2009, 11:23:41 | National Council for Palliative Care&lt;/A&gt;&lt;BR&gt;"The National Council for Palliative Care has commented as follows in response to recent media coverage of the Liverpool Care Pathway: The Liverpool Care Pathway is a nationally-recognised evidence-based tool intended to help clinicians give appropriate and high-quality care to people who have reached the last few hours or days of life. Its purpose is to promote the comfort of dying people and to address the needs of their informal carers. It should not be substituted for a clinician’s professional judgement in the individual circumstances of each case..."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.timesonline.co.uk/tol/life_and_style/health/article6832958.ece" target="_blank"&gt;The Liverpool Care Pathway brings the subject of dying into the open&lt;BR&gt;21 October 2009, 14:36:35 | Joan Bakewell, Times&lt;/A&gt;&lt;BR&gt;"How we die and who makes that decision is once again a subject of public concern. Attention has been drawn to the Liverpool Care Pathway, a series of guidelines for health professionals charged with supervising deaths under their care...Many people were not aware of the guidelines until recently but alarmist letters to the press have made them more widely known and questions are being asked. This can only be good: the debate is on..."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.telegraph.co.uk/comment/letters/6133157/Dying-patients.html" target="_blank"&gt;Dying patients - A group of experts who care for the terminally ill claim that some patients are being wrongly judged as close to death&lt;BR&gt;15 October 2009, 11:31:05 | PH Millard - Emeritus Professor of Geriatrics - University of London et al (letter) Telegraph&lt;/A&gt;&lt;BR&gt;"SIR – The Patients Association has done well to expose the poor treatment of elderly patients in some parts of the NHS (report, August 27). We would like to draw attention to the new “gold standard” treatment of those categorised as “dying”. Forecasting death is an inexact science...." &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.guardian.co.uk/society/2009/sep/23/assisted-suicide-guidelines-legal" target="_blank"&gt;New assisted suicide guidelines to give 'clear advice' to relatives&lt;BR&gt;24 September 2009, 11:06:55 | Alexandra Topping, Guardian&lt;/A&gt;&lt;BR&gt;"Director of public prosecutions says assisted suicide remains illegal and guidance will not mean immunity from legal action".&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/6169809/Cancer-molecule-breakthrough-could-halt-deadly-muscle-loss.html" target="_blank"&gt;Cancer molecule breakthrough could halt deadly muscle loss&lt;BR&gt;14 September 2009, 07:52:43 | Telegraph&lt;/A&gt;&lt;BR&gt;"Cancer deaths through muscle loss could be prevented after British scientists discovered a molecule which stops suffers fatally wasting away."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/6135781/Over-the-counter-painkillers-can-cause-addiction-within-three-days.html" target="_blank"&gt;Over-the-counter painkillers 'can cause addiction within three days'&lt;BR&gt;07 September 2009, 14:10:41 | Kate Devlin, Telegraph&lt;/A&gt;&lt;BR&gt;"Over-the-counter painkillers taken by millions can cause addiction in just three days, the Government’s drug watchdog has said. The pills, which contain codeine, include brand names such as Nurofen Plus and Solpadeine Plus. They are sold without prescription and are routinely used to ease headaches, back problems and period pain."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/6127514/Sentenced-to-death-on-the-NHS.html" target="_blank"&gt;Sentenced to death on the NHS&lt;BR&gt;03 September 2009, 13:30:31 | Kate Devlin, Telegraph&lt;/A&gt;&lt;BR&gt;"Patients with terminal illnesses are being made to die prematurely under an NHS scheme to help end their lives, leading doctors have warned."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.telegraph.co.uk/news/uknews/6061790/Doctor-facing-disciplinary-action-over-drug-prescriptions.html" target="_blank"&gt;Doctor facing disciplinary action over drug prescriptions&lt;BR&gt;02 September 2009, 14:29:44 | Telegraph&lt;/A&gt;&lt;BR&gt;"Dr Jane Barton, who prescribed "potentially hazardous" levels of drugs to elderly patients at Gosport War Memorial Hospital, could be struck off after she was found guilty of recklessly prescribing the powerful painkillers."&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326298</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326298]]&gt;</url>
    <title>2009-September. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2009-September. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;NICE: (All Guidance Published 23 September 2009)&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:325540:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Sunitinib for the treatment of gastrointestinal stromal tumours. NICE Technology Appraisal Guidance 179&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:325578:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Pemetrexed for the first-line treatment of non-small-cell lung cancer. NICE Technology Appraisal Guidance 181&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;Academy of Medical Royal Colleges&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:326042:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Common competences framework for doctors. Published August 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;College of Optometrists&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324057:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Basal cell carcinoma (BCC) (of eyelid). Published 16 January 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;European Society for Clinical Nutrition and Metabolism (ESPEN)&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:325375:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;ESPEN guidelines on parenteral nutrition. Published 10 September 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:325463:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;ESPEN/ESPGHAN guidelines on paediatric parenteral nutrition. Published November 2005&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;Royal College of Nursing&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324966:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The recognition and assessment of acute pain in children. Update of full guideline. Published September 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;Royal College of Radiologists&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324954:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;RCR guidance on the management of cancer patients during an influenza pandemic. Published August 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;EM&gt;European Federation of Neurological Societies&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:294992:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;EFNS guideline on the drug treatment of migraine: revised report of an EFNS task force. Published September 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Royal College of Pathologists&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:37425:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Guidelines on inter-departmental dispatch and funding of histopathology referrals - updated guideline. Published February 2009&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324152:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;A qualitative systematic review of morphine treatment in children with postoperative pain&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324144:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;A review of outcome studies on cognitive-behavioral therapy for reducing fear-avoidance beliefs among individuals with chronic pain&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324205:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;A review of the efficacy of dexamethasone in the prevention of postoperative nausea and vomiting&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324199:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;A systematic review of nurse-assisted case management to improve hospital discharge transition outcomes for the elderly&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324214:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;A systematic review of the benefits of home telecare for frail elderly people and those with long-term conditions&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324125:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Acupuncture for chemotherapy-induced leukopenia: exploratory meta-analysis ofrandomized controlled trials&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324219:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324213:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324168:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Children facing a family member's acute illness: a review of intervention studies&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324193:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Collection and use of cancer family history in primary care&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324131:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Corticosteroid treatment of severe community-acquired pneumonia&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324281:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Corticosteroids for pain relief in sore throat: systematic review and meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324123:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Does music reduce anxiety during invasive procedures with procedural sedation: an integrative research review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324121:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324228:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Impact of physical therapy for Parkinson's disease: a critical review of the literature&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324252:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs)&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324203:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;n-3 Fatty acids, cancer and cachexia: a systematic review of the literature&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324280:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324277:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Radiation-induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow-up duration&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324196:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Static magnets for reducing pain: systematic review and meta-analysis of randomized trials&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324148:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324240:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Systematic review of dexketoprofen in acute and chronic pain&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324137:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Systematic review of information and support interventions for caregivers of people with dementia&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324210:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Systematic review of noninvasive positive pressure ventilation in severe stable COPD&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324182:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Systematic review of studies of patients' satisfaction with breast reconstruction after mastectomy&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324113:0" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324130:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The effects of reminiscence on psychological well-being in older adults: a meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324256:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324145:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324128:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324141:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324146:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Treatments for metastatic melanoma: synthesis of evidence from randomized trials&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED)&lt;o:p&gt;&lt;/o:p&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324081:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Cost effective management of low-risk papillary thyroid carcinoma&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324082:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324096:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324098:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:324102:1" name=internalLink&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>372862</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=372862]]&gt;</url>
    <title>2010-April. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-April. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;DIV&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:372330:0" name=internalLink&gt;NHS continuing healthcare practice guidance. Published 1 April 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372097:0" name=internalLink&gt;Delivering enhanced recovery: helping patients to get better sooner after surgery. Published 31 March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;European Association for Palliative Care:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:372293:0" name=internalLink&gt;White Paper on standards and norms for hospice and palliative care in Europe: parts 1 and 2. Recommendations from the European Association for Palliative Care. Published 01 November 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Health Protection Agency:&amp;nbsp; &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:372151:0" name=internalLink&gt;Universal HIV testing for TB patients: guidance for healthcare professionals working with TB. Published August 2009&lt;/A&gt;. &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372107:0" name=internalLink&gt;Substance misuse and TB: guidance for those affected. Published October 2007&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372107:0" name=internalLink&gt;Substance misuse and TB: guidance for key workers (care workers, social workers, project workers and health professionals). Published October 2007&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372110:0" name=internalLink&gt;Substance misuse and TB: guidance for families affected. Published October 2007&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372019:0" name=internalLink&gt;Tuberculosis (TB): guidance for prison officials. Published August 2006&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372020:0" name=internalLink&gt;TB and homelessness: guidance for homeless service managers. Published August 2006&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372029:0" name=internalLink&gt;TB &amp;amp; homelessness: guidance for homelessness sector staff. Published August 2006&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372093:0" name=internalLink&gt;Tuberculosis (TB): guidance for staff working with people seeking asylum. Published May 2006&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372031:0" name=internalLink&gt;Pregnancy and tuberculosis: guidance for clinicians. Published March 2006&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:372035:0" name=internalLink&gt;Tuberculosis and children: a guide for all of those who work with children. Published March 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;&lt;/DIV&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:371996:0" name=internalLink&gt;Aspirin with or without an antiemetic for acute migraine headaches in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:371994:0" name=internalLink&gt;Interventions for non-metastatic squamous cell carcinoma of the skin&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:371997:0" name=internalLink&gt;Triptans for acute cluster headache&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database&amp;nbsp;(NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:366422:0" name=internalLink&gt;Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366733:0" name=internalLink&gt;Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:368486:0" name=internalLink&gt;Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:370680:0" name=internalLink&gt;Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:368160:0" name=internalLink&gt;Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366382:0" name=internalLink&gt;Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective - the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:370585:0" name=internalLink&gt;Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:370203:0" name=internalLink&gt;Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:364189:0" name=internalLink&gt;Cost-effectiveness of UGT1A1 genotyping in second-line, high-dose, once every 3 weeks irinotecan monotherapy treatment of colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366713:0" name=internalLink&gt;Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:360094:0" name=internalLink&gt;&lt;A href="nelh:360094:0" name=internalLink&gt;18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the lite&lt;/A&gt;&lt;A href="nelh:360094:0" name=internalLink&gt;rature&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360169:0" name=internalLink&gt;A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359768:0" name=internalLink&gt;A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358782:0" name=internalLink&gt;Acupuncture for the management of chronic headache: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359673:0" name=internalLink&gt;Acupuncture for treating hot flashes in breast cancer patients: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359857:0" name=internalLink&gt;Acupuncture for treating hot flushes in men with prostate cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358333:0" name=internalLink&gt;Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360246:0" name=internalLink&gt;Aerobic fitness in people with Parkinson's disease: a review of the evidence&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360135:0" name=internalLink&gt;An evidence-based review of yoga as a complementary intervention for patients with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360885:0" name=internalLink&gt;Arm exercise training in patients with chronic obstructive pulmonary disease: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360329:0" name=internalLink&gt;Associations between statins and COPD: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358479:0" name=internalLink&gt;Biofeedback treatment for headache disorders: a comprehensive efficacy review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359368:0" name=internalLink&gt;Blood cultures for community-acquired pneumonia: are they worthy of two quality measures: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358191:0" name=internalLink&gt;Case management used to optimize cancer care pathways: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360994:0" name=internalLink&gt;Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358144:0" name=internalLink&gt;Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360025:0" name=internalLink&gt;Discharge planning from hospital to home for elderly patients: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358209:0" name=internalLink&gt;Does narrative information bias individual's decision making: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359162:0" name=internalLink&gt;Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359264:0" name=internalLink&gt;Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359054:0" name=internalLink&gt;Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360165:0" name=internalLink&gt;Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357952:0" name=internalLink&gt;Effectiveness of acupuncture for Parkinson disease: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360368:0" name=internalLink&gt;Effects of probiotics for the prevention and treatment of radiation-induced diarrhea&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359214:0" name=internalLink&gt;Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359771:0" name=internalLink&gt;Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359829:0" name=internalLink&gt;Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: a meta-analysis of the published literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359091:0" name=internalLink&gt;Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359404:0" name=internalLink&gt;Evaluation of morbidity of suction drains after retroperitoneal lymphadenectomy in gynecological tumors: a systematic literature review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358238:0" name=internalLink&gt;Extended perioperative thromboprophylaxis in patients with cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360393:0" name=internalLink&gt;Follow-up of cancer in primary care versus secondary care: systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358028:0" name=internalLink&gt;GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359296:0" name=internalLink&gt;Herbal medicine for dementia: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359183:0" name=internalLink&gt;How sustainable is strength training in chronic obstructive pulmonary disease?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359212:0" name=internalLink&gt;Imaging in assessing lymph node status in gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360717:0" name=internalLink&gt;Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358688:0" name=internalLink&gt;Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357808:0" name=internalLink&gt;Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360600:0" name=internalLink&gt;&lt;A href="nelh:360600:0" name=internalLink&gt;Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer?&lt;/A&gt;&lt;A href="nelh:360600:0" name=internalLink&gt; A review of the literature&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359611:0" name=internalLink&gt;Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359137:0" name=internalLink&gt;Meta-analysis comparing different behavioral treatments for late-life anxiety&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359314:0" name=internalLink&gt;Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359823:0" name=internalLink&gt;Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360466:0" name=internalLink&gt;Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358624:0" name=internalLink&gt;Off-label use of medicines in children: can available evidence avoid useless paediatric trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358432:0" name=internalLink&gt;Positive expiratory pressure in patients with chronic obstructive pulmonary disease: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359087:0" name=internalLink&gt;Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360483:0" name=internalLink&gt;Psychosocial interventions for adolescent cancer patients: a systematic review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360192:0" name=internalLink&gt;Rifapentine vs rifampicin for the treatment of pulmonary tuberculosis: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359597:0" name=internalLink&gt;Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360086:0" name=internalLink&gt;Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359775:0" name=internalLink&gt;Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359720:0" name=internalLink&gt;Second-line treatments in non-small cell lung cancer: a systematic review of literature and metaanalysis of randomized clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360081:0" name=internalLink&gt;Serotonin antagonists for the treatment of opioid-induced nausea and vomiting in non-surgical patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359649:0" name=internalLink&gt;Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359845:0" name=internalLink&gt;Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360360:0" name=internalLink&gt;Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359836:0" name=internalLink&gt;Systematic review and meta-analysis of prophylactic gastroenterostomy for unresectable advanced pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359031:0" name=internalLink&gt;Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360344:0" name=internalLink&gt;The effectiveness of cognitive and behavioural treatment of chronic pain in the elderly: a quantitative review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360538:0" name=internalLink&gt;The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360311:0" name=internalLink&gt;The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358680:0" name=internalLink&gt;The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358100:0" name=internalLink&gt;The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360701:0" name=internalLink&gt;Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359773:0" name=internalLink&gt;TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359765:0" name=internalLink&gt;Use of dry powder inhalers in acute exacerbations of asthma and COPD&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359997:0" name=internalLink&gt;Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359089:0" name=internalLink&gt;What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:372301:0" name=internalLink&gt;The management of depression in palliative care. Draft European guidelines. European Palliative Care Research Collaborative&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;SPAN style="FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=371443&amp;amp;tabID=289" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;&lt;FONT face=Calibri&gt;Pain in supportive and palliative care - 2010 Annual Evidence Update&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/7563220/Near-death-experiences-trick-of-the-mind-caused-by-high-levels-of-CO2-in-the-blood.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;&lt;FONT face=Calibri&gt;Near death experiences 'trick of the mind caused by high levels of CO2 in the blood'&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>344876</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=344876]]&gt;</url>
    <title>2010-February. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-February. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:344719:0" name=internalLink&gt;Trabectedin for the treatment of advanced soft tissue sarcoma. NICE Technology Appraisal Guidance 185. Published 24 February 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344765:0" name=internalLink&gt;Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. NICE Interventional Procedure&lt;BR&gt;Guidance 331. Published 24 February 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:344079:0" name=internalLink&gt;Chemotherapy services in the community: a guide for PCTs. Published 18 February 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;American Academy of Neurology: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:344133:0" name=internalLink&gt;Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Published 13 October 2009&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344147:0" name=internalLink&gt;Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.&lt;BR&gt;Published 13 October 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:342849:0" name=internalLink&gt;A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342978:0" name=internalLink&gt;A systematic review of clinical outcomes, clinical process, healthcare utilization and costs associated with telerehabilitation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342818:0" name=internalLink&gt;A systematic review of radiofrequency ablation for lung tumors&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342836:0" name=internalLink&gt;A systematic review of the accuracy and utility of early markers of ifosfamide-induced proximal tubulopathy in survivors of childhood cancers&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342957:0" name=internalLink&gt;A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342917:0" name=internalLink&gt;An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342953:0" name=internalLink&gt;Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy; a meta-analysis of clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342898:0" name=internalLink&gt;Chemotherapy in metastatic breast cancer: a summary of all randomised trials reported 2000-2007&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342934:0" name=internalLink&gt;Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342923:0" name=internalLink&gt;Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342985:0" name=internalLink&gt;Effectiveness of topical administration of opioids in palliative care: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342971:0" name=internalLink&gt;Effects of case management for frail older people or those with chronic illness: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342986:0" name=internalLink&gt;E-health self-care interventions for persons with chronic illnesses: review and future directions&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342885:0" name=internalLink&gt;Evidence-based choice of esophageal stent for the palliative management of malignant dysphagia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342866:0" name=internalLink&gt;Is reiki beneficial for pain management?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342968:0" name=internalLink&gt;Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342867:0" name=internalLink&gt;Nursing intervention for fatigue during the treatment for cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342853:0" name=internalLink&gt;Oncologic outcomes of laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:343011:0" name=internalLink&gt;Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342916:0" name=internalLink&gt;Screening for psychological distress in palliative care: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:342815:0" name=internalLink&gt;Treatment of fatigue in multiple sclerosis: a systematic review of the literature&lt;/A&gt;&lt;A href="nelh:342815:0" name=internalLink&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;/A&gt;&lt;A href="nelh:342822:0" name=internalLink&gt;&lt;A href="nelh:342822:0" name=internalLink&gt;What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant&lt;/A&gt;&lt;A href="nelh:342822:0" name=internalLink&gt;&amp;nbsp;drug-related behaviors: a structured evidence-based review&lt;/A&gt;&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;&lt;A href="nelh:343028:0" name=internalLink&gt;
&lt;LI&gt;&lt;A href="nelh:334202:0" name=internalLink&gt;Bevacizumab, sorafenib tosylate and sunitinib for renal cell carcinoma: a systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database&amp;nbsp;(NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:343088:0" name=internalLink&gt;z18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:343048:0" name=internalLink&gt;A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:343070:0" name=internalLink&gt;An economic analysis of an acid-reflux breath test in the evaluation of chronic cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:343072:0" name=internalLink&gt;Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer: economic evaluation in an Italian NHS set&lt;/A&gt;ting&lt;A href="nelh:328656:0" name=internalLink&gt;&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;'Evidence in the News' RSS feed&lt;/A&gt; last month&lt;/STRONG&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="COLOR: #3165c6"&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;SPAN style="COLOR: windowtext"&gt;&lt;/SPAN&gt;&lt;o:p&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: windowtext; FONT-SIZE: 8pt; mso-bidi-font-size: 11.0pt"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="COLOR: windowtext; mso-bidi-font-size: 11.0pt"&gt;&lt;/SPAN&gt;&lt;o:p&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL style="MARGIN-TOP: 0cm" type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.cps.gov.uk/news/press_releases/109_10/" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;DPP publishes assisted suicide policy&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.cps.gov.uk/publications/prosecution/assisted_suicide_policy.pdf" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Policy for Prosecutors in Respect of Cases of Encouraging or Assisting Suicide PDF&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8536231.stm" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Motivation key over assisted death prosecutions&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8530305.stm" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Scientists find why tamoxifen fails some breast cancers&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.dh.gov.uk/en/News/Recentstories/DH_113007" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Dept of Health launches consultation on a strategy for Chronic Obstructive Pulmonary Disease&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.telegraph.co.uk/health/7271547/Huge-rise-in-prescriptions-for-strongest-painkillers.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Huge rise in prescriptions for strongest painkillers&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.act.org.uk/documents.asp?section=191&amp;amp;itemTitle=Free+resources&amp;amp;profilecode=0001300000010011" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Paed Pal Lit - International Journal of Paediatric Palliative Care PDFs&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.truecolourstrust.org.uk/chair.aspx" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Chair in Palliative Care for Children and Young People&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.childrenshospiceweek.org.uk/" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;What is Children's Hospice Week&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.guardian.co.uk/politics/2010/feb/07/labour-pledge-personal-cancer-care" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Gordon Brown - All cancer patients to get home care&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.scottish.parliament.uk/s3/bills/38-EndLifeAssist/index.htm" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;End of Life Assistance - Scotland - Bill&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; COLOR: blue; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-bidi-font-family: Arial"&gt;&lt;A href="http://www.bbc.co.uk/programmes/b00qmfgn" target="_blank"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;Richard Dimbleby Lecture - Shaking Hands with Death - Sir Terry Pratchett&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>341827</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=341827]]&gt;</url>
    <title>2010-January. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-January. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;SIGN:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:336938:0" name=internalLink&gt;Diagnosis and pharmacological management of Parkinson’s disease. SIGN guideline 113. Published 08 January 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;College of Emergency Medicine:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:333979:0" name=internalLink&gt;Guideline for the management of lone acute severe headache. Published December 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Association of British Neurologists:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:123827:0" name=internalLink&gt;Association of British Neurologists revised (2009) guidelines for prescribing in multiple sclerosis. Published 2001, updated March 2007, revised November 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Thoracic Society: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:93874:0" name=internalLink&gt;Guidelines for the management of community acquired pneumonia in adults. Published 2001, updated October 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:341757:1" name=internalLink&gt;Antigen-specific active immunotherapy for ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341751:1" name=internalLink&gt;Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341720:1" name=internalLink&gt;Chinese herbal medicines for induction of remission in advanced or late gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341731:1" name=internalLink&gt;Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341769:0" name=internalLink&gt;Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341794:0" name=internalLink&gt;End-of-life care pathways for improving outcomes in caring for the dying&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341789:0" name=internalLink&gt;Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341716:0" name=internalLink&gt;Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341767:0" name=internalLink&gt;Honey for acute cough in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341709:1" name=internalLink&gt;Interferon-alpha for maintenance of follicular lymphoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341744:0" name=internalLink&gt;Long-term opioid management for chronic noncancer pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341785:0" name=internalLink&gt;Lymphadenectomy for the management of endometrial cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341781:0" name=internalLink&gt;Management of drainage for malignant ascites in gynaecological cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341793:0" name=internalLink&gt;Massage therapy for people with HIV/AIDS&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341758:0" name=internalLink&gt;Music therapy for end-of-life care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341748:0" name=internalLink&gt;Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341734:0" name=internalLink&gt;Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341798:0" name=internalLink&gt;Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341752:0" name=internalLink&gt;Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341733:0" name=internalLink&gt;Serotonin receptor antagonists for highly emetogenic chemotherapy in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341778:0" name=internalLink&gt;Treadmill training for patients with Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341780:0" name=internalLink&gt;Vitamin D for the treatment of chronic painful conditions in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:334082:0" name=internalLink&gt;Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334103:0" name=internalLink&gt;Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334129:0" name=internalLink&gt;Manual therapy for non-specific thoracic pain in adults: review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334089:0" name=internalLink&gt;Meta-analysis of survival prediction with Palliative Performance Scale&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334083:0" name=internalLink&gt;One-to-one volunteer support programs for people with cancer: a review of the literature&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:334202:0" name=internalLink&gt;Active surveillance and radical prostatectomy for clinically localized, low-risk prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334206:0" name=internalLink&gt;Cladribine (CdA) for the treatment of hairy-cell leukemia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334207:0" name=internalLink&gt;Deep brain stimulation for the treatment of Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:334254:0" name=internalLink&gt;Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal lymph nodes in patients with lung cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;UK DUETs (Database of Uncertainties of the Effects of Treatments)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:328570:0" name=internalLink&gt;Anti-angiogenic therapies for metastatic colorectal cancer in patients with cardiovascular disease or a history of prior thromboembolic events&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328577:0" name=internalLink&gt;Chemoradiation versus hyperthermia versus chemoradiation plus hyperthermia for locally advanced rectal cancer&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328620:0" name=internalLink&gt;Laparoscopic versus open surgery for colon cancer in elderly patients with comorbidities&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328593:0" name=internalLink&gt;Laparoscopic versus open surgery for colon cancer in patients with tumours in the transverse colon&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328579:0" name=internalLink&gt;Optimal surgical procedure for obstruction from primary left colorectal carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328566:0" name=internalLink&gt;Optimum chemotherapy backbone for bevacizumab treatment of metastatic colorectal cancer&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328569:0" name=internalLink&gt;Treatment duration for bevacizumab in metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328651:0" name=internalLink&gt;Covered versus uncovered metal palliative biliary stents for obstructing pancreatic carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328628:0" name=internalLink&gt;Laparoscopic versus open surgery for rectal cancer&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:328656:0" name=internalLink&gt;Percutaneous acetic acid injection for early hepatocellular carcinoma Percutaneous ethanol injection for early hepatocellular carcinoma&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;The 'NHS Evidence - commissioning' specialist collection&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:287028:0" name=internalLink&gt;Palliative care services for children and young people in England&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341675:0" name=internalLink&gt;National Cancer Survivorship Initiative (NSCI) vision&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;The 'NHS Evidence - quality and productivity' specialist collection&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:331562:0" name=internalLink&gt;Enhanced home-based palliative care for adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:330701:0" name=internalLink&gt;Primary care rapid response assessment of dysphagia in end of life care&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;'Evidence in the News' RSS feed&lt;/A&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.kingsfund.org.uk/research/publications/leeds_castle_eolc.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Delivering better care at end of life - The next steps PDF&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Rachael Addicott, Rebecca Ashton (Eds) &lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.nhs.uk/news/2009/12December/Pages/Hospital-flowers-not-harmful.aspx" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;'You don't bring me flowers anymore'&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Behind the headlines (Appraisal of story in Daily Mail) &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.nhs.uk/news/2010/01January/Pages/Genes-affect-cancer-treatment.aspx" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Genes 'affect cancer treatment'&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Behind the Headlines (Appraisal of story in Daily Telegraph) &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.telegraph.co.uk/news/newstopics/politics/lawandorder/7072965/Kay-Gilderdale-assisted-suicide-mercy-killing-and-the-law.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Kay Gilderdale - assisted suicide mercy killing and the law&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Caroline Gammell, Telegraph&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.guardian.co.uk/society/2010/jan/18/kay-gilderdale-lynn-attempted-murder" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;'Devoted mother' on trial for helping daughter die&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Sandra Laville, Guardian&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/7005394/Doctor-faces-action-over-morphine-deaths-of-elderly-patients.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Doctor faces action over morphine deaths of elderly patients&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Robert Mendick, Telegraph&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/palliative/viewResource.aspx?resid=338802&amp;amp;code=bfdde902c300c22818e02f816646c304" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Books on spiritual care added to St Christopher's Hospice Library 2007-2009&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Denise Brady, Librarian, St Christopher's Hospice&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.rcplondon.ac.uk/media/Press-releases/Pages/06-Jan-2010-Nil-by-mouth-should-be-last-resort-according-to-RCP-report.aspx" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;06 Jan 2010 - Nil by mouth should be last resort according to RCP published report&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Royal College of Physicians&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=338644&amp;amp;tabID=289" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;2010 Annual Evidence Update on patient and carer involvement in chronic disease&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Sam H Ahmedzai et al, NHS Evidence&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.bmj.com/cgi/content/extract/340/jan06_2/b5683" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Bad medicine - pain&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Des Spence, BMJ&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://news.bbc.co.uk/1/hi/health/8440881.stm" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Inappropriate tube feeding of patients 'widespread' &lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Jane Dreaper, BBC&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=320499&amp;amp;tabID=290" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Trans-Pennine Palliative Care Research Meeting - Thurs 20th May 2010&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Pauline Hutchinson, Academic Unit of Supportive Care, Sheffield&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.guardian.co.uk/society/2010/jan/01/doctor-mcpherson-law-terminally-die" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Doctor backs law change to help terminally ill die&lt;/SPAN&gt;&lt;/A&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Sarah Boseley, health editor, Guardian&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 2" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>377363</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=377363]]&gt;</url>
    <title>2010-July. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-July. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt; &lt;/P&gt;
&lt;P&gt;[All July guidance published July 28 2010]&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:381874:0" name=internalLink&gt;Motor neurone disease: the use of non-invasive ventilation in the management of motor neurone disease. NICE Clinical Guideline 105&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:381795:0" name=internalLink&gt;Metastatic malignant disease of unknown primary origin: diagnosis and management of metastatic malignant disease of unknown primary origin. NICE Clinical Guideline 104&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382004:0" name=internalLink&gt;Denosumab for the treatment of therapy-induced bone loss in non-metastatic prostate cancer (terminated appraisal). NICE Technology Appraisal 194&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382005:0" name=internalLink&gt;Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia. NICE Technology Appraisal 193&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:381965:0" name=internalLink&gt;Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. NICE Technology Appraisal 192&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:381946:0" name=internalLink&gt;Capecitabine for the treatment of advanced gastric cancer. NICE Technology Appraisal 191&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:60852:0" name=internalLink&gt;Percutaneous radiofrequency ablation for renal cancer. NICE Interventional Procedure Guidance 353&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379753:0" name=internalLink&gt;Quality standard for dementia. NICE Quality Standard published 28 June 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;American College of Radiology:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:380129:0" name=internalLink&gt;ACR Appropriateness Criteria®: suspected small-bowel obstruction. Published 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Association of Endocrine and Thyroid Surgeons (BAETS):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:381051:0" name=internalLink&gt;Head, neck and thyroid cancers 2012 - vision paper. Published July 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Association of Urological Surgeons:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:380030:0" name=internalLink&gt;MDT (multi-disciplinary team) guidance for managing prostate cancer (2nd edition) Published November 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Cancer Care Ontario (CCO):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:380120:0" name=internalLink&gt;Imatinib mesylate in the adjuvant treatment of gastrointestinal stromal tumours (GIST). Published 31 May 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380108:0" name=internalLink&gt;PET imaging in colorectal cancer – recommendations. Published 19 January 2009&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380103:0" name=internalLink&gt;PET imaging in esophageal cancer – recommendations. Published 19 January 2009&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380106:0" name=internalLink&gt;PET imaging in pancreatic cancer – recommendations. Published 19 January 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;European Respiratory Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:381085:0" name=internalLink&gt;Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Published March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;General Medical Council:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:61418:0" name=internalLink&gt;Treatment and care towards the end of life: good practice in decision making. Published 01 July 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Human Tissue Authority:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:381287:0" name=internalLink&gt;Code of practice 8: import and export of human bodies, body parts and tissue. Published May 2007&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;National Patient Safety Agency:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:381468:0" name=internalLink&gt;Delayed diagnosis of cancer: thematic review. Published 26 March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;World Gastroenterology Organisation:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:379863:0" name=internalLink&gt;Hepatocellular carcinoma (HCC): a global perspective. Published November 2009&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:380435:0" name=internalLink&gt;&lt;A href="nelh:380435:0" name=internalLink&gt;Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy &lt;/A&gt;&lt;A href="nelh:380435:0" name=internalLink&gt;in Parkinson´s disease patients with motor complications&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380441:0" name=internalLink&gt;High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380438:0" name=internalLink&gt;Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380442:0" name=internalLink&gt;Lactulose versus Polyethylene Glycol for Chronic Constipation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380427:0" name=internalLink&gt;Music therapy for acquired brain injury&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380418:0" name=internalLink&gt;Nutritional support in children and young people with cancer undergoing chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380439:0" name=internalLink&gt;Palliative surgery versus medical management for bowel obstruction in ovarian cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:382084:0" name=internalLink&gt;[Development of criteria, complexity indicators and management strategies on frailty]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382105:0" name=internalLink&gt;Controlled medication agreements for opioid use in chronic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382101:0" name=internalLink&gt;Dexmedetomidine for sedation during intubation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382110:0" name=internalLink&gt;Dexmedetomidine for sedation of non-surgical patients&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:360859:0" name=internalLink&gt;A systematic review to investigate the effectiveness and acceptability of interventions for moist desquamation in radiotherapy patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359990:0" name=internalLink&gt;Bach flower remedies for psychological problems and pain: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360096:0" name=internalLink&gt;Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:353046:0" name=internalLink&gt;Comparison of docetaxel- and Vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361087:0" name=internalLink&gt;EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375751:0" name=internalLink&gt;Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360464:0" name=internalLink&gt;Internal qigong for pain conditions: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360299:0" name=internalLink&gt;No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359812:0" name=internalLink&gt;Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360282:0" name=internalLink&gt;R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359522:0" name=internalLink&gt;Status of psychological trials in breast cancer patients: a report of three meta-analyses&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361073:0" name=internalLink&gt;Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361095:0" name=internalLink&gt;Systematic review of day surgery for breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360944:0" name=internalLink&gt;The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358838:0" name=internalLink&gt;The effect of whole body vibration in common neurological conditions: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360811:0" name=internalLink&gt;The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED&lt;/STRONG&gt;) &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:362329:0" name=internalLink&gt;Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:371275:0" name=internalLink&gt;Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Other&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:382764:0" name=internalLink&gt;Supporting people to live and die well: a framework for social care at the end of life. Report of the Social Care Advisory Group of the National End of Life Care Programme&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:381668:0" name=internalLink&gt;End of life in heart failure: A framework for implementation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380942:0" name=internalLink&gt;&lt;A href="nelh:380942:0" name=internalLink&gt;Dying Matters website&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;£50m additional funding for cancer drugs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;National End of Life Care Newsletter issue 23 published&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;UK comes top on end of life care - report&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;Legal assisted suicide creates'slippery slope' to doctors killing without consent - expert claims&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>380475</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=380475]]&gt;</url>
    <title>2010-June. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-June. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:378601:0" name=internalLink&gt;Pemetrexed for the maintenance treatment of non-small-cell lung cancer. NICE Technology Appraisal 190. Published 23 June 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:34497:0" name=internalLink&gt;Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). NICE Clinical Guideline 101. Published 21 June 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:379567:0" name=internalLink&gt;Manual for Cancer Services 2008: head and neck measures. Updated 24 June 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:177521:0" name=internalLink&gt;Help is at hand: a resource for people bereaved by suicide and other sudden, traumatic death. Published 28 April 2010, updates previous guidance of September 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Pain Society: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:379475:0" name=internalLink&gt;Cancer pain management. Published January 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:250460:0" name=internalLink&gt;Opioids for persistent pain: good practice. Published March 2004, updated January 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Thoracic Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:378084:0" name=internalLink&gt;Guidelines for the prevention and management of mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Published June 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:377484:0" name=internalLink&gt;Sedation guideline. Published 2007&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Royal Pharmaceutical Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:261130:0" name=internalLink&gt;Practice guidance: bowel cancer. Updated April 2010&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:378120:0" name=internalLink&gt;Creatine for amyotrophic lateral sclerosis/motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378138:0" name=internalLink&gt;Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378146:0" name=internalLink&gt;Daclizumab for relapsing remitting multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378137:0" name=internalLink&gt;DNA-repair pathway inhibitors for the treatment of ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378121:0" name=internalLink&gt;Exercise interventions for upper-limb dysfunction due to breast cancer treatment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378147:0" name=internalLink&gt;Perioperative enhanced recovery programmes for gynaecological cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378130:0" name=internalLink&gt;Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378122:0" name=internalLink&gt;Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:378776:0" name=internalLink&gt;[Anti-GD2 immunotherapy in patients with high risk neuroblastoma]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378842:0" name=internalLink&gt;[Applicability of sentinel-lymph-node detection and biopsy in the treatment of vulval cancer]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378791:0" name=internalLink&gt;[Hadrontherapy in the treatment of cancer]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378799:0" name=internalLink&gt;[Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378857:0" name=internalLink&gt;An evaluation of current pharmacogenetic tests across three cancers: breast, colorectal and non-small cell lung&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378880:0" name=internalLink&gt;Autologous stem cell transplantation for breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378879:0" name=internalLink&gt;Autologous stem cell transplantation for soft tissue sarcoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378833:0" name=internalLink&gt;Capecitabine (Xeloda) in combination with docetaxel for adjuvant therapy in breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378832:0" name=internalLink&gt;Cladribine (Movectro) for multiple sclerosis; relapsing-remitting&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378763:0" name=internalLink&gt;Clinical Practice Guideline on the care for people with Alzheimer's disease and dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378767:0" name=internalLink&gt;Clinical Practice Guideline on tuberculosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378845:0" name=internalLink&gt;CT and MRI scans in the evaluation of chronic headaches&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378813:0" name=internalLink&gt;Everolimus (RAD-001) for advanced gastroenteropancreatic neuroendocrine tumours&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378827:0" name=internalLink&gt;Everolimus for advanced and/or metastatic renal cell carcinoma - second line&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378726:0" name=internalLink&gt;Fibromyalgia and chronic fatigue syndrome: update of diagnostic criteria and treatments&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378826:0" name=internalLink&gt;GV1001 for advanced and/or metastatic pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378730:0" name=internalLink&gt;High-Intensity Focused Ultrasounds (HIFU) in the treatment of solid tumors&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378876:0" name=internalLink&gt;Memantine in Alzheimer's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378809:0" name=internalLink&gt;Nilotinib (Tasigna) for chronic myeloid leukaemia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378808:0" name=internalLink&gt;Nilotinib (Tasigna) for gastrointestinal stromal tumours&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378807:0" name=internalLink&gt;Panitumumab (Vectibix) for first-line metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378761:0" name=internalLink&gt;Patterns of utilization for new cytostatics and appropriateness of chemotherapy drugs for the treatment of patients with breast, lung, colon, rectum and ovarian cancer in Catalonia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378820:0" name=internalLink&gt;Pazopanib (GW786034) for advanced and/or metastatic renal cell carcinoma - first/second line&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378838:0" name=internalLink&gt;Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378865:0" name=internalLink&gt;Positron emission tomography (PET) in malignant lymphoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378878:0" name=internalLink&gt;Quality of haematological and oncological care in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378716:0" name=internalLink&gt;TomoTherapy HI-ART System radiotherapy planning and treatment for cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378822:0" name=internalLink&gt;TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma&amp;nbsp;with first line therapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378883:0" name=internalLink&gt;Update search on Report A05-19A (cholinesterase inhibitors in the treatment of Alzheimer's Disease) - Rapid report&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378837:0" name=internalLink&gt;Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:360293:0" name=internalLink&gt;A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357174:0" name=internalLink&gt;A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357833:0" name=internalLink&gt;A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375795:0" name=internalLink&gt;Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359064:0" name=internalLink&gt;Breast cancer: sentinel node identification and classification after neoadjuvant chemotherapy; systematic review and meta analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361135:0" name=internalLink&gt;Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361069:0" name=internalLink&gt;Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379033:0" name=internalLink&gt;Follow-up for women after treatment for cervical cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359632:0" name=internalLink&gt;Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361022:0" name=internalLink&gt;Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360243:0" name=internalLink&gt;Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360262:0" name=internalLink&gt;Nutritional support and tumour growth in humans: a narrative review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379048:0" name=internalLink&gt;Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361055:0" name=internalLink&gt;Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359341:0" name=internalLink&gt;Psychophysiological outcomes of health qigong for chronic conditions: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360679:0" name=internalLink&gt;Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358596:0" name=internalLink&gt;Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379076:0" name=internalLink&gt;&lt;A href="nelh:379076:0" name=internalLink&gt;Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists&lt;/A&gt;&lt;A href="nelh:379076:0" name=internalLink&gt;&amp;nbsp;monotherapy for stable COPD: a systematic review&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329174:0" name=internalLink&gt;Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359552:0" name=internalLink&gt;Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379447:0" name=internalLink&gt;Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360877:0" name=internalLink&gt;Therapeutic interventions in the treatment of people with multiple sclerosis with mobility problems: a literature review&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;UK Database of Uncertainties about the Effects of Treatments (DUETs)&lt;/STRONG&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:341720:0" name=internalLink&gt;Chinese herbal medicines for induction of remission in advanced or late gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:343383:0" name=internalLink&gt;Systemic chemotherapy versus radiofrequency ablation plus systemic therapy for liver-predominant hepatic metastases of colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:304881:0" name=internalLink&gt;Anticholinergics for urinary symptoms in multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344682:0" name=internalLink&gt;Antiepileptic treatments for seizures in multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344693:0" name=internalLink&gt;Comprehensive exercise interventions for multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344652:0" name=internalLink&gt;Interferon beta for primary progressive multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344691:0" name=internalLink&gt;Intravenous polyclonal human immunoglobins for relapse-remitting multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344689:0" name=internalLink&gt;Natalizumab (alone or in combination with other therapies) for multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344687:0" name=internalLink&gt;Risk of progressive multifocal leukoencephalopathy after natalizumab treatment of multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344680:0" name=internalLink&gt;Vocational rehabilitation for persons with multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345079:0" name=internalLink&gt;Cognitive rehabilitation (for domains other than memory and learning) in multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345083:0" name=internalLink&gt;Resistance exercise for walking mobility in people with multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345074:0" name=internalLink&gt;Water-based exercise programmes for the treatment of mild multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345073:0" name=internalLink&gt;Yoga for the treatment of mild multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346303:0" name=internalLink&gt;Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:341778:0" name=internalLink&gt;Treadmill training for patients with Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:304915:0" name=internalLink&gt;Treatment for familial amyotrophic lateral sclerosis/motor neuron disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:329049:0" name=internalLink&gt;A systematic review of the role of immunonutrition in patients undergoing surgery for head and neck cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378203:0" name=internalLink&gt;A systematic review to investigate the effectiveness and acceptability of interventions for moist desquamation in radiotherapy patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378204:0" name=internalLink&gt;Effectiveness of topical administration of opioids in palliative care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378213:0" name=internalLink&gt;Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378212:0" name=internalLink&gt;Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:378473:0" name=internalLink&gt;Mortality and quality of life with protective defunctioning stoma versus no stoma protection in low anterior resection for rectal carcinoma&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED&lt;/STRONG&gt;) &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:369451:0" name=internalLink&gt;Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:365503:0" name=internalLink&gt;Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366396:0" name=internalLink&gt;Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:364292:0" name=internalLink&gt;Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;MS sufferers welcome first licensed cannabis-based drug&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;Acupuncture pain molecule pinpointed&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346837</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=346837]]&gt;</url>
    <title>2010-March. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-March. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;National Library of Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: (all published 24 March 2010)&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:346529:0" name=internalLink&gt;Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. NICE Clinical Guideline 95&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346559:0" name=internalLink&gt;Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. NICE Clinical Guideline 96&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345786:0" name=internalLink&gt;Manual for Cancer Services 2008: cancer research network measures. Published 12 March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;American College of Gastroenterology:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:345635:0" name=internalLink&gt;Role of esophageal stents in benign and malignant diseases. Published February 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Thoracic Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:345082:0" name=internalLink&gt;BTS guidelines for home oxygen in children. Published August 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;World Health Organisation:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:345565:0" name=internalLink&gt;Treatment of tuberculosis guidelines: fourth edition. Published March 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:345574:0" name=internalLink&gt;Guidelines for surveillance of drug resistance in tuberculosis: fourth edition. Published September 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:321440:0" name=internalLink&gt;Angiogenesis-inhibitors for metastatic thyroid cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346309:0" name=internalLink&gt;Antidepressants for depression in physically ill people&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346299:0" name=internalLink&gt;Carnitine for fatigue in multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346282:0" name=internalLink&gt;Chest physiotherapy for pneumonia in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346293:0" name=internalLink&gt;Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346281:0" name=internalLink&gt;Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346303:0" name=internalLink&gt;Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346286:0" name=internalLink&gt;Pharmacological treatment of depression in patients with a primary brain tumour&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Clinical Kknowledge Summaries (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:345944:0" name=internalLink&gt;Depression: Bereavement&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347188:0" name=internalLink&gt;Breast pain - cyclical: Diagnosis of cyclical breast pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347157:0" name=internalLink&gt;Dementia&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347158:0" name=internalLink&gt;Dementia: Dementia screening, diagnosis, and assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347160:0" name=internalLink&gt;Dementia: Managing end-of-life problems (palliative care)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347159:0" name=internalLink&gt;Dementia: Ongoing management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:347161:0" name=internalLink&gt;Dementia: Supporting carers of people with dementia&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.northernireland.gov.uk/news/news-dhssps/news-dhssps-18032010-individuals-must-be.htm" target="_blank"&gt;Individuals must be supported to die in their place of choice&lt;/A&gt;&amp;nbsp; - Northern Ireland Executive&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://news.bbc.co.uk/1/hi/scotland/8566762.stm" target="_blank"&gt;Cancer patients 'miss out' on 8 million pounds&lt;/A&gt; - BBC&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.e-lfh.org.uk/projects/e-elca/launch/index.html" target="_blank"&gt;e-learning for End of Life Care e-ELCA&lt;/A&gt; - e-Learning for Healthcare&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/7345855/Chronic-pain-is-a-disease-experts-argue.html" target="_blank"&gt;Chronic pain is a disease, experts argue&lt;/A&gt; - Rebecca Smith, Telegraph&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371617</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=371617]]&gt;</url>
    <title>2010-May. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-May. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:375357:0" name=internalLink&gt;Constipation in children and young people: diagnosis and management of idiopathic childhood constipation in primary and secondary care. NICE Care Guideline 99. Published 26 May 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375377:0" name=internalLink&gt;Sorafenib for the treatment of advanced hepatocellular carcinoma. NICE Technology Appraisal Guidance 188. Published 26 May 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:122080:0" name=internalLink&gt;Guidance on cancer services: improving outcomes for people with skin tumours including melanoma. NICE Cancer Service Guidance. Published May 2006, updated 25 May 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374351:0" name=internalLink&gt;Laparoscopic radical hysterectomy for early stage cervical cancer. NICE Interventional Procedure Guidance 338. Published 19 May 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;SIGN:&lt;/EM&gt;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:29889:0" name=internalLink&gt;Management of sore throat and indications for tonsillectomy. SIGN National Clinical Guideline 117. Published 30 April 2010&lt;/A&gt;.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept&lt;/EM&gt; of Health:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:373199:0" name=internalLink&gt;Manual for cancer services 2008 - colorectal measures. Published 26 March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;College of Occupational Therapists:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:374202:0" name=internalLink&gt;Occupational therapy for people with Parkinson’s disease: best practice guidelines. Published 17 May 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;GAIN:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:182145:0" name=internalLink&gt;Northern Ireland guidelines for management of chronic kidney disease. Published February 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:374527:0" name=internalLink&gt;Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374532:0" name=internalLink&gt;Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374523:0" name=internalLink&gt;Covering ileo- or colostomy in anterior resection for rectal carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374520:0" name=internalLink&gt;High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374541:0" name=internalLink&gt;Perianal injectable bulking agents as treatment for faecal incontinence in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374530:0" name=internalLink&gt;Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Clinical Knowledge Summaries (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:374417:0" name=internalLink&gt;Headache - cluster: Diagnosis of cluster headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374418:0" name=internalLink&gt;Headache - medication overuse: Diagnosis of medication overuse headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374419:0" name=internalLink&gt;Headache - tension-type: Diagnosis of tension-type headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374492:0" name=internalLink&gt;Tiredness/fatigue in adults: Assessment of tiredness/fatigue in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:375510:0" name=internalLink&gt;A systematic review of tests for lymph node status in primary endometrial cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375589:0" name=internalLink&gt;A systematic review of the effectiveness of communication interventions for health care providers caring for patients in residential care settings&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375628:0" name=internalLink&gt;Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374772:0" name=internalLink&gt;Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375524:0" name=internalLink&gt;Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: guideline recommendations&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375588:0" name=internalLink&gt;Anticonvulsant drugs for pediatric migraine prevention: an evidence-based review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374552:0" name=internalLink&gt;Are cancer-related decision aids effective? A systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374762:0" name=internalLink&gt;Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374743:0" name=internalLink&gt;Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375605:0" name=internalLink&gt;Biofeedback therapy in fecal incontinence and constipation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374587:0" name=internalLink&gt;Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375495:0" name=internalLink&gt;Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375499:0" name=internalLink&gt;Comparative effectiveness of therapies for clinically localized prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374595:0" name=internalLink&gt;Current status of research on osteoporosis in COPD: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374768:0" name=internalLink&gt;Does exercise therapy improve headache? A systematic review with meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375579:0" name=internalLink&gt;Erythropoiesis-stimulating agents for anemia of chronic kidney disease: systematic review and economic evaluation&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375720:0" name=internalLink&gt;Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375526:0" name=internalLink&gt;Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374565:0" name=internalLink&gt;Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a literature-based meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375608:0" name=internalLink&gt;Ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma: a clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374550:0" name=internalLink&gt;Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375789:0" name=internalLink&gt;Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374705:0" name=internalLink&gt;Interventions to promote cancer awareness and early presentation: systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374711:0" name=internalLink&gt;Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374633:0" name=internalLink&gt;Lymphoedema therapy in breast cancer patients: a systematic review on effectiveness and a survey of current practices and costs in Finland&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375509:0" name=internalLink&gt;Management of brain metastases: role of radiotherapy alone or in combination with other treatment modalities&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374554:0" name=internalLink&gt;Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375530:0" name=internalLink&gt;Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375567:0" name=internalLink&gt;Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374651:0" name=internalLink&gt;Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375542:0" name=internalLink&gt;Quality of life in children with acute lymphoblastic leukaemia: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375700:0" name=internalLink&gt;Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374625:0" name=internalLink&gt;Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374641:0" name=internalLink&gt;Tailored information about cancer risk and screening: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375483:0" name=internalLink&gt;The "relative" efficacy of involving family in psychosocial interventions for chronic illness: are there added benefits to patients and family members?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374715:0" name=internalLink&gt;The prognostic value of symptom responses in the conservative management of spinal pain: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375502:0" name=internalLink&gt;The use of bisphosphonates in men with hormone-refractory prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374617:0" name=internalLink&gt;Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374786:0" name=internalLink&gt;Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED&lt;/STRONG&gt;)&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:374791:0" name=internalLink&gt;Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374816:0" name=internalLink&gt;Nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374814:0" name=internalLink&gt;The value of positron emission tomography in patients with non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374833:0" name=internalLink&gt;Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374793:0" name=internalLink&gt;VA healthcare costs of a collaborative intervention for chronic pain in primary care&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>396444</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=396444]]&gt;</url>
    <title>2010-November. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-November. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE:&lt;/EM&gt; (All guidance published 24 November 2010)&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:394987:0" name=internalLink&gt;Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours: part review of NICE technology appraisal guidance 86. NICE Technology Appraisal Guidance 209&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:394968:0" name=internalLink&gt;Trastuzumab for the treatment of HER2-positive metastatic gastric cancer. NICE Technology Appraisal Guidance 208&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Dept of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:394586:0" name=internalLink&gt;Improving care for people with long term conditions: 'at a glance' information sheets for healthcare professionals Published 17 November 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:393823:0" name=internalLink&gt;Nothing ventured, nothing gained: risk guidance for people with dementia. Published 09 November 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Thoracic Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:393682:0" name=internalLink&gt;Guidelines on the radical management of patients with lung cancer. Published 23 October 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;NHS Quality Improvement Scotland:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:394093:0" name=internalLink&gt;Clinical Standards: chronic obstructive pulmonary disease services. Published March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Multiple Sclerosis Society:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:296489:0" name=internalLink&gt;A guide to MS for GPs and primary care professionals. Updated December 2009, replaces earlier guidance of 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:393869:0" name=internalLink&gt;Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:393856:0" name=internalLink&gt;Pharmacological treatments for fatigue associated with palliative care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:393859:0" name=internalLink&gt;Probiotics for treating persistent diarrhoea in children&lt;BR&gt;Radical prostatectomy versus watchful waiting for prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:393868:0" name=internalLink&gt;Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:379369:0" name=internalLink&gt;A systematic review of integrated use of disease-management interventions in asthma and COPD&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382394:0" name=internalLink&gt;A systematic review of oxymorphone in the management of chronic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375724:0" name=internalLink&gt;A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:361163:0" name=internalLink&gt;Accuracy of ultrasonography with color doppler in ovarian tumor: a systematic quantitative review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379264:0" name=internalLink&gt;Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner [cancer]: meta-analysis of six randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382398:0" name=internalLink&gt;Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382330:0" name=internalLink&gt;Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358647:0" name=internalLink&gt;Drug treatment of delirium: past, present and future&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358120:0" name=internalLink&gt;Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382565:0" name=internalLink&gt;Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357418:0" name=internalLink&gt;Is rectal washout effective for preventing localized recurrence after anterior resection for rectal cancer?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359100:0" name=internalLink&gt;Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:385615:0" name=internalLink&gt;Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359976:0" name=internalLink&gt;Pain management interventions in the nursing home: a structured review of the literature&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382336:0" name=internalLink&gt;Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382408:0" name=internalLink&gt;The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375783:0" name=internalLink&gt;The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382600:0" name=internalLink&gt;Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:395330:0" name=internalLink&gt;Acupuncture and&amp;nbsp;acupressure for the treatment of nausea and vomiting&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395410:0" name=internalLink&gt;Anemia in heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395331:0" name=internalLink&gt;Botulinum toxin treatment for primary headache&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395287:0" name=internalLink&gt;Comparative evaluation of radiation treatments for clinically localized prostate cancer: an update&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395292:0" name=internalLink&gt;Consideration of evidence on antiemetic drugs for nausea and vomiting associated with chemotherapy or radiation therapy in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395291:0" name=internalLink&gt;Diagnosis and treatment of secondary lymphedema&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395356:0" name=internalLink&gt;HeartMate II (Thoratec Corp.) Left Ventricular Assist Device (LVAD) for destination therapy in adult patients with chronic heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395279:0" name=internalLink&gt;Home tests for use in the management of chronic diseases&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395286:0" name=internalLink&gt;Report on the evidence regarding off-label indications for targeted therapies used in cancer treatment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395352:0" name=internalLink&gt;Rituxan (Rituximab) (Genentech Inc. and Biogen Idec Inc.) for multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395340:0" name=internalLink&gt;Transcutaneous electrical nerve stimulation for postoperative and procedural pain&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Clinical Knowledge Summaries (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:395243:0" name=internalLink&gt;Chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395247:0" name=internalLink&gt;Chronic obstructive pulmonary disease: Acute exacerbation of chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395245:0" name=internalLink&gt;Chronic obstructive pulmonary disease: Diagnosis of acute exacerbation of chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395244:0" name=internalLink&gt;Chronic obstructive pulmonary disease: Diagnosis of chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395248:0" name=internalLink&gt;Chronic obstructive pulmonary disease: End-stage chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395246:0" name=internalLink&gt;Chronic obstructive pulmonary disease: Stable chronic obstructive pulmonary disease&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395223:0" name=internalLink&gt;Heart failure - chronic&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395225:0" name=internalLink&gt;Heart failure - chronic: Chronic heart failure with left ventricular systolic dysfunction on echocardiography&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395227:0" name=internalLink&gt;Heart failure - chronic: End-stage chronic heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395226:0" name=internalLink&gt;Heart failure - chronic: Heart failure symptoms with preserved left ventricular ejection fraction&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395228:0" name=internalLink&gt;Heart failure - chronic: Managing comorbidities in heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:395224:0" name=internalLink&gt;Heart failure - chronic: Suspected heart failure&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:391413:0" name=internalLink&gt;Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366391:0" name=internalLink&gt;Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:391417:0" name=internalLink&gt;Cost-effectiveness analysis of trastuzumab (Herceptin) in HER2-overexpressed metastatic breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:386102:0" name=internalLink&gt;Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:362241:0" name=internalLink&gt;Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:365940:0" name=internalLink&gt;Cost-utility analysis of the CyberKnife system for metastatic spinal tumors&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;SPAN lang=EN style="FONT-SIZE: 9pt; COLOR: black; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold; mso-ansi-language: EN"&gt;Some of the items added to the &lt;/SPAN&gt;&lt;SPAN lang=EN style="FONT-SIZE: 9pt; COLOR: black; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN"&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-weight: bold"&gt;'Evidence in the News' RSS feed&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt; last month&lt;/SPAN&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=394486" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Annual Evidence Update on Supportive and palliative care in chronic lung disease&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/respiratory/ViewResource.aspx?resID=394010&amp;amp;tabID=289&amp;amp;catID=5880" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;2010 Annual Evidence Update on Chronic Obstructive Pulmonary Disease &lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.bmj.com/content/341/bmj.c6622.extract" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Commission is set up to consider law on assisted dying&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.telegraph.co.uk/health/healthnews/8140857/Cancer-patients-abandoned-after-treatment.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Cancer patients 'abandoned after treatment'&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.bbc.co.uk/news/health-11776503" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Report into cancer care in England shows improvement&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.endoflifecareforadults.nhs.uk/news/all/neolcp-publishes-end-of-life-care-in-long-term-neurological-conditions" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;NEoLCP publishes End of Life care in Long Term Neurological Conditions&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.guardian.co.uk/society/2010/nov/14/dying-at-home-demos-report" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Demos thinktank calls for change in British approach to death&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.endoflifecareforadults.nhs.uk/news/all/nhs-north-east-publishes-a-good-death-time-to-think" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;NHS North East publishes A Good Death - time to think&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.bbc.co.uk/news/health-11742166" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;People 'denied' die at home wish&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Arial','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/IMPROVEMENT/ViewResource.aspx?resID=393960&amp;amp;tabID=289" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;End of Life Care - Annual Evidence Update&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; LINE-HEIGHT: 115%; FONT-FAMILY: 'Arial','sans-serif'"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 2"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>389446</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=389446]]&gt;</url>
    <title>2010-October. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-October. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NICE: &lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:392558:0" name=internalLink&gt;Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal). NICE Technology Appraisal Guidance 207. Published 27 October 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:392554:0" name=internalLink&gt;Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal). NICE Technology Appraisal Guidance 206. Published 27 October 2010&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Australian and New Zealand Intensive Care Society (ANZICS):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:391505:0" name=internalLink&gt;The ANZICS statement on death and organ donation. Published 15 September 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;British Committee for Standards in Haematology:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:392089:0" name=internalLink&gt;Guidelines on the diagnosis and management of multiple myeloma. Published 14 October 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:392075:0" name=internalLink&gt;Guidelines for supportive care in myeloma. Published 14 October 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:392120:0" name=internalLink&gt;Facilities for the treatment of adults with haematological malignancies – ‘Levels of Care’. Published 20 April 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Resuscitation Council (UK):&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:391545:0" name=internalLink&gt;The legal status of those who attempt resuscitation, Published August 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:111764:0" name=internalLink&gt;Resuscitation Guidelines 2010 published 18 October 2010, replacing RC(UK) guidelines of 2005. 10 URLS updated&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;Department of Health:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:273242:0" name=internalLink&gt;Essence of Care 2010. Published 01 October 2010, updates and replaces all previous editions from 2001 onwards&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;UK Blood Transfusion Services:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:123945:0" name=internalLink&gt;Position statement: Creutzfeldt-Jakob Disease. Published 15 July 2010, replaces earlier guidance of March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews&lt;/P&gt;&lt;/STRONG&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:389387:0" name=internalLink&gt;Droperidol for treatment of nausea and vomiting in palliative care patients&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389409:0" name=internalLink&gt;Ibuprofen with or without an antiemetic for acute migraine headaches in adults&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Health Technology Assessments (HTA)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:389729:0" name=internalLink&gt;Avastin (Bevacizumab) (Genentech Inc.) for the treatment of metastatic renal cell carcinoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389815:0" name=internalLink&gt;Bendamustine (Ribomustin/Treanda/ Levact) for indolent non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukaemia (CLL) and multiple myeloma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389694:0" name=internalLink&gt;Bioimpedance for assessment of lymphedema&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389621:0" name=internalLink&gt;Chemoembolization of hepatocellular carcinoma with drug eluting beads (DC Beads)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389620:0" name=internalLink&gt;Clofarabine for the treatment of adult leukemia and lymphoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389615:0" name=internalLink&gt;Electrical stimulation for the treatment of headaches&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389794:0" name=internalLink&gt;From efficacy to effectiveness in cancer research&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389752:0" name=internalLink&gt;High-dose immunosuppressive therapy with or without hematopoietic transplantation for the treatment of multiple sclerosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389630:0" name=internalLink&gt;High-intensity focused ultrasound treatment for prostate cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389631:0" name=internalLink&gt;Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from cancers of the lower gastrointestinal tract&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389632:0" name=internalLink&gt;Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389633:0" name=internalLink&gt;Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from ovarian cancer, peritoneal mesothelioma, or abdominal sarcoma&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389814:0" name=internalLink&gt;Lapatinib ditosylate (Tyverb/Tykerb) as first-line therapy for the treatment of advanced/metastatic breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389786:0" name=internalLink&gt;Neoadjuvant radiochemotherapy for rectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389795:0" name=internalLink&gt;Neuroimaging for the evaluation of chronic headaches&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389816:0" name=internalLink&gt;Panitumumab (Vectibix) for the first-line treatment of metastatic colorectal cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389702:0" name=internalLink&gt;Pneumatic compression therapy for mastectomy-related lymphedema&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389649:0" name=internalLink&gt;TheraGuide 5-FU (Myriad Genetic Laboratories Inc.) for predicting toxicity to 5-Fluorouracil (5-FU) / Capecitabine-based Chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389817:0" name=internalLink&gt;Trastuzumab (Herceptin) in addition to standard chemotherapy as first-line therapy for advanced gastric cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389716:0" name=internalLink&gt;Trigger point injections for myofascial pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389771:0" name=internalLink&gt;UGT1A1 Sequence Variant Testing for Predicting Response to Irinotecan Therapy in Colorectal Cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389744:0" name=internalLink&gt;Velcade (Bortezomib) (Millennium: The Takeda Oncology Company) for mantle cell lymphoma&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Database of Abstracts of Reviews of Effects (DARE)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:382347:0" name=internalLink&gt;Do specialized centers and specialists produce better outcomes for patients with chronic diseases than primary care generalists? A systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:360354:0" name=internalLink&gt;Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375740:0" name=internalLink&gt;Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359779:0" name=internalLink&gt;Implementation of integrated care for patients with cancer: a systematic review of interventions and effects&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:357822:0" name=internalLink&gt;Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:379301:0" name=internalLink&gt;Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:359750:0" name=internalLink&gt;Risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy: meta-analysis of nine epidemiological studies&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:375785:0" name=internalLink&gt;The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:374713:0" name=internalLink&gt;Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:358677:0" name=internalLink&gt;Whole brain radiotherapy with radiosensitizer for brain metastases&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;UK Database of Uncertainties about the Effects of Treatments (DUETs)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:345400:0" name=internalLink&gt;Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:383819:0" name=internalLink&gt;Transcutaneous electric nerve stimulation (TENS) in the treatment of pain in neurologic disorders&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:385320:0" name=internalLink&gt;Nutritional support in children and young people with cancer undergoing chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:385322:0" name=internalLink&gt;Palliative surgery versus medical management for bowel obstruction in ovarian cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Clinical Knowledge Summaries (CKS)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:389335:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: Aspirin&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389333:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: Choice of analgesic&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389338:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: Combining analgesics&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389336:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: NSAIDs&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389334:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: Paracetamol&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389337:0" name=internalLink&gt;Analgesia - mild-to-moderate pain: Weak opioids&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389332:0" name=internalLink&gt;Analgesia - mild-to-moderate pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:300562:0" name=internalLink&gt;Breast pain - cyclical: Breast pain - cyclical&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:300561:0" name=internalLink&gt;Breast pain - cyclical&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389344:0" name=internalLink&gt;Constipation in children: Constipation in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389343:0" name=internalLink&gt;Constipation in children: Diagnosis and assessment of constipation in children older than 1 year&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389342:0" name=internalLink&gt;Constipation in children: Diagnosis and assessment of constipation in children younger than 1 year&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389341:0" name=internalLink&gt;Constipation in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389353:0" name=internalLink&gt;Cough: Diagnosis - cough 3-8 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389352:0" name=internalLink&gt;Cough: Diagnosis - cough less than 3 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389354:0" name=internalLink&gt;Cough: Diagnosis - cough more than 8 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389356:0" name=internalLink&gt;Cough: Management - cough 3-8 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389355:0" name=internalLink&gt;Cough: Management - cough less than 3 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389357:0" name=internalLink&gt;Cough: Management - cough more than 8 weeks' duration&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389351:0" name=internalLink&gt;Cough&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326885:0" name=internalLink&gt;Diarrhoea - antibiotic associated: Diarrhoea - antibiotic associated&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326884:0" name=internalLink&gt;Diarrhoea - antibiotic associated&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323366:0" name=internalLink&gt;Headache - assessment: Headache - assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323365:0" name=internalLink&gt;Headache - assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323368:0" name=internalLink&gt;Headache - cluster: Headache - cluster&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323367:0" name=internalLink&gt;Headache - cluster&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323372:0" name=internalLink&gt;Headache - tension-type: Managing tension-type headache in adults&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323373:0" name=internalLink&gt;Headache - tension-type: Managing tension-type headache in children&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:323371:0" name=internalLink&gt;Headache - tension-type&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:319125:0" name=internalLink&gt;Heart failure - chronic: End-stage chronic heart failure&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389340:0" name=internalLink&gt;Neuropathic pain - drug treatment: Neuropathic pain - drug treatment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:389339:0" name=internalLink&gt;Neuropathic pain - drug treatment&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;NHS Economic Evaluation Database (NEED)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:370328:0" name=internalLink&gt;An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:366736:0" name=internalLink&gt;Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:363203:0" name=internalLink&gt;Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:385740:0" name=internalLink&gt;Cost-effectiveness of erlotinib versus docetaxel for second-line treatment of advanced non-small-cell lung cancer in the United Kingdom&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:391381:0" name=internalLink&gt;Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:382175:0" name=internalLink&gt;The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic Markov model&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:369086:0" name=internalLink&gt;Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications&lt;/A&gt;&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;Does aspirin cut bowel cancer risk?&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSS/CMS.aspx?feed=115" target="_blank"&gt;Cancer Drugs Fund will provide £200million per year&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>387534</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=387534]]&gt;</url>
    <title>2010-September. New records added to the Supportive and Palliative Care specialist collection</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;2010-September. New records added to the Supportive and Palliative Care specialist collection&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Guidelines&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;British Association of Perinatal Medicine:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:387696:0" name=internalLink&gt;Palliative care (supportive and end of life care): a framework for clinical practice in perinatal medicine. Published August 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane Database of Systematic Reviews &lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:387505:0" name=internalLink&gt;Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387502:0" name=internalLink&gt;Interventions for cough in cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387509:0" name=internalLink&gt;Interventions for nausea and vomiting in early pregnancy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387508:0" name=internalLink&gt;Interventions for the treatment of borderline ovarian tumours&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387521:0" name=internalLink&gt;Interventions for the treatment of keratocystic odontogenic tumours (KCOT, odontogenic keratocysts (OKC))&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387488:0" name=internalLink&gt;Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387497:0" name=internalLink&gt;Maintenance chemotherapy for ovarian cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387482:0" name=internalLink&gt;Non-hormonal interventions for hot flushes in women with a history of breast cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387511:0" name=internalLink&gt;Non-invasive brain stimulation techniques for chronic pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:387498:0" name=internalLink&gt;Vaginal dilator therapy for women receiving pelvic radiotherapy&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Some of the items added to the &lt;/STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/RSSFeed.aspx?feed=115" target="_blank"&gt;&lt;STRONG&gt;'Evidence in the News' RSS feed&lt;/STRONG&gt;&lt;/A&gt;&lt;STRONG&gt; last month&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=386964" target="_blank"&gt;Annual Evidence Update 6 Sep 2010 'Gastrointestinal symptoms in supportive and palliative care' - anorexia and cachexia&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;A class=__feedview__feedItemUnreadTitleLink href="http://info.cancerresearchuk.org/news/archive/pressrelease/UK-cancer-plans-need-focus" target="_blank"&gt;Report card delivered on UK cancer plans&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A class=__feedview__feedItemUnreadTitleLink href="http://www.ncpc.org.uk/" target="_blank"&gt;The NCPC and the Dying Matters Coalition respond to the publication of the End of Life Care Strategy 2nd Annual Report&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A class=__feedview__feedItemUnreadTitleLink href="http://www.bbc.co.uk/news/health-11406741" target="_blank"&gt;Breast cancer partners' mood risk&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>305896</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=305896]]&gt;</url>
    <title>9 February 2009 AEU: Bowel obstruction</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ GASTRO-INTESTINAL,SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE,COLON &amp; RECTUM,GASTROENTEROLOGY &amp; LIVER DISEASES,FEBRUARY 2009,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;9 February 2009 AEU: Bowel obstruction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;RETURN TO THE CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Methods&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We searched Pubmed with the following search strategy:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Intestinal Obstruction[MeSH Terms]&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;AND&lt;/P&gt;
&lt;P&gt;systematic or "meta-analysis" or "meta analysis"&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;AND&lt;/P&gt;
&lt;P&gt;palliat* or supportive or hospice*&lt;BR&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Limits =&amp;nbsp;2007 to the present date.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2 Cochrane reviews from 2000 are also&amp;nbsp;included. In addition, some other key sources are included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Included records&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Colonic stenting for malignant disease: review of literature&lt;/STRONG&gt;. Dionigi G, Villa F, Rovera F, Boni L, Carrafiello G, Annoni M, Castano P, Bianchi V, Mangini M, Recaldini C, Laganà D, Bacuzzi A, Dionigi R. Surg Oncol. 2007 Dec;16 Suppl 1:S153-5. Epub 2007 Nov 26.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18023172" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review&lt;/STRONG&gt;. Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ. Ann Surg. 2007 Jul;246(1):24-30. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17592286" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review&lt;/STRONG&gt;. Mercadante S, Casuccio A, Mangione S. J Pain Symptom Manage. 2007 Feb;33(2):217-23. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17280927" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Comparison of colonic stenting and open surgery for malignant large bowel obstruction&lt;/STRONG&gt;. Tilney HS, Lovegrove RE, Purkayastha S, Sains PS, Weston-Petrides GK, Darzi AW, Tekkis PP, Heriot AG. Surg Endosc. 2007 Feb;21(2):225-33. Epub 2006 Dec 9. PMID: 17160651 &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17160651" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer&lt;/STRONG&gt;. Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Cochrane Database Syst Rev. 2000;(4):CD002764. &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=237502&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer&lt;/STRONG&gt;. Feuer DJ, Broadley KE. Cochrane Database Syst Rev. 2000;(2):CD001219. &lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=236902&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Other key sources&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction&lt;/STRONG&gt;. Anthony T, Baron T, Mercadante S, Green S, Chi D, Cunningham J, Herbst A, Smart E, Krouse RS. J Pain Symptom Manage. 2007 Jul;34(1 Suppl):S49-59. Epub 2007 Jun 4. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17544243" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Ethical issues in research to improve the management of malignant bowel obstruction: challenges and recommendations&lt;/STRONG&gt;. Laneader A, Angelos P, Ferrell BR, Kolker A, Miner T, Padilla G, Swaney J, Krouse RS, Casarett D. J Pain Symptom Manage. 2007 Jul;34(1 Suppl):S20-7. Epub 2007 May 25. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17532176" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Prospective integration of cultural consideration in biomedical research for patients with advanced cancer: recommendations from an international conference on malignant bowel obstruction in palliative care&lt;/STRONG&gt;. Fineberg IC, Grant M, Aziz NM, Payne R, Kagawa-Singer M, Dunn GP, Kinzbrunner BM, Palos G, Shinagawa SM, Krouse RS. J Pain Symptom Manage. 2007 Jul;34(1 Suppl):S28-39. Epub 2007 May 25. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17532174" target="_blank"&gt;[Link&amp;nbsp;to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial&lt;/STRONG&gt;.&amp;nbsp;Mystakidou K, Tsilika E, Kalaidopoulou O, Chondros K, Georgaki S, Papadimitriou L. Anticancer Res. 2002 Mar-Apr;22(2B):1187-92. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/12168923" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/results.aspx?t=bowel+obstruction&amp;amp;stfo=False&amp;amp;sc=evi,gui,spl&amp;amp;p=1&amp;amp;sf=&amp;amp;sr=all.search&amp;amp;sfld=fld.title&amp;amp;tab=spl" target="_blank"&gt;Contents of the Library on 'Bowel obstruction'&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;RETURN TO THE CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>305890</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=305890]]&gt;</url>
    <title>9 February 2009 AEU: Constipation</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTROENTEROLOGY &amp; LIVER DISEASES,COMMON CLINICAL PRESENTATIONS,CONSTIPATION,RECENT ADDITIONS,CONSTIPATION AND OTHER BOWEL PROBLEMS,FEBRUARY 2009]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;9 February 2009 AEU: Constipation&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;RETURN TO THE CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Methods&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A Medline search was conducted using the Ovid interface.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;1.Explode palliative care (MESH TERM)&lt;/P&gt;
&lt;P&gt;2.Palliative care as free text&lt;/P&gt;
&lt;P&gt;3. Explode terminal care (MESH TERM)&lt;/P&gt;
&lt;P&gt;4. Terminal care as free text&lt;/P&gt;
&lt;P&gt;5. Explode terminally ill (MESH TERM)&lt;/P&gt;
&lt;P&gt;6.Terminally ill as free text&lt;/P&gt;
&lt;P&gt;7.Hospice$ as free text&lt;/P&gt;
&lt;P&gt;8. Explode hospices (MESH TERM)&lt;/P&gt;
&lt;P&gt;9. End of life as free text &lt;/P&gt;
&lt;P&gt;10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9&lt;/P&gt;
&lt;P&gt;11. Limit above to years 1999-2009, to humans and to English&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; language&lt;/P&gt;
&lt;P&gt;12. Constipation as free text or explode constipation (MESH TERM)&lt;/P&gt;
&lt;P&gt;13. 11 and 12&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;173 items were retrieved in search 13. &lt;/P&gt;
&lt;P&gt;4 systematic reviews were identified.&lt;/P&gt;
&lt;P&gt;In addition, 5 other abstracts were included. &lt;/P&gt;
&lt;P&gt;a) Clinical guidelines published in Palliative Medicine in 2008. (An international&amp;nbsp; panel of palliative care practitioners reviewed&amp;nbsp; the best available evidence) &lt;/P&gt;
&lt;P&gt;b) The abstracts of three articles indicated that a comprehensive literature had been undertaken on constipation management. &lt;/P&gt;
&lt;P&gt;c) One article outlined a survey of constipation management practice in the UK&lt;/P&gt;
&lt;P&gt;A clinical knowledge summary on the subject is available at:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;A href="http://cks.library.nhs.uk/palliative_cancer_care_constipation" target="_blank"&gt;http://cks.library.nhs.uk/palliative_cancer_care_constipation&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Performing a similar search on EMBASE produced no new systematic reviews or meta-analyses. Another systematic review from Clinical Evidence was also found.&lt;/P&gt;
&lt;P&gt;From the list of records included at that stage, just 7 were included in our final list below. This includes a key consensus paper and a recent good quality review&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Included records&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;A systematic review of treatments for constipation in children and young adults undergoing cancer treatment&lt;/STRONG&gt;. J Pediatr Hematol Oncol. 2008 Nov;30(11):829-30. Phillips RS, Gibson F. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18989160" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Constipation in people prescribed opioids&lt;/STRONG&gt;. Ahmedzai SH, Boland J. Clinical Evidence 2007. &lt;A href="http://clinicalevidence.bmj.com/ceweb/conditions/bly/2407/2407.jsp" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review&lt;/STRONG&gt;. J Pain Symptom Manage. 2007 Nov;34(5):547-65. Epub 2007 Sep 27.Becker G, Galandi D, Blum HE. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17900855" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Laxatives for the management of constipation in palliative care patients&lt;/STRONG&gt;.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003448.Miles CL, Fellowes D, Goodman ML, Wilkinson S. &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238139&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation&lt;/STRONG&gt;. J Pain Symptom Manage. 2002 Jul;24(1):71-90. Choi YS, Billings JA.PMID: 12183097 &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/12183097" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In addition, although not&amp;nbsp;systematic reviews, we&amp;nbsp;include a key consensus paper and a recent good quality review:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;The management of constipation in palliative care: clinical practice recommendations&lt;/STRONG&gt;. Palliat Med. 2008 Oct;22(7):796-807. Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW; European Consensus Group on Constipation in Palliative Care. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18838491" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Management of constipation in palliative care patients&lt;/STRONG&gt;. Clemens KE, Klaschik E. Curr Opin Support Palliat Care. 2008 Mar;2(1):22-7.&amp;nbsp;&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685390" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/SearchResults.aspx?tabID=289&amp;amp;catID=12206" target="_blank"&gt;Contents of the Library on Constipation&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;RETURN TO THE CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>305891</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=305891]]&gt;</url>
    <title>9 February 2009 AEU: Nausea and vomiting</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE,COMMON CLINICAL PRESENTATIONS,GASTROENTEROLOGY &amp; LIVER DISEASES,NAUSEA &amp; VOMITING,NAUSEA &amp; VOMITING,FEBRUARY 2009,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;9 February 2009 AEU: Nausea and vomiting&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;RETURN TO THE CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Methods&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We ran an "advanced" search on Pubmed, selecting the "clinical queries" option and then using the "Find systematic reviews" field to enter this search string:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Search (emesis[tw] OR vomiting[mh] OR nausea[mh]) AND systematic[sb] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Limits: Humans, English&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2005 to present date&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Our initial search (without limiting by year)&amp;nbsp;gave 377 hits of which 197 were listed under the review tab.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We then limited by year. In addition, we included some additional sources we found.&lt;/P&gt;
&lt;P&gt;We included 20 records in our final list.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Included records&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;The impact of prophylactic dexamethasone on nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis&lt;/STRONG&gt;. Karanicolas PJ, Smith SE, Kanbur B, Davies E, Guyatt GH. Ann Surg. 2008 Nov;248(5):751-62.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18948802" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;P6 stimulation for the prevention of nausea and vomiting associated with cesarean delivery under neuraxial anesthesia: a systematic review of randomized controlled trials&lt;/STRONG&gt;. Allen TK, Habib AS. Anesth Analg. 2008 Oct;107(4):1308-12.&amp;nbsp;&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18806045" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Evidence-based recommendations for cancer nausea and vomiting&lt;/STRONG&gt;. Naeim A, Dy SM, Lorenz KA, Sanati H, Walling A, Asch SM. J Clin Oncol. 2008 Aug 10;26(23):3903-10.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18688059" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis&lt;/STRONG&gt;. Machado Rocha FC, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX. Eur J Cancer Care (Engl). 2008 Sep;17(5):431-43. Epub 2008 Jul 9.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18625004" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Use of intrathecal midazolam to improve perioperative analgesia: a meta-analysis&lt;/STRONG&gt;. Ho KM, Ismail H. Anaesth Intensive Care. 2008 May;36(3):365-73. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18564797" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Does supplemental oxygen reduce postoperative nausea and vomiting? A meta-analysis of randomized controlled trials&lt;/STRONG&gt;. Orhan-Sungur M, Kranke P, Sessler D, Apfel CC. Anesth Analg. 2008 Jun;106(6):1733-8.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18499603" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Antiemetics: an update and the MASCC guidelines applied in clinical practice&lt;/STRONG&gt;. Herrstedt J. Nat Clin Pract Oncol. 2008 Jan;5(1):32-43.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18097455" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain&lt;/STRONG&gt;. Davis MP. Expert Opin Investig Drugs. 2008 Jan;17(1):85-95.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18095921" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Is ondansetron more effective than granisetron for chemotherapy-induced nausea and vomiting? A review of comparative trials&lt;/STRONG&gt;. Vrabel M. Clin J Oncol Nurs. 2007 Dec;11(6):809-13.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18063539" target="_blank"&gt; [Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence&lt;/STRONG&gt;. Richardson J, Smith JE, McCall G, Richardson A, Pilkington K, Kirsch I. Eur J Cancer Care (Engl). 2007 Sep;16(5):402-12.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17760926" target="_blank"&gt; [Link to Pubmed abstract] &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Prevention of postoperative nausea and vomiting&lt;/STRONG&gt;.&amp;nbsp; Wilhelm SM, Dehoorne-Smith ML, Kale-Pradhan PB. Ann Pharmacother. 2007 Jan;41(1):68-78. Epub 2007 Jan 2.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17200430" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis&lt;/STRONG&gt;. Neufeld SM, Newburn-Cook CV. J Neurosurg Anesthesiol. 2007 Jan;19(1):10-7.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17198095" target="_blank"&gt;[Link to Pubmed abstract] &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents&lt;/STRONG&gt;. Alhashimi D, Alhashimi H, Fedorowicz Z. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005506.&amp;nbsp; Update of: Cochrane Database Syst Rev. 2006;3:CD005506. &lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=239143&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Acupuncture for nausea and vomiting: an update of clinical and experimental studies&lt;/STRONG&gt;. Streitberger K, Ezzo J, Schneider A. Auton Neurosci. 2006 Oct 30;129(1-2):107-17. Epub 2006 Sep 1.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16950659" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents&lt;/STRONG&gt;. Alhashimi D, Alhashimi H, Fedorowicz Z. Cochrane Database Syst Rev. 2006 Jul 19;3:CD005506.&amp;nbsp; Update in: Cochrane Database Syst Rev. 2006;(4):CD005506. &lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=239143&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Drugs for preventing postoperative nausea and vomiting&lt;/STRONG&gt;. Carlisle JB, Stevenson CA. Cochrane Database Syst Rev. 2006 Jul 19;3:CD004125.&amp;nbsp; &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238713&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting&lt;/STRONG&gt;. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002285.&amp;nbsp; &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=237457&amp;amp;tabID=289" target="_blank"&gt;[Link to full text]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis.&lt;/STRONG&gt; Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. Am J Obstet Gynecol. 2006 Jan;194(1):95-9.&amp;nbsp;Comment in: Evid Based Nurs. 2006 Jul;9(3):80.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17725149" target="_blank"&gt; [Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference.&lt;/STRONG&gt; Ann Oncol. 2006 Jan;17(1):20-8. Epub 2005 Nov 28.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16314401" target="_blank"&gt;[Link to Pubmed abstract] &lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting&lt;/STRONG&gt;. Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA.Obstet Gynecol. 2005 Apr;105(4):849-56. Comment in: Obstet Gynecol. 2005 Sep;106(3):640; author reply 640-1. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15802416" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/SearchResults.aspx?tabID=289&amp;amp;catID=10291" target="_blank"&gt;Contents of the Library on 'Nausea and vomiting'&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Clinical Knowledge Summaries:&lt;/STRONG&gt;&lt;/LI&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=272737&amp;amp;tabID=288&amp;amp;catID=10291" target="_blank"&gt;Palliative cancer care - nausea &amp;amp; vomit: Nausea and vomiting - assessment&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=272738&amp;amp;tabID=288&amp;amp;catID=10291" target="_blank"&gt;Palliative cancer care - nausea &amp;amp; vomit: Nausea and vomiting - management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=272739&amp;amp;tabID=288&amp;amp;catID=10291" target="_blank"&gt;Palliative cancer care - nausea &amp;amp; vomit: Nausea and vomiting at the end of life&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=272736&amp;amp;tabID=288&amp;amp;catID=10291" target="_blank"&gt;Palliative cancer care - nausea and vomiting&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305892&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;RETURN TO THE CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>187544</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.cambslpc.org.uk/PDF%20documents/CPCT/Policy%20for%20Subcutaneous%20Administration%20of%20Fluids%20(Hypodermoclysis)%20to%20Adults%20in%20Community%20%20Community%20Hospitals.pdf]]&gt;</url>
    <title>Administration of subcutaneous fluids</title>
    <publicationDate></publicationDate>
    <publisher>Cambridge City PCT and South Cambridgeshire PCT</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,NUTRITION,MOUTH CARE AND DYSPHAGIA,SLEEP,PSYCHIATRIC,NAUSEA &amp; VOMITING,HEADACHE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Procedure guidelines developed to highlight the need for a collaborative approach for District Nurses considering this intervention.]]&gt;</body>
  </document>
  <document>
    <id>88921</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/805/CN-00047805/frame.html]]&gt;</url>
    <title>Aggressiveness of nursing care for older patients and those with do-not-resuscitate orders</title>
    <publicationDate>2009-03-02T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SERVICE PROVISION,ETHICS &amp; LAW,WITHHOLDING &amp; WITHDRAWING TREATMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Age and do-not-resuscitate (DNR) orders were experimentally manipulated with a 2 X 2 factorial design using four vignettes which were randomly assigned to 95 staff nurses from four sites in a mid-Atlantic metropolitan area.]]&gt;</body>
  </document>
  <document>
    <id>101601</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/601/CN-00155601/frame.html]]&gt;</url>
    <title>An assessment of open communication between people with terminal cancer, caring relatives, and others during home care</title>
    <publicationDate></publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,SERVICE PROVISION,SERVICE TYPE,PLACE OF CARE,HOME-BASED CARE,OWN HOME,COMMUNICATION ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &amp;nbsp;]]&gt;</body>
  </document>
  <document>
    <id>304346</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304346]]&gt;</url>
    <title>Annotated reference/bibliography on user involvement in palliative care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annotated reference/bibliography on user involvement in palliative care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;&lt;BR&gt;Beresford, P, Broughton, F, Croft, S, Fouquet, S, Oliviere, D, Rhodes, P. (2000) Palliative Care: developing user involvement, improving quality. Middlesex: Brunel University&lt;/H2&gt;
&lt;P&gt;Significant, as this is a report of the first seminar held, at St Christopher’s Hospice, on user involvement as it related to palliative care. The themes that emerged are of interest at a time when the concept of user involvement was generally foreign to the field of palliative care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Beresford, P, Croft, S, Adshead, L, Walker, J, Wilman, K (2005). Involving service users in palliative care: from theory to practice. In Firth, P, Luff, G, Oliviere, D. Loss, change and bereavement in palliative care. Maidenhead: Open University Press&lt;/H2&gt;
&lt;P&gt;This chapter explores the meaning of participation and relates it to palliative care. It provides a very good overview of thinking underpinning user involvement in palliative care from experienced writers on the topic along with service users.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Beresford, P, Adshead L, Croft S (2006) Palliative care, social work and service users, Making life possible. London: Jessica Kingsley&lt;/H2&gt;
&lt;P&gt;Based on a range of interviews with consumers of social work services in palliative care, this groundbreaking study offers insights into the value of palliative care social work and involvement which is of benefit to all professions working in palliative care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Clark, D, Thomas, C, McDermott, E, Bingley, A, Payne, S, Seymour, J (2005) What are the views of people affected by cancer and other illnesses about end of life issues? Professional and patient perspectives. Lancaster: International Observatory on End of Life Care, Institute of Health Research, Lancaster University &lt;/H2&gt;
&lt;P&gt;The report of the research study to explore narratives written about end of life issues: medical professionals’ writings since 1975 concerning their experience of caring for people with cancer and writings since 1950 of people facing death. The different issues that emerged are identified and differing perspectives fascinating.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Cotterell, P, Findlay, H, Macfarlane, A (2009) Patient and carer narratives and stories. In Gunaratnam, Y and Oliviere, D Narrative and Stories in Health Care. Illness, Death and Bereavement. Oxford: Oxford University Press&amp;nbsp; ( in press)&lt;/H2&gt;
&lt;P&gt;The role and uses of patient stories are presented, as part of user involvement initiatives in palliative care. Narrative and storied accounts are discussed as a form of knowledge that can and should be utilized to greater effect. Some powerful stories.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Coulter, A, Ellins, J (2007) Effectiveness of strategies for informing, educating, and involving patients. BMJ&amp;nbsp; 335 (7 July): 24-27&lt;/H2&gt;
&lt;P&gt;The paper argues that effective strategies to strengthen patient engagement are substantial.&amp;nbsp; However, any strategy to reduce health inequalities must promote patient understanding of all aspects of care ie “health literacy”. The research for the study on which this useful article is based, is by the Picker Institute, an independent research and development institute specialising in measuring patients’ experience of health care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Edmonds, P, Burman, R, Sinnott, C (2004) The goldfish bowl. European Journal of Palliative Care: 11(2): 69-71 &lt;/H2&gt;
&lt;P&gt;This article summaries the experience of an education method for training fifth year medical students in palliative care, using the ‘goldfish bowl’. The method is highly evaluated by the medical students and service users speak of it as empowering.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Jarrett, L (2007) (ed) Creative engagement in palliative care. New perspectives on user involvement. Abingdon: Radcliffe Publishing&lt;/H2&gt;
&lt;P&gt;Although largely a collection of examples of creative work with patients and of patient-centred care, the whole philosophy underpinning this work is good user involvement and the empowerment of users and carers through therapeutic interventions.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Kraus, F, Levy, J, Oliviere, D. (2003) Brief report on user involvement at St Christopher’s Hospice. Palliative Medicine 17(4):375-377&lt;/H2&gt;
&lt;P&gt;This brief account outlines developments at St Christopher’s pioneering a User Forum and other methods of eliciting the user voice and fuller partnership working with users and carers. It offers some practice experience to those working in the field.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Monroe, B, Oliviere, D (eds) (2003) Patient participation in palliative care. A voice for the voiceless. Oxford: Oxford University Press&lt;/H2&gt;
&lt;P&gt;A wide variety of clinical, team and organisational aspects of palliative care are considered from a patient-centred perspective. The second half of the book provides a critical analysis on how to involve users from the perspective of five different professional groups in the multi-professional palliative care team.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;National Council for Palliative Care (2004) Listening to Users. Helping professionals address User Involvement in Palliative Care. London: National Council for Palliative Care&lt;/H2&gt;
&lt;P&gt;The short publication aims to put ideas about user involvement into the palliative care context and make them of practical use to health professionals. In addition to providing helpful information and guidance, it attempts to present some of the debates around user involvement within palliative care. The original document is:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;National Council for Palliative Care (2008) Listening to the experts. A summary of ‘User involvement in palliative care: a scoping study’. London: National Council for Palliative Care&lt;/H2&gt;
&lt;P&gt;The&amp;nbsp;summary of this scoping study offers a thorough literature review as well as the analysis of interviews of users/carers, professionals and experts. Examples of user involvement in action are given and attention drawn to the limitations of research and enquiry in the field. The work offers one of the few comprehensive studies of user involvement within the field of palliative care by a high profile research team.&lt;/P&gt;
&lt;P&gt;Original study: Payne, S, Gott, M, Small, N, Oliviere, D, Sargeant, A, Young, E (2005) User involvement in palliative care: a scoping study. Sheffield: University of Sheffield.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Oliviere, D (2006) User involvement – the patient and carer as team members? In Speck, P. Teamwork in palliative care. Fullfiling or frustrating? Oxford: Oxford University Press&lt;/H2&gt;
&lt;P&gt;A comprehensive account of the roles and functions of users and carers in their contributions to the multi-professional team. Within the team, the user/carers are presented as having seven core aspects.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Sahlsten, MJM, Larssen, IE, Sjostrom,B, Plos, KAE (2008) An analysis of the concept of patient participation. Nursing Forum 43(1): 2-11&lt;/H2&gt;
&lt;P&gt;A thorough exploration of various terms linked with participation, using concept analysis. Collaboration, partnership and power sharing are discussed within the context of the nurse-patient relationship. A Swedish study.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Sargeant A, Payne S, Gott M, Small N, Oliviere D. (2007) User involvement in palliative care: motivational factors for service users and professionals. Progress in Palliative Care 15(3):126-132&lt;/H2&gt;
&lt;P&gt;This study addresses what motivates or discourages users, carers and professionals from participating in user involvement activities, as part of the larger scoping study into user involvement in palliative care. (See National Council for Pallaitive Care 2008 above) &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Small, N, Rhodes, P (2000). Too ill to talk? User involvement and palliative care. London: Routledge&lt;/H2&gt;An ‘early’ yet thoughtful contribution to debates around user involvement in the field of palliative care. The second part of the book offers useful perspectives based on narratives of users with cystic fibrosis, multiple sclerosis and motor neurone disease. 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Small N (2005) User voices in palliative care. In Faull, C, Carter, Y and Daniels, L (eds) Handbook of palliative care. 2nd. Ed. Oxford: Blackwell&lt;/H2&gt;
&lt;P&gt;This is an excellent summary of the issues and concerns involved and the contribution of user voices in three areas: the impact on individual professionals; users shaping organisations; and how national policy engages with and reflects user views.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Tritter, J, Daykin, N, Evans, S, Sanidas, M (2004). Improving cancer services through patient involvement. Abingdon: Radcliffe Medical Press &lt;/H2&gt;
&lt;P&gt;This publication is more concerned with user involvement systems in healthcare organisations and the potential impact on cancer services. However, the principles and practices are relevant to palliative care. A toolkit style approach is taken, with case studies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Organisations that have funded or provide key information on aspects of user participation:&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Cancer Experiences Collaborative&lt;BR&gt;&lt;A href="http://www.ceco.org.uk/narratives/index.php" target="_blank"&gt;http://www.ceco.org.uk/narratives/index.php&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;Joseph Rowntree Foundation &lt;BR&gt;&lt;A href="http://www.jrf.org.uk/" target="_blank"&gt;http://www.jrf.org.uk/&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;NHS Centre for Involvement&lt;BR&gt;&lt;A href="http://www.nhscentreforinvolvement.nhs.uk/" target="_blank"&gt;http://www.nhscentreforinvolvement.nhs.uk/&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;David Oliviere&lt;BR&gt;Director of Education and Training&lt;BR&gt;St Christopher’s Hospice&lt;BR&gt;January 2008&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371443</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=371443]]&gt;</url>
    <title>Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Contents</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;&lt;A href="nelh:371603:0" name=internalLink&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;Introduction&lt;/A&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:346852:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:371632:0" name=internalLink&gt;Methodology&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:371603:0" name=internalLink&gt;&lt;A href="nelh:371603:0" name=internalLink&gt;&lt;A href="nelh:371603:0" name=internalLink&gt;Included references&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371421:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371603</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=371603]]&gt;</url>
    <title>Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Included references</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Included references&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to Contents page]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2010&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:236851:0" name=internalLink&gt;&lt;A href="nelh:236851:0" name=internalLink&gt;Anticonvulsant drugs for acute and chronic pain. W&lt;A href="nelh:236851:0" name=internalLink&gt;iffen Philip J, Collins Sally, McQuay Henry J, Carroll Dawn, Jadad Alejandro, Moore R Andrew.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2010 Issue 1 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Intraspinal techniques for pain management in cancer patients: a systematic review. Myers J., Chan V., Jarvis V., Walker-Dilks C. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, February 2010, vol./is. 18/2(137-149), 1433-7339 (Feb 2010) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19943068" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:341744:0" name=internalLink&gt;Long-term opioid management for chronic noncancer pain. Noble Meredith, Treadwell Jonathan R, Tregear Stephen J, Coates Vivian H, Wiffen Philip J, Akafomo Clarisse, Schoelles Karen M. Cochrane Database of Systematic Reviews: Reviews 2010 Issue 1 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:346559:0" name=internalLink&gt;Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. NICE Guideline 24 March 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The use of morphine to treat cancer-related pain:&amp;nbsp;a synthesis of quantitative and qualitative research. Flemming K. Journal of Pain and Symptom Management, January 2010, vol./is. 39/1(139-154), 0885-3924 (January 2010)&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19783398" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:341780:0" name=internalLink&gt;Vitamin D for the treatment of chronic painful conditions in adults. Cochrane review 20 Jan 2010&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:342822:0" name=internalLink&gt;What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors: a structured evidence-based review. DARE abstract 2010. Original research 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2009&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Acupuncture is underutilized in hospice and palliative medicine. Deutsche Zeitschrift fur Akupunktur, 2009, vol./is. 52/1(54-55), 0415-6412 (2009). Standish L.J., Kozak L., Congdon S., Kramer S. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18539767" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:143916:0" name=internalLink&gt;Best Practice Statement&lt;/A&gt;&lt;A href="nelh:143916:0" name=internalLink&gt;: the management of pain in patients with cancer. Guideline. NHS Quality Improvement Scotland 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Classification of pain in cancer patients - a systematic literature review. Knudsen AK. Aass N. Fainsinger R. Caraceni A. Klepstad P. Jordhoy M. Hjermstad MJ. Kaasa S. Palliative Medicine. 23(4):295-308, 2009 Jun. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19286741" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:327232:0" name=internalLink&gt;Duloxetine for treating painful neuropathy or chronic pain. Lunn Michael PT, Hughes Richard AC, Wiffen Philip J. Cochrane Database of Systematic Reviews: Reviews 2009 Issue 4 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt;&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Costa L., Major P.P. Nature Clinical Practice Oncology, 2009, vol./is. 6/3(163-174), 1743-4254;1743-4262 (2009) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19190592" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Effectiveness of topical administration of opioids in palliative care: a systematic review.&amp;nbsp;LeBon B. Zeppetella G. Higginson IJ. Journal of Pain &amp;amp; Symptom Management. 37(5):913-7, 2009 May. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19321297" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://annonc.oxfordjournals.org/content/21/3/615.full.pdf+html" target="_blank"&gt;Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative.&amp;nbsp;N. I. Cherny,&amp;nbsp;J. Baselga,&amp;nbsp;F. de Conno,&amp;nbsp;L. Radbruch. Annals of Oncology volume 21, Issue 3 2009 p. 615-626.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:258666:0" name=internalLink&gt;Guidelines on pain management. European Association of Urology 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. Kirou-Mauro A.M., Hird A., Wong J., Sinclair E., Barnes E.A., Tsao M., Danjoux C., Chow E. Journal of Pain and Symptom Management, January 2009, vol./is. 37/1(77-84), 0885-3924 (January 2009)&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18504094" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Massage therapy for cancer palliation and supportive care: A systematic review of randomised clinical trials. Ernst E. Supportive Care in Cancer, April 2009, vol./is. 17/4(333-337), 0941-4355 (April 2009) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19148685" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Pain assessment in palliative care. Schofield P. International Journal on Disability and Human Development, January 2009, vol./is. 8/1(9-14), 1565-012X (January/March 2009) [abstract not available online] [&lt;A href="http://www.freundpublishing.com/Disability%20and%20Human%20Development/IJDHD%202008%208_1_%20TOC.pdf" target="_blank"&gt;view journal contents page&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Pain management within the palliative and end-of-life care experience in the ICU. Mularski R.A., Puntillo K., Varkey B., Erstad B.L., Grap M.J., Gilbert H.C., Li D., Medina J., Pasero C., Sessler C.N. Chest, May 2009, vol./is. 135/5(1360-1369), 0012-3692;1931-3543 (01 May 2009) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19420206" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:320800:0" name=internalLink&gt;Pregabalin for acute and chronic pain in adults. Moore R Andrew, Straube Sebastian, Wiffen Philip J, Derry Sheena, McQuay Henry J.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2009 Issue 3 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:312242:0" name=internalLink&gt;Psychological therapies for the management of chronic pain (excluding headache) in adults. Eccleston Christopher, Williams Amanda C de C, Morley Stephen.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2009 Issue 2 Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:238355:0" name=internalLink&gt;Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Review 15 April 2009&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:312242:0" name=internalLink&gt;Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Review 15 April 2009&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:324196:0" name=internalLink&gt;Static magnets for reducing pain: systematic review and meta-analysis of randomized trials. DARE abstract 2009. Original research 2007&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:331882:0" name=internalLink&gt;The effectiveness of hypnosis for reducing procedure-related pain in children and adolescents: a comprehensive methodological review. DARE abstract 2009. Original research 2009&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;Racial and ethnic disparities in pain: causes and consequences of unequal care. Anderson K.O., Green C.R., Payne R. Journal of Pain, December 2009, vol./is. 10/12(1187-1204), 1526-5900;1528-8447 (December 2009) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19944378" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Davies A.N., Dickman A., Reid C., Stevens A.-M., Zeppetella G. European Journal of Pain, April 2009, vol./is. 13/4(331-338), 1090-3801;1532-2149 (April 2009) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18707904" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:320820:0" name=internalLink&gt;Topical rubefacients for acute and chronic pain in adults. Matthews Paul, Derry Sheena, Moore R Andrew, McQuay Henry J. Cochrane Database of Systematic Reviews: Reviews 2009 Issue 3 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:312186:0" name=internalLink&gt;Transcutaneous electrical nerve stimulation for acute pain. Cochrane Review 15 April 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Transdermal fentanyl as a front-line approach to moderate-severe pain: A meta-analysis of randomized clinical trials. Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M. J Palliat Care, 2009, vol./is. 25/3(172-80), 0825-8597 (2009 Autumn) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19824278" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2008&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;A systematic review of opioid conversion ratios used with methadone for the treatment of pain.&amp;nbsp;Weschules DJ. Bain KT.&amp;nbsp;Pain Medicine. 9(5):595-612, 2008 Jul-Aug.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18565004" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:295687:0" name=internalLink&gt;Antipsychotics for acute and chronic pain in adults. Seidel Stefan, Aigner Martin, Ossege Michael, Pernicka Elisabeth, Wildner Brigitte, Sycha Thomas. Cochrane Database of Systematic Reviews: Reviews 2008 Issue 4 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:298074:0" name=internalLink&gt;Control of pain in adults with cancer. SIGN Guideline 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:293642:0" name=internalLink&gt;Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease. Brettschneider Johannes, Kurent Jerome, Ludolph Albert, Mitchell J&amp;nbsp; Douglas.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2008 Issue 3 John Wiley &amp;amp; Sons, Ltd Chichester, UK&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:283009:0" name=internalLink&gt;Guidelines on chronic pelvic pain. European Association of Urology 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:286981:0" name=internalLink&gt;Guidelines on the management of neuropathic pain. The Clinical Resource Efficiency Support Team. 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.biomedcentral.com/content/pdf/1472-684X-7-13.pdf" target="_blank"&gt;How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. Wee B., Hadley G., Derry S. BMC Palliative Care, 2008, vol./is. 7/1, 1472-684X (2008)&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;[Influence of patient education on pain experience in patients with malignant tumours].&amp;nbsp;[German]. Schulc E. Ecker C. Deufert D. Sandbichler S. Sydow N. Them C. Pflege Zeitschrift. 61(4):214-9, 2008 Apr. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18481704" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Management of pain in the older person with cancer. Part 2: Treatment options. Delgado-Guay M.O., Bruera E. Oncology, February 2008, vol./is. 22/2(148-152), 0890-9091 (February 2008) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18409661" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Pain assessment tools in palliative care: An urgent need for consensus. Hjermstad M.J., Gibbins J., Haugen D.F., Caraceni A., Loge J.H., Kaasa S. Palliative Medicine, 2008, vol./is. 22/8(895-903), 0269-2163 (2008) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18799513" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Prevalence of undertreatment in cancer pain. A review of published literature. Deandrea S., Montanari M., Moja L., Apolone G. Annals of Oncology, 2008, vol./is. 19/12(1985-1991), 0923-7534;1569-8041 (2008)&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18632721" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Systematic review of the role of thoracoscopic splanchnicectomy in palliating the pain of patients with chronic pancreatitis. [Review] [21 refs]. Baghdadi S. Abbas MH. Albouz F. Ammori BJ. Surgical Endoscopy. 22(3):580-8, 2008 Mar. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18163168" target="_blank"&gt;view abstract&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:278855:0" name=internalLink&gt;The WHO analgesic ladder for cancer pain control, twenty years of use: how much pain relief does one get from using it? DARE abstract 2008. Original research 2006&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:293657:0" name=internalLink&gt;Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. [Review] [60 refs] Robb KA. Bennett MI. Johnson MI. Simpson KJ. Oxberry SG.&amp;nbsp;Cochrane Database of Systematic Reviews. (3):CD006276, 2008.&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:295734:0" name=internalLink&gt;Touch therapies for pain relief in adults. Cochrane review 8 Oct 2008&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:293657:0" name=internalLink&gt;Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Review 16 July 2008&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;&lt;A href="nelh:237684:0" name=internalLink&gt;Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Review 16 July 2008&lt;/A&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P&gt;[&lt;STRONG&gt;NOTE:&lt;/STRONG&gt; some other 2008 references were included in our &lt;A href="nelh:283525:0" name=internalLink&gt;2008 pain AEU&lt;/A&gt;]&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Previous pain AEUs &lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:310615:0" name=internalLink&gt;Our 2009 AEU on pain is available here&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:283525:0" name=internalLink&gt;Our 2008 AEU on pain is available here&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:326826:0" name=internalLink&gt;Our 2007 AEU on pain is available here&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to Contents page]&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346852</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=346852]]&gt;</url>
    <title>Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to the Contents page]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Welcome to this AEU on pain - the 4th we have produced since starting the Supportive and Palliative Care specialist collection in 2005 (originally under the title of Palliative and Supportive Care specialist library). &amp;nbsp;We have included only material published in 2008, 2009 and 2010, because of the large volume of material now emerging in the topic of pain.&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Once again, we have taken a broad inclusive view of supportive and palliative care, which extends to non-malignant disease as well as cancer and at all stages of disease. &amp;nbsp;You can read more about our definition of supportive and palliative care &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?prv=y&amp;amp;pagename=AIMS" target="_blank"&gt;here&lt;/A&gt;.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We would like to thank the members of the editorial team who have contributed to this AEU:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Denise Brady &lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;
&lt;LI&gt;Julia Barnes&lt;/LI&gt;
&lt;LI&gt;Elaine Cachia&lt;/LI&gt;
&lt;LI&gt;Clare Rayment&lt;/LI&gt;
&lt;LI&gt;Rachel Vedder&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Sam H Ahmedzai, Clinical Lead &lt;/P&gt;
&lt;P&gt;Richard Stevens, Project Manager/Information Specialist&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to the Contents page]&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371632</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=371632]]&gt;</url>
    <title>Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Methodology</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 12 April 2010: Pain in supportive and palliative care. Methodology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to Contents page]&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Databases searched&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Medline, EMBASE, Cochrane, CINAHL, DARE, AMED.&lt;/P&gt;
&lt;P&gt;We also searched: NHS Evidence main page, 'NHS Evidence - Supportive and palliative care' specialist collection, EAPC website, British Pain Society website.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Search strategy&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;We used &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260231" target="_blank"&gt;the same search strategy as when the previous general pain AEU searches were run in&amp;nbsp;2007 and 2008&lt;/A&gt;. We amended this to fit the requirements of the&amp;nbsp;various databases.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Reviewing&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search results were passed to four reviewers (Julia Barnes, Elaine Cachia, Clare Rayment and Rachel Vedder) for assessment of abstracts for basic quality and relevance. The final list was agreed by Prof Sam H Ahmedzai. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:371443:0" name=internalLink&gt;[Go to Contents page]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>298550</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=298550]]&gt;</url>
    <title>Annual Evidence Update 17 November 2008. Supportive and palliative care in chronic lung disease</title>
    <publicationDate></publicationDate>
    <publisher>Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 17 November 2008. Supportive and palliative care in chronic lung disease&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This Annual Evidence Update&amp;nbsp;complements the &lt;A href="http://www.library.nhs.uk/respiratory/ViewResource.aspx?resID=298651&amp;amp;tabID=290&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=TITLE&amp;amp;catID=5880" target="_blank"&gt;Respiratory Library's COPD Annual Evidence Update&lt;/A&gt; by providing links to the newest evidence in this area that is of particular interest for supportive and palliative care professionals. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The&amp;nbsp;evidence update is based upon the knowledge set out in a new document published by the &lt;A href="http://www.ncpc.org.uk/index.html" target="_blank"&gt;National Council for Palliative Care&lt;/A&gt;&amp;nbsp;and a special conference on this topic. The national conference&amp;nbsp;&lt;EM&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;'A Breath Of Fresh Air: Implementing the End of Life Care Strategy for Respiratory Disease'&lt;/A&gt; &lt;/EM&gt;took place on 18 November 2008 in London to explore the issues arising. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;All the talks from the conference are available to download as pdf files from NCPC:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Respiratory Disease: The Size of the Problem&lt;/A&gt;.&amp;nbsp; Martyn R Partridge, MD FRCP. Professor of Respiratory Medicine, Imperial College London&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;The Palliative Care Perspective&lt;/A&gt;.&amp;nbsp; Dr Sharon Chadwick&lt;BR&gt;Macmillan Consultant in Palliative Medicine, Hospice of St Francis&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Perceptions &amp;amp; Levels of Current Involvement: Results of the first National Survey&lt;/A&gt;.&amp;nbsp; Professor Sam Ahmedzai. Professor of Palliative Medicine, University of Sheffield&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Palliative Care Needs in COPD – What Evidence &amp;amp; What Direction Should We Take?&lt;/A&gt;&amp;nbsp; Dr Patrick White, Senior Lecturer, Kings College London School of Medicine&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;The End of Life Care Strategy &amp;amp; Its Importance for CRD&lt;/A&gt;.&amp;nbsp; Lucy Sutton, Director of Policy Development, NCPC&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;The National Service Framework for COPD &amp;amp; EoLC&lt;/A&gt;.&amp;nbsp; Kevin Holton, Head of COPD programme, Department of Health&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Putting It All Together: The NHS Next Stage Review&lt;/A&gt;.&amp;nbsp; Dr Mark Roland, Consultant Respiratory Physician &amp;amp; Director of Cancer Services, Portsmouth Hospitals NHS Trust&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Surviving from Dying: A Personal Experience&lt;/A&gt;.&amp;nbsp; Mandy Paine, Service User&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;What People with CRD Tell Us: Results of a National Survey&lt;/A&gt;.&amp;nbsp;Jo Black, User Involvement Project Manager, NCPC&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Integrating Health &amp;amp; Social Care&lt;/A&gt;.&amp;nbsp; Dr David Lyon, GP, Castlefield Health Centre&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Advanced COPD: A Study of Palliative Care Needs &amp;amp; Service Provision&lt;/A&gt;.&amp;nbsp;Allison Spence, Hospice Community Nurse&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/events/breath.html" target="_blank"&gt;Specialist Palliative Care &amp;amp; Respiratory Services: Developing a Systematic Process&lt;/A&gt;.&amp;nbsp;Clare Littlewood, Consultant in Palliative Medicine, Whiston Hospital &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9109&amp;amp;tabID=289" target="_blank"&gt;Contents of the Supportive Care Library on the topic COPD&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/respiratory/ViewResource.aspx?resID=298651&amp;amp;tabID=290&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=TITLE&amp;amp;catID=5880" target="_blank"&gt;See the Respiratory Library's COPD Annual Evidence Update&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Comment from Lucy Sutton, National Council for Palliative Care; and Policy Team, Help the Hospices&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Chronic respiratory diseases (CRD) account for a significant number of UK deaths. The World Health Organization has found that the growing number of people affected means that CRD is set to become the fourth leading cause of death worldwide by 2030, surpassed only by cardio vascular disease, pneumonia and HIV/AIDS.&amp;nbsp; In England and Wales, CRD, excluding lung cancer, already accounts for 14% of all deaths. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Despite the significant numbers involved, people affected by these conditions can struggle to receive palliative and end of life care that addresses their needs. The symptoms experienced by many people with CRD are often more severe versions of those of people with lung cancer. Current palliative care services may sometimes still focus on specialist palliative care which has historically been developed for people with cancer. It is much harder to give a prognosis for many forms of CRD than for cancer, which often has made it difficult to determine when a person has specific palliative or end of life care needs.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;These issues led The National Council for Palliative Care to set up the CRD Policy Group in June 2007. This group has carried out extensive work since this time and is now able to offer some solutions to these issues. In it’s first publication Focus on Chronic Respiratory Disease the group presents the results of a survey into the interaction between respiratory and palliative care consultants, what users and carers have said they need and some examples of good practice all of which will help services implement the recommendations set out in recent policy notably The End of Life Care Strategy. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For further information visit &lt;A href="http://www.ncpc.org.uk/" target="_blank"&gt;www.ncpc.org.uk&lt;/A&gt;.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>338644</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=338644]]&gt;</url>
    <title>Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Contents Page</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PATIENT EXPERIENCE,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,RESEARCH,FAMILIES &amp; CARERS,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,CHRONIC KIDNEY DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Contents Page&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;&lt;A href="nelh:338647:1" name=internalLink&gt;Introduction&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="nelh:338645:0" name=internalLink&gt;List of included references&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="nelh:338648:1" name=internalLink&gt;Methods&lt;/A&gt;&lt;/H2&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For the policy background and further information please see: &lt;/P&gt;
&lt;H3&gt;&lt;A href="http://www.library.nhs.uk/ppi/" target="_blank"&gt;'NHS Evidence - patient and public involvement' specialist collection&lt;/A&gt;&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>338647</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=338647]]&gt;</url>
    <title>Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PATIENT EXPERIENCE,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,RESEARCH,FAMILIES &amp; CARERS,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,CHRONIC KIDNEY DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN" lang=EN&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt; 
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;[&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=338644&amp;amp;pgID=1" target="_blank"&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;The Annual Evidence Update on ‘Patient and carer&amp;nbsp;involvement in chronic disease’ for 2010 was published online on 18 January 2010.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;This was the second AEU on patient and carer engagement in chronic disease management and we have continued to broaden the scope of the literature we accessed, in order to reflect the widening field of supportive and end of life care.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;Our understanding of supportive care is based on the NICE (2004) guidance on supportive and palliative care for adults with cancer, but it is readily accepted that this definition can apply just as well out of malignant disease &lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-fareast-theme-font: minor-latin; mso-bidi-theme-font: minor-bidi; mso-bidi-language: AR-SA" lang=EN&gt;[&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?prv=y&amp;amp;pagename=AIMS" target="_blank"&gt;&lt;SPAN style="LINE-HEIGHT: 115%; mso-ansi-font-size: 10.0pt; mso-bidi-font-size: 10.0pt"&gt;see definition&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;].&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;In this AEU, we have included literature mainly from 2009 but also included a few publications of note from earlier years.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;The papers we have identified fall into three broad groups –&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;STRONG&gt;1. Systematic reviews of published and quality-checked literature on user experience of healthcare&lt;/STRONG&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;For an interesting example of this group, see:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;Long-term oxygen therapy: review from the patients' perspective. Cullen DL, Stiffler D. Chron Respir Dis. 2009;6(3):141-7.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; [Link to abstract &lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19643828" target="_blank"&gt;PMID: 19643828&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&lt;STRONG&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: Calibri; mso-bidi-font-family: Calibri; mso-fareast-language: EN-GB" lang=EN&gt;2.&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/STRONG&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;STRONG&gt;Systematic reviews of user involvement in educating healthcare professionals in giving better care in chronic and terminal conditions&lt;/STRONG&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P style="LINE-HEIGHT: normal; TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;For example, see:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 18pt; mso-outline-level: 1; tab-stops: 45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Courier New'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Perceptions of service user and carer involvement in healthcare education and impact on students' knowledge and practice: A literature review. Morgan A., Jones D. Medical Teacher, February 2009, vol./is. 31/2(82-95), 0142-159X;1466-187X. [Link to abstract &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19090412" target="_blank"&gt;PMID: 19090412&lt;/A&gt;] &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: Calibri; mso-bidi-font-family: Calibri; mso-fareast-language: EN-GB" lang=EN&gt;&lt;STRONG&gt;3. &lt;/STRONG&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;STRONG&gt;Guidance and policy documents published on user involvement in chronic illnesses and end of life care&lt;/STRONG&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;These come from the Department of Health and influential bodies such as National Council for Palliative Care.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;For an example, see:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold" lang=EN&gt;A Guide to Involving patients, carers and the public in palliative care and end of life care services. Including a Practical Educational Tool. &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;National Council for Palliative Care.&amp;nbsp;[&lt;A href="http://www.ncpc.org.uk/download/publications/InvolvingPatientsCarersAndThePublicInPalliativeCareAndEndOfLifeCareServices.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;It is possible that even with our exhaustive web-searches, we may have missed important examples of the last group, perhaps coming from other national charities.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;If readers of the AEU are aware of other key policy documents or guidance, preferably available freely on the internet, please let us know and we will try to include them in our listings.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;We also welcome feedback on this AEU from healthcare professionals, students, managers – and of course, users of healthcare who are the focus of this evidence review.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;Please send your comments to our email discussion group – joining is easy and allows you to receive monthly updates on the literature in&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;the field of supportive and palliative care:&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;A href="http://www.jiscmail.ac.uk/lists/supportive-and-palliative-care-evidence.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;www.jiscmail.ac.uk/lists/supportive-and-palliative-care-evidence.html&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Many thanks go to the following colleagues who have contributed to this evidence update, either by conducting the original internet searches or by reviewing and sifting out the key papers –&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l0 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Denise Brady&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l0 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Melanie Hodson&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l0 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Ashique Ahamed&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l0 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Julia Barnes&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l0 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Clare Rayment &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; TEXT-INDENT: -18pt; MARGIN: 0cm 0cm 0pt 36pt; mso-add-space: auto" class=MsoNormalCxSpMiddle&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Sam H Ahmedzai&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Clinical Lead&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Richard Stevens&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 10pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;Project Manager/Information Specialist&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB" lang=EN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;[&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=338644&amp;amp;pgID=1" target="_blank"&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>338645</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=338645]]&gt;</url>
    <title>Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. List of included references</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ INDIVIDUAL INVOLVEMENT,COMMUNICATION ISSUES,RESEARCH,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,PALLIATIVE AND SUPPORTIVE CARE,PPI IN PRACTICE,PATIENT EXPERIENCE,PATIENT AND PUBLIC INVOLVEMENT,KIDNEY DISEASES,CHRONIC KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. List of included references&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[&lt;A href="nelh:338644:1" name=internalLink&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.library.nhs.uk/booksandjournals/journals/default.aspx" target="_blank"&gt;CHECK WHICH JOURNALS ARE AVAILABLE ONLINE VIA NHS E-JOURNALS&lt;/A&gt;]&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Published 2009&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A guide to involving patients and members of the public with long term conditions.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.nhscentreforinvolvement.nhs.uk/docs/Learning%20-%20Resources%20-%20PPI%20Guides%20-%20Long%20Term%20Conditions.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A Guide to Involving patients, carers and the public in palliative care and end of life care services. Including a Practical Educational Tool.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;National Council for Palliative Care. 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.ncpc.org.uk/download/publications/InvolvingPatientsCarersAndThePublicInPalliativeCareAndEndOfLifeCareServices.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A review of the efficacy of the self-management model on health outcomes in community-residing older adults with arthritis.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Nuñez DE, Keller C, Ananian CD. Worldviews on Evidence-Based Nursing, 01 September 2009, vol./is. 6/3(130-148), 1545102X. &lt;/P&gt;
&lt;P&gt;[Link to abstract: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19656354" target="_blank"&gt;PMID: 19656354&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A systematic review examining the literature on attitudes of patients with advanced cancer toward research.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Todd AM, Laird BJ, Boyle D, Boyd AC, Colvin LA, Fallon MT. Journal of Pain &amp;amp; Symptom Management, 01 June 2009, vol./is. 37/6(1078-1085), 08853924. &lt;/P&gt;
&lt;P&gt;[Link to abstract: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19419837" target="_blank"&gt;PMID: 19419837&lt;/A&gt;] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A systematic review of factors influencing decision-making in adults living with chronic kidney disease.&lt;/STRONG&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Murray MA, Brunier G, Chung JO, Craig LA, Mills C, Thomas A, Stacey D. Patient Education &amp;amp;&amp;nbsp;Counseling, 01 August 2009, vol./is. 76/2(149-158), 07383991. &lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19324509" target="_blank"&gt;PMID: 19324509&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;A systematic review of informal caregivers' needs in providing home-based end-of-life care to people with cancer.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Bee PE, Barnes P, Luker KA. Journal of Clinical Nursing, 15 May 2009, vol./is. 18/10(1379-1393), 09621067. &lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18624779" target="_blank"&gt;PMID: 18624779&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane reviews of educational and self-management interventions to guide nursing practice: a review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Coster S, Norman I. International Journal of Nursing Studies, 01 April 2009, vol./is. 46/4(508-528), 00207489.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19012889" target="_blank"&gt;PMID: 19012889&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Effecting positive change with bereaved service users in a hospice setting.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Agnew A, Duffy J. International Journal of Palliative Nursing, 01 March 2009, vol./is. 15/3(110-116), 13576321.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19537531" target="_blank"&gt;PMID: 19537531&lt;/A&gt;] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For information – the expert patients programme. (Letter).&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Department of Health. July 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_103170.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Getting ready for user involvement in a systematic review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Smith E, Donovan S, Beresford P, Manthorpe J, Brearley S, Sitzia J, Ross F. Health Expectations, 01 June 2009, vol./is. 12/2(197-208), 13696513.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19236632" target="_blank"&gt;PMID: 19236632&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Impact assessment for implementing personalised care planning for people with long-term conditions (including guidance to NHS and social care).&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_098503.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trials.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Wade J, Donovan JL, Lane JA, Neal DE, Hamdy FC. Soc Sci Med. 2009 Jun;68(11):2018-28. Epub 2009 Apr 11.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19364625" target="_blank"&gt;PMID: 19364625&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Long-term oxygen therapy: review from the patients' perspective.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Cullen DL, Stiffler D. Chron Respir Dis. 2009;6(3):141-7.&lt;/P&gt;
&lt;P&gt;[Link to abstract: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19643828" target="_blank"&gt;PMID: 19643828&lt;/A&gt;] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Managing long term conditions. Reference list. NHS Evidence - health management. &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NHS Evidence - health management. 2009. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=32021&amp;amp;tabID=290" target="_blank"&gt;Link to website&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Our Health, our care, our say.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/en/Healthcare/ourhealthourcareoursay/index.htm" target="_blank"&gt;Link to website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Participation in online patient support groups endorses patients' empowerment.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;van Uden-Kraan C.F., Drossaert C.H.C., Taal E., Seydel E.R., van de Laar M.A.F.J. Patient Education and Counseling, January 2009, vol./is. 74/1(61-69), 0738-3991.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18778909" target="_blank"&gt;PMID: 18778909&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Patient and public involvement.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/en/Managingyourorganisation/PatientAndPublicinvolvement/DH_085874" target="_blank"&gt;Link to website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Patient-preference disability assessment for disabling chronic low back pain: a cross-sectional survey.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Sanchez K, Papelard A, Nguyen C, Jousse M, Rannou F, Revel M, Poiraudeau S. Spine (Phila Pa 1976). 2009 May 1;34(10):1052-9.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19363459" target="_blank"&gt;PMID: 19363459&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Perceptions of service user and carer involvement in healthcare education and impact on students' knowledge and practice: A literature review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Morgan A., Jones D. Medical Teacher, February 2009, vol./is. 31/2(82-95), 0142-159X;1466-187X.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19090412" target="_blank"&gt;PMID: 19090412&lt;/A&gt;] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Self-help groups for patients with coronary heart disease as a resource for rehabilitation and secondary prevention - what is the evidence?&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Jackson AM, Gregory S, McKinstry B. Heart &amp;amp; Lung, 01 May 2009, vol./is. 38/3(192-200), 01479563.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19486787" target="_blank"&gt;PMID: 19486787&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Strategies and interventions for the involvement of real patients in medical education: a systematic review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Jha V, Quinton ND, Bekker HL, Roberts TE. Medical Education, 01 January 2009, vol./is. 43/1(10-20), 03080110.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19140994" target="_blank"&gt;PMID: 19140994&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Supporting lay carers in end of life care: current gaps and future priorities. &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Grande G, Stajduhar K, Aoun S, Toye C, Funk L, Addington-Hall J, Payne S, Todd C. Palliative Medicine, 01 May 2009, vol./is. 23/4(339-344), 02692163.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19304804" target="_blank"&gt;PMID: 19304804&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Supporting People with Long Term Conditions. Commissioning Personalised Care Planning.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_093360.pdf" target="_blank"&gt;Download pdf&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The effectiveness and active ingredients of mutual support groups for family caregivers of people with psychotic disorders: a literature review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Chien WT, Norman I. International Journal of Nursing Studies, 01 December 2009, vol./is. 46/12(1604-1623), 00207489.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19481205" target="_blank"&gt;PMID: 19481205&lt;/A&gt;]&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;UK self-care support initiatives for older patients with long-term conditions: a review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Berzins K, Reilly S, Abell J, Hughes J, Challis D. Chronic Illn. 2009 Mar;5(1):56-72.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=329079&amp;amp;tabID=289" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;User involvement for professionals. Some resources.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;National Council for Palliative Care. 2009. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.ncpc.org.uk/users/resources.html" target="_blank"&gt;Link to website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Your health, your way - A guide to long term conditions and self care.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_097588" target="_blank"&gt;Link to website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Your health, your way - A guide to long term conditions and self care. Communications toolkit.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Department of Health. 2009.&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.dh.gov.uk/en/Healthcare/Longtermconditions/yourhealth/DH_105073" target="_blank"&gt;Link to website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Published 2008&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;SATIS-Stroke: A satisfaction measure of activities and participation in the actual environment experienced by patients with chronic stroke.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Bouffioulx E, Arnould C, Thonnard JL. J. Rehabil Med. 2008 Nov;40(10):836-43.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19242621" target="_blank"&gt;PMID: 19242621&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;An assessment of patient education and self-management in diabetes disease-management. Two case studies.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Fitzner K, Greenwood D, Payne H, Thomson J, Vukovljak L, McCulloch A, Specker JE. Popul Health Manag. 2008 Dec;11(6):329-40.&lt;/P&gt;
&lt;P&gt;[Link to abstract:&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19108648" target="_blank"&gt;PMID: 19108648&lt;/A&gt;] &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Listening to the experts. A summary of 'User involvement in palliative care: a scoping study'&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Payne, S, Oliviere, D, Sargeant A., Small N. National Council for Palliative Care. 2008. &lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.ncpc.org.uk/publications/pubs_list2.html" target="_blank"&gt;Further information from website&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Published pre-2008 but not included in previous AEU&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information giving and decision-making in patients with advanced cancer: a systematic review.&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Gaston C M, Mitchell G. Social Science and Medicine 2005; 61(10): 2252-2264.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[&lt;A href="nelh:314205:1" name=internalLink&gt;DARE abstract 2009&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Produced by&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Sam H Ahmedzai&lt;/LI&gt;
&lt;LI&gt;Richard Stevens&lt;/LI&gt;
&lt;LI&gt;Denise Brady&lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;
&lt;LI&gt;Ashique Ahamed&lt;/LI&gt;
&lt;LI&gt;Julia Barnes&lt;/LI&gt;
&lt;LI&gt;Clare Rayment&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;January 2010&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[&lt;A href="http://www.library.nhs.uk/booksandjournals/journals/default.aspx" target="_blank"&gt;CHECK WHICH JOURNALS ARE AVAILABLE ONLINE VIA NHS E-JOURNALS&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[&lt;A href="nelh:338644:1" name=internalLink&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>338648</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=338648]]&gt;</url>
    <title>Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Methodology</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ INDIVIDUAL INVOLVEMENT,COMMUNICATION ISSUES,FAMILIES &amp; CARERS,RESEARCH,SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE,PPI IN PRACTICE,PATIENT EXPERIENCE,PATIENT AND PUBLIC INVOLVEMENT,KIDNEY DISEASES,CHRONIC KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 18 January 2010: Patient and carer involvement in chronic disease. Methodology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;[&lt;A href="nelh:338644:1" name=internalLink&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;/SPAN&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;Databases searched&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;1. PubMed&lt;BR&gt;2. DARE&lt;BR&gt;3. Cochrane database of systematic reviews&lt;BR&gt;4. NHS Evidence: National Library of Guidelines&lt;BR&gt;5. NHS Evidence: supportive and palliative care specialist collection&lt;BR&gt;6. Cinahl&lt;BR&gt;7. Embase&lt;BR&gt;8. Whole of NHS evidence&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;/SPAN&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;Notes on the methods&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;Melanie Hodson and Denise Brady searched the databases – CINAHL, PUBMED and EMBASE expanding on the &lt;A name=internalLink&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303870&amp;amp;tabID=290" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="COLOR: blue; mso-bidi-font-size: 11.0pt"&gt;search performed by Richard Stevens in 2009&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;.&amp;nbsp;We searched CINAHL and EMBASE&amp;nbsp; for 2009 only – but it was possible to be more specific on PUBMED and we were able to search back to November 2008 on this database.&amp;nbsp; A search on self care was added as well as a search using the Clinical query resource on Pubmed.&amp;nbsp;&amp;nbsp; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;A search using only&amp;nbsp;the terms &lt;/SPAN&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;Participation, involvement, self-man* and ”self man*"&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;was also conducted on the Cochrane database and on DARE (2009).&amp;nbsp; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;Searching NHS Evidence as a whole, there were hundreds of references&amp;nbsp;- so rather than search the whole database for relevant material, we only searched the patient and public involvement and the Supportive and Palliative Care specialist collections.&amp;nbsp;Having looked through this on a second occasion we have highlighted what we think are the most relevant items. Unlike the searches on PUBMED, CINAHL&amp;nbsp; and EMBASE this search was not confined to systematic reviews or meta-analyses.&amp;nbsp;This has yielded a variety of government reports and highlighted the work of the National Council for Palliative Care. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold"&gt;&lt;STRONG&gt;Search strategies&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;We searched Medline, Cinahl, Embase using the following terms in each database. They are broadly similar except for the different subject headings in each database. See below.&amp;nbsp;Our initial search yielded 31 items. &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE class=MsoNormalTable style="mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 0cm 0cm 0cm" cellPadding=0 border=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#22 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;#17 OR #21&lt;/SPAN&gt; Limits: &lt;SPAN style="mso-bidi-font-weight: bold"&gt;Humans, English&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;294 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#21 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;("2008/11/01"[Publication Date] : "2009/12/14"[Publication Date]) AND (#20)&lt;/SPAN&gt; Limits: &lt;SPAN style="mso-bidi-font-weight: bold"&gt;Humans, English&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;225 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#20 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;#3 AND #15 AND (systematic OR meta analysis OR "meta-analysis")&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3747 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#19 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;systematic OR meta analysis OR "meta-analysis"&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;617222 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#17 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;("2008/11/01"[Publication Date] : "2009/12/14"[Publication Date]) AND (#3 AND #15)&lt;/SPAN&gt; Limits: &lt;SPAN style="mso-bidi-font-weight: bold"&gt;Humans, English, Systematic Reviews&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;137 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#16 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;#3 AND #15&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;69659 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#15 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;#4 OR #5 OR #7 OR #9 OR #10 OR 11# OR #12 OR #13 OR #14&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2628138 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#14 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;hospices[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3811 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#13 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;terminally ill[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4266 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#12 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;terminal care[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;33678 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#11 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;palliative care[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;31187 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#10 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;palliat* OR terminal care OR terminally ill* or hospice* OR end of life care OR "end-of-life care" OR supportive&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;117663 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#9 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;chronic OR long-term OR persistent OR "long-term"&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1172092 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#7 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;self-management[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;29617 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#5 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;long term care[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;18507 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 15"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#4 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;chronic disease[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;185487 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 16"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#3 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;#1 OR #2&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;336829 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 17"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#2 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;patient participation[MeSH Terms]&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;13446 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 18; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;#1 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;Search &lt;SPAN style="mso-bidi-font-weight: bold"&gt;participation OR self-manag* OR self manag* OR involvement&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" vAlign=top&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21.6pt; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;336829 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(Chose 22 from final search) &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;STRONG&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial; mso-bidi-font-size: 11.0pt"&gt;EMBASE &lt;/SPAN&gt;&lt;/I&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE class=MsoNormalTable style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 0cm 0cm 0cm" cellPadding=0 width="100%" border=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp PATIENT PARTICIPATION/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 36pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;3363 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(participation OR self-manag* OR "self manag*" OR involvement).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;255759 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1 OR 2 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;257784 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(chronic OR long-term OR persistent OR "long-term" OR "end of life care" OR end AND of AND life AND care OR supportive).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;33968 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;"end-of-life care".ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1676 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;6&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(palliative AND care).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;7695 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;7&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp PALLIATIVE THERAPY/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;25540 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;8&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;terminal*.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;256814 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;9&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp TERMINAL DISEASE/ OR exp TERMINAL CARE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;13420 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;10&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp TERMINALLY ILL PATIENT/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1237 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;12&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp HOSPICE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1438 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;13&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;hospice*.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2541 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;14&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 12 OR 13 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;320278 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;15&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3 and 14 [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;302 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;16&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(meta-analysis OR "meta analysis").ti,ab [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2107 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 15"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;17&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp META ANALYSIS/ [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1506 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 16"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;18&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp "SYSTEMATIC REVIEW"/ [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3623 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 17"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;19&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(systematic AND review).ti,ab [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2591 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 18"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;20&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;16 OR 17 OR 18 OR 19 [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5012 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 19; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;22&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;15 AND 20 [Limit to: Publication Year 2009-2009 and Human and English Language] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(chose 2 from final search) &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; mso-outline-level: 1"&gt;&lt;STRONG&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial; mso-bidi-font-size: 11.0pt"&gt;CINAHL&lt;/SPAN&gt;&lt;/I&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE class=MsoNormalTable style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 0cm 0cm 0cm" cellPadding=0 width="100%" border=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(participation OR "self manag" OR self-manag* OR involvement).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&amp;nbsp; 34379 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CONSUMER PARTICIPATION/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;6993 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1 OR 2 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;39484 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(chronic OR long-term OR persistent OR "long term" OR palliat* OR terminal* OR hospice* OR "end-of-life care" OR "end of life care").ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;115979 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CHRONIC DISEASE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;18644 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;6&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;LONG TERM CARE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;12244 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;7&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;PALLIATIVE CARE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;11053 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;8&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp TERMINAL CARE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;24458 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;10&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp TERMINALLY ILL PATIENTS/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5241 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;12&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;HOSPICES/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1593 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;14&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;HOSPICE AND PALLIATIVE NURSING/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2447 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;15&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;4 OR 5 OR 6 OR 7 OR 8 OR 10 OR 12 OR 14 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;143726 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;16&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3 and 15 [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;497 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;17&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;SYSTEMATIC REVIEW/ [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;572 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;18&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(systematic AND review*).ti,ab [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2124 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 15"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;19&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(meta AND analysis).ti,ab [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;972 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 16"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;20&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;META ANALYSIS/ [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1034 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 17"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;21&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;meta-analysis.ti,ab [Limit to: Publication Year 2009-2009 and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;905 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 18"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;22&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;17 OR 18 OR 19 OR 20 OR 21 [Limit to: Publication Year 2009-2009 and (Language English) and (Language English) and (Language English) and (Language English) and (Language English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3234 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 19; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;23&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;16 AND 22 [Limit to: Publication Year 2009-2009 and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English)]&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(Chose 9 from final search)&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial; mso-bidi-font-size: 11.0pt"&gt;&lt;STRONG&gt;2&lt;SUP&gt;nd&lt;/SUP&gt; SEARCH ON EMBASE&lt;/STRONG&gt; &lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE class=MsoNormalTable style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 0cm 0cm 0cm" cellPadding=0 width="100%" border=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(patient AND participation).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5032 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;25&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp PATIENT PARTICIPATION/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3363 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;26&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(participation OR "self manag*" OR self-manag* OR involvement).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;255759 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;27&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;25 OR 26 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;257784 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;28&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp CHRONIC DISEASE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;38186 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;30&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp LONG TERM CARE/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;404279 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;31&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;28 OR 30 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;437932 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;32&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;27 AND 31 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;14396 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;33&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;32 [Limit to: Publication Year 2009-2009 and Human and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;897 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;34&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(systematic AND review).ti,ab [Limit to: Publication Year 2009-2009 and Human and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2591 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;35&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp "SYSTEMATIC REVIEW"/ [Limit to: Publication Year 2009-2009 and Human and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;3623 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;36&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(meta-analysis OR "meta analysis").ti,ab [Limit to: Publication Year 2009-2009 and Human and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;2107 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;37&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;exp META ANALYSIS/ [Limit to: Publication Year 2009-2009 and Human and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;1506 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;38&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;34 OR 35 OR 36 OR 37 [Limit to: Publication Year 2009-2009 and Human and (Languages English) and (Languages English) and (Languages English) and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;5012 &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;39&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;33 AND 38 [Limit to: Publication Year 2009-2009 and Human and (Languages English) and (Languages English) and (Languages English) and (Languages English) and (Languages English)] &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 0.75pt; PADDING-BOTTOM: 0.75pt; BORDER-LEFT: #ece9d8; PADDING-TOP: 0.75pt; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent" noWrap&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal; TEXT-ALIGN: right" align=right&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;20&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;(None chosen) &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial; mso-bidi-font-size: 11.0pt"&gt;&lt;STRONG&gt;Cochrane and DARE databases (2009)&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;I&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;"&lt;SPAN style="mso-bidi-font-weight: bold"&gt;participation or involvement or self-manag* or "self manag*"&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;/SPAN&gt;&lt;o:p&gt;[&lt;A href="nelh:338644:1" name=internalLink&gt;RETURN TO CONTENTS PAGE&lt;/A&gt;]&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 8pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="BACKGROUND: white; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"&gt;&lt;SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: 'Times New Roman'"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304326</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304326]]&gt;</url>
    <title>Annual Evidence Update 19 January 2009: Patient and carer involvement in chronic disease. Contents Page</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Pallliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ INDIVIDUAL INVOLVEMENT,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,COMMUNICATION ISSUES,FAMILIES &amp; CARERS,SYMPTOM MANAGEMENT,PPI IN PRACTICE,PATIENT AND PUBLIC INVOLVEMENT,ACUTE KIDNEY INJURY,CHRONIC KIDNEY DISEASE,COMPLICATIONS OF KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 19 January 2009: Patient and carer involvement in chronic disease. Contents Page&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="MARGIN-RIGHT: 0px" dir=ltr&gt;The policy background:&amp;nbsp;&lt;/H2&gt;
&lt;UL&gt;
&lt;LI dir=ltr&gt;
&lt;H2&gt;&lt;A href="http://www.dh.gov.uk/en/Aboutus/MinistersandDepartmentLeaders/ChiefMedicalOfficer/ProgressOnPolicy/ProgressBrowsableDocument/DH_4102757" target="_blank"&gt;&lt;FONT size=2&gt;From the Dept of Health website&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;
&lt;LI dir=ltr&gt;
&lt;H2&gt;&lt;A href="http://www.expertpatients.co.uk/public/default.aspx?load=ArticleViewer&amp;amp;ArticleId=500" target="_blank"&gt;&lt;FONT size=2&gt;Expert Patient Programme website&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304366&amp;amp;tabID=290" target="_blank"&gt;Introduction&lt;/A&gt; &lt;/H2&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=303870&amp;amp;tabID=290" target="_blank"&gt;Patient and carer involvement in chronic disease.&amp;nbsp;A search for systematic reviews 2000-2008&lt;/A&gt; &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Patient and carer involvement in&amp;nbsp;specific&amp;nbsp;contexts:&lt;/STRONG&gt; &lt;/P&gt;
&lt;H3&gt;&lt;/H3&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Kidney disease:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=304360" target="_blank"&gt;Family members in end-stage kidney disease in palliative and supportive care (by Joe Low)&amp;nbsp;[Download pdf]&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/BLOCKQUOTE&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Lymphoedema:&lt;/EM&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=304469" target="_blank"&gt;Lymphoedema Update for NLH: Information for patient and carer involvement (by Vaughan Keeley and Lisa Lawrence) [Download pdf]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=304475&amp;amp;tabID=290" target="_blank"&gt;Lymphoedema. List of useful resources. (Updated 2009)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P dir=ltr&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P dir=ltr&gt;&lt;EM&gt;End of Life Care:&lt;/EM&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=304351" target="_blank"&gt;User involvement in EoLC: how involved can patients/carers be? (by Joanna Black) [Download pdf]&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304323&amp;amp;tabID=290" target="_blank"&gt;User involvement and End of Life Care. Contextualising User Involvement (by Denise Brady &amp;amp; David Oliviere)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304346&amp;amp;tabID=290" target="_blank"&gt;Annotated reference/bibliography on user involvement in palliative care (by David Oliviere)&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304336&amp;amp;tabID=290" target="_blank"&gt;Patient and carer involvement in End of Life Care: A literature review (by Denise Brady &amp;amp; David Oliviere)&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/BLOCKQUOTE&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>394486</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=394486]]&gt;</url>
    <title>Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Contents</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;UL style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="nelh:394487:0" name=internalLink&gt;Introduction&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;H2 dir=ltr&gt;&amp;nbsp;&lt;/H2&gt;
&lt;UL style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="nelh:394493:0" name=internalLink&gt;Methods&lt;/A&gt; &lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;H2 dir=ltr&gt;&amp;nbsp;&lt;/H2&gt;
&lt;UL style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="nelh:394489:0" name=internalLink&gt;List of included references&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>394487</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=394487]]&gt;</url>
    <title>Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;Welcome to the Annual Evidence Update on supportive and palliative care issues in people with respiratory disease.&amp;nbsp; We are again&amp;nbsp;linking this update to the recent &lt;A href="http://www.library.nhs.uk/respiratory/ViewResource.aspx?resID=394010&amp;amp;tabID=289&amp;amp;catID=5880" target="_blank"&gt;AEU presented by the Respiratory Specialist Collection, which focused on COPD&lt;/A&gt;.&amp;nbsp; Readers will find many relevant topics for professionals and researchers regarding supportive and palliative care in that collection.&lt;/P&gt;
&lt;P&gt;For our own specific search through the literature, we have concentrated on two of the most important issues for patients with pulmonary problems.&amp;nbsp; The first is dyspnoea (or breathlessness).&amp;nbsp; This symptom is usually one of the most prevalent in surveys of problems associated with respiratory and also many other systemic illnesses.&amp;nbsp; For this AEU, we have taken our customary broad and inclusive view of supportive and palliative care, and have therefore included reviews and studies which cover cancer treatment as well as end of life care topics. &lt;/P&gt;
&lt;P&gt;Our second specific topic is cough, which is less common but can nevertheless be just as distressing for patients with cancer and other chronic conditions.&amp;nbsp; Again, we have chosen key publications representing the best systematic reviews and selected studies from the last few years, covering the whole disease trajectory. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:394489:0" name=internalLink&gt;GO TO THE LIST OF REFERENCES&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Sam H Ahmedzai&lt;/LI&gt;
&lt;LI&gt;Denise Brady&lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;
&lt;LI&gt;Richard Stevens&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;[Project team of the Specialist Collection for Supportive and Palliative Care]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We would like to thank the following for their helpful contribution in reviewing and appraising the literature –&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Jason Boland [Clinical Lecturer and PhD student, Sheffield]&lt;/LI&gt;
&lt;LI&gt;Sarah Mollart [Specialist Registrar in Palliative Medicine, Sheffield and Chesterfield training programme]&lt;/LI&gt;
&lt;LI&gt;Dilanki Ranmuthu &lt;/LI&gt;
&lt;LI&gt;Clare Rayment [Specialist Registrar in Palliative Medicine, Leeds]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>394489</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=394489]]&gt;</url>
    <title>Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. List of included references</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. List of included references&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;1. Epidemiology and measurement &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;1a. Dyspnoea&lt;/STRONG&gt;&lt;/SPAN&gt;
&lt;UL&gt;
&lt;LI&gt;Understanding Breathlessness: Cross-Sectional Comparison of Symptom Burden and Palliative Care Needs in Chronic Obstructive Pulmonary Disease and Cancer. Bausewein C, Booth S, Gysels M, Kahnbach R, Haberland B, Higginson IJ.&amp;nbsp; Journal of Palliative Medicine, 01 September 2010, vol./is. 13/9(1109-1118), 10966218 [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20836635" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Measurement of breathlessness in clinical trials in patients with chronic heart failure: The need for a standardized approach: A systematic review. Johnson M.J., Oxberry S.G., Cleland J.G.F., Clark A.L. European Journal of Heart Failure, February 2010, vol./is. 12/2(137-147), 1388-9842;1879-0844&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20083623" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;?xml:namespace prefix = o /&gt;&lt;o:p&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Quantification of dyspnoea using descriptors: Development and initial testing of the dyspnoea-12. Yorke J., Moosavi S.H., Shuldham C., Jones P.W. Thorax, January 2010, vol./is. 65/1(21-26), 0040-6376;1468-3296&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19996336" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;1b. Cough&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l3 level1 lfo2; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Clinical pathways for chronic cough in children. Bailey Emily J, Morris Peter S, Kruske Sue G, Chang Anne B.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2008 Issue 2 John Wiley &amp;amp; Sons, Ltd Chichester, UK&amp;nbsp;[&lt;A name=internalLink&gt;&lt;/A&gt;&lt;A href="nelh:283720:0" name=internalLink&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="COLOR: blue"&gt;&lt;A href="nelh:283720:0" name=internalLink&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="COLOR: blue"&gt;Full text&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;1c. Mixed/non-specific/quality of life&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo3; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Diagnosis and treatment of malignant pleural effusion: A systematic literature review and new approaches. Lombardi G., Zustovich F., Nicoletto M.O., Donach M., Artioli G., Pastorelli D. American Journal of Clinical Oncology: Cancer Clinical Trials, August 2010, vol./is. 33/4(420-423), 0277-3732;1537-453X (August 2010) [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19858695" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo3; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Malignant respiratory-digestive fistulas.&amp;nbsp;Rodriguez AN, Diaz-Jimenez JP.&amp;nbsp;Curr Opin Pulm Med. 2010 Jul;16(4):329-33.&amp;nbsp; Curr Opin Pulm Med. 2010 Jul;16(4):329-33. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20531081" target="_blank"&gt;PubMed abstract&lt;/A&gt;].&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo3; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Health-Related Quality of Life in End-Stage COPD and Lung Cancer Patients. Habraken J.M., ter Riet G., Gore J.M., Greenstone M.A., Weersink E.J.M., Bindels P.J.E., Willems D.L. Journal of Pain and Symptom Management, June 2009, vol./is. 37/6(973-981), 0885-3924 [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19394792" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo3; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Quality Measures for Supportive Cancer Care: The Cancer Quality-ASSIST Project. Lorenz K.A., Dy S.M., Naeim A., Walling A.M., Sanati H., Smith P., Shanman R., Roth C.P., Asch S.M. &lt;FONT face=Verdana size=2&gt;Journal of Pain and Symptom Management, June 2009, vol./is. 37/6(943-964), 0885-3924 (June 2009) &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19359135" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l6 level1 lfo3; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health technology assessment. &lt;FONT face=Verdana size=2&gt;Mant J., Doust J., Roalfe A., Barton P., Cowie M.R., Glasziou P., Mant D., McManus R.J., Holder R., Deeks J., Fletcher K., Qume M., Sohanpal S., Sanders S., Hobbs F.D.&amp;nbsp;&lt;/FONT&gt;&amp;nbsp;(Winchester, England), July 2009, vol./is.13/32(1-207, iii), 1366-5278 (Jul 2009)&amp;nbsp;&lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19586584" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2. Interventions&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2a. Dyspnoea&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007354.&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20091630" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;[&lt;A href="nelh:341751:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL dir=ltr style="MARGIN-RIGHT: 0px"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients. Varkey B. Current Opinion in Pulmonary Medicine, March 2010, vol./is. 16/2(150-154), 1070-5287;1531-6971&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20071992" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Heliox, dyspnoea and exercise in COPD. Hunt T., Williams M.T., Frith P., Schembri D. European Respiratory Review, March 2010, vol./is. 19/115(30-38), 0905-9180&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20956163" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;The impact of home-based physiotherapy interventions on breathlessness during activities of daily living in severe COPD: A systematic review. Thomas M.J., Simpson J., Riley R., Grant E. Physiotherapy, June 2010, vol./is. 96/2(108-119), 0031-9406&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20420957" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Nonoyama M., Brooks D., Lacasse Y., Guyatt G.H., Goldstein R. Cochrane Database of Systematic Reviews, 2009, vol./is. /4, 1469-493X [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17443585" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:260026:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;
&lt;LI&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;Evidence-based review of interventions to improve palliation of pain, dyspnea, depression. Naqvi F., Cervo F., Fields S. Geriatrics, 2009, vol./is. 64/8(8-14), 0016-867X&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20722311" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/UL&gt;
&lt;UL dir=ltr style="MARGIN-RIGHT: 0px"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Bausewein Claudia, Booth Sara, Gysels Marjolein, Higginson Irene J.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2008 Issue 2 John Wiley &amp;amp; Sons, Ltd Chichester, UK [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18425927" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:283692:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l2 level1 lfo4; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Interventions for alleviating cancer-related dyspnea: a systematic review&amp;nbsp; Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer S M.&amp;nbsp;&amp;nbsp;Journal of Clinical Oncology 2008; 26(14): 2396-2404 [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18467732" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2b. Cough&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data. Cazzola M., Floriani I., Page C.P. Pulmonary Pharmacology and Therapeutics, April 2010, vol./is. 23/2(135-144), 1094-5539;1522-9629 [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19854285" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;COPD - management of breathlessness. (specialist care). Map of Medicine&amp;nbsp;[&lt;A href="http://eng.mapofmedicine.com/evidence/map/chronic_obstructive_pulmonary_disease_copd_4.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Full text&lt;/SPAN&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Current clinical trials for the treatment of idiopathic pulmonary fibrosis. Klingsberg RC, Mutsaers SE, Lasky JA. Respirology. 2010 Jan;15(1):19-31.&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20199632" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Interventions for cough in cancer. Molassiotis A, Bailey C, Caress A, Brunton L, Smith J. Cochrane Database of Systematic Reviews: Reviews.&amp;nbsp; John Wiley &amp;amp; Sons, Ltd. 2010 Issue 9 [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20824870" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:387502:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Poole P, Black PN. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001287.&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20166060" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;FONT size=2&gt;[&lt;A href="nelh:236943:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Clinical cough VI: the need for new therapies for cough: disease-specific and symptom-related antitussives. Chung KF.&amp;nbsp; Handb Exp Pharmacol. 2009;(187):343-68. Citation: Handbook of experimental pharmacology, 2009, vol./is. /187(343-368), 0171-2004 (2009) [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18825350" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Oscillating devices for airway clearance in people with cystic fibrosis. Morrison Lisa, Agnew Jennifer. Cochrane Database of Systematic Reviews: Reviews 2009 Issue 1 John Wiley &amp;amp; Sons, Ltd Chichester, UK [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160305" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:304966:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l1 level1 lfo5; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Anti-histamines for prolonged non-specific cough in children. Chang Anne B, Peake Jane, McElrea Margaret S.&amp;nbsp;Cochrane Database of Systematic Reviews: Reviews 2008 Issue 2 John Wiley &amp;amp; Sons, Ltd Chichester, UK [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18425925" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;FONT size=2&gt;[&lt;A href="nelh:239120:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2c. Mixed/non-specific/quality of life&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): A systematic review. Tang C.Y., Taylor N.F., Blackstock F.C. Physiotherapy, March 2010, vol./is. 96/1(1-13), 0031-9406 (March 2010)&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20113757" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Diagnosis and treatment of malignant pleural effusion: A systematic literature review and new approaches.&amp;nbsp; American Journal of Clinical Oncology: Cancer Clinical Trials, August 2010, vol./is. 33/4(420-423), 0277-3732;1537-453X (August 2010)&amp;nbsp; Author(s): Lombardi G., Zustovich F., Nicoletto M.O., Donach M., Artioli G., Pastorelli D. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19858695" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Exercise for women with heart failure: Systematic review. Journal of Cardiopulmonary Rehabilitation and Prevention, September 2010, vol./is. 30/5(353), 1932-7501 (September-October 2010). Rizza S.A. &lt;FONT size=2&gt;[PubMed abstract unavailable]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Hypofractionated radiotherapy in non small cell lung cancer: a review of the current literature. Beli I, Koukourakis G, Platoni K, Tolia M, Kelekis N, Kouvaris J, Syrigos C, Mystakidou K, Varveris C, Kouloulias V. Rev Recent Clin Trials. 2010 May;5(2):103-11.&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20423316" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;COPD - specialist management. Map of Medicine&amp;nbsp;[&lt;A href="http://eng.mapofmedicine.com/evidence/map/chronic_obstructive_pulmonary_disease_copd_6.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Full text&lt;/SPAN&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;COPD - management in non-specialist care. Map of Medicine&amp;nbsp;[&lt;A href="http://eng.mapofmedicine.com/evidence/map/chronic_obstructive_pulmonary_disease_copd_5.html" target="_blank"&gt;&lt;SPAN style="COLOR: blue"&gt;Full text&lt;/SPAN&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Arm exercise training in patients with chronic obstructive pulmonary disease: A systematic review Journal of Cardiopulmonary Rehabilitation and Prevention, September 2009, vol./is. 29/5(277-283), 1932-7501;1932-751X (September-October 2009)&amp;nbsp; Janaudis-Ferreira T., Hill K., Goldstein R., Wadell K., Brooks D. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19935139" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Associations between statins and COPD: A systematic review BMC Pulmonary Medicine, July 2009, vol./is. 9/, 1471-2466 (12 Jul 2009)&amp;nbsp;Dobler C.C., Wong K.K., Marks G.B. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19594891" target="_blank"&gt;PubMed abstract&lt;/A&gt;] [&lt;A href="http://www.biomedcentral.com/content/pdf/1471-2466-9-32.pdf" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;Chronic respiratory care for neuromuscular diseases in adults. Ambrosino N, Carpenè N, Gherardi M. Eur Respir J. 2009 Aug;34(2):444-51. Comment in: Eur Respir J. 2010 May;35(5):1192; author reply 1192-3. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19648521" target="_blank"&gt;PubMed abstract&lt;/A&gt;].&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: A systematic review of the english-language literatureCitation: Chest, July 2009, vol./is. 136/1(44-61), 0012-3692;1931-3543 (01 Jul 2009)&amp;nbsp;Sillen M.J.H., Speksnijder C.M., Eterman R.-M.A., Janssen P.P., Wagers S.S., Wouters E.F.M., Uszko-Lencer N.H.M.K., Spruit M.A. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19363213" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic reviewCitation: Physical Therapy, May 2009, vol./is. 89/5(443-455), 0031-9023 (May 2009)&amp;nbsp;Costi S., Bari M.D., Pillastrini P., D'Amico R., Crisafulli E., Arletti C., Fabbri L.M., Clini E.M. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19282362" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Citation: Cochrane database of systematic reviews (Online), 2009, vol./is. /1(CD001288), 1469-493X (2009)&amp;nbsp; Walters J.A., Gibson P.G., Wood-Baker R., Hannay M., Walters E.H. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160195" target="_blank"&gt;PubMed abstract&lt;/A&gt;] [&lt;A href="nelh:236944:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;The efficacy of treatment for systemic sclerosis. interstitial lung disease: results from a meta-analysis. &lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Broad K, Pope JE.&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;Med Sci Monit. 2010 Aug 7;16(9):RA187-90. &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20802426" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Inhaled steroids for bronchiectasis. Kapur Nitin AU: Bell Scott AU: Kolbe John AU: Chang Anne B.&amp;nbsp;&amp;nbsp; Cochrane Database of Systematic Reviews: Reviews.&amp;nbsp; John Wiley &amp;amp; Sons, Ltd. 2009 [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160186" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:236757:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Non-invasive ventilation for cystic fibrosis. Moran F., Bradley J.M., Piper A.J.&amp;nbsp; Cochrane Database of Systematic Reviews, 2009, vol./is. /1, 1469-493X [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160211" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;FONT size=2&gt;[&lt;A href="nelh:237507:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Puhan M., Scharplatz M., Troosters T., Walters E.H., Steurer J. Cochrane database of systematic reviews (Online), 2009, vol./is. /1(CD005305), 1469-493X [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160250" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:304888:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Treatment options for malignant pleural effusion. Musani AI. Curr Opin Pulm Med. 2009 Jul;15(4):380-7.&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19436206" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Self-management education for patients with chronic obstructive pulmonary disease. Effing T., Monninkhof E.E.M., Van Der Valk P.P.D.L.P.M., Zielhuis G.G.A., Haydn Walters E., Van Der Palen J.J., Zwerink M. Cochrane Database of Systematic Reviews, 2009, vol./is. /4, 1469-493X [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17943778" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:237975:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. Rosenzweig KE, Movsas B, Bradley J, Gewanter RM, Gopal RS, Komaki RU, Kong FM, Lee HK, Feins RH, Langer CJ. J Am Coll Radiol. 2009 Feb;6(2):85-95.&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19179235" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo6; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Palliative endobronchial brachytherapy for non-small cell lung cancer. Cardona Zorrilla Andrés Felipe, Reveiz Ludovic, Ospina Edgar Guillermo, Yepes Andrés. Cochrane Database of Systematic Reviews: Reviews 2008 Issue 2 John Wiley &amp;amp; Sons, Ltd Chichester, UK [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18425900" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:283670:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;3. Guidelines or pathways&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI&gt;
&lt;DIV class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease - practical issues: A Canadian thoracic society clinical practice guideline [French] L'optimisation de la readaptationpulmonaire en cas de maladie pulmonaire obstructive chronique - des enjeux pratiques : Directives cliniques de la Societe canadienne de thoracologie Citation: Canadian Respiratory Journal, July 2010, vol./is. 17/4(159-168), 1198-2241 (July/August 2010) &lt;FONT size=2&gt;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20808973" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;BTS Pleural Disease Guideline 2010. A Quick Reference Guide. British Thoracic Society&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:388042:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Mark E Roberts, Edmund Neville, Richard G Berrisford, George Antunes, Nabeel J Ali. Thorax 2010;65(Suppl 2):ii32eii40&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Pleural%20Disease/Pleural%20Guideline%202010/Pleural%20disease%202010%20malignant%20pleural%20effusion.pdf" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Full text&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Motor neurone disease. The use of non-invasive ventilation in the management of motor neurone disease. NICE Clinical Guideline 105. NICE,&amp;nbsp;2010&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;[&lt;A href="nelh:381874:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;(and slideset&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://guidance.nice.org.uk/CG105/SlideSet/ppt/English" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Full text&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;])&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update).&amp;nbsp;NICE, 2010.&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 'Courier New'; mso-fareast-font-family: 'Courier New'; mso-fareast-language: EN-GB; mso-bidi-font-size: 9.0pt"&gt;&lt;SPAN style="mso-list: Ignore"&gt;&lt;SPAN style="FONT: 7pt 'Times New Roman'"&gt; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Full document [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2&gt;&lt;A href="nelh:34497:0" name=internalLink&gt;Full text&lt;/A&gt;];&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Slideset. [&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://guidance.nice.org.uk/CG101/SlideSet/ppt/English" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Full text&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;];&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Update guideline&amp;nbsp;[&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;A href="http://www.nice.org.uk/nicemedia/live/13029/49425/49425.pdf" target="_blank"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; COLOR: blue; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Full text&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;])&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;BTS guidelines for home oxygen in children. British Thoracic Society Home Oxygen Guideline Development Group (Paediatric Section). Thorax, 2009 Supplement 2 v64 August&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;FONT size=2&gt;[&lt;A href="nelh:345082:0" name=internalLink&gt;Full text&lt;/A&gt;]&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;British Thoracic Society Concise BTS/ACPRC guidelines. Physiotherapy management of the adult, medical, spontaneously breathing patient. British Thoracic Society 2009.&amp;nbsp;[&lt;A href="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Physiotherapy/PhysiotherapyGuideline/PhysioConcise-web.pdf" target="_blank"&gt;Full text&lt;/A&gt;] &lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient (full guidelines of above). Thorax&amp;nbsp; 2009 v64 no 2 Supplement 1 May 2009 [&lt;A href="http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Physiotherapy/PhysiotherapyGuideline/PhysioFullGuideline.pdf" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="mso-bookmark: internalLink"&gt;&lt;SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. &lt;FONT size=2&gt;Langer D., Hendriks E.J.M., Burtin C., Probst V., van der Schans C.P., Paterson W.J., Verhoef-de Wijk M.C.E., Straver R.V.M., Klaassen M., Troosters T., Decramer M., Ninane V., Delguste P., Muris J., Gosselink R.&lt;/FONT&gt;&amp;nbsp;Clinical Rehabilitation, 2009, vol./is. 23/5(445-462), 0269-2155 (2009)&amp;nbsp; [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19389745" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 10pt; LINE-HEIGHT: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l5 level1 lfo7; tab-stops: list 36.0pt"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>394493</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=394493]]&gt;</url>
    <title>Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Methods</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 22 November 2010. Supportive and palliative care in chronic lung disease. Methods&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;BR&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Databases searched&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;PubMed&lt;/LI&gt;
&lt;LI&gt;DARE&lt;/LI&gt;
&lt;LI&gt;Cochrane database of systematic reviews&lt;/LI&gt;
&lt;LI&gt;NHS Evidence: Guidelines&lt;/LI&gt;
&lt;LI&gt;NHS Evidence - supportive and palliative care &lt;/LI&gt;
&lt;LI&gt;Cinahl&lt;/LI&gt;
&lt;LI&gt;Embase&lt;/LI&gt;
&lt;LI&gt;Whole of NHS evidence &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Search notes on cough&amp;nbsp;-&amp;nbsp;Melanie Hodson&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;H3 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;EM&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;NHS Evidence - whole site&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/H3&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Searched: &lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.evidence.nhs.uk/default.aspx" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;http://www.evidence.nhs.uk/default.aspx&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search string: Cough&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Limits: Published date = last year;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: Symbol; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Types of information = systematic reviews&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search results: 61&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Date searched: 14 Oct. 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;'NHS Evidence - supportive and palliative care' only&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Searched string: cough &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Limits: None&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search results: 40 of which 8 were selected (remainder published before 2009)&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Date searched: 14 Oct. 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;H3 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;EM&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;'NHS Evidence - respiratory' only&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/H3&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Searched string: cough &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Limits: 2009-2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search results: 171 of which 19 were selected (remainder published before 2009)&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Date searched: 14 Oct. 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;EM&gt;DARE&lt;/EM&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search string: cough &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Limits: Year published = 2009-2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search results: 25 of which all were selected as results list quite small.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Notes: Used ‘Year published’ which means the year when the original document was published.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Date searched: 14 Oct. 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;EM&gt;Cocharane&lt;/EM&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 9pt 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Searched string: &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;cough* AND (terminal* OR hospice* OR palliat* OR "end-of-life" OR "end of life" OR supportive)&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; (all text)&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Limits: 2009 to 2010 &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Search results: 80 – all selected.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;Date searched: 14 Oct. 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE style="mso-cellspacing: 1.5pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;A name=EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva&gt;&lt;/A&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=24&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#24&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;#14 AND #23&lt;/B&gt; Limits: &lt;B&gt;Humans, English, Publication Date from 2009/01/01 to 2010/10/13&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:21:21&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=24&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;14&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=25&amp;amp;dbase=pubmed&amp;amp;querytype=eSelect&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#25&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Select &lt;B&gt;14&lt;/B&gt; document(s)&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:20:11&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=25&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;14&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=23&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#23&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;PubMed&lt;/SPAN&gt;&lt;/B&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;#19 OR #22&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:16:43&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=23&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2020975&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=22&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#22&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;systematic [tw] OR "meta-analysis" [tw] OR "meta analysis" [tw] OR randomised [tw] OR randomized [tw]&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:14:59&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=22&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;553266&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=19&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#19&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;((("Review Literature as Topic"[Mesh] OR "Review "[Publication Type])) OR ("Meta-Analysis "[Publication Type] OR "Meta-Analysis as Topic"[Mesh])) OR ("Randomized Controlled Trial "[Publication Type] OR "Randomized Controlled Trials as Topic"[Mesh])&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:11:39&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=19&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;1889490&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=14&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#14&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;#5 AND #13&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:09:32&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=14&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;507&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=13&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#13&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;#11 OR #12&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:09:03&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=13&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;115389&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=12&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#12&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;palliat* [tw] OR hospice* [tw] OR "terminal care" [tw] OR "terminally ill" [tw] OR "end of life" [tw] OR "end-of-life" [tw] OR supportive [tw]&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:08:37&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=12&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;104043&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=11&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#11&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;((("Hospice Care"[Mesh] OR "Hospices"[Mesh])) OR ("Palliative Care"[Mesh] OR "Terminal Care"[Mesh])) OR "Terminally Ill"[Mesh]&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:06:35&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=11&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;65562&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=5&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#5&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;#3 OR #4&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:03:22&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=5&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;35187&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=4&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#4&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;cough*[tw]&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:02:43&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=4&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;35187&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=3&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#3&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;"Cough"[Mesh]&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:01:45&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=3&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;10201&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;PubMed clinical query search&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;This included one result not found by the search above.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE style="mso-cellspacing: 1.5pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?querykey=27&amp;amp;dbase=pubmed&amp;amp;querytype=eSearch&amp;amp;" target="_blank"&gt;&lt;FONT face=Verdana&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin"&gt;#27&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search &lt;B&gt;((cough [mh] OR cough* [tw]) AND (hospice care [mh] OR hospice* [tw] OR palliative care [mh] OR palliat* [tw] OR terminal care [mh] OR hospices [mh] OR terminally ill [mh] OR terminal* [tw])) AND systematic[sb]&lt;/B&gt; Limits: &lt;B&gt;Humans, English, Publication Date from 2009/01/01 to 2010/10/13&lt;/B&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;07:35:09&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" vAlign=top&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: 21.6pt; MARGIN: 0cm 0cm 7.2pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/?cmd=HistorySearch&amp;amp;querykey=27&amp;amp;" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;SPAN style="mso-bookmark: 'EntrezSystem2.PEntrez.Pubmed.Pubmed_Adva'"&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;PubMed searched 14 Oct 2010.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;EM&gt;CINAHL&lt;/EM&gt; &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;1. CINAHL; cough*.ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 505 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;2. CINAHL; COUGH/ [Limit to: Publication Year 2009-2010 and (Language English)]; 293 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;3. CINAHL; 1 OR 2 [Limit to: Publication Year 2009-2010 and (Language English) and (Language English)]; 609 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;4. CINAHL; hospice*.ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 702 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;5. CINAHL; HOSPICES/ OR HOSPICE CARE/ OR HOSPICE AND PALLIATIVE NURSING/ OR HOSPICE PATIENTS/ [Limit to: Publication Year 2009-2010 and (Language English)]; 996 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;6. CINAHL; palliat*.ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 1951 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;7. CINAHL; PALLIATIVE CARE/ OR TERMINAL CARE/ [Limit to: Publication Year 2009-2010 and (Language English)]; 3044 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;8. CINAHL; terminal*.ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 972 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;9. CINAHL; TERMINALLY ILL PATIENTS/ [Limit to: Publication Year 2009-2010 and (Language English)]; 804 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;10. CINAHL; "end of life".ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 1178 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;11. CINAHL; "end-of-life".ti,ab [Limit to: Publication Year 2009-2010 and (Language English)]; 1178 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;12. CINAHL; 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 [Limit to: Publication Year 2009-2010 and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English)]; 5393 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;13. CINAHL; 3 AND 12 [Limit to: Publication Year 2009-2010 and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English) and (Language English)]; 10 results. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;Cinahl searched 14 October 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;EMBASE&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;1&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp COUGHING/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=1" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;5516&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;2&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;cough*.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=2" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2201&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;3&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;1 OR 2 [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=3" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6108&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;4&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp HOSPICE/ OR exp HOSPICE CARE/ OR exp HOSPICE NURSING/ OR exp HOSPICE PATIENT/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=4" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;618&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;5&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;palliat*.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=5" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;3368&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;6&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp CANCER PALLIATIVE THERAPY/ OR exp PALLIATIVE NURSING/ OR exp PALLIATIVE THERAPY/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=6" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;3719&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;7&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;terminal*.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=7" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;11178&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;8&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp TERMINAL CARE/ OR exp TERMINAL DISEASE/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=8" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;1993&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;9&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp TERMINALLY ILL PATIENT/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=9" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;362&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;10&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;"end-of-life".ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=10" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;1136&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;11&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;"end of life".ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=11" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;1136&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;12&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=12" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;17363&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;13&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;3 AND 12 [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=13" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;103&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;14&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp "SYSTEMATIC REVIEW"/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=14" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;7785&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;15&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;systematic.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=15" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;13098&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 15"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;16&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;exp RANDOMIZED CONTROLLED TRIAL/ [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=16" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;31027&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 16"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;17&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;randomised.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=17" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6831&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 17"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;18&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;randomized.ti,ab [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=18" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;29618&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 18"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;19&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;14 OR 15 OR 16 OR 17 OR 18 [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=19" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;57625&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 19; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;20&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;EMBASE &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB"&gt;13 AND 19 [Limit to: Publication Year 2009-2010 and Human and English Language] &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=20" target="_blank"&gt;&lt;SPAN style="mso-bidi-font-family: Tahoma; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;17&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;FONT face=Calibri&gt;Adding meta analysis (tw and subject heading) made no difference to total result.&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;Embase searched: 14 October 2010&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Tahoma; mso-fareast-language: EN-GB; mso-ansi-language: EN-US" lang=EN-US&gt;Melanie Hodson, October 2010.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Search notes&amp;nbsp;on dyspnoea&amp;nbsp;-&amp;nbsp;Denise Brady&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;Medline and Embase&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0 width="100%"&gt;
&lt;THEAD&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=center&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Database&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=center&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Search term&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; WIDTH: 77pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" width=103&gt;
&lt;P style="TEXT-ALIGN: center; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=center&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;Hits&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/THEAD&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;1&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp DYSPNEA/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=1" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;12578&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;2&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnoea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=2" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;5399&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;3&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=3" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;19173&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;breathlessness.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=4" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2449&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;5&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;1 OR 3 OR 4 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=5" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;28667&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;7&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(systematic ADJ review).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=7" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;21949&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;9&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;meta-analysis.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=9" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;27117&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;10&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(meta ADJ analysis).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=10" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;27117&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;11&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp META-ANALYSIS AS TOPIC/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=11" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;10829&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;12&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;7 OR 9 OR 10 OR 11 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=12" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;50339&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;13&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;5 AND 12 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=13" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;126&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 12"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;14&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;MEDLINE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;13 [Limit to: Publication Year 2009-Current] &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=14" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;29&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 13"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;19&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnoea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=19" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6462&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 14"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;20&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=20" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;23151&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 15"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;21&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp DYSPNEA/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=21" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;50909&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 16"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;22&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;breathlessness.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=22" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2817&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 17"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;23&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;19 OR 20 OR 21 OR 22 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=23" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;64313&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 18"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;24&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp "SYSTEMATIC REVIEW"/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=24" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;36038&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 19"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;25&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(systematic ADJ review).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=25" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;24506&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 20"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;26&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;meta-analysis.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=26" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;31444&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 21"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;27&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(meta ADJ analysis).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=27" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;31444&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 22"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;28&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp META ANALYSIS/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=28" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;51119&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 23"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;29&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;24 OR 25 OR 26 OR 27 OR 28 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=29" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;89195&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 24"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;30&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;23 AND 29 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=30" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;814&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 25; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;31&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;EMBASE &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;30 [Limit to: Publication Year 2009-Current] &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=31" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;153&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;FONT face=Calibri&gt;Search 14 and 31 were examined for relevance and results are provided in separate files &lt;BR&gt;Combine with: ANDOR &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;CINAHL&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;
&lt;TABLE style="WIDTH: 100%; mso-cellspacing: 1.5pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-yfti-tbllook: 1184" class=MsoNormalTable border=0 cellPadding=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR style="mso-yfti-irow: 0; mso-yfti-firstrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;exp DYSPNEA/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=1" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2749&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 1"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;2&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnoea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=2" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;379&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 2"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;3&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;dyspnea.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=3" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;2757&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 3"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;4&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;breathlessness.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=4" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;505&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 4"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;5&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;meta-analysis.ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=5" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6614&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 5"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;6&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(meta ADJ analysis).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=6" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6676&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 6"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;7&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;META ANALYSIS/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=7" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;9648&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 7"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;8&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;(systematic ADJ review).ti,ab &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=8" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;9026&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 8"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;9&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;SYSTEMATIC REVIEW/ &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=9" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;6729&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 9"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;10&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;5 OR 6 OR 7 OR 8 OR 9 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=10" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;22053&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 10"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;11&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;1 OR 2 OR 3 OR 4 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=11" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;4743&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;
&lt;TR style="mso-yfti-irow: 11; mso-yfti-lastrow: yes"&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;12&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;CINAHL &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt"&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;10 and 11 [Limit to: Publication Year 2009-2010] &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;
&lt;TD style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0.75pt; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0.75pt; PADDING-RIGHT: 0.75pt; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0.75pt" noWrap&gt;
&lt;P style="TEXT-ALIGN: right; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=right&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;A title="View results" href="http://www.library.nhs.uk/booksandjournals/advanced/search.aspx?viewAction=view&amp;amp;resultItem=12" target="_blank"&gt;&lt;SPAN style="mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin; mso-ansi-font-size: 9.0pt; mso-bidi-font-size: 9.0pt"&gt;&lt;FONT face=Verdana&gt;25&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT face=Calibri&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="COLOR: #272627; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;NHS EVIDENCE&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="COLOR: #272627; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="COLOR: #272627; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: ArialNarrow; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="COLOR: #272627; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;This was confined to 2009-2010 using the NHS Evidence main interface and using &lt;I style="mso-bidi-font-style: normal"&gt;dyspnoea and palliative care &lt;/I&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;in the search box.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;Some items were excluded if they were short items from BNF, items&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;that seemed broader in scope and items that were primarily patient information. &lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;Of course not all are systematic reviews/meta-analyses but it always checked for relevant material.&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;Cochrane&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;All text: dyspnoea or dyspnea or breathlessness 2009-2010&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;297 items&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt; were examined for relevance and results are provided in a separate file&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;Items dated before 2009 (despite being found in the text were excluded).&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;FONT face=Calibri&gt;&lt;EM&gt;&lt;B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;DARE&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;All text: dyspnoea or dyspnea or breathlessness 2009-2010&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;29 items&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN"&gt; &lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;were examined for relevance and results are provided in separate file&lt;/SPAN&gt;&lt;/FONT&gt;&lt;FONT face=Calibri&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt; &lt;BR&gt;&lt;BR style="mso-special-character: line-break"&gt;&lt;BR style="mso-special-character: line-break"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;No items were found on PSYCINFO using a search strategy the same as CINAHL. &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;ASTHMA and BRONCHIECTASIS were generally not included in items retrieved from above searches. &lt;BR&gt;&lt;BR&gt;Denise Brady, October 2010&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Post-search processing of reference lists - Richard Stevens&lt;/SPAN&gt;&lt;/H2&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt;The lists of&amp;nbsp;search results were formatted in separate Word documents (with html links to abstracts in some cases) in such a way as to&amp;nbsp;make the appraisal process&amp;nbsp;more reader-friendly.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Appraisal of &lt;FONT size=2&gt;reference &lt;/FONT&gt;lists - Jason Boland&lt;/SPAN&gt;&lt;/H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;The Word documents were passed to Jason Boland, who organised distribution&amp;nbsp;amongst the review team for first appraisal. Titles were highlighted in green, yellow or red using the highlight function in Word&amp;nbsp;(to indicate 'yes', 'maybe' or 'no') by each reviewer. In some cases comments were added alongside references where the decision was contentious or to make other points. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;After this first appraisal, the amended documents were sent by each reviewer&amp;nbsp;to Prof Sam H Ahmedzai for approval, who then passed his amended and annotated final versions of these files to Richard Stevens.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Preparation of final list and formatting for the web with other pages&amp;nbsp;- Richard Stevens&lt;/SPAN&gt;&lt;/H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;The references highlighted for inclusion in the Word&amp;nbsp;documents received from Prof Ahmedzai after second appraisal were compiled into an aggregated list and duplicates removed.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;References were put in appropriate categories as indicated by the review team.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT size=2 face=Calibri&gt;PubMed and full text web links were put in as appropriate. Final checks of references were done. The pages were put online and navigational links checked.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt;Richard Stevens, November 2010 &lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&lt;A href="nelh:394486:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-SIZE: 9pt"&gt;&lt;o:p&gt;&lt;FONT face=Calibri&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326819</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326819]]&gt;</url>
    <title>Annual Evidence Update 22 October 2007. National Knowledge Week on Palliative and supportive care in chronic non-malignant diseases [inc. chronic lung disease]</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,CARDIOVASCULAR DISEASES,RESPIRATORY DISEASES,MOTOR NEURONE DISEASE,ALZHEIMER’S DISEASE,LYMPHOEDEMA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),RENAL DISEASES,HAEMATOLOGIC AND LYMPHATIC DISEASES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 22 October 2007. National Knowledge Week on Palliative and supportive care in chronic non-malignant diseases [inc. chronic lung disease]&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;FONT color=#000000 size=5&gt;&lt;FONT color=#000000 size=2&gt;&lt;STRONG&gt;This National Knowledge Week was organised by the National Library for Palliative and Supportive Care to provide a concise summary of some key points in the best current evidence on these topics in an easy-to-read format. &lt;/STRONG&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000 size=2&gt;The National Knowledge Week pages include the results of a literature search for systematic reviews for each topic, supported by commentaries on current knowledge by expert clinicians and a summary of the Library's contents in that area. Systematic reviews are regarded as the highest level of evidence on health interventions.&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000 size=2&gt;The items below will be published on a day-by-day basis. The pages will remain accessible until the next Annual Evidence Update for each topic&amp;nbsp;in 12 months time. If you would like to contribute to this activity or you have any comments on how it could be improved, please use our &lt;/FONT&gt;&lt;A href="http://www.library.nhs.uk/palliative/ContactUs.aspx" target="_blank"&gt;&lt;FONT color=#0066ff size=2&gt;feedback form&lt;/FONT&gt;&lt;/A&gt;&lt;FONT color=#000000 size=2&gt;.&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000 size=5&gt;&lt;STRONG&gt;Contents&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&amp;nbsp;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#0000ff size=4&gt;Day One - Monday 22nd October:&lt;/FONT&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=270867&amp;amp;tabID=290" target="_blank"&gt;Introduction&amp;nbsp;from the National Library for Palliative and Supportive Care&amp;nbsp;- Sam H. Ahmedzai, Clinical Lead&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=270868&amp;amp;tabID=290" target="_blank"&gt;Introduction from the National Council for Palliative Care's Policy Unit - Lucy Sutton, National Policy Lead&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271104&amp;amp;tabID=290" target="_blank"&gt;Methodology - National Knowledge Week 22-26 Oct 2007. By Richard Stevens, Information Specialist.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;/P&gt;
&lt;HR&gt;

&lt;P&gt;
&lt;P align=left&gt;&lt;FONT color=#0000ff size=4&gt;Day Two - Tuesday 23rd October:&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;[Cardiovascular Diseases]: Chronic Heart Failure&lt;/FONT&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.radcliffe-oxford.com/heartfailure.htm" target="_blank"&gt;'Heart failure and palliative care: a team approach' e-book&lt;/A&gt;.&amp;nbsp;For a limited period only we are able to provide online access to the entire text of the book “Heart Failure and Palliative Care: a team approach”, edited by Miriam Johnson and Richard Lehman.&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271030&amp;amp;tabID=289" target="_blank"&gt;Chronic heart failure - systematic reviews in 2007. By Jason Boland&lt;/A&gt;.&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9088" target="_blank"&gt;'Cardiovascular Diseases' - search of the Pallilative and Supportive Care Library&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;STRONG&gt;Elsewhere in NLH:&lt;/STRONG&gt; &lt;A href="http://www.library.nhs.uk/cardiovascular/Page.aspx?&amp;amp;pagename=ED25" target="_blank"&gt;'The importance of palliative care in heart failure'&lt;/A&gt;. By Louise Gibbs (for the &lt;A href="http://www.library.nhs.uk/cardiovascular/" target="_blank"&gt;Cardiovascular Diseases Library&lt;/A&gt;).&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;&lt;FONT color=#000000&gt;[Respiratory Conditions]:&lt;/FONT&gt; Chronic Obstructive Pulmonary Disease (COPD)&lt;/FONT&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271039&amp;amp;tabID=289" target="_blank"&gt;COPD&amp;nbsp;- systematic reviews in 2006-07. By Jason Boland&lt;/A&gt;.&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9109" target="_blank"&gt;'COPD' - search of the Palliative and Supportive Care Specialist Library&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&amp;nbsp;&lt;STRONG&gt;Elsewhere in NLH:&lt;/STRONG&gt; &lt;A href="http://www.library.nhs.uk/respiratory/ViewResource.aspx?resID=197442" target="_blank"&gt;'COPD and palliative and supportive care'&lt;/A&gt;. By Sam H. Ahmedzai (for the &lt;A href="http://www.library.nhs.uk/respiratory/" target="_blank"&gt;Respiratory Library&lt;/A&gt;).&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;
&lt;P align=left&gt;&lt;/P&gt;
&lt;HR&gt;

&lt;P&gt;
&lt;P align=left&gt;&lt;FONT color=#0000ff size=4&gt;Day Three - Wednesday 24th October:&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;[Renal Diseases]: End-Stage Renal Disease&lt;/FONT&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=267423&amp;amp;tabID=290" target="_blank"&gt;Introduction to end-stage renal disease in palliative and supportive care. By Fliss Murtagh.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271071&amp;amp;tabID=289" target="_blank"&gt;Epidemiology and prognosis in advanced chronic kidney disease: Implications for palliative care. By Neil Sheerin.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271069&amp;amp;tabID=289" target="_blank"&gt;Dialysis decision-making and advance planning – an evidence guide for palliative professionals.&amp;nbsp;By Helen Noble.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271068&amp;amp;tabID=289" target="_blank"&gt;Using strong opioids in advanced chronic kidney disease –&amp;nbsp; what is the evidence? By Claire A. Douglas.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?tabID=289&amp;amp;catID=10295" target="_blank"&gt;'Renal Diseases' - search of the Palliative and Supportive Care Library.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;STRONG&gt;Elsewhere in NLH:&lt;/STRONG&gt; &lt;A href="http://www.library.nhs.uk/kidney/" target="_blank"&gt;Kidney Diseases Specialist Library&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;&lt;FONT size=3&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;/P&gt;
&lt;HR&gt;
&lt;/STRONG&gt;
&lt;P&gt;
&lt;P align=left&gt;&lt;/FONT&gt;&lt;FONT color=#0000ff size=4&gt;Day Four - Thursday 25th October:&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;[Haematologic and Lymphatic Diseases]: Lymphoedema&lt;/FONT&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271125&amp;amp;tabID=289" target="_blank"&gt;Lymphoedema / chronic oedema – a neglected area? By Vaughan Keeley.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271133&amp;amp;tabID=289" target="_blank"&gt;The treatment of lymphoedema / chronic oedema. By Vaughan Keeley.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271073&amp;amp;tabID=290" target="_blank"&gt;Other sources of information. By Vaughan Keeley.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9107&amp;amp;tabID=289" target="_blank"&gt;'Lymphoedema' - search of the Pallliative and Supportive Care Library.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;FONT size=3&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;/P&gt;
&lt;HR&gt;
&lt;/STRONG&gt;
&lt;P&gt;
&lt;P align=left&gt;&lt;/FONT&gt;&lt;FONT color=#0000ff size=4&gt;Day Five - Friday 26th October:&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;[Nervous System Diseases]:&lt;/FONT&gt; &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271215&amp;amp;tabID=290" target="_blank"&gt;Palliative care input and advance decision-making in patients with long-term neurological conditions. By Joy Waldock.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271212&amp;amp;tabID=289" target="_blank"&gt;Palliative care for Motor Neurone Disease. By Nigel Sykes.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=271075&amp;amp;tabID=290" target="_blank"&gt;Dementia: Some background reading. By Sharon Scott.&lt;/A&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV align=left&gt;&lt;STRONG&gt;Elsewhere in NLH:&lt;/STRONG&gt; &lt;A href="http://www.library.nhs.uk/laterlife/" target="_blank"&gt;Later Life Specialist Library&lt;/A&gt;.&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330785</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=330785]]&gt;</url>
    <title>Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Contents</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;Introduction &lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330783" target="_blank"&gt;&lt;/P&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&lt;/A&gt;&lt;A href="nelh:326859:0" name=internalLink&gt;&lt;A href="nelh:326859:0" name=internalLink&gt;&lt;A href="nelh:326859:1" name=internalLink&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=326859" target="_blank"&gt;Methods&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=326859" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=326859" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=326859" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330783" target="_blank"&gt; &lt;/P&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&lt;/A&gt;&lt;A href="nelh:330782:0" name=internalLink&gt;&lt;A href="nelh:330782:0" name=internalLink&gt;&lt;A href="nelh:330782:1" name=internalLink&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330782" target="_blank"&gt;Cough&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330782" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330782" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330782" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330783" target="_blank"&gt; &lt;/P&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&lt;/A&gt;&lt;A href="nelh:330783:0" name=internalLink&gt;&lt;A href="nelh:330783:0" name=internalLink&gt;&lt;A href="nelh:330783:1" name=internalLink&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330783" target="_blank"&gt;Dyspnoea&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=330783" target="_blank"&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;&lt;/A&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330782</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=330782]]&gt;</url>
    <title>Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Cough</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Cough&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;List of references for cough&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2009&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:313790:1" name=internalLink&gt;Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient&lt;/A&gt;&amp;nbsp;Thorax&amp;nbsp;May 2009: Vol 64, Supplement 1.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2008&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685405" target="_blank"&gt;Chronic cough&lt;/A&gt;&amp;nbsp;Wee B.&amp;nbsp;Curr Opin Support Palliat Care. 2008 Jun;2(2):105-9. Review. PubMed PMID: 18685405&lt;SPAN class=src&gt;.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18801874" target="_blank"&gt;Daily symptom burden in end-stage chronic organ failure: A systematic review&lt;/A&gt;&amp;nbsp;Janssen DJ, Spruit MA, Wouters EF, Schols JM. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med. 2008. Dec;22(8):938-48. Epub 2008 Sep 18. Review. PubMed PMID: 18801874.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18356033" target="_blank"&gt;Emerging paradigms in the management of malignant pleural effusions&lt;/A&gt;&amp;nbsp;Khaleeq G, Musani AI. &lt;SPAN class=src&gt;&lt;SPAN class=jrnl title="Respiratory medicine"&gt;Respir Med&lt;/SPAN&gt;. 2008 Jul;102(7):939-48. Epub 2008 Mar 19. Review.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=src&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=src&gt;&lt;STRONG&gt;2007&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=src&gt;&lt;A href="http://chestjournal.chestpubs.org/content/132/3_suppl" target="_blank"&gt;Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)&lt;/A&gt;&amp;nbsp;Chest September 2007 132:1S-19S; doi:10.1378/chest.07-1860&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN class=src&gt;
&lt;P&gt;&lt;A href="nelh:272856:1" name=internalLink&gt;Palliative cancer care – cough &lt;/A&gt;Clinical Knowledge Summaries 2007&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:272857:1" name=internalLink&gt;Palliative cancer care - cough: Assessment of cough&lt;/A&gt;&amp;nbsp;Clinical Knowledge Summaries&amp;nbsp;2007&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:272858:1" name=internalLink&gt;Palliative cancer care - cough: Known cause of cough&lt;/A&gt;&amp;nbsp;Clinical Knowledge Summaries&amp;nbsp;2007 &lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:272859:1" name=internalLink&gt;Palliative cancer care - cough: Symptomatic treatment of cough&lt;/A&gt;&amp;nbsp;Clinical Knowledge Summaries&amp;nbsp;2007 &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17502441" target="_blank"&gt;Recent advances in the palliative management of respiratory symptoms in advanced-stage oncology patients &lt;/A&gt;Haas AR. Am J Hosp Palliat Care. 2007 Apr-May;24(2):144-51. Review. PubMed PMID: 17502441.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2006&lt;/STRONG&gt;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;A href="nelh:238644:1" name=internalLink&gt;Antibiotics for exacerbations of chronic obstructive pulmonary disease&lt;/A&gt;&amp;nbsp; Ram FSF, Rodriguez-Roisin R, Granados-Navarrete A, Garcia-Aymerich J, Barnes NC.&amp;nbsp;&lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2006, Issue 2. Art. No.: CD004403. DOI: 10.1002/14651858.CD004403.pub2.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16867201" target="_blank"&gt;Management of airway clearance in neuromuscular disease &lt;/A&gt;Boitano LJ.&amp;nbsp;Respir Care. 2006 Aug;51(8):913-22; discussion 922-4. Review. PubMed PMID: 16867201.&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:237517:1" name=internalLink&gt;Palliative radiotherapy regimens for non-small cell lung cancer&lt;/A&gt;&amp;nbsp;Lester JF, MacBeth F, Toy E, Coles B. &lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2006, Issue 4. Art. No.: CD002143. DOI: 10.1002/14651858.CD002143.pub2.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16864071" target="_blank"&gt;The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review&lt;/A&gt;&amp;nbsp;Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK, Lung Cancer Disease Site Group Of Cancer Care Ontario's Program In Evidence-Based Care. Brachytherapy. 2006&lt;BR&gt;Jul-Sep;5(3):189-202. Review. PubMed PMID: 16864071.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16442479" target="_blank"&gt;Using the symptom monitor in a randomized controlled trial: The effect on symptom prevalence and severity &lt;/A&gt;Hoekstra J, de Vos R, van Duijn NP, Schadé E, Bindels PJ.&amp;nbsp;J Pain Symptom Manage. 2006 Jan;31(1):22-30. PubMed PMID: 16442479.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2005&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15691221" target="_blank"&gt;Interstitial lung disease in lung cancer: separating disease progression from treatment effects &lt;/A&gt;Danson S, Blackhall F, Hulse P, Ranson M.&amp;nbsp;Drug Saf. 2005;28(2):103-13. Review. PubMed PMID: 15691221.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330783</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=330783]]&gt;</url>
    <title>Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Dyspnoea</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,DYSPNOEA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Dyspnoea&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;List of references for dyspnoea (breathlessness)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2009 &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP. Br J Cancer. 2008 Jan 29;98(2):294-9.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18182991" target="_blank"&gt;PMID: 18182991&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Advances in the pharmacological management of breathlessness.&amp;nbsp;Currow DC, Ward AM, Abernethy AP. Curr Opin Support Palliat Care. 2009 Jun;3(2):103-6. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19333124" target="_blank"&gt;PMID: 19333124 &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Pulmonary rehabilitation for dyspnea in the palliative-care setting.&amp;nbsp;Sachs S, Weinberg RL.&amp;nbsp;Curr Opin Support Palliat Care. 2009 Jun;3(2):112-9.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19381095" target="_blank"&gt;PMID: 19381095&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2008&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Booth S, Moosavi SH, Higginson IJ. Nat Clin Pract Oncol. 2008 Feb;5(2):90-100. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18235441" target="_blank"&gt;PMID: 18235441 &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:316759:1" name=internalLink&gt;Interventions for alleviating cancer-related dyspnea: a systematic review.&lt;/A&gt; J Clin Oncol. 2008 May 10;26(14):2396-404.&amp;nbsp;Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM.&lt;/P&gt;
&lt;P&gt;The management of dyspnea in cancer patients: a systematic review.Support Care Cancer. 2008 Apr;16(4):329-37. Epub 2008 Jan 24. Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RK; Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18214551" target="_blank"&gt;PMID: 18214551&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:283692:1" name=internalLink&gt;Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases&lt;/A&gt;. Bausewein C, Booth S, Gysels M, Higginson IJ.&amp;nbsp;&lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2008, Issue 2. Art. No.: CD005623. DOI: 10.1002/14651858.CD005623.pub2.&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:293639:1" name=internalLink&gt;Oxygen therapy for dyspnoea in adults&lt;/A&gt;. Cranston JM, Crockett A, Currow D.&amp;nbsp;Cochrane Database Syst Rev. 2008 Jul 16;(3):CD004769. &lt;/P&gt;
&lt;P&gt;Oxygen for relief of dyspnea: what is the evidence? Uronis HE, Abernethy AP. Curr Opin Support Palliat Care. 2008 Jun;2(2):89-94. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685402" target="_blank"&gt;PMID: 18685402&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians.Qaseem A, Snow V, Shekelle P, Casey DE Jr, Cross JT Jr, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians, Dallas P, Dolan NC, Forciea MA, Halasyamani L, Hopkins RH Jr, Shekelle P. Ann Intern Med. 2008 Jan 15;148(2):141-6.&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18195338" target="_blank"&gt;PMID: 18195338&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Management of dyspnea in advanced motor neuron diseases.&amp;nbsp;&amp;nbsp; Tripodoro VA, De Vito EL. Curr Opin Support Palliat Care. 2008 Sep;2(3):173-9.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685417" target="_blank"&gt;PMID: 18685417&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;Review of the evidence for the management of dyspnoea in people with chronic heart failure.&amp;nbsp;&amp;nbsp; Not systematic review. Oxberry SG, Johnson MJ. Curr Opin Support Palliat Care. 2008 Jun;2(2):84-8. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685401" target="_blank"&gt;PMID: 18685401&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;National LCP Renal Symptom Control Guidelines. Marie Curie Palliative Care Institute Liverpool [&lt;A href="http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_085997.pdf" target="_blank"&gt;Download PDF&lt;/A&gt;]&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2007&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Measurement of breathlessness in advanced disease: a systematic review. Respir Med. 2007 Mar;101(3):399-410. Epub 2006 Aug 17.&lt;BR&gt;Bausewein C, Farquhar M, Booth S, Gysels M, Higginson IJ.&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16914301" target="_blank"&gt;PMID: 16914301&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:324210:1" name=internalLink&gt;Systematic review of noninvasive positive pressure ventilation in severe stable COPD&lt;/A&gt;. Kolodziej M A, Jensen L, Rowe B, Sin D. European Respiratory Journal 2007 ; 30(2): 293-306&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17459893" target="_blank"&gt;PMID: 17459893&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Dorman S, Byrne A, Edwards A. Palliat Med. 2007 Apr;21(3):177-91. Epub 2007 Mar 15.&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17363394" target="_blank"&gt;PMID: 17363394&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Palliative care in chronic obstructive pulmonary disease: a review for cliniciansJ R Soc Med. 2007 May;100(5):225-33.&lt;BR&gt;Seamark DA, Seamark CJ, Halpin DM.&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17470930" target="_blank"&gt;PMID: 17470930&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Pre-2007&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:237423:1" name=internalLink&gt;&lt;A href="nelh:237423:0" name=internalLink&gt;Nebulised morphine for severe interstitial lung disease &lt;/A&gt;Polosa R, Simidchiev A, Walters EH. Nebulised morphine for severe interstitial lung disease. &lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2002, Issue 3. Art. No.: CD002872. DOI: 10.1002/14651858.CD002872.&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:237423:0" name=internalLink&gt;&lt;/A&gt;&lt;A href="nelh:237626:1" name=internalLink&gt;Opioids for the palliation of breathlessness in terminal illness&lt;/A&gt;&amp;nbsp;Jennings AL, Davies AN, Higgins JPT, Broadley KE, Anzures-Cabrera J. Opioids for the palliation of breathlessness in terminal illness. &lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2001, Issue 3. Art. No.: CD002066. DOI: 10.1002/14651858.CD002066&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>330784</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=330784]]&gt;</url>
    <title>Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Introduction&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Welcome to the Annual Evidence Update on supportive and palliative care issues in people with respiratory disease.&amp;nbsp;&amp;nbsp;We are linking this update to the &lt;A href="http://www.library.nhs.uk/RESPIRATORY/ViewResource.aspx?resID=328903&amp;amp;tabID=288&amp;amp;catID=5880" target="_blank"&gt;recent AEU presented by the Respiratory Specialist Collection, which focused on COPD&lt;/A&gt;.&amp;nbsp; Readers will find many relevant topics for professionals and researchers regarding supportive and palliative care in that collection.&lt;/P&gt;
&lt;P&gt;For our own specific search through the literature, we have concentrated on two of the most important issues for patients with pulmonary problems.&amp;nbsp; The first is dyspnoea (or breathlessness).&amp;nbsp; This symptom is usually one of the most prevalent in surveys of problems associated with respiratory and also many other systemic illnesses.&amp;nbsp; For this AEU, we have taken our customary &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?prv=y&amp;amp;pagename=AIMS" target="_blank"&gt;broad and inclusive view of supportive and palliative care&lt;/A&gt;, and have therefore included reviews and studies which cover cancer treatment as well as end of life care topics. &lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;A href="nelh:330783:0" name=internalLink&gt;GO TO THE LIST OF DYSPNOEA REFERENCES&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;Our second specific topic is cough, which is less common but can nevertheless be just as distressing for patients with cancer and other chronic conditions.&amp;nbsp; Again, we have chosen key publications representing the best systematic reviews and selected studies from the last few years, covering the whole disease trajectory. &lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;A href="nelh:330782:1" name=internalLink&gt;GO TO THE LIST OF COUGH REFERENCES&lt;/A&gt;&lt;A href="nelh:330783:0" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;UL&gt;
&lt;LI&gt;Sam H Ahmedzai&lt;/LI&gt;
&lt;LI&gt;Denise Brady&lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;
&lt;LI&gt;Richard Stevens&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/AboutUs.aspx" target="_blank"&gt;Specialist Collection for Supportive and Palliative Care&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;We would like to thank the following for their helpful contribution in reviewing and appraising the literature –&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Jason Boland&lt;/LI&gt;
&lt;LI&gt;Sarah Mollart&lt;/LI&gt;
&lt;LI&gt;Rachel Vedder&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Specialist Registrars in Palliative Medicine, Sheffield and Chesterfield training programme&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P dir=ltr&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;/P&gt;
&lt;P dir=ltr&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326859</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326859]]&gt;</url>
    <title>Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Methods</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,DYSPNOEA,COUGH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 23 November 2009. Supportive and palliative care in chronic lung disease. Methods&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Databases searched&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;1.&amp;nbsp;PubMed&lt;BR&gt;2.&amp;nbsp;DARE&lt;BR&gt;3.&amp;nbsp;Cochrane database of systematic reviews&lt;BR&gt;4.&amp;nbsp;NHS Evidence: National Library of Guidelines&lt;BR&gt;5.&amp;nbsp;NHS Evidence: supportive and palliative care specialist collection&lt;BR&gt;6.&amp;nbsp;Cinahl&lt;BR&gt;7.&amp;nbsp;Embase&lt;BR&gt;8.&amp;nbsp;Whole of NHS evidence&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Search notes - Cough. &lt;STRONG&gt;Searcher =&lt;/STRONG&gt; Melanie Hodson&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;PubMed &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search: ("2005/01/01"[Publication Date] : "2009/10/31"[Publication Date]) AND ((cough* [tw] OR cough [mh]) AND (hospice* [tw] OR hospice care [mh] OR hospices [mh] OR palliative care [mh] OR palliat* [tw] OR terminal care [mh] OR terminally ill [mh] OR "terminal care" [tw] OR terminally ill [tw] OR "end of life care" [tw] OR "end-of-life-care" [tw] OR supportive [tw]) AND (systematic [sb] OR systematic [tw] OR "meta-analysis" [tw] OR "meta analysis" [tw])) Limits: English = 11 results&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;DARE &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search string: cough AND ( hospice* OR palliative* OR "end-of-life-care" OR "end of life care" OR supportive OR terminal* ) RESTRICT YR 2005 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cochrane &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search string: cough* AND “terminally ill” OR “terminal care” OR hospice* OR palliat* OR “supportive care” OR “end of life care”, from 2005 to 2009 in Cochrane Database of Systematic Reviews. Excluded protocols. Results= 23&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS evidence: supportive and palliative care specialist collection &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search string: cough = 16 results. No date restriction.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Embase &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;1. EMBASE; exp COUGHING/ [Limit to: Publication Year 2005-2009 and English Language]; 12110 results.&lt;BR&gt;2. EMBASE; cough*.tw. [Limit to: Publication Year 2005-2009 and English Language]; 5108 results.&lt;BR&gt;3. EMBASE; 1 OR 2 [Limit to: Publication Year 2005-2009 and English Language]; 13306 results.&lt;BR&gt;4. EMBASE; exp HOSPICE/ OR exp HOSPICE CARE/ OR exp HOSPICE NURSING/ OR exp HOSPICE PATIENT/&lt;BR&gt;[Limit to: Publication Year 2005-2009 and English Language]; 1119 results.&lt;BR&gt;5. EMBASE; hospice*.tw. [Limit to: Publication Year 2005-2009 and English Language]; 817 results.&lt;BR&gt;6. EMBASE; exp CANCER PALLIATIVE THERAPY/ OR exp PALLIATIVE NURSING/ OR exp PALLIATIVE&lt;BR&gt;THERAPY/ [Limit to: Publication Year 2005-2009 and English Language]; 8552 results.&lt;BR&gt;7. EMBASE; palliative*.tw. [Limit to: Publication Year 2005-2009 and English Language]; 5903 results.&lt;BR&gt;8. EMBASE; exp TERMINALLY ILL PATIENT/ OR exp TERMINAL DISEASE/ OR exp TERMINAL CARE/ [Limit&lt;BR&gt;to: Publication Year 2005-2009 and English Language]; 4615 results.&lt;BR&gt;9. EMBASE; terminal*.tw. [Limit to: Publication Year 2005-2009 and English Language]; 55553 results.&lt;BR&gt;10. EMBASE; supportive ADJ care.tw. [Limit to: Publication Year 2005-2009 and English Language]; 1628 results.&lt;BR&gt;11. EMBASE; end ADJ of ADJ life.tw. [Limit to: Publication Year 2005-2009 and English Language]; 2016 results.&lt;BR&gt;12. EMBASE; 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 [Limit to: Publication Year 2005-2009 and English&lt;BR&gt;Language]; 70097 results.&lt;BR&gt;13. EMBASE; 3 AND 12 [Limit to: Publication Year 2005-2009 and English Language]; 295 results.&lt;BR&gt;14. EMBASE; exp "SYSTEMATIC REVIEW"/ [Limit to: Publication Year 2005-2009 and English Language]; 23550&lt;BR&gt;results.&lt;BR&gt;15. EMBASE; systematic* AND review.tw. [Limit to: Publication Year 2005-2009 and English Language]; 17849&lt;BR&gt;results.&lt;BR&gt;16. EMBASE; exp RANDOMIZED CONTROLLED TRIAL/ [Limit to: Publication Year 2005-2009 and English&lt;BR&gt;Language]; 56646 results.&lt;BR&gt;17. EMBASE; random* ADJ control* ADJ trial.tw. [Limit to: Publication Year 2005-2009 and English Language];&lt;BR&gt;10671 results.&lt;BR&gt;18. EMBASE; exp META ANALYSIS/ [Limit to: Publication Year 2005-2009 and English Language]; 13882 results.&lt;BR&gt;19. EMBASE; meta ADJ analys*.tw. [Limit to: Publication Year 2005-2009 and English Language]; 11648 results.&lt;BR&gt;20. EMBASE; 14 OR 15 OR 16 OR 17 OR 18 OR 19 [Limit to: Publication Year 2005-2009 and English Language];&lt;BR&gt;90777 results.&lt;BR&gt;21. EMBASE; 13 AND 20 [Limit to: Publication Year 2005-2009 and English Language]; 48 results.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS evidence: whole collection &lt;STRONG&gt;search&amp;nbsp;for cough&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search string: cough* AND (hospice* OR palliat* OR "end of life care" OR "supportive care" OR "terminal care" OR "terminally ill"), results sorted by date = 513. Then selected search filter: systematic reviews = 58&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Melanie Hodson, November 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Search notes - Dyspnoea. Searcher = Denise Brady&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Main search on Pubmed – using search terms as defined by NHS Evidence&amp;nbsp;project team.&amp;nbsp; However, I did not limit this to clinical queries.&amp;nbsp; So I searched Dyspnoea and the agreed subject headings that relate to palliative care:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;palliat* OR hospice* OR “terminal care” OR “terminally ill” OR “end-of-life-care” OR “end of life care” OR supportive&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;I then chose what I regarded as systematic reviews, meta-analyses and what seemed to be reviews from these results. &lt;/P&gt;
&lt;P&gt;I used NHS Evidence suite of databases to search CINAHL&amp;nbsp;confining myself to systematic reviews and meta-analyses.&lt;/P&gt;
&lt;P&gt;I used Ovid to search Embase.&lt;/P&gt;
&lt;P&gt;I searched Cochrane and DARE using&amp;nbsp; the term dyspnoea or dyspnea only.&amp;nbsp; I included only references that seemed to pertain to late stage disease. &lt;/P&gt;
&lt;P&gt;I used dyspnoea to search NHS Evidence - supportive and palliative care.&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;I used dyspnoea and palliative care as terms in all of NHS Evidence&lt;/P&gt;
&lt;P&gt;Search was from 2007 to date based on the fact that a &lt;A href="nelh:272777:1" name=internalLink&gt;clinical knowledge summary was completed in 2007&lt;/A&gt;.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;NHS evidence: whole collection search for dyspnoea&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;Database&amp;nbsp;Search term&amp;nbsp;Hits&lt;BR&gt;1&amp;nbsp;CINAHL &amp;nbsp;dyspnoea.ti,ab &amp;nbsp;324 &lt;BR&gt;2&amp;nbsp;CINAHL &amp;nbsp;dyspnea.ti,ab &amp;nbsp;2532 &lt;BR&gt;3&amp;nbsp;CINAHL &amp;nbsp;dyspnea.ti,ab &amp;nbsp;2532 &lt;BR&gt;4&amp;nbsp;CINAHL &amp;nbsp;exp DYSPNEA/ &amp;nbsp;2482 &lt;BR&gt;5&amp;nbsp;CINAHL &amp;nbsp;1 OR 2 OR 4 &amp;nbsp;4077 &lt;BR&gt;6&amp;nbsp;CINAHL &amp;nbsp;palliat*.ti,ab &amp;nbsp;10154 &lt;BR&gt;7&amp;nbsp;CINAHL &amp;nbsp;PALLIATIVE CARE/ &amp;nbsp;10866 &lt;BR&gt;8&amp;nbsp;CINAHL &amp;nbsp;(terminal AND care).ti,ab &amp;nbsp;1436 &lt;BR&gt;9&amp;nbsp;CINAHL &amp;nbsp;exp TERMINAL CARE/ &amp;nbsp;24146 &lt;BR&gt;10&amp;nbsp;CINAHL &amp;nbsp;(terminally AND ill).ti,ab &amp;nbsp;1896 &lt;BR&gt;11&amp;nbsp;CINAHL &amp;nbsp;exp TERMINALLY ILL PATIENTS/ &amp;nbsp;5179 &lt;BR&gt;12&amp;nbsp;CINAHL &amp;nbsp;hospice*.ti,ab &amp;nbsp;5695 &lt;BR&gt;13&amp;nbsp;CINAHL &amp;nbsp;HOSPICES/ &amp;nbsp;1574 &lt;BR&gt;14&amp;nbsp;CINAHL &amp;nbsp;(end AND of AND life AND care).ti,ab &amp;nbsp;4567 &lt;BR&gt;15&amp;nbsp;CINAHL &amp;nbsp;(end-of-life AND care).ti,ab &amp;nbsp;3934 &lt;BR&gt;16&amp;nbsp;CINAHL &amp;nbsp;supportive.ti,ab &amp;nbsp;6772 &lt;BR&gt;17&amp;nbsp;CINAHL &amp;nbsp;6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 &amp;nbsp;38083 &lt;BR&gt;18&amp;nbsp;CINAHL &amp;nbsp;5 AND 17 &amp;nbsp;&amp;nbsp;544 &lt;BR&gt;19&amp;nbsp;CINAHL &amp;nbsp;18 [Limit to: Publication Year 2007-2009] &amp;nbsp;172 &lt;BR&gt;22&amp;nbsp;CINAHL &amp;nbsp;META ANALYSIS/ [Limit to: Publication Year 2007-2009] &amp;nbsp;3117 &lt;BR&gt;23&amp;nbsp;CINAHL &amp;nbsp;SYSTEMATIC REVIEW/ &amp;nbsp;4973 &lt;BR&gt;24&amp;nbsp;CINAHL &amp;nbsp;22 OR 23 [Limit to: Publication Year 2007-2009] &amp;nbsp;4527 &lt;BR&gt;25&amp;nbsp;CINAHL &amp;nbsp;19 AND 24 [Limit to: Publication Year 2007-2009] &amp;nbsp;9 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Embase search&amp;nbsp;&lt;STRONG&gt;for dyspnoea&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;1 dyspnea/&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 36083&lt;BR&gt;2 dyspnoea.mp. or dyspnea/&amp;nbsp;&amp;nbsp;&amp;nbsp; 37269&lt;BR&gt;3 dyspnea.mp. or dyspnea/&amp;nbsp;&amp;nbsp;&amp;nbsp; 40387&lt;BR&gt;4 1 or 3 or 2&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 41558&lt;BR&gt;5 exp dyspnea/&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 36638&lt;BR&gt;6 4 or 1 or 3 or 2 or 5&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 42025&lt;BR&gt;7 exp palliative therapy/ or palliat*.mp.&amp;nbsp;&amp;nbsp; 34982&lt;BR&gt;8 terminal care.mp. or terminal care/&amp;nbsp;&amp;nbsp; 4800&lt;BR&gt;9 terminally ill.mp. or exp terminally ill patient/&amp;nbsp; 2538&lt;BR&gt;10 end of life care.mp. or terminal care/&amp;nbsp;&amp;nbsp; 5422&lt;BR&gt;11 end-of-life care.mp. or terminal care/&amp;nbsp;&amp;nbsp; 5422&lt;BR&gt;12 8 or 11 or 7 or 10 or 9&amp;nbsp;&amp;nbsp;&amp;nbsp; 39241&lt;BR&gt;13 supportive.mp.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 19044&lt;BR&gt;14 13 or 12&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 57167&lt;BR&gt;15 6 and 14&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 1931&lt;BR&gt;16 14&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 57167&lt;BR&gt;17 limit 15 to yr="2007 - 2009"&amp;nbsp;&amp;nbsp;&amp;nbsp; 601&lt;BR&gt;18 "systematic review"/&amp;nbsp;&amp;nbsp;&amp;nbsp; 29176&lt;BR&gt;19 meta analysis/&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 36152&lt;BR&gt;20 18 or 19&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 50364&lt;BR&gt;21 17 and 20&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 29&lt;BR&gt;22 from 21 keep 10, 13-14, &lt;BR&gt;21-23&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 6&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Denise Brady, November 2009.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Addendum:&lt;/STRONG&gt; In addition, the reviewers also chose to include two earlier references which were found in the 'cough' searches.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;GO TO THE CONTENTS PAGE&lt;/A&gt;&lt;A href="nelh:330785:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:330784:0" name=internalLink&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>283525</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=283525]]&gt;</url>
    <title>Annual Evidence Update 28 April 2008. Pain in supportive and palliative care. 2008</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Pallliative Care Specialist Library</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 28 April 2008. Pain in supportive and palliative care. 2008&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;This page gives the results of our search for systematic reviews and other high quality reviews on pain in supportive and palliative&amp;nbsp;care published since our previous review 12 months ago. This comprises our Annual Evidence Update on pain for 2008. &amp;nbsp;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260224&amp;amp;tabID=290" target="_blank"&gt;2007 Annual Evidence Update on pain&lt;/A&gt;&amp;nbsp;is still available. Being our first on this topic,&amp;nbsp;it included articles from the years 2000 to 2006. &lt;/P&gt;
&lt;P&gt;The methodology for our search strategy can be found &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260231" target="_blank"&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;The coverage includes not only advanced cancer (ie most of palliative care) but also other non-malignant conditions with chronic pain and cancer patients in the earlier stages of disease (supportive care). &lt;/P&gt;
&lt;P&gt;This time there are 12 included reviews from the original total of 22 potential items in the first sift of&amp;nbsp;our search. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Accessing these reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Links are included to PubMed abstracts or to the full text of Cochrane reviews. Full text versions may also be available for some items via online journals.&lt;/P&gt;
&lt;P&gt;In addition to the journal subscriptions that your organisation may hold, the NHS buys a number of online journals which can be accessed if you have an Athens password. The A-Z list of NHS online journals is here: &lt;A href="http://journals.library.nhs.uk/" target="_blank"&gt;http://journals.library.nhs.uk/&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;If you need help accessing any of the resources listed here, or with getting an Athens password, please contact your local health library. The staff there will be happy to help.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Commentary &lt;/H2&gt;&lt;EM&gt;(By Jason Boland)&lt;/EM&gt; 
&lt;P&gt;Over the past year there has been a diversity of&amp;nbsp;systematic reviews added to the palliative and supportive&amp;nbsp;care literature. These include:&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;A&amp;nbsp;review on the TRPV1 receptor&lt;/STRONG&gt; and its role in pain with special reference to the role in capsaicin in pain management –&amp;nbsp; predicting a “revival” of this class of drug.&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;A review of the cannabinoid nabilone&lt;/STRONG&gt;, suggests a role in both nerve pain and when central sensitisation exists.&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;The use of Oxycodone&lt;/STRONG&gt; in pain management indicated that this strong opioid is useful across a range of pain conditions and that the biphasic pharmacokinetic profile of the prolonged release offers rapid pain relief and due to its different properties may be an alternative to morphine.&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Despite this a review of physician barriers to cancer pain management&lt;/STRONG&gt; shows that concerns about side effects led to ineffective doses being used, which is compounded by poor prescription of medicines to counteract the side effects.&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;A review of the evidence for palliative care at the end of life&lt;/STRONG&gt;, indicted that there is evidence for interventions to improve end of life care, but many important issues lack quality evidence and this highlights the need for further work across the range of terminal conditions.&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;There have been Cochrane reviews on the opioids methadone and morphine&lt;/STRONG&gt;, as well as antidepressants for nerve pain.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;2008&lt;/H2&gt;
&lt;P&gt;Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?&lt;BR&gt;Knotkova H, Pappagallo M, Szallasi A.&lt;BR&gt;Clin J Pain. 2008 Feb;24(2):142-54.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18209521" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/18209521&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Evidence for improving palliative care at the end of life: a systematic review.&lt;BR&gt;Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG.&lt;BR&gt;Lorenz KA&lt;BR&gt;Ann Intern Med. 2008 Jan 15;148(2):147-59.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18195339" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/18195339&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.&lt;BR&gt;Davis MP&lt;BR&gt;Expert Opin Investig Drugs. 2008 Jan;17(1):85-95.Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18095921" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/18095921&lt;/A&gt; 
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Oxycodone: a review of its use in the management of pain.&lt;BR&gt;Riley J, Eisenberg E, Müller-Schwefe G, Drewes AM, Arendt-Nielsen L.&lt;BR&gt;Curr Med Res Opin. 2008 Jan;24(1):175-92.&lt;BR&gt;Link to pubmed&lt;BR&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18039433" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/18039433&lt;/A&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;BR&gt;2007&lt;/H2&gt;
&lt;P&gt;Physician-related barriers to cancer pain management with opioid analgesics: a&amp;nbsp;systematic review.&lt;BR&gt;Jacobsen R, Sjøgren P, Møldrup C, Christrup L.&lt;BR&gt;J Opioid Manag. 2007 Jul-Aug;3(4):207-14.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17957980" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17957980&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Antidepressants for neuropathic pain.&lt;BR&gt;Saarto T, Wiffen PJ.&lt;BR&gt;Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454.&lt;BR&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=239179&amp;amp;tabID=289" target="_blank"&gt;Link to full text&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Methadone for cancer pain.&lt;BR&gt;Nicholson AB&lt;BR&gt;Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003971.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17943808" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17943808&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Oral morphine for cancer pain.&lt;BR&gt;Wiffen PJ, McQuay HJ.&lt;BR&gt;Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003868.&lt;BR&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238422&amp;amp;tabID=289" target="_blank"&gt;Link to full text&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Peripherally acting opioid antagonists in the treatment of opiate-related&amp;nbsp;constipation: a systematic review.&lt;BR&gt;Becker G, Galandi D, Blum HE.&lt;BR&gt;J Pain Symptom Manage. 2007 Nov;34(5):547-65. Epub 2007 Sep 27.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17900855" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17900855&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Optimal management of metastatic bone disease.&lt;BR&gt;Major P&lt;BR&gt;Eur J Oncol Nurs. 2007;11 Suppl 2:S32-7. Epub 2007 Sep 4.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17804294" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17804294&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Burden of bone disease.&lt;BR&gt;Kinnane N&lt;BR&gt;Eur J Oncol Nurs. 2007;11 Suppl 2:S28-31. Epub 2007 Sep 4.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17768092" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17768092&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Should we add clonidine to local anesthetic for peripheral nerve blockade? A&amp;nbsp;qualitative systematic review of the literature.&lt;BR&gt;McCartney CJ, Duggan E, Apatu E.&lt;BR&gt;Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8.&lt;BR&gt;Link to pubmed: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17720118" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/pubmed/17720118&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For systematic reviews in 2000-2006 see the &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260224&amp;amp;tabID=290" target="_blank"&gt;2007 Annual Evidence Update on pain&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326822</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326822]]&gt;</url>
    <title>Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Contents Page</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Contents Page&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;This National Knowledge Week was organised by the National Library for Palliative and Supportive Care to highlight the best current evidence on this topic in a concise, easy to read format. &lt;/H2&gt;
&lt;P&gt;The National Knowledge Week pages include our first Annual Evidence Update on this topic, which this year was the result of a search for systematic reviews covering a broad view of pain in palliative and supportive care. Systematic reviews are regarded as the highest level of evidence on health interventions.&lt;/P&gt;
&lt;P&gt;There are also links to other sources of information on pain in palliative and supportive care, and a range of invited commentaries from specialists.&lt;/P&gt;
&lt;P&gt;As the National Knowledge Week comes one week after the &lt;A href="http://www.britishpainsociety.org/meet_pasasm.htm#2007" target="_blank"&gt;British Pain Society Annual Scientific Meeting 2007&lt;/A&gt;, a special feature will be daily &lt;EM&gt;'Meet the Expert'&lt;/EM&gt; interviews with selected speakers at the conference.&lt;/P&gt;
&lt;P&gt;The items below will be published on a day-by-day basis. The pages will remain accessible until the next Annual Evidence update in 12 months time. If you would like to contribute to this activity or you have any comments on how it could be improved, please use our &lt;A href="http://www.library.nhs.uk/palliative/ContactUs.aspx" target="_blank"&gt;feedback form&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#006600 size=5&gt;Contents&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=3&gt;Contributors' details and photos&amp;nbsp;&lt;A href="nelh:326831:1" name=internalLink&gt;&lt;A href="nelh:326831:1" name=internalLink&gt;&lt;/A&gt;&lt;FONT size=3&gt;&lt;A href="nelh:326822:1" name=internalLink&gt;&lt;FONT size=3&gt;here&lt;/FONT&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/A&gt;&lt;/A&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;FONT size=3&gt;.&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;FONT size=3&gt;&lt;STRONG&gt;Day One - Monday 30th April:&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/EM&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:326826:1" name=internalLink&gt;&lt;/A&gt;&lt;A href="nelh:326826:0" name=internalLink&gt;1. Introduction&lt;/A&gt;.&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=AHMEDZAI" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt; By Professor Sam H Ahmedzai, Clinical Lead, National Library for Palliative and Supportive Care.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260224&amp;amp;tabID=290" target="_blank"&gt;2. Annual Evidence Update on pain in palliative and supportive care - Systematic reviews.&lt;/A&gt; By&amp;nbsp;Jason Boland, Richard Stevens, Sam H Ahmedzai.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260231&amp;amp;tabID=290" target="_blank"&gt;3. Methodology for the Annual Evidence Update on pain in palliative and supportive care.&lt;/A&gt; By Richard Stevens.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=311189&amp;amp;tabID=290" target="_blank"&gt;4. Conference highlight:&amp;nbsp; Dr Joan Hester, President of the British Pain Society, introduces the Annual Scientific Meeting 2007.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;&lt;EM&gt;Day Two - Tuesday 1st May:&lt;/EM&gt;&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260090&amp;amp;tabID=290" target="_blank"&gt;5. Sources of knowledge on pain in palliative and supportive care within the Specialist Library.&lt;/A&gt; By Jason Boland, Richard Stevens, Sam H Ahmedzai.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260301&amp;amp;tabID=290" target="_blank"&gt;6. Other resources on pain.&lt;/A&gt; Sam H Ahmedzai. Richard Stevens.&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:326827:1" name=internalLink&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PATIENTS" target="_blank"&gt;7. Conference highlight: Pete Moore and Di Wright from the Expert Patients Programme introduce&amp;nbsp;PPP (Persistent Pain Programme) - helping patients to improve their own quality of life.&lt;/A&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PATIENTS" target="_blank"&gt;&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;&lt;EM&gt;Day Three - Wednesday 2nd May:&lt;/EM&gt;&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=259098&amp;amp;tabID=290" target="_blank"&gt;8. Knowledge outline: "Mechanisms of pain". By Jason Boland.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260255&amp;amp;tabID=290" target="_blank"&gt;9. Conference highlight: Professor Jürgen Sandkühler. The cellular mechanisms of pain memory.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260354&amp;amp;tabID=290" target="_blank"&gt;10. Conference highlight: Professor Mike Salter. Microglia and pain.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;&lt;EM&gt;Day Four - Thursday 3rd May:&lt;/EM&gt;&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=259099&amp;amp;tabID=290" target="_blank"&gt;11. Knowledge outline: "Medical management of cancer and chronic pain". Jason Boland, Sam H Ahmedzai.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260250&amp;amp;tabID=290" target="_blank"&gt;12. Knowledge outline: "Breakthrough pain". By Laura McTague.&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=259348&amp;amp;tabID=290" target="_blank"&gt;13. Knowledge outline: "Pain in HIV disease". By Jason Boland, David H Dockrell.&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260464&amp;amp;tabID=290" target="_blank"&gt;14. Conference highlight:&lt;STRONG&gt;&lt;FONT color=#000000&gt; &lt;/FONT&gt;&lt;/STRONG&gt;Professor Henry McQuay. What have systematic reviews told us about managing pain?&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT size=3&gt;&lt;STRONG&gt;&lt;EM&gt;Day Five - Friday 4th May:&lt;/EM&gt;&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=259097&amp;amp;tabID=290" target="_blank"&gt;15. Knowledge outline: "The role of the pain clinic".&lt;/A&gt; By Donald Graham.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;16. Conference highlight:&lt;/STRONG&gt; &lt;STRONG&gt;Workshop on pain in cancer survivors&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260510&amp;amp;tabID=290" target="_blank"&gt;(a) Post-surgical pain in breast cancer. John Williams &lt;/A&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260508&amp;amp;tabID=290" target="_blank"&gt;(b) Chemotherapy-induced neuropathic pain.&amp;nbsp;Paul Farquhar-Smith &lt;/A&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260507&amp;amp;tabID=290" target="_blank"&gt;(c) Pain in cancer survivors following radiotherapy.&amp;nbsp;Bill Macrae&lt;/A&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260509&amp;amp;tabID=290" target="_blank"&gt;17. British Pain Society Cancer Pain Committee: Jon Raphael&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260251&amp;amp;tabID=290" target="_blank"&gt;18. "Pain in palliative and supportive care: The next 12 months". By Professor Sam H Ahmedzai, Clinical Lead, National Library for Palliative and Supportive Care. &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326827</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326827]]&gt;</url>
    <title>Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Expert Patients</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Expert Patients&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Persistent Pain Programme – helping patients to improve their own quality of life&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Pete Moore and Di Wright&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Expert Patients Programme has generated a large variety of self-help projects for patients with a wide range of chronic conditions.&amp;nbsp; One of these is the ‘Persistent Pain Programme’ (PPP), which was presented at the &lt;A href="http://www.britishpainsociety.org/" target="_blank"&gt;British Pain Society&lt;/A&gt;’s Annual Scientific Meeting in Glasgow on 24-27 April 2007.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Two of the programme’s leaders, Pete Moore and Di Wright, were actively engaging delegates to the conference and informing them of the problems associated with persistent pain, and the benefits of PPP for these patients.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Patients with persistent pain say they feel –&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Different to other people 
&lt;LI&gt;Their life is out of control 
&lt;LI&gt;Becoming and keeping active could cause more harm 
&lt;LI&gt;Depressed, angry and lack self-confidence 
&lt;LI&gt;That they can’t enjoy a full life.&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;According to Pete and Di, the pain self-management approach of PPP consists of ‘learning and using simple skills to let YOU take more control of YOUR persistent pain’.&lt;/P&gt;
&lt;P&gt;People who attend PPP learn &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;How to reduce good day – bad day episodes 
&lt;LI&gt;How to pace daily activities 
&lt;LI&gt;How to set goals and make action plans 
&lt;LI&gt;Problem-solving techniques 
&lt;LI&gt;How to manage pain flare-ups 
&lt;LI&gt;How to manage the distress and low moods that come with persistent pain 
&lt;LI&gt;Keeping active does not cause harm 
&lt;LI&gt;How to manage relationships with family, friends, work colleagues and healthcare professionals 
&lt;LI&gt;How to maintain a healthy diet 
&lt;LI&gt;How to look forward and plan for the future.&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Each programme runs for approximately two and a half hours each week for six weeks.&amp;nbsp; They are organised and run by trained tutors with direct experience of living with persistent pain.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For further details, contact –&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;Pete Moore &lt;A href="mailto:pete.moore1@nhsepp.org" target="_blank"&gt;pete.moore1@nhsepp.org&lt;/A&gt;&lt;BR&gt;Di Wright &lt;A href="mailto:Dianne.wright@nhsepp.org" target="_blank"&gt;Dianne.wright@nhsepp.org&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.expertpatients.nhs.uk/" target="_blank"&gt;www.expertpatients.nhs.uk&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowedge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326826</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326826]]&gt;</url>
    <title>Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Welcome to the first National Knowledge Week run by the Specialist Library for Palliative and Supportive Care.&amp;nbsp; We chose ‘pain’, as this is probably the topic that is most commonly associated with the specialty of palliative care and it is also a major concern within the broader interdisciplinary field of supportive care.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We acknowledge that pain management is clearly an important part of other acute illnesses and of chronic disease management, but these are covered by other specialist libraries in the National Library for Health (see, for example, the &lt;A href="http://www.library.nhs.uk/musculoskeletal/" target="_blank"&gt;Musculoskeletal Diseases Library&lt;/A&gt;, the &lt;A href="http://www.library.nhs.uk/trauma_orthopaedics/" target="_blank"&gt;Trauma and Orthopaedics Library&lt;/A&gt;, and the &lt;A href="http://www.library.nhs.uk/theatres/" target="_blank"&gt;Surgery, Theatres and Anaesthesia Library&lt;/A&gt;). &lt;/P&gt;
&lt;P&gt;Our approach to searching for evidence is deliberately broad, encompassing both cancer and non-malignant diseases; early and advanced stages of disease; patients who are having treatment with curative or life-prolonging intent, and those at the end of life.&lt;/P&gt;
&lt;P&gt;We have timed this National Knowledge Week on Pain to run just after the British Pain Society’s Annual Scientific Meeting, which was held in Glasgow from 25-27 April 2007.&amp;nbsp; For details of this exciting mixture of basic science, clinical research and patient experience, &lt;A href="http://www.britishpainsociety.org/" target="_blank"&gt;visit the BPS website&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;Day by day the National Knowledge Week will contain a mixture of items –&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Evidence review from the National Library for Health database and beyond 
&lt;LI&gt;Specialist reviews focusing on topics of particular interest to practitioners in palliative and supportive care 
&lt;LI&gt;Useful resources on pain 
&lt;LI&gt;Highlights from the BPS 2007 Annual Scientific Meeting.&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Please visit our webpages each day to take in this vast field of literature.&amp;nbsp; We will revisit the subject as a whole in one year’s time, but meanwhile, do visit the &lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100" target="_blank"&gt;Pain section&lt;/A&gt; within the Palliative and Supportive Care specialist library for more frequent incremental additions to this evidence database.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326831</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326831]]&gt;</url>
    <title>Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. People</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 April 2007. National Knowledge Week on pain in palliative and supportive care. People&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Professor Sam H Ahmedzai&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Clinical Lead, National Library for Palliative and Supportive Care. The University of Sheffield Academic Unit of Supportive Care. [further details &lt;A href="http://www.shef.ac.uk/medicine/staff/ahmedzai.html" target="_blank"&gt;here&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Jason Boland&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Specialist Registrar in Palliative Medicine. The University of Sheffield Academic Unit of Supportive Care.&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Richard Stevens&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Information Specialist, National Library for Palliative and Supportive Care. Research Associate, The University of Sheffield Academic Unit of Supportive Care.&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Joan B. Hester&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;President, &lt;A href="http://www.britishpainsociety.org/" target="_blank"&gt;the British Pain Society&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Di Wright and Pete Moore&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Senior Trainers, &lt;A href="http://www.expertpatients.nhs.uk/" target="_blank"&gt;the Expert Patients Programme&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;&lt;STRONG&gt;Dr Laura McTague&lt;/STRONG&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;Specialist Registrar in Palliative Medicine, Sheffield Teaching Hospitals NHS Trust. The University of Sheffield Academic Unit of Supportive Care.&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;FONT size=3&gt;&lt;STRONG&gt;Dr. David H Dockrell&amp;nbsp; &lt;/STRONG&gt;&lt;FONT size=2&gt;[photo, bibliography etc. &lt;/FONT&gt;&lt;A href="http://www.shef.ac.uk/medicine/staff/dockrell.html" target="_blank"&gt;&lt;FONT size=2&gt;here&lt;/FONT&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;FONT size=2&gt;]&lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;Reader in Infectious Diseases, The University of Sheffield Academic Unit of Respiratory Medicine. &lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Donald Graham&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Consultant in Pain Management, Doncaster &amp;amp; Bassetlaw Foundation NHS Trust.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr John Williams&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Consultant Anaesthetist, Royal Marsden NHS Foundation Trust, London.&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Paul Farquhar-Smith&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Consultant Anaesthetist, Royal Marsden NHS Foundation Trust, London.&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Bill Macrae&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Consultant Anaesthetist, Tayside Pain Service, Ninewells Hospital, Dundee.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Dr Jon H. Raphael&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Consultant in Pain Management,&amp;nbsp;Dudley Group of Hospitals, West Midlands.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>310085</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=310085]]&gt;</url>
    <title>Annual Evidence Update 30 March 2009: Pain in supportive and palliative care [1: Pain and cancer survivorship]</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 March 2009: Pain in supportive and palliative care [1: Pain and cancer survivorship]&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Methods&lt;/H2&gt;
&lt;P&gt;We searched PubMed and the St Christopher's Hospice Library literature database.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;Search strategies&lt;/H3&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;PubMed&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;MeSH term search:&lt;BR&gt;Search string: ("Pain"[Mesh] AND "Neoplasms"[Mesh]) AND "Survivors"[Mesh]&lt;BR&gt;Limits: Human. Added to PubMed between 01 Jan 2004 – 31 Jan 2009&lt;BR&gt;(All results = 51)&lt;BR&gt;Records defined by PubMed as 'Review' = 10&lt;/P&gt;
&lt;P&gt;Textword search&lt;BR&gt;Search string: (pain [tw] AND survivor* [tw] AND (cancer [tw] OR neoplasm* [tw]) ) AND systematic[sb]&lt;BR&gt;Using “Clinical Query” and “Find systematic reviews” field&lt;BR&gt;Limits: human, English language&lt;BR&gt;Date added to PubMed: 01 Jan 2008 – 31 Jan 2009&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;EM&gt;St Christopher's Hospice Library database&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Searched simply for&amp;nbsp;"cancer survivors"&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Commentary&lt;/H2&gt;
&lt;P&gt;No meta-analyses or systematic reviews were found. References found in the search were mostly review articles/case reviews/comparative studies. There was one small RCT. We looked at the full text of some articles which we thought may be good quality ‘other’ studies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic reviews and meta-analyses&lt;/H2&gt;
&lt;P&gt;None were found.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Other resources&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;2008&lt;/P&gt;
&lt;P&gt;Opioids and cancer survivors: issues in side-effect management. Palos GR. Oncol Nurs Forum. 2008 Nov;35 Suppl:13-9. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18980935" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. McNeely ML, Parliament MB, Seikaly H, Jha N, Magee DJ, Haykowsky MJ, Courneya KS. Cancer. 2008 Jul 1;113(1):214-22. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18457329" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Chronic pain in the cancer survivor: a new frontier. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Pain Med. 2007 Mar;8(2):189-98. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17305690" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review.&amp;nbsp; Tschiesner U, Rogers SN, Harréus U, Berghaus A, Cieza A. Eur Arch Otorhinolaryngol. 2008 Jun;265(6):627-37.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18392633" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Helgeson VS, Tomich PL. Psycho-Oncol 05 v14 no4 p307-17&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15386765" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction. Sclafani LM, Baron RH.&amp;nbsp;Cancer J. 2008 Jul-Aug;14(4):216-22.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18677128" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. J Clin Oncol. 2008 Jul 20;26(21):3536-42.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18640935" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2007&lt;/P&gt;
&lt;P&gt;Patient-reported outcomes in cancer: a review of recent research and policy initiatives. Lipscomb J, Gotay CC, Snyder CF. CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17855485" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L. Qual Life Res. 2007 Aug;16(6):947-60. Epub 2007 Apr 25 &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17457697" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Physical activity, long-term symptoms, and physical health-related quality of life among breast cancer survivors: a prospective analysis. Alfano CM, Smith AW, Irwin ML, Bowen DJ, Sorensen B, Reeve BB, Meeske KA, Bernstein L, Baumgartner KB, Ballard-Barbash R, Malone KE, McTiernan A. .J Cancer Surviv. 2007 Jun;1(2):116-28. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18648952" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;See also&lt;/H3&gt;
&lt;P&gt;&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_088879" target="_blank"&gt;National Cancer Survivorship Initiative Newsletters&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Authors&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Ashique Ahamed&lt;/LI&gt;
&lt;LI&gt;Sam H Ahmedzai&lt;/LI&gt;
&lt;LI&gt;Jason Boland&lt;/LI&gt;
&lt;LI&gt;Denise Brady&lt;/LI&gt;
&lt;LI&gt;Elaine Cachia&lt;/LI&gt;
&lt;LI&gt;Clare Farrington&lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;
&lt;LI&gt;Georgina Keenleyside&lt;/LI&gt;
&lt;LI&gt;Richard Stevens&lt;/LI&gt;
&lt;LI&gt;Phil Wiffen&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>310413</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=310413]]&gt;</url>
    <title>Annual Evidence Update 30 March 2009: Pain in supportive and palliative care [3: Pain and cannabinoids]</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,MEDICINES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 March 2009: Pain in supportive and palliative care [3: Pain and cannabinoids]&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Methods&lt;/H2&gt;
&lt;P&gt;We used the &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query/static/clinical.shtml" target="_blank"&gt;PubMed Clinical Queries search filter to find Systematic Reviews&lt;/A&gt;&amp;nbsp;and&amp;nbsp;limited the search to 'humans', published 2007 to date&lt;/P&gt;
&lt;P&gt;First of all we searched for ‘pain’ systematic reviews, then&amp;nbsp;searched for ‘cannabi*’ within those.&lt;/P&gt;
&lt;P&gt;Of the 9 records found,&amp;nbsp;6 are labelled ‘reviews’ by PubMed.&amp;nbsp;We included 5 of these in our list below.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Systematic reviews&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2008&lt;/P&gt;
&lt;P&gt;Complementary therapies for neuropathic and neuralgic pain: systematic review. Pittler MH, Ernst E. Clin J Pain. 2008 Oct;24(8):731-3.&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18806539" target="_blank"&gt; [Get PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Adverse effects of medical cannabinoids: a systematic review. Wang T, Collet JP, Shapiro S, Ware MA. CMAJ. 2008 Jun 17;178(13):1669-78. Comment in:&amp;nbsp;CMAJ. 2008 Jun 17;178(13):1685-6.&amp;nbsp;&amp;nbsp;&amp;nbsp; Evid Based Nurs. 2009 Jan;12(1):16.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18559804" target="_blank"&gt;[Get PubMed abstract] &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pharmacological management of neuropathic pain following spinal cord injury.&amp;nbsp;Baastrup C, Finnerup NB. CNS Drugs. 2008;22(6):455-75. PMID: 18484790 &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18484790" target="_blank"&gt;[Get PubMed abstract] &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. Davis MP. Expert Opin Investig Drugs. 2008 Jan;17(1):85-95.&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18095921" target="_blank"&gt;[Get PubMed abstract] &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2007&lt;/P&gt;
&lt;P&gt;Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, Coderre T,Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M,Mailis-Gagnon A, Panju A, Rollman GB, Velly A; Canadian Pain Society. Pain Res Manag. 2007 Spring;12(1):13-21. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17372630" target="_blank"&gt;[Get PubMed abstract] &lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>310411</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=310411]]&gt;</url>
    <title>Annual Evidence Update 30 March 2009: Pain in supportive and palliative care. [2: Pain and dementia]</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,ALZHEIMER’S DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 March 2009: Pain in supportive and palliative care. [2: Pain and dementia]&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Methods&lt;/H2&gt;
&lt;H3&gt;Search strategies&lt;/H3&gt;
&lt;P&gt;&lt;EM&gt;MEDLINE&lt;/EM&gt;&lt;BR&gt;1.&amp;nbsp;Pain (exploded subject heading)&lt;BR&gt;2.&amp;nbsp;Pain measurement (exploded subject heading)&lt;BR&gt;3.&amp;nbsp;1 or 2&lt;BR&gt;4.&amp;nbsp;Dementia (exploded subject heading and major descriptor/focus)&lt;BR&gt;5.&amp;nbsp;3 and 4&amp;nbsp;&amp;nbsp; (176 items)&lt;BR&gt;6.&amp;nbsp;Limit to meta analysis as publication type&lt;BR&gt;7.&amp;nbsp;Limit to systematic and review (title or abstract)&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;EMBASE&lt;/EM&gt;&lt;BR&gt;1.&amp;nbsp;Dementia (exploded subject heading and major descriptor/focus)&lt;BR&gt;2.&amp;nbsp;Pain assessment (exploded subject heading) or pain assessment (exploded subject heading)&lt;BR&gt;3.&amp;nbsp;Meta analysis or systematic review (as subject headings)&lt;BR&gt;4.&amp;nbsp;1 or 2 or 3&amp;nbsp; (53 results but only 3 appeared relevant of which&amp;nbsp; one was already retrieved from the Medline search)&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;CINAHL&lt;/EM&gt; &lt;BR&gt;1.&amp;nbsp;Dementia (exploded subject heading)&lt;BR&gt;2.&amp;nbsp;Pain (exploded subject heading)&lt;BR&gt;3.&amp;nbsp;Pain measurement&amp;nbsp; (exploded subject heading)&lt;BR&gt;4.&amp;nbsp;2 or 3&lt;BR&gt;5.&amp;nbsp;1 and 4&lt;BR&gt;6.&amp;nbsp;Limit 5 to publication type systematic review &lt;BR&gt;7.&amp;nbsp;Meta analysis (subject heading)&lt;BR&gt;8.&amp;nbsp;5 and 7&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;The Cochrane database &lt;BR&gt;&lt;/EM&gt;Using the terms pain and dementia, seven items were retrieved. &lt;BR&gt;NONE INCLUDED&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;National Library for Health &lt;BR&gt;&lt;/EM&gt;The Evidence based reviews, guidance and specialist libraries sections of the NLH were searched using the terms pain and dementia.&amp;nbsp;&amp;nbsp; &lt;BR&gt;ONE ITEM INCLUDED&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic reviews&lt;/H2&gt;
&lt;P&gt;Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. Zwakhalen SM, Hamers JP, Abu-Saad HH, Berger MP.&amp;nbsp;BMC Geriatr. 2006 Jan 27;6:3. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16441889" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt; &lt;A href="http://www.biomedcentral.com/1471-2318/6/3" target="_blank"&gt;[Get full text]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Assessment and management of pain in older adults with dementia: a review of current practice and future directions. Current Opinion in Supportive &amp;amp; Palliative Care, Jun 2008, vol./is. 2/2(128-32), 1751-4266. Schofield P &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685410" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt; &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=doas" target="_blank"&gt;[See also Do Once and Share project on pain assessment]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tools for assessment of pain in nonverbal older adults with dementia: a state-of-the-science review. Herr K, Bjoro K, Decker S. Journal of Pain &amp;amp; Symptom Management, Feb 2006, vol./is. 31/2(170-92), 0885-3924. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16488350" target="_blank"&gt;[Get PubMed abstract]&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;Smith M. Pain assessment in nonverbal older adults with advanced dementia. Perspectives in Psychiatric Care, 01 July 2005, vol./is. 41/3(99-113), 00315990. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16138819" target="_blank"&gt;[Get full text]&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;Responding to the pain experiences of older people with a learning difficulty and dementia. Publisher: Joseph Rowntree Foundation. &lt;A href="http://www.library.nhs.uk/learningdisabilities/viewResource.aspx?resID=126524" target="_blank"&gt;[Get full text] &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Other resources&lt;/H2&gt;
&lt;P&gt;Acute versus chronic pain treatment in Alzheimer's disease. Pickering G, Jourdan D, Dubray C. European Journal of Pain: Ejp, May 2006, vol./is. 10/4(379-84), 1090-3801 &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16087372" target="_blank"&gt;[Get PubMed abstract] &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;The role of postoperative analgesia in delirium and cognitive decline in elderly patients: A systematic review. Fong HK, Sands LP, Leung JM. Anesthesia and Analgesia, April 2006, vol./is. 102/4(1255-1266), 0003-2999. &lt;A href="http://www.anesthesia-analgesia.org/cgi/reprint/102/4/1255.pdf" target="_blank"&gt;[Get full text]&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;The assessment of pain in older people: National guidelines. Royal College of Physicians/British Geriatrics Society/British Pain Society (2007).&amp;nbsp;&lt;A href="http://www.britishpainsociety.org/book_pain_older_people.pdf" target="_blank"&gt;[Get full text]&lt;/A&gt;&lt;/P&gt;
&lt;P class=pagehead2&gt;Help the Aged - Pain in Older People: Reflections and Experiences from an older person's persepctive. Kumar A, Allcock, C. (2008) &lt;A href="http://www.britishpainsociety.org/pub_professional.htm#painolderpeople" target="_blank"&gt;[Get full text]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>310615</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=310615]]&gt;</url>
    <title>Annual Evidence Update 30 March 2009: Pain in supportive and palliative care. Contents Page</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,NERVOUS SYSTEM DISEASES,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,ALZHEIMER’S DISEASE,MEDICINES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 30 March 2009: Pain in supportive and palliative care. Contents Page&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310085&amp;amp;tabID=289" target="_blank"&gt;1: Pain and cancer survivorship&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310411&amp;amp;tabID=289" target="_blank"&gt;2: Pain and dementia&lt;/A&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310413&amp;amp;tabID=289" target="_blank"&gt;3: Pain and cannabinoids&lt;/A&gt;&lt;/H2&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310413&amp;amp;tabID=289" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;Welcome to the third Annual Evidence Update from the Supportive and Palliative Care Specialist Library on pain.&amp;nbsp; This year we have broadened our scope somewhat to capture three areas which are of increasing clinical interest: pain in the expanding group of cancer ‘survivors’; pain in older people with dementia; and the use of cannabinoids for pain management. Although these are clinically of relevance to specific groups of professionals (broadly speaking, to oncologists, geriatricians and chronic pain specialists respectively), we hope that the literature in these areas will be of interest to all who deal with chronic pain.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We were disappointed to find relatively little grade 1 evidence (systematic review and meta-analysis) in any of the areas, and so we have included lower grade publications and also additional resources such as reports and individual trials.&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>387230</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=387230]]&gt;</url>
    <title>Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Commentary</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,NUTRITION,WEIGHT LOSS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Commentary&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Anorexia (lack of appetite and interest in eating) is one of the commonest symptoms in patients with acute and chronic illnesses. The pathophysiology behind it is very complex and still incompletely understood. It is one of the main factors leading to poor quality of life in patients and carers.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;It is distressing for both professional and family carers as providing food is one of the principal ways of caring for someone. &lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Cachexia is a metabolic syndrome which is found not only in patients with cancer, but also in many other chronic illnesses such as COPD, heart failure, rheumatoid conditions, AIDS etc. Ongoing research is revealing the complicated interactions between different organs and biological systems that result in the clinical manifestations of this syndrome, namely anorexia, loss of muscle and fat, weight loss and asthenia (weakness) (Evans 2008). It is partly due to this marked complexity that current clinical interventions have failed to provide much benefit.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;It appears that inflammation, insulin resistance and break down of muscle and fat are important components of the anorexia-cachexia syndrome (ACS).&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;These are not helped by simple protein and energy supplementation, except in highly selected cases. A systematic review on the management of cancer-related anorexia and cachexia concluded that current approaches to treatment, with use of nutritional supplements and dietary advice to increase energy and protein intake, have failed to improve nutritional status or any other examined outcome, such as appetite, quality of life, survival, disease progression etc (Brown, 2002). Megestrol acetate increased appetite and weight and improved the sense of well-being but had no effect on nutritional status of patients or survival, while exercise seemed to bring some benefit to nutritional parameters. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;A number of recent studies and reviews covered in this AEU have examined various treatment strategies. Still it appears that we have a long way to go. The first step in the provision of nutritional care is to use a nutrition screening tool to recognise those patients that require special care and attention. The second step is a formal nutrition assessment (carried out by trained staff) which aims to identify the nutrition issues for the patient, which should then lead to an individualised nutritional care plan. Although a number of such screening and assessment tools exist in other areas, one adapted to the specific needs of palliative care patients has yet to be developed. The Food and Nutrition Group at Help the Hospices is currently in the process of developing such a specific nutritional screening and assessment tool for palliative care and has produced a Consensus Statement that has been endorsed by many organisations (Food and Nutrition Group 2009). &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;There is an urgent need to advance the care of patients with anorexia and cachexia and move it to the modern age of nutrigenomics and epigenetics (Ornish 2008; Tollefsbol 2010). Nutrition and its importance is gaining more interest and awareness among healthcare professionals. Additionally, more research to evaluate the potential benefits of different methods of care is needed. The wide-range of research findings produced by other disciplines have the potential to develop into better possibilities of helping patients with chronic, incurable diseases. For example: &lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;scientific evidence points to certain foods, cooking methods and physical activity as having a significant pro-inflammatory or anti-inflammatory effect (Warnberg 2009; O’Connor 2010).&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;In cancer patients with ACS, nutrients such as omega-3 fatty acids have been shown to have anti-inflammatory effect and help them stabilise their weight (August 2009), while&amp;nbsp;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: Symbol; FONT-SIZE: 8pt; mso-ansi-language: EN-US; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol" lang=EN-US&gt;&lt;SPAN style="mso-list: Ignore"&gt;&lt;SPAN style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;increased consumption of lean and oily fish has led to a reduction in serum C-reactive protein (Pot 2010) .&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Until further research increases our understanding still further, using our present knowledge and best judgment can help each individual patient benefit from recent discoveries. The benefits of a scientific approach to understanding and managing ACS should apply across the whole spectrum of chronic disease, not only in the palliative or end of life stage. The author makes a plea for the recognition that many aspects of healthcare and medicine centered on nutritional considerations need to be stepped up fundamentally.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;STRONG&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-fareast-language: EN-GB" lang=EN-US&gt;Dr Eleni Tsiompanou&lt;/SPAN&gt;&lt;/B&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB" lang=EN-US&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold" lang=EN-US&gt;Associate Specialist in Palliative Medicine&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold" lang=EN-US&gt;Kingston Hospital and Princess Alice Hospice&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold" lang=EN-US&gt;Chair of the Food and Nutrition Group at Help the Hospices&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;August, D. A., Huhmann, M. B.; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, 2009. A.S.P.E.N. clinical guidelines: nutrition support therapy during anticancer treatment and in hematopoietic cell transplantation. Journal of Parenteral and Enteral Nutrition, 33: 472-500. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19713551" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Brown JK (2002) A systematic review on the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum 29(3):517-32. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/11979284" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Evans WJ, Morley JE, Argiles j et al (2008) Cachexia: A New Definition. Clin Nutr 27:793-9. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18718696" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Food and Nutrition Group at Help the Hospices, 2009. Professional consensus statement of nutritional care in palliative care patients. &lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;thttp://www.helpthehospices.org.uk/our-services/running-your-hospice/food-and-nutrition/consensus-statement/&amp;nbsp;&amp;nbsp;[&lt;A href="http://www.helpthehospices.org.uk/our-services/running-your-hospice/food-and-nutrition/consensus-statement/" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;O’Connor, M. F. &amp;amp; Irvin, M. R., 2010. Links between behavioral factors and inflammation. Clinical Pharmacology and Therapeutics, doi:10.1038/clpt.2009.255. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20130566" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Ornish, D., Magbanua, M. J., Weidner, G, Weinberg, V., Kemp, C. Green, C., Mattie, M. D., Marlin, R., Simko, J., Shinohara, K., Haqq, C. M. &amp;amp; Carroll, P. R., 2008 (1). Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proceedings of the National Academies of Sciences USA, 105: 8369-8374. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18559852" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Pot, G. K., Geelen, A., Majsak-Newman, G., Harvey, L. J., Nagengast, F. M., Witteman, B. J., van de Meeberg, P. C., Hart, A. R., Schaafsma, G., Lund, E. K., Rijkers, G. T. &amp;amp; Kampman, E, 2010. Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and colonic biopsies. Journal of Nutrition, 140: 371-6. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20032491" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Tollefsbol, T. O. Role of epigenetics in cancer. In: Cancer epigenetics, ed. Tollefsbol Trygve O, 1-4. CRC Press; Boca Raton: 2009. [&lt;A href="http://copac.ac.uk/search?rn=1&amp;amp;au=Tollefsbol+Trygve+&amp;amp;ti=Cancer+epigenetics&amp;amp;sort-order=ti%2C%2Ddate" target="_blank"&gt;COPAC citation&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;Warnberg, L., Gomez-Martinez, S., Romeo, J., Diaz, L. E. &amp;amp; Marcos, A., 2009. Nutrition, inflammation and cognitive function. Annals of the New York Academy of Sciences, 1153: 164-75. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19236339" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;H3 style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;EM&gt;For further information about the Help the Hospices' Food and Nutrition Group, visit:&lt;/EM&gt;&lt;/SPAN&gt;&lt;/H3&gt;
&lt;H3 style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;A href="http://www.helpthehospices.org.uk/our-services/running-your-hospice/food-and-nutrition" target="_blank"&gt;&lt;EM&gt;http://www.helpthehospices.org.uk/our-services/running-your-hospice/food-and-nutrition&lt;/EM&gt;&lt;/A&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/H3&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;o:p&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;o:p&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;o:p&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 200%; MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386964</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=386964]]&gt;</url>
    <title>Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Contents</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,WEIGHT LOSS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Contents&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:386965:0" name=internalLink&gt;Introduction&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:386978:0" name=internalLink&gt;Methodology&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:387230:0" name=internalLink&gt;Commentary&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:386987:0" name=internalLink&gt;Included references&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386987</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=386987]]&gt;</url>
    <title>Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Included references</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,WEIGHT LOSS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Included references&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang="EN-US[&lt;A" name="internalLink" href="nelh:386964:0"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2010&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Nutritional support in children and young people with cancer undergoing chemotherapy. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Jones L, Watling RM, Wilkins S, Pizer B. &lt;/SPAN&gt;Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD003298. DOI: 10.1002/14651858.CD003298.pub2. [&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=380418&amp;amp;tabID=289" target="_blank"&gt;Full text&lt;/A&gt;] &lt;/SPAN&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=380418&amp;amp;tabID=289" target="_blank"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-language: EN-GB"&gt;&lt;FONT color=#800080&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-bidi-font-family: 'Times New Roman'"&gt;Male hypogonadism associated with advanced canc&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;er: a systematic review, Vigano A, Piccioni M, Trutschnigg B, Hornby L, Chaudhury P, Kilgour R. Lancet Oncol. 2010 Jul;11(7):679-84. Epub 2010 Jun 10.[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20541464" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-size: 8.0pt"&gt;&lt;SPAN style="mso-list: Ignore"&gt;&lt;SPAN style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-bidi-font-family: 'Times New Roman'"&gt;Understanding weight loss in patients with colorectal cancer: a hu&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;man response to illness, Bapuji SB, Sawatzky JA.&amp;nbsp;Oncol Nurs Forum. 2010 May;37(3):303-10 [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20439214" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Review of muscle wasting associated with chronic kidney disease. Workeneh B.T., Mitch W.E. American Journal of Clinical Nutrition, April 2010, vol./is. 91/4(1128S-1132S), 0002-9165 (01 Apr 2010)&amp;nbsp; [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20181807" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) " cachexia-anorexia in chronic wasting diseases" and " nutrition in geriatrics". Muscaritoli M., Anker S.D.., Argiles J., Aversa Z., Bauer J.M., Biolo G., Boirie Y., Bosaeus I., Cederholm T., Costelli P., Fearon K.C., Laviano A., Maggio M., Fanelli F.R., Schneider S.M., Schols A., Sieber C.C. Clinical Nutrition, April 2010, vol./is. 29/2(154-159), 0261-5614 (April 2010) [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20060626" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Glutamine as indispensable nutrient in oncology: experimental and clinical evidence. Kuhn KS, Muscaritoli M, Wischmeyer P, Stehle P. European Journal of Nutrition, 01 June 2010, vol./is. 49/4(197-210), 14366207 [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19936817" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l4 level1 lfo1" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Reid J, McKenna HP, Fitzsimons D, McCance TV.&lt;/SPAN&gt; Eur J Cancer Care (Engl). 2010 Sep;19(5):682-9. Epub 2009 Nov 13.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19912306" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2009&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l13 level1 lfo6" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Quality measures for supportive cancer care: the cancer quality-ASSIST project. Lorenz KA, Dy SM, Naeim A, Walling AM, Sanati H, Smith P, Shanman R, Roth CP, Asch SM. J Pain Symptom Manage. 2009 jun;37(6):943-64.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19359135" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l13 level1 lfo6" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Churm D., Andrew I.M., Holden K., Hildreth A.J., Hawkins C. Supportive Care in Cancer, May 2009, vol./is. 17/5(503-507), 0941-4355 (May 2009).&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18663481" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l13 level1 lfo6" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life. Mazzotta P, Jeney CM. Journal of Pain &amp;amp; Symptom Management, 01 June 2009, vol./is. 37/6(1069-1077), 08853924. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19054647" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l13 level1 lfo6" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;ESPEN Guidelines on Parenteral Nutrition: on cardiology and pneumology. Anker SD, Laviano A, Filippatos G, John M, Paccagnella A, Ponikowski P, Schols AM; ESPEN. Clin Nutr. 2009 Aug;28(4):455-60. Epub 2009 Jun 9.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19515464" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l13 level1 lfo6" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M;ESPEN. Clin Nutr. 2009 Aug;28(4):445-54. Epub 2009 May 23. PubMed PMID: 19477052. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19477052" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l2 level1 lfo8" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Putting evidence into practice: evidence-based interventions to prevent and manage anorexia. Adams LA, Shepard N, Caruso RA, Norling MJ, Belansky H, Cunningham RS. Clinical Journal of Oncology Nursing, 01 February 2009, vol./is. 13/1(95-102), 10921095. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank"&gt;Abstract&lt;/A&gt;]&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l10 level1 lfo9" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;An update on promising agents for the treatment of cancer cachexia. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Madeddu C, Mantovani G. &lt;/SPAN&gt;Curr Opin Support Palliat Care. 2009 Dec;3(4):258-62.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19667995" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l10 level1 lfo9" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Inflammatory burden and amino acid metabolism in cancer cachexia. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Durham WJ, Dillon EL, Sheffield-Moore M. &lt;/SPAN&gt;Curr Opin Clin Nutr Metab Care. 2009&lt;BR&gt;Jan;12(1):72-7.[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19057191" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l10 level1 lfo9" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2008&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l12 level1 lfo10" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome - a systematic review and meta-analysis, Lesniak W, Bala M, Jaeschke R, Krzakowski M. Pol Arch Med Wewn. 2008 Nov;118(11):636-44. 2008. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19140567" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l8 level1 lfo11" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM. J Clin Oncol. 2008 Aug 10;26(23):3886-95. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18688057" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l8 level1 lfo11" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Audit of symptoms and prescribing in patients with the anorexia-cachexia syndrome. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Andrew I, Kirkpatrick G, Holden K, Hawkins C. &lt;/SPAN&gt;Pharm World Sci. 2008 Oct;30(5):489-96. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18246443" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l8 level1 lfo11" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Interventions for cachexia-anorexia syndrome in people with lung cancer (&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;DUETS&lt;/SPAN&gt;)&amp;nbsp;[&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=303318&amp;amp;tabID=289" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2007&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-bidi-font-family: 'Times New Roman'"&gt;Symptom clusters in cancer patients: a review of the literature, Fan G, Filipczak L, Chow E. Curr Oncol. 2007 Oct;14(5):173-9. [&lt;A href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002479/pdf/co14_5p173.pdf" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-bidi-font-family: 'Times New Roman'"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-bidi-font-family: 'Times New Roman'"&gt;Symptom prevalence in patients with incurable cancer: a systematic review, &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A.&amp;nbsp;J Pain Symptom Manage. 2007 Jul;34(1):94-104.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17509812" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia, 2007. Dewey A, Baughan C, Dean TP, Higgins B, Johnson I.&amp;nbsp;Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004597. DOI: 10.1002/14651858.CD004597.pub2. [&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=238941&amp;amp;tabID=289" target="_blank"&gt;Full text&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/SPAN&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l3 level1 lfo13" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Appetite stimulants in cystic fibrosis: a systematic review. Chinuck RS, Fortnum H, Baldwin DR. Journal of Human Nutrition &amp;amp; Dietetics, 01 December 2007, vol./is. 20/6(526-537), 09523871. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18001374" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l7 level1 lfo14" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;n-3 Fatty acids, cancer and cachexia: a systematic review of the literature. Colomer R, Moreno-Nogueira JM, García-Luna PP, García-Peris P, García-de-Lorenzo A, Zarazaga A, Quecedo L, del Llano J, Usán L, Casimiro C. British Journal of Nutrition, 01 May 2007, vol./is. 97/5(823-831), 00071145' [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17408522" target="_blank"&gt;Abstract&lt;/A&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l7 level1 lfo14" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Appraisal of current and experimental approaches to the treatment of cachexia. Strasser F. Curr Opin Support Palliat Care. 2007 Dec;1(4):312-6.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18685381" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l7 level1 lfo14" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment. Gelato M, McNurlan M, Freedland E. Clin Ther. 2007 Nov;29(11):2269-88.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18158071" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l7 level1 lfo14" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient. Polo R, Gómez-Candela C, Miralles C, Locutura J, Alvarez J, Barreiro F, Bellido D, Câncer E, Cánoves D, Domingo P, Estrada V, Fumaz CR, Galindo MJ, García-Benayas T, Iglesias C, Irles JA, Jiménez-Nacher I, Lozano F, Marqués I, Martínez-Alvarez JR, Mellado MJ, Miján A, Ramos JT, Riobo P; SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA. Nutr Hosp. 2007 Mar-Apr;22(2):229-43. Review. PubMed PMID: 17416041. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17416041" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l7 level1 lfo14" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Does alcohol stimulate appetite and energy intake? Br J Community Nurs. &lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;Gee C. &lt;/SPAN&gt;2006 Jul;11(7):298-302.&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16926710" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;2005&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l16 level1 lfo15" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from children's oncology group. Ladas EJ, Sacks N, Meacham L, Henry D, Enriquez L, Lowry G, Hawkes R, Dadd G, Rogers P. Nutr Clin Pract. 2005 Aug;20(4):377-93. Review. PubMed PMID: 16207678. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16207678" target="_blank"&gt;Abstract&lt;/A&gt;] &lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l16 level1 lfo15" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Systematic review of the treatment of cancer-associated anorexia and weight loss. Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Journal of Clinical Oncology, 20 November 2005, vol./is. 23/33(8500-8511), 0732183X. [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16293879" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l16 level1 lfo15" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database of Systematic Reviews, 01 June 2005, vol./is. /2(0-), 1469493X Berenstein G, Ortiz Z. [&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=238581&amp;amp;tabID=289" target="_blank"&gt;Full text&lt;/A&gt;]&amp;nbsp;&lt;/SPAN&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=238581&amp;amp;tabID=289" target="_blank"&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-language: EN-GB"&gt;&lt;FONT color=#800080&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l15 level1 lfo16" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Branched-chain amino acids: the best compromise to achieve anabolism? Laviano A, Muscaritoli M, Cascino A, Preziosa I, Inui A, Mantovani G, Rossi-Fanelli F. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):408-14.&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'"&gt; [&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15930966" target="_blank"&gt;Abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l15 level1 lfo16" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l15 level1 lfo16" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'"&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386965</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=386965]]&gt;</url>
    <title>Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,WEIGHT LOSS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;Welcome to this AEU on treatments for anorexia and cachexia in chronic disease and palliative care. This is our third AEU on gastrointestinal symptoms in supportive and palliative care. The previous two are still available &lt;A href="http://www.library.nhs.uk/palliative/page.aspx?pagename=AEUS" target="_blank"&gt;here&lt;/A&gt;.&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;
&lt;P style="MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 6pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;We are grateful to Dr Eleni Tsiompanou for providing the commentary. Dr Tsiompanou is Associate Specialist in Palliative Medicine at Kingston Hospital and Princess Alice Hospice, and Chair of the &lt;A href="http://www.helpthehospices.org.uk/our-services/running-your-hospice/food-and-nutrition/" target="_blank"&gt;Food and Nutrition Group at Help the Hospices&lt;/A&gt;.&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;We would also like to thank the members of the editorial team who have contributed to this AEU:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL type=disc&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;Ashique Ahamed&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;Denise Brady&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;Melanie Hodson&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;Sarah Mollart&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/LI&gt;
&lt;LI style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; COLOR: black; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-family: Arial" lang=EN&gt;Clare Rayment&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;EM&gt;Sam H Ahmedzai, Clinical Lead &lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 10pt; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB"&gt;&lt;EM&gt;Richard Stevens, Project Manager/Information Specialist&lt;o:p&gt;&lt;/o:p&gt;&lt;/EM&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386978</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=386978]]&gt;</url>
    <title>Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Methodology</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,WEIGHT LOSS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 6 September 2010: Treatments for anorexia and cachexia in chronic disease and palliative care. Methodology&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Databases searched&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Pubmed/Medline, EMBASE, Cochrane, CINAHL, DARE, AMED.&lt;/P&gt;
&lt;P&gt;We also searched: NHS Evidence main page, 'NHS Evidence - Supportive and palliative care' specialist collection.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Search strategies&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;PUBMED [anorexia]:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;The “Clinical Query” PubMed search on anorexia, covered material published in the last five years. &lt;/P&gt;
&lt;P&gt;The search string below shows the strategy&amp;nbsp;entered with number of results.&amp;nbsp;There were 122 results in all We went through the results list and excluded references:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;relating to anorexia nervosa&lt;/LI&gt;
&lt;LI&gt;two withdrawn references (one relating to tacrine for alzheimer’s disease and the other about dopamine agonists for cocaine dependence). &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;However, some of the results were “false hits” – ie: records where we were unsure if there could be any clinical relevance, so&amp;nbsp;we included them just in case.&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;(anorexia [mh] OR anorex* [tw]) AND systematic[sb] Limits: Humans, English, Publication Date from 2005/01/01 to 2010/07/31&amp;nbsp;06:07:28&amp;nbsp;122&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&lt;BR&gt;("anorexia"[MeSH Terms] OR (anorexia[tw] OR anorexia/adipsia[tw] OR anorexia/bulimia[tw] OR anorexia/cachexia[tw] OR anorexia/decreased[tw] OR anorexia/early[tw] OR anorexia/fatigue[tw] OR anorexia/feed[tw] OR anorexia/hunger[tw] OR anorexia/hypokalemia[tw] OR anorexia/hypophagia[tw] OR anorexia/inapettence[tw] OR anorexia/low[tw] OR anorexia/nausea[tw] OR anorexia/nausea/vomiting[tw] OR anorexia/pharyngitis[tw] OR anorexia/poor[tw] OR anorexia/vomiting[tw] OR anorexia/weight[tw] OR anorexia'[tw] OR anorexia's[tw] OR anorexiagenic[tw] OR anorexiant[tw] OR anorexiants[tw] OR anorexias[tw] OR anorexic[tw] OR anorexic's[tw] OR anorexicants[tw] OR anorexicnation[tw] OR anorexics[tw] OR anorexics'[tw] OR anorexictics[tw] OR anorexient[tw] OR anorexients[tw] OR anorexigen[tw] OR anorexigene[tw] OR anorexigenesis[tw] OR anorexigenic[tw] OR anorexigenic/catabolic[tw] OR anorexigenic/orexigenic[tw] OR anorexigenics[tw] OR anorexigenig[tw] OR anorexigens[tw] OR anorexigens'[tw] OR anorexignic[tw] OR anorexikum[tw] OR anorexin[tw] OR anorexine[tw] OR anorexinergic[tw] OR anorexinogen[tw] OR anorexinogens[tw] OR anorexins[tw] OR anorexiogenic[tw] OR anorexipens[tw] OR anorexogen[tw] OR anorexogenic[tw] OR anorexua[tw] OR anorexy[tw] OR anorexygenic[tw])) AND systematic[sb] AND ("humans"[MeSH Terms] AND English[lang] AND ("2005/01/01"[PDAT] : "2010/07/31"[PDAT]))&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;PUBMED [cahexia]:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;The PubMed “Clinical Query” search on Cachexia is below. This is for period 2000-2010 and as there were just 48 results we did not sift this list at this stage.&lt;/P&gt;
&lt;P&gt;Search string&amp;nbsp;used here was:&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;Search (cachexia [mh] OR cachex* [tw]) AND systematic[sb] Limits: Humans, English, Publication Date from 2000/01/01 to 2010/07/31&amp;nbsp;08:04:30&amp;nbsp;48&lt;/P&gt;
&lt;P&gt;And this was translated by PubMed into:&lt;BR&gt;("cachexia"[MeSH Terms] OR (cachexia[tw] OR cachexia/anorexia[tw] OR cachexia/dehydration[tw] OR cachexia/disability[tw] OR cachexia/proteolysis[tw] OR cachexia/uremia[tw] OR cachexia/wasting[tw] OR cachexia'[tw] OR cachexia's[tw] OR cachexias[tw] OR cachexic[tw] OR cachexigenic[tw] OR cachexin[tw] OR cachexins[tw] OR cachexy[tw] OR cachexysing[tw])) AND systematic[sb] AND ("humans"[MeSH Terms] AND English[lang] AND ("2000/01/01"[PDAT] : "2010/07/31"[PDAT]))&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;CINAHL:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;1. Anorexia (Subject heading)&lt;BR&gt;2. Cachexia&amp;nbsp; (Subject heading)&lt;BR&gt;3. Systematic review (Subject heading)&lt;BR&gt;4. systematic review (free text)&lt;BR&gt;5. Meta analysis (Subject heading)&lt;BR&gt;6. Practice guidelines (Subject heading)&lt;BR&gt;7. consensus (free text) &lt;BR&gt;8. 3 or 4 or 5 or 6 or 7&lt;BR&gt;9. 1 or 2&lt;BR&gt;10. 8 and 9 &lt;/P&gt;
&lt;P&gt;(no year restriction)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;EMBASE:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;(focused on the first 2 subject headings because there were such large numbers -&amp;nbsp;over 27,000 for anorexia and over&amp;nbsp;5690 for cachexia)&lt;/P&gt;
&lt;P&gt;1. Anorexia (Subject heading focussed) &lt;BR&gt;2. Cachexia (Subject heading and focussed)&lt;BR&gt;3. Systematic review (Subject heading)&lt;BR&gt;4. systematic review (free text)&lt;BR&gt;5&amp;nbsp; Meta analysis (Subject heading)&lt;BR&gt;6. Practice guideline (Subject heading)&lt;BR&gt;7. Consensus (Subject heading)&lt;BR&gt;8. 1 or 2&lt;BR&gt;9. 3 or 4 or 5 or 6 or 7 &lt;BR&gt;10. 8 and 9 and&amp;nbsp; (2005-2010)&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;NHS EVIDENCE:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;In searching NHS evidence&amp;nbsp;we searched anorexia and cachexia as joint terms and found 169 items which&amp;nbsp;were looked through.&amp;nbsp; If already found in one of the above searches,&amp;nbsp;we did not included them in results.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We also searched the first 30 items on anorexia as a stand-alone term and the first 30 items on cachexia.&amp;nbsp; This should be the items most recently added to NHS Evidence and thus, the most recent.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Reviewing&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Search results were passed to three reviewers (Ashique Ahamed, Sarah Mollart and Clare Rayment) for assessment of abstracts for quality and relevance. The final list was agreed by Prof Sam H Ahmedzai. At this final stage, after further reflection,&amp;nbsp;we decided to exclude anything published before 2005.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;&lt;SPAN style="LINE-HEIGHT: 200%; FONT-FAMILY: 'Verdana','sans-serif'; FONT-SIZE: 8pt; mso-ansi-language: EN-US" lang=EN-US&gt;[&lt;A href="nelh:386964:0" name=internalLink&gt;&lt;A href="nelh:386964:0" name=internalLink&gt;Return to AEU contents page&lt;/A&gt;&lt;/A&gt;]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>305892</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=305892]]&gt;</url>
    <title>Annual Evidence Update 9 February 2009: Gastrointestinal symptoms in supportive and palliative care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,NAUSEA &amp; VOMITING,STOMACH,GASTROENTEROLOGY &amp; LIVER DISEASES,COMMON CLINICAL PRESENTATIONS,COLON &amp; RECTUM,CANCER,RECENT ADDITIONS,FEBRUARY 2009]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update 9 February 2009: Gastrointestinal symptoms in supportive and palliative care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Contents&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;
&lt;BLOCKQUOTE&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=305891&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;Nausea and vomiting&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=305890&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;Constipation&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305896&amp;amp;tabID=289" target="_blank"&gt;&lt;FONT size=2&gt;Bowel obstruction&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/BLOCKQUOTE&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This week we are pleased to present the first supportive and palliative care Annual Evidence Update on symptom management in gastroenterology. The latest high quality evidence is collected together on three common and troublesome conditions which continue to pose challenges in symptom management. These areas are Nausea &amp;amp; Vomiting, Bowel Obstruction and Constipation. All of these have a multitude of aetiologies and although critical to investigate and if possible treat the underlying problem, it is important to also manage the symptoms themselves. &lt;/P&gt;
&lt;P&gt;Supportive and palliative care in our view, encompasses much more than cancer and terminal illness - see &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?prv=y&amp;amp;pagename=AIMS" target="_blank"&gt;definitions&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;We therefore embrace the symptom management (both physical and psychological) aspects of many illnesses, especially chronic diseases. However, even with acute illnesses there may be important lessons to be learnt about symptom management which may be transferable to other conditions.&amp;nbsp; Thus, the reviews included encompass a range of medical topics which would not normally be found in a ‘traditional palliative care’ review, eg nausea and vomiting associated with gastroenteritis and following cranial surgery.&lt;/P&gt;
&lt;P&gt;This update collects together the best current knowledge on the supportive care management of these conditions, concentrating on systematic reviews as well as high quality reviews and randomised controlled trials within the scope of supportive and palliative care.&amp;nbsp; We have also included some expert-led consensus statements and guidelines, as although they may not meet the definition of ‘systematic review’, they may be more immediately applicable in a clinical situation and they do contain detailed references.&lt;/P&gt;
&lt;P&gt;The contents of this Annual Evidence Update should be browsed in conjunction with the often much more detailed literature on the underlying conditions which are found in the Specialist Library for &lt;A href="http://www.library.nhs.uk/gastroliver/" target="_blank"&gt;Gastroenterology and Liver Diseases&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Jason Boland&lt;BR&gt;Elaine Cachia&lt;BR&gt;Clare Wotton&lt;BR&gt;Sam H Ahmedzai&lt;BR&gt;Richard Stevens&lt;BR&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260224</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260224]]&gt;</url>
    <title>Annual Evidence Update on pain in palliative and supportive care - Systematic reviews</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update on pain in palliative and supportive care - Systematic reviews&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This page gives the results of our search for systematic reviews and other high quality reviews on pain in palliative and supportive care.&lt;/P&gt;
&lt;P&gt;The methodology of our search strategy can be found &lt;A href="nelh:260231:0" name=internalLink&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;We have made a deliberately broad sweep of the literature for this, our first National Knowledge Update on Pain within this specialist library –&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Inclusion of articles from 2000 up till 2006.&amp;nbsp; Future annual evidence updates will be restricted to the previous year’s literature output&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Inclusion of not only advanced cancer (ie most of palliative care) but also other non-malignant conditions with chronic pain and cancer patients in the earlier stages of disease (supportive care).&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;The 37 included reviews (from the original&amp;nbsp;total of 93) are below. They are listed by year of publication, in reverse chronological order from 2006 back to 2000. &lt;/P&gt;
&lt;P&gt;Links are included to PubMed abstracts (full text versions may also be available for some items) or Cochrane reviews.&lt;/P&gt;
&lt;P&gt;In addition to the journal subscriptions that your organisation may hold, the NHS buys a number of online journals which can be accessed if you have an &lt;A href="https://register.athensams.net/nhs/" target="_blank"&gt;Athens password&lt;/A&gt;. The A-Z list of NHS online journals is here: &lt;A href="http://journals.library.nhs.uk/" target="_blank"&gt;http://journals.library.nhs.uk/&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;If you need help accessing any of the resources listed here, or with getting an Athens password, please contact your local health library. The staff there will be happy to help.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2 align=left&gt;&lt;EM&gt;Published in 2006:&lt;/EM&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;[1] &lt;STRONG&gt;Pain assessment tools: is the content appropriate for use in palliative care?&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17157759&amp;amp;query_hl=28&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Holen JC, Hjermstad MJ, Loge JH, Fayers PM, Caraceni A, De Conno F, Forbes K, Furst CJ, Radbruch L, Kaasa S. J Pain Symptom Manage. 2006 Dec;32(6):567-80.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2] &lt;STRONG&gt;Chemotherapy for hormone-refractory prostate cancer. &lt;/STRONG&gt;&lt;A href="nelh:238974:0" name=internalLink&gt;Link to Cochrane&amp;nbsp;Review&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mike S, Harrison C, Coles B, Staffurth J, Wilt TJ, Mason MD. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005247.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[3] &lt;STRONG&gt;Calcitonin for metastatic bone pain.&lt;/STRONG&gt; &lt;A href="nelh:237685:0" name=internalLink&gt;&lt;A href="nelh:237685:0" name=internalLink&gt;Link to Cochrane&amp;nbsp;Review&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Martinez-Zapata MJ, Roque M, Alonso-Coello P, Catala E. Cochrane Database Syst Rev. 2006 Jul 19;3:CD003223.&lt;BR&gt;&amp;nbsp; &lt;BR&gt;Update of: &lt;BR&gt;Cochrane Database Syst Rev. 2003;(3):CD003223.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4] &lt;STRONG&gt;Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16705312&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Bell RF, Wisloff T, Eccleston C, Kalso E. Br J Cancer. 2006 Jun 5;94(11):1559-67.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5] &lt;STRONG&gt;Opioid switching: a systematic and critical review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16624490&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mercadante S, Bruera E. Cancer Treat Rev. 2006 Jun;32(4):304-15. Epub 2006 Apr 19.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6] &lt;STRONG&gt;Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16765848&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Lafferty WE, Downey L, McCarty RL, Standish LJ, Patrick DL. Complement Ther Med. 2006 Jun;14(2):100-12. Epub 2006 Mar 29.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7] &lt;STRONG&gt;The role of basic oral care and good clinical practice principles in the management of oral mucositis.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16775649&amp;amp;query_hl=6&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;McGuire DB, Correa ME, Johnson J, Wienandts P. Support Care Cancer. 2006 Jun;14(6):541-7. Epub 2006 Apr 25.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[8] &lt;STRONG&gt;Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16636208&amp;amp;query_hl=8&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Reid CM, Martin RM, Sterne JA, Davies AN, Hanks GW. Arch Intern Med. 2006 Apr 24;166(8):837-43.&lt;/P&gt;
&lt;P&gt;Erratum in: &lt;BR&gt;Arch Intern Med. 2006 Nov 27;166(21):2387.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[9] &lt;STRONG&gt;The pharmacotherapy of chronic pain: a review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16511612&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Lynch ME, Watson CP. Pain Res Manag. 2006 Spring;11(1):11-38.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[10] &lt;STRONG&gt;Interprofessional education to improve pain management. &lt;/STRONG&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16493295&amp;amp;query_hl=17&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Br J Community Nurs. 2006 Jan;11(1):29-32.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[11] &lt;STRONG&gt;The potential role of ketamine in hospice analgesia: a literature review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16524352&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Legge J, Ball N, Elliott DP. Consult Pharm. 2006 Jan;21(1):51-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;Published in 2005:&lt;/EM&gt;&lt;/H2&gt;
&lt;H2 align=left&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P align=left&gt;[12] &lt;STRONG&gt;Antidepressants for neuropathic pain.&lt;/STRONG&gt; &lt;A href="nelh:239179:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Saarto T, Wiffen PJ. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005454.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[13] &lt;STRONG&gt;Radioisotopes for the palliation of metastatic bone cancer: a systematic review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15925817&amp;amp;query_hl=22&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Finlay IG, Mason MD, Shelley M. Lancet Oncol. 2005 Jun;6(6):392-400.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;Published in 2004:&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[14] &lt;STRONG&gt;Complementary and alternative approaches to the treatment of persistent musculoskeletal pain.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15218409&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Weiner DK, Ernst E. Clin J Pain. 2004 Jul-Aug;20(4):244-55.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[15] &lt;STRONG&gt;Continuous subcutaneous infusion of opiates at end-of-life.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15122000&amp;amp;query_hl=26&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Anderson SL, Shreve ST. Ann Pharmacother. 2004 Jun;38(6):1015-23. Epub 2004 Apr 30.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[16] &lt;STRONG&gt;Opioid dose titration for severe cancer pain: a systematic evidence-based review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15265356&amp;amp;query_hl=29&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Davis MP, Weissman DE, Arnold RM. J Palliat Med. 2004 Jun;7(3):462-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[17] &lt;STRONG&gt;The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15050665&amp;amp;query_hl=31&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Taylor RS, Taylor RJ, Van Buyten JP, Buchser E, North R, Bayliss S. J Pain Symptom Manage. 2004 Apr;27(4):370-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[18] &lt;STRONG&gt;Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.&lt;/STRONG&gt; &lt;A href="nelh:238822:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wai MS, Mike S, Ines H, Malcolm M. Cochrane Database Syst Rev. 2004;(2):CD004721.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[19] &lt;STRONG&gt;&lt;STRONG&gt;Methadone for cancer pain&lt;/STRONG&gt;.&lt;/STRONG&gt; &lt;A href="nelh:238356:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Nicholson AB. Cochrane Database Syst Rev. 2004;(2):CD003971.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[20] &lt;STRONG&gt;&lt;STRONG&gt;Aromatherapy and massage &lt;/STRONG&gt;for symptom relief in patients with cancer.&lt;/STRONG&gt; &lt;A href="nelh:237459:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Fellowes D, Barnes K, Wilkinson S. Cochrane Database Syst Rev. 2004;(2):CD002287.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[21] &lt;STRONG&gt;Evidence report on the treatment of pain in cancer patients.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15263038&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. J Natl Cancer Inst Monogr. 2004;(32):23-31.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;Published in 2003:&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[22] &lt;STRONG&gt;Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14524489&amp;amp;query_hl=37&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Clin Oncol (R Coll Radiol). 2003 Sep;15(6):345-52.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[23] &lt;STRONG&gt;Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12967737&amp;amp;query_hl=39&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Bell RF, Eccleston C, Kalso E.&amp;nbsp;&amp;nbsp;J Pain Symptom Manage. 2003 Sep;26(3):867-75.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[24] &lt;STRONG&gt;Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12573746&amp;amp;query_hl=42&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):594-605.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[25] &lt;STRONG&gt;A systematic review of hydromorphone in acute and chronic pain.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12590032&amp;amp;query_hl=44&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Quigley C, Wiffen P. J Pain Symptom Manage. 2003 Feb;25(2):169-78.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[26] &lt;STRONG&gt;Quality of life concerns in patients with breast cancer: evidence for disparity of outcomes and experiences in pain management and palliative care among African-American women.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12491494&amp;amp;query_hl=37&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Payne R, Medina E, Hampton JW. Cancer. 2003 Jan 1;97(1 Suppl):311-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[27] &lt;STRONG&gt;&lt;STRONG&gt;Oral morphine for cancer pain&lt;/STRONG&gt;.&lt;/STRONG&gt; &lt;A href="nelh:238422:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wiffen PJ, Edwards JE, Barden J, McQuay HJ. Cochrane Database Syst Rev. 2003;(4):CD003868.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[28] &lt;STRONG&gt;Ketamine as an adjuvant to opioids for cancer pain.&lt;/STRONG&gt; &lt;A href="nelh:238220:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Bell R, Eccleston C, Kalso E. Cochrane Database Syst Rev. 2003;(1):CD003351.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[29] &lt;STRONG&gt;Topical agents or dressings for pain in venous leg ulcers.&lt;/STRONG&gt; &lt;A href="nelh:236881:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Briggs M, Nelson EA. Cochrane Database Syst Rev. 2003;(1):CD001177.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[30] &lt;STRONG&gt;Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12515986&amp;amp;query_hl=49&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Devine EC. Oncol Nurs Forum. 2003 Jan-Feb;30(1):75-89.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;EM&gt;Published in 2002:&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[31] &lt;STRONG&gt;The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11920548&amp;amp;query_hl=51&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Lawlor PG. Cancer. 2002 Mar 15;94(6):1836-53.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[32] &lt;STRONG&gt;Bisphosphonates for the relief of pain secondary to bone metastases.&lt;/STRONG&gt; &lt;A href="nelh:237628:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wong R, Wiffen PJ.&amp;nbsp;Cochrane Database Syst Rev. 2002;(2):CD002068.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[33] &lt;STRONG&gt;Psychological therapies for sickle cell disease and pain.&lt;/STRONG&gt; &lt;A href="nelh:237007:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Anie KA, Green J. Cochrane Database Syst Rev. 2002;(2):CD001916.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Update of: &lt;BR&gt;Cochrane Database Syst Rev. 2000;(3):CD001916.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 align=left&gt;&lt;EM&gt;Published in 2001:&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[34] &lt;STRONG&gt;Equianalgesic dose ratios for opioids\. a critical review and proposals for long-term dosing.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11495714&amp;amp;query_hl=54&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. J Pain Symptom Manage. 2001 Aug;22(2):672-87.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[35] &lt;STRONG&gt;Educational interventions to improve cancer pain control: a systematic review.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11441627&amp;amp;query_hl=56&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Allard P, Maunsell E, Labbe J, Dorval M.&amp;nbsp;J Palliat Med. 2001 Summer;4(2):191-203.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;EM&gt;Published in 2000:&lt;/EM&gt;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[36] &lt;STRONG&gt;Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care.&lt;/STRONG&gt; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11219875&amp;amp;query_hl=37&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mannix K, Ahmedzai SH, Anderson H, Bennett M, Lloyd-Williams M, Wilcock A. Palliat Med. 2000 Nov;14(6):455-61.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[37] &lt;STRONG&gt;Radiotherapy for the palliation of painful bone metastases.&lt;/STRONG&gt; &lt;A href="nelh:237096:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;McQuay HJ, Collins SL, Carroll D, Moore RA. Cochrane Database Syst Rev. 2000;(2):CD001793.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowedge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>323663</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=323663]]&gt;</url>
    <title>Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 1: Mouth care</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,MOUTH CARE AND DYSPHAGIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 1: Mouth care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Note on scope&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;One of our original 'topics' was 'Mouth care', which would have included such diverse clinical situations as candidiasis to xerostomia (dry mouth). We have therefore focused this time on just one subject - mucositis - as this conceptually, and pathophysiologically, links in with another topic of this AEU, namely chemotherapy-related diarrhoea.&amp;nbsp;Other important&amp;nbsp; mouth care subjects will be reviewed in future AEUs.&lt;/P&gt;
&lt;P&gt;We assigned the selected records to 3 categories: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Radiotherapy and chemotherapy (mixed)&lt;/LI&gt;
&lt;LI&gt;Radiotherapy alone&lt;/LI&gt;
&lt;LI&gt;Chemotherapy alone&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Radiotherapy and&amp;nbsp;chemotherapy (Mixed)&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;A review of quality assessment of the methodology used in guidelines and systematic reviews on oral mucositis&lt;/STRONG&gt;. Potting, Carin. Mistiaen, Patriek. Poot, Else. Blijlevens, Nicole. Donnelly, Peter. van Achterberg, Theo. Journal of Clinical Nursing. 18(1):3-12, 2009. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19120727" target="_blank"&gt;PMID: 19120727&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations&lt;/STRONG&gt;. Peterson D.E., Bensadoun R.-J., Roila F. Annals of Oncology. 20(SUPPL. 4)(pp iv174-iv177), 2009. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19454447" target="_blank"&gt;PMID: 19454447&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="http://annonc.oxfordjournals.org/cgi/reprint/19/suppl_2/ii122?etoc" target="_blank"&gt;Full text&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;NCCN task force report: Prevention and management of mucositis in cancer care&lt;/STRONG&gt;. Bensinger W. Schubert M. Ang K.-K. Brizel D. Brown E. Eilers J.G. Elting L. Mittal B.B. Schattner M.A. Spielberger R. Treister N.S. Trotti III A.M. JNCCN Journal of the National Comprehensive Cancer Network. 6(SUPPL. 1)(pp S1-S21), 2008. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18289497" target="_blank"&gt;PMID: 18289497&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="http://www.nccn.org/JNCCN/PDF/mucositis_2008.pdf" target="_blank"&gt;Full text&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Interventions for preventing oral mucositis for patients with cancer receiving treatment&lt;/STRONG&gt;. Helen V Worthington, Jan E Clarkson, Tim OB Eden. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000978. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17943748" target="_blank"&gt;PMID: 17943748&lt;/A&gt; &amp;nbsp; &lt;A href="nelh:236744:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Several therapies may prevent or reduce the severity of oral mucositis associated with cancer treatment.[comment]&lt;/STRONG&gt;. Sutherland S. Evid Based Dent. 2006;7(4):104-5. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17187045" target="_blank"&gt;PMID: 17187045&lt;/A&gt;&amp;nbsp; &lt;EM&gt;Note - although this record is&amp;nbsp;labelled in pubmed merely a 'comment', it is more of a summary review.&lt;/EM&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses&lt;/STRONG&gt;. Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG. Journal of Dental Research. 85(8):690-700, 2006 Aug. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16861284" target="_blank"&gt;PMID: 16861284&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Chemotherapy&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Emerging drugs for chemotherapy-induced mucositis&lt;/STRONG&gt;. Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22.&amp;nbsp; Keefe DM, Sonis ST, Bowen JM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18764726" target="_blank"&gt;PMID: 18764726&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review&lt;/STRONG&gt;. Potting CMJ, Uitterhoeve R, Scholte Op Reimer W, Van Achterberg T.&amp;nbsp;European Journal of Cancer Care, 01 December 2006, vol./is. 15/5(431-439), 09615423. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17177899" target="_blank"&gt;PMID: 17177899&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Radiotherapy&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis&lt;/STRONG&gt;. Sasse, Andre Deeke. Clark, Luciana Gontijo de Oliveira. Sasse, Emma Chen. Clark, Otavio Augusto Camara. International Journal of Radiation Oncology, Biology, Physics 2006. 64(3):784-91.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16198504" target="_blank"&gt;PMID: 16198504&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16198504" target="_blank"&gt;Full text&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>323665</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=323665]]&gt;</url>
    <title>Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 2: PEG feeding</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,GASTRO-INTESTINAL,NUTRITION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 2: PEG feeding&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Search&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;Following a preliminary search, we searched Pubmed for the last 10 years for systematic reviews (clinical queries filter) for:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;EM&gt;percutaneous endoscopic gastrostomy (PEG)&lt;/EM&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;We did not limit to ‘palliative’ at all. &lt;/P&gt;
&lt;P&gt;48 results were found&amp;nbsp;which are tagged by medline as ‘reviews’ and potentially systematic reviews. &lt;/P&gt;
&lt;P&gt;We selected 9 records from the list of 48 which we considered to be most relevant for our field and of sufficient quality. We assigned them to 3 categories: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Cancer&lt;/LI&gt;
&lt;LI&gt;Non-malignant disease&lt;/LI&gt;
&lt;LI&gt;General management. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cancer&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis&lt;/STRONG&gt;. Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, Birchall MA. Clin Otolaryngol. 2009 Apr;34(2):103-12. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19413607" target="_blank"&gt;PMID: 19413607&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Non-malignant disease&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Enteral tube feeding for older people with advanced dementia&lt;/STRONG&gt;. Sampson EL, Candy B, Jones L. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007209. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19370678" target="_blank"&gt;PMID: 19370678&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="nelh:312223:1" name=internalLink&gt;Full text&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points&lt;/STRONG&gt;. EALSC Working Group. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B; EALSC Working Group. Amyotroph Lateral Scler. 2007 Aug;8(4):195-213. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17653917" target="_blank"&gt;PMID: 17653917&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease&lt;/STRONG&gt;. Langmore SE, Kasarskis EJ, Manca ML, Olney RK. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004030. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17054194" target="_blank"&gt;PMID: 17054194&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="nelh:238273:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;BR&gt;&lt;STRONG&gt;Gastrostomy feeding in cerebral palsy: a systematic review&lt;/STRONG&gt;. Sleigh G, Brocklehurst P. Arch Dis Child. 2004 Jun;89(6):534-9. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15155398" target="_blank"&gt;PMID: 15155398&lt;/A&gt;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;Interventions for dysphagia in acute stroke. Bath PM, Bath FJ, Smithard DG. Cochrane Database Syst Rev. 2000;(2):CD000323. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/10796343" target="_blank"&gt;PMID: 10796343&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="nelh:236553:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;General management&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;A systematic review of nursing administration of medication via enteral tubes in adults&lt;/STRONG&gt;. Phillips NM, Nay R. J Clin Nurs. 2008 Sep;17(17):2257-65. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18705702" target="_blank"&gt;PMID: 18705702&lt;/A&gt;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Meta-analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy&lt;/STRONG&gt;. Jafri NS, Mahid SS, Minor KS, Idstein SR, Hornung CA, Galandiuk S. Aliment Pharmacol Ther. 2007 Mar 15;25(6):647-56. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17311597" target="_blank"&gt;PMID: 17311597&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy&lt;/STRONG&gt;.&amp;nbsp;Lipp A, Lusardi G. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005571. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17054265" target="_blank"&gt;PMID: 17054265&lt;/A&gt;&amp;nbsp; &lt;A href="nelh:239162:1" name=internalLink&gt;Full text&lt;/A&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>323667</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=323667]]&gt;</url>
    <title>Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 3: Diarrhoea</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,CONSTIPATION AND OTHER BOWEL PROBLEMS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. 3: Diarrhoea&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;We did a "Clinical Queries" search on PubMed to find systematic reviews published between Jan 2007 and July 2009. The search was not restricted to palliative care.&amp;nbsp;We searched for diarrhea as a mesh term and diarrhoea / diarrhea as textwords. Limits applied: human and English language. This retrieved 176 results.&lt;/P&gt;
&lt;P&gt;Search string: (diarrhea[mh] OR diarrhea[tw] OR diarrhoea[tw]) AND systematic[sb] Limits: Publication Date from 2007/01/01 to 2009/07/31, Humans, English. We excluded those records dealing only with children. &lt;/P&gt;
&lt;P&gt;We assigned the list of selected records to&amp;nbsp;7 categories:&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Treatment-induced&lt;/LI&gt;
&lt;LI&gt;Infectious&lt;/LI&gt;
&lt;LI&gt;Malabsorption&lt;/LI&gt;
&lt;LI&gt;Assessment&lt;/LI&gt;
&lt;LI&gt;Faecal incontinence&lt;/LI&gt;
&lt;LI&gt;Inflammatory&lt;/LI&gt;
&lt;LI&gt;Functional&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Treatment-induced&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Emerging drugs for chemotherapy-induced mucositis&lt;/STRONG&gt;. Expert Opin Emerg Drugs. 2008 Sep;13(3):511-22.&amp;nbsp; Keefe DM, Sonis ST, Bowen JM. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18764726" target="_blank"&gt;PMID: 18764726&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review&lt;/STRONG&gt;. Cherny NI. J Pain Symptom Manage. 2008 Oct;36(4):413-23. Epub 2008 Apr 14.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18411014" target="_blank"&gt;PMID: 18411014&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Safety of multi-targeted kinase inhibitors as monotherapy treatment of cancer: a systematic review of the literature&lt;/STRONG&gt;. Curr Drug Saf. 2009 Crean S, Boyd DM, Sercus B, Lahn M. May;4(2):143-54.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19442108" target="_blank"&gt;PMID: 19442108&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer&lt;/STRONG&gt;. Eng C. Nat Rev Clin Oncol. 2009 Apr;6(4):207-18. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19333227" target="_blank"&gt;PMID: 19333227&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation&lt;/STRONG&gt;. Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18462574" target="_blank"&gt;PMID: 18462574&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="http://www.ncchta.org/fullmono/mon1215.pdf" target="_blank"&gt;Full text&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Infectious&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Probiotics, critical illness, and methodologic bias&lt;/STRONG&gt;. Koretz RL. Nutr Clin Pract. 2009 Feb-Mar;24(1):45-9. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19244148" target="_blank"&gt;PMID: 19244148&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes&lt;/STRONG&gt;. Johnson S. J Infect. 2009 Jun;58(6):403-10. Epub 2009 Apr 5.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19394704" target="_blank"&gt;PMID: 19394704&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis&lt;/STRONG&gt;. Koo HL, Koo DC, Musher DM, DuPont HL. Clin Infect Dis. 2009 Mar 1;48(5):598-605.&amp;nbsp;&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19191646" target="_blank"&gt;PMID: 19191646&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Meta-analysis to assess risk factors for recurrent Clostridium difficile infection&lt;/STRONG&gt;. Garey KW, Sethi S, Yadav Y, DuPont HL. J Hosp Infect. 2008 Dec;70(4):298-304. Epub 2008 Oct 31. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18951661" target="_blank"&gt;PMID: 18951661&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Clinical review of the management of fulminant clostridium difficile infection&lt;/STRONG&gt;. Jaber MR, Olafsson S, Fung WL, Reeves ME. Am J Gastroenterol. 2008 Dec;103(12):3195-203; quiz 3204. Epub 2008 Oct 1. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18853982" target="_blank"&gt;PMID: 18853982&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Infection control measures to limit the spread of Clostridium difficile&lt;/STRONG&gt;. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tüll P, Gastmeier P; Clin Microbiol Infect. 2008 May;14 Suppl 5:2-20.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18412710" target="_blank"&gt;PMID: 18412710&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Probiotics for prevention of antibiotic-associated diarrhea&lt;/STRONG&gt;. Doron SI, Hibberd PL, Gorbach SL. J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S58-63. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18542041" target="_blank"&gt;PMID: 18542041&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Probiotics, prebiotics, and synbiotics&lt;/STRONG&gt;. de Vrese M, Schrezenmeir J. Adv Biochem Eng Biotechnol. 2008;111:1-66.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18461293" target="_blank"&gt;PMID: 18461293&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea&lt;/STRONG&gt;. Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Ann Pharmacother. 2008 Jun;42(6):827-35. Epub 2008 Apr 22. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18430792" target="_blank"&gt;PMID: 18430792&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Defining surgical therapy for pseudomembranous colitis with toxic megacolon&lt;/STRONG&gt;. Berman L, Carling T, Fitzgerald TN, Bell RL, Duffy AJ, Longo WE, Roberts KE. J Clin Gastroenterol. 2008 May-Jun;42(5):476-80. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18277885" target="_blank"&gt;PMID: 18277885&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Probiotics for treatment of Clostridium difficile-associated colitis in adults&lt;/STRONG&gt;. Pillai A, Nelson R. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004611. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18254055" target="_blank"&gt;PMID: 18254055&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="nelh:279134:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Malabsorption&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis&lt;/STRONG&gt;. Waljee AK, Dimagno MJ, Wu BU, Schoenfeld PS, Conwell DL. Aliment Pharmacol Ther. 2009 Feb 1;29(3):235-46. Epub 2008 Nov 8. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19035969" target="_blank"&gt;PMID: 19035969&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Assessment&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease&lt;/STRONG&gt;. Schusselé Filliettaz S, Juillerat P, Burnand B, Arditi C, Windsor A, Beglinger C, Dubois RW, Peytremann-Bridevaux I, Pittet V, Gonvers JJ, Froehlich F, Vader JP; EPAGE II Study Group. Endoscopy. 2009 Mar;41(3):218-26. Epub 2009 Mar 11. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19280533" target="_blank"&gt;PMID: 19280533&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Faecal incontinence&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors - Part C Special Pharmacology&lt;/STRONG&gt;. Bergert FW, Conrad D, Ehrenthal K, Fessler J, Gross J, Gundermann K, Kluthe B, Lang Heinrich W, Liesenfeld A, Loew PG, Luther E, Pchalek R, Seffrin J, Sterzing A, Wolfring HJ, Zimmermann U; Guideline Group Hesse. Int J Clin Pharmacol Ther. 2009 Apr;47(4):223-8. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19356387" target="_blank"&gt;PMID: 19356387&lt;/A&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Inflammatory&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease&lt;/STRONG&gt;. Turner D, Zlotkin SH, Shah PS, Griffiths AM. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006320.&amp;nbsp; Update of: Cochrane Database Syst Rev. 2007;(2):CD006320. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19160277" target="_blank"&gt;PMID: 19160277&lt;/A&gt;&amp;nbsp;&amp;nbsp; &lt;A href="nelh:260031:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Interventions for treating lymphocytic colitis&lt;/STRONG&gt;. Chande N, McDonald JW, Macdonald JK. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006096.&amp;nbsp; Update of:&amp;nbsp;Cochrane Database Syst Rev. 2007;(1):CD006096.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18425936" target="_blank"&gt;PMID: 18425936&lt;/A&gt;&amp;nbsp; &lt;A href="nelh:239251:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Interventions for treating collagenous colitis&lt;/STRONG&gt;. Chande N, McDonald JW, Macdonald JK. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003575.&amp;nbsp;Update of: Cochrane Database Syst Rev. 2006;(4):CD003575. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18425892" target="_blank"&gt;PMID: 18425892&lt;/A&gt;&amp;nbsp; &lt;A href="nelh:238087:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Functional&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?&lt;/STRONG&gt; Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. JAMA. 2008 Oct 15;300(15):1793-805.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18854541" target="_blank"&gt;PMID: 18854541&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials&lt;/STRONG&gt;. Rahimi R, Nikfar S, Abdollahi M. Clin Ther. 2008 May;30(5):884-901. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18555935" target="_blank"&gt;PMID: 18555935&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials&lt;/STRONG&gt;. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Clin Gastroenterol Hepatol. 2008 May;6(5):545-55. Epub 2008 Jan 31. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18242143" target="_blank"&gt;PMID: 18242143&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: a systematic review&lt;/STRONG&gt;. Shi J, Tong Y, Shen JG, Li HX. World J Gastroenterol. 2008 Jan 21;14(3):454-62. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18200670" target="_blank"&gt;PMID: 18200670&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Hypnotherapy for treatment of irritable bowel syndrome&lt;/STRONG&gt;. Webb AN, Kukuruzovic RH, Catto-Smith AG, Sawyer SM. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005110. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17943840" target="_blank"&gt;PMID: 17943840&lt;/A&gt;&amp;nbsp; &amp;nbsp;&lt;A href="nelh:270900:1" name=internalLink&gt;Full text&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;A href="nelh:323419:1" name=internalLink&gt;Go to the Contents page for this AEU &lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>323419</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=323419]]&gt;</url>
    <title>Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. Contents and introduction</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,MOUTH CARE AND DYSPHAGIA,NUTRITION,GASTRO-INTESTINAL,SYMPTOM MANAGEMENT,COLON &amp; RECTUM,SMALL INTESTINE,INFLAMMATORY BOWEL DISEASE,GASTROENTEROLOGY &amp; LIVER DISEASES,COMMON CLINICAL PRESENTATIONS,CHRONIC PANCREATITIS,PANCREAS,FAECAL INCONTINENCE,DIARRHOEA,INFECTIONS,ENTERAL,PSEUDOMEMBRANOUS COLITIS,CROHN'S DISEASE,PANCREATITIS,RECENT ADDITIONS,CONSTIPATION AND OTHER BOWEL PROBLEMS,SEPTEMBER 2009,THERAPEUTIC NUTRITION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update. 7 September 2009: Gastrointestinal symptoms in supportive and palliative care. Contents and introduction&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Contents&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;
&lt;BLOCKQUOTE&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;FONT size=2&gt;&lt;A href="nelh:323663:1" name=internalLink&gt;&lt;FONT size=2&gt;Mouth care (focus on Mucositis)&lt;/FONT&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;FONT size=2&gt;&lt;A href="nelh:323665:1" name=internalLink&gt;&lt;FONT size=2&gt;Percutaneous endoscopic gastrostomy (PEG) feeding&lt;/FONT&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;H2&gt;&lt;FONT size=2&gt;&lt;A href="nelh:323667:1" name=internalLink&gt;&lt;FONT size=2&gt;Diarrhoea&lt;/FONT&gt;&lt;/A&gt;&lt;/FONT&gt;&lt;/H2&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/BLOCKQUOTE&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;This week we are pleased to present the second supportive and palliative care Annual Evidence Update on symptom management in gastroenterology. The latest high quality evidence is collected together on three topics which continue to pose challenges in symptom management. These areas are: Mouth care (focussing specifically&amp;nbsp;on mucositis); Percutaneous endoscopic gastrostomy (PEG) feeding; and Diarrhoea. &lt;/P&gt;
&lt;P&gt;One of our original 'topics' was 'Mouth care', which would have included such diverse clinical situations as candidiasis to xerostomia (dry mouth). We have therefore focused this time on just one subject - mucositis - as this conceptually, and pathophysiologically, links in with another topic of this AEU, namely chemotherapy-related diarrhoea.&amp;nbsp; Other important&amp;nbsp; mouth care subjects will be reviewed in future AEUs.&lt;/P&gt;
&lt;P&gt;Supportive and palliative care encompass much more than cancer and terminal illness - see &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?prv=y&amp;amp;pagename=AIMS" target="_blank"&gt;definitions&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;We therefore embrace the symptom management (both physical and psychological) aspects of many illnesses, especially chronic diseases.&lt;BR&gt;However, even with acute illnesses there may be important lessons to be learnt about symptom management which may be transferable to other conditions.&amp;nbsp; Supportive care is especially concerned with the management of adverse effects of disease therapies. Thus, the reviews included encompass a range of medical and nursing topics which would not normally be found in a 'traditional palliative care' review, eg mucositis arising from chemotherapy for bone marrow transplantation; PEG feeding in MND/ALS; diarrhoea as an adverse effect of cancer chemotherapy or in association with infectious or inflammatory bowel disease.&lt;/P&gt;
&lt;P&gt;This update collects together the best current knowledge on the supportive care management in these areas, concentrating on systematic reviews as well as high quality reviews and randomised controlled trials within the scope of supportive and palliative care.&amp;nbsp; We have also included some expert-led consensus statements and guidelines, as although they may not meet the definition of 'systematic review', they may be more immediately applicable&lt;BR&gt;in a clinical situation and they do contain detailed references.&lt;/P&gt;
&lt;P&gt;In general, we have focused on the literature in adult disease, because the issues with respect to childhood illnesses - especially for diarrhoea - are very different from adult supportive care.&lt;/P&gt;
&lt;P&gt;The contents of this Annual Evidence Update should be browsed in conjunction with the often much more detailed literature on the underlying conditions which are found in the specialist collection for &lt;A href="http://www.library.nhs.uk/gastroliver/" target="_blank"&gt;Gastroenterology and Liver Diseases&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Sam H Ahmedzai&lt;/LI&gt;
&lt;LI&gt;Ruth Broadhurst&lt;/LI&gt;
&lt;LI&gt;Richard Stevens&lt;/LI&gt;
&lt;LI&gt;Denise Brady&lt;/LI&gt;
&lt;LI&gt;Melanie Hodson&lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;BR&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>303870</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=303870]]&gt;</url>
    <title>Annual Evidence Update: 19 January 2009. Patient and carer involvement in chronic disease. Systematic reviews</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,SERVICE PROVISION,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update: 19 January 2009. Patient and carer involvement in chronic disease. Systematic reviews&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Methods and search strategy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The following search strategy was used to retrieve references to systematic reviews on 'patient and carer involvement in chronic disease' from the &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed&amp;amp;itool=toolbar" target="_blank"&gt;Pubmed&lt;/A&gt;&amp;nbsp;database.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;EM&gt;"patient participation"[MeSH Terms] &lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;OR&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;"participation" OR "self-manag*" &lt;EM&gt;OR "self manag*" OR "involvement"&lt;/EM&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;AND&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;((chronic OR long-term OR persistent OR "long term")&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Limits: &lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Publication Date from 2000 to 2009, Humans, English, &lt;/EM&gt;&lt;EM&gt;Meta analysis or review&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;AND&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;"systematic" or "meta analysis" or "meta-analysis"&lt;/EM&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;311&amp;nbsp;records were found. Pubmed defined 292 of these as ‘reviews’. These 292 were saved as 'abstract plus' format, put into a word file, formatted to minimize the number of pages, and page numbering added. The citations were carefully analysed to determine whether a record was likely to be&amp;nbsp;(a) a true systematic review or meta-analysis, and (b) of relevant subject matter. Due to the nature of the topic, the relevance of each record was not always clear. However, where there appeared to be potentially-relevant material in a review, on balance we chose to include rather than exclude&amp;nbsp;it. Full text versions of the papers were not acquired or analysed. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;32&amp;nbsp;records were&amp;nbsp;included in the final Annual Evidence Update:&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;2008&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The nature of informational continuity of care in general practice&lt;/H2&gt;
&lt;P&gt;Agarwal G, Crooks VA.&lt;/P&gt;
&lt;P&gt;Br J Gen Pract. 2008 Nov;58(556):e17-24.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/19000395" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status&lt;/H2&gt;
&lt;P&gt;Joosten EA, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CP, de Jong CA.&lt;/P&gt;
&lt;P&gt;Psychother Psychosom. 2008;77(4):219-26. Epub 2008 Apr 16.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18418028" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Does sharing care across the primary-specialty interface improve outcomes in chronic disease? A systematic review&lt;/H2&gt;
&lt;P&gt;Smith SM, Allwright S, O'Dowd T.&lt;/P&gt;
&lt;P&gt;Am J Manag Care. 2008 Apr;14(4):213-24.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18402514" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management strategies to reduce pain and improve function among older adults in community settings: a review of the evidence&lt;/H2&gt;
&lt;P&gt;Reid MC, Papaleontiou M, Ong A, Breckman R, Wethington E, Pillemer K.&lt;/P&gt;
&lt;P&gt;Pain Med. 2008 May-Jun;9(4):409-24. Epub 2008 Mar 11.&lt;/P&gt;
&lt;P&gt;[Link to PubMed abstract]&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18346056" target="_blank"&gt;[Link to PubMed]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The development of an evidence-based physical self-management rehabilitation programme for cancer survivors&lt;/H2&gt;
&lt;P&gt;van Weert E, Hoekstra-Weebers JE, May AM, Korstjens I, Ros WJ, van der Schans CP.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Patient Educ Couns. 2008 May;71(2):169-90. Epub 2008 Feb 5.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18255249" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;PMID: 18255249 [PubMed - indexed for MEDLINE]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management education programmes by lay leaders for people with chronic conditions&lt;/H2&gt;
&lt;P&gt;Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=270899&amp;amp;tabID=289" target="_blank"&gt;Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005108.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Effectiveness of shared care across the interface between primary and specialty care in chronic disease management&lt;/H2&gt;
&lt;P&gt;Smith SM, Allwright S, O'Dowd T.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=266513&amp;amp;tabID=289" target="_blank"&gt;Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004910.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Management of functional somatic syndromes&lt;/H2&gt;
&lt;P&gt;Henningsen P, Zipfel S, Herzog W.&lt;/P&gt;
&lt;P&gt;Lancet. 2007 Mar 17;369(9565):946-55.&lt;/P&gt;
&lt;P&gt;Comment in:&amp;nbsp;Lancet. 2007 May 19;369(9574):1691-2.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17368156" target="_blank"&gt;[Link to PubMed&amp;nbsp;abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Interventions for improving older patients' involvement in primary care episodes&lt;/H2&gt;
&lt;P&gt;Wetzels R, Harmsen M, Van Weel C, Grol R, Wensing M.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238558&amp;amp;tabID=289" target="_blank"&gt;Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004273.&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Patient empowerment in theory and practice: polysemy or cacophony?&lt;/H2&gt;
&lt;P&gt;Aujoulat I, d'Hoore W, Deccache A.&lt;/P&gt;
&lt;P&gt;Patient Educ Couns. 2007 Apr;66(1):13-20. Epub 2006 Nov 2.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17084059" target="_blank"&gt;[Link to PubMed&amp;nbsp;abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Information technology to support improved care for chronic illness&lt;/H2&gt;
&lt;P&gt;Young AS, Chaney E, Shoai R, Bonner L, Cohen AN, Doebbeling B, Dorr D, Goldstein MK, Kerr E, Nichol P, Perrin R.&lt;/P&gt;
&lt;P&gt;J Gen Intern Med. 2007 Dec;22 Suppl 3:425-30.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18026812" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence&lt;/H2&gt;
&lt;P&gt;Rao JK, Anderson LA, Inui TS, Frankel RM.&lt;/P&gt;
&lt;P&gt;Med Care. 2007 Apr;45(4):340-9.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17496718" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Effectiveness of community health workers in the care of people with hypertension&lt;/H2&gt;
&lt;P&gt;Brownstein JN, Chowdhury FM, Norris SL, Horsley T, Jack L Jr, Zhang X, Satterfield D.&lt;/P&gt;
&lt;P&gt;Am J Prev Med. 2007 May;32(5):435-47.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17478270" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Multidisciplinary rehabilitation for adults with multiple sclerosis&lt;BR&gt;&lt;/H2&gt;
&lt;P&gt;Khan F, Turner-Stokes L, Ng L, Kilpatrick T.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Cochrane Database Syst Rev. 2007 Apr 18;(2):CD006036.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17443610" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Disease-specific health education for COPD: a systematic review of changes in health outcomes&lt;/H2&gt;
&lt;P&gt;Blackstock F, Webster K.&lt;/P&gt;
&lt;P&gt;Health Educ Res. 2007 Oct;22(5):703-17. Epub 2006 Nov 30.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17138617" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management of oral anticoagulant therapy: a systematic review and meta-analysis&lt;/H2&gt;
&lt;P&gt;Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM.&lt;/P&gt;
&lt;P&gt;Int J Cardiol. 2007 May 16;118(1):54-61. Epub 2006 Aug 7.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16891008" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2006&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Strategies to enhance chronic disease self-management: how can we apply this to stroke?&lt;/H2&gt;
&lt;P&gt;Jones F.&lt;/P&gt;
&lt;P&gt;Disabil Rehabil. 2006 Jul 15-30;28(13-14):841-7.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16777771" target="_blank"&gt;[Link to PubMed&amp;nbsp;abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Patient participation in the consultation process: a structured review of intervention strategies&lt;/H2&gt;
&lt;P&gt;Haywood K, Marshall S, Fitzpatrick R.&lt;/P&gt;
&lt;P&gt;Patient Educ Couns. 2006 Oct;63(1-2):12-23. Epub 2006 Jan 6.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16406464" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Lay-led self-management in chronic illness: a review of the evidence&lt;/H2&gt;
&lt;P&gt;Newbould J, Taylor D, Bury M.&lt;/P&gt;
&lt;P&gt;Chronic Illn. 2006 Dec;2(4):249-61.&lt;BR&gt;Comment in:&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; Chronic Illn. 2006 Dec;2(4):262-4.&amp;nbsp;&amp;nbsp;&amp;nbsp; Chronic Illn. 2006 Dec;2(4):265-9.&amp;nbsp;&amp;nbsp;&amp;nbsp; Chronic Illn. 2006 Dec;2(4):270-1.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/17212872" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;A systematic review of interactive computer-assisted technology in diabetes care. Interactive information technology in diabetes care&lt;/H2&gt;
&lt;P&gt;Jackson CL, Bolen S, Brancati FL, Batts-Turner ML, Gary TL.&lt;/P&gt;
&lt;P&gt;J Gen Intern Med. 2006 Feb;21(2):105-10. Epub 2005 Dec 22.&lt;BR&gt;Comment in:&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; J Gen Intern Med. 2006 Feb;21(2):201-2.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16390512" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2005&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Involving the patient: impact of inflammatory skin disease and patient-focused care&lt;/H2&gt;
&lt;P&gt;Feldman S, Behnam SM, Behnam SE, Koo JY.&lt;/P&gt;
&lt;P&gt;J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S78-85.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15968267" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Action plans for chronic obstructive pulmonary disease&lt;/H2&gt;
&lt;P&gt;Turnock AC, Walters EH, Walters JA, Wood-Baker R.&lt;/P&gt;
&lt;P&gt;Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005074.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16235392" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2004&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The effectiveness of Web-based vs. non-Web-based interventions: a meta-analysis of behavioral change outcomes&lt;/H2&gt;
&lt;P&gt;Wantland DJ, Portillo CJ, Holzemer WL, Slaughter R, McGhee EM.&lt;/P&gt;
&lt;P&gt;J Med Internet Res. 2004 Nov 10;6(4):e40.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15631964" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Occupational therapy for community dwelling elderly people: a systematic review&lt;/H2&gt;
&lt;P&gt;Steultjens EM, Dekker J, Bouter LM, Jellema S, Bakker EB, van den Ende CH.&lt;/P&gt;
&lt;P&gt;Age Ageing. 2004 Sep;33(5):453-60.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15315918" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Psycho-educational interventions for children with chronic disease, parents and siblings: an overview of the research evidence base&lt;/H2&gt;
&lt;P&gt;Barlow JH, Ellard DR.&lt;/P&gt;
&lt;P&gt;Child Care Health Dev. 2004 Nov;30(6):637-45.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15527474" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management education programs in chronic disease: a systematic review and methodological critique of the literature&lt;/H2&gt;
&lt;P&gt;Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH.&lt;/P&gt;
&lt;P&gt;Arch Intern Med. 2004 Aug 9-23;164(15):1641-9.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/15302634" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Systematic review of studies of self-management of oral anticoagulation&lt;/H2&gt;
&lt;P&gt;Siebenhofer A, Berghold A, Sawicki PT.&lt;/P&gt;
&lt;P&gt;Thromb Haemost. 2004 Feb;91(2):225-32.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/14961147" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2003&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management education for patients with chronic obstructive pulmonary disease: a systematic review&lt;/H2&gt;
&lt;P&gt;Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Partridge MR, Zielhuis G.&lt;/P&gt;
&lt;P&gt;Thorax. 2003 May;58(5):394-8.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/12728158" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Self-management education for chronic obstructive pulmonary disease&lt;/H2&gt;
&lt;P&gt;Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA.&lt;/P&gt;
&lt;P&gt;Cochrane Database Syst Rev. 2003;(1):CD002990.&lt;BR&gt;Update in:&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; Cochrane Database Syst Rev. 2007;(4):CD002990.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/12535447" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;2002&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Increasing diabetes self-management education in community settings. A systematic review&lt;/H2&gt;
&lt;P&gt;Norris SL, Nichols PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, Snyder SR, Carande-Kulis VG, Isham G, Garfield S, Briss P, McCulloch D.&lt;/P&gt;
&lt;P&gt;Am J Prev Med. 2002 May;22(4 Suppl):39-66.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/11985934" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Reaching those most in need: a review of diabetes self-management interventions in disadvantaged populations&lt;/H2&gt;
&lt;P&gt;Eakin EG, Bull SS, Glasgow RE, Mason M.&lt;/P&gt;
&lt;P&gt;Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):26-35.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/11921415" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2001&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials&lt;/H2&gt;
&lt;P&gt;Norris SL, Engelgau MM, Narayan KM. &lt;/P&gt;
&lt;P&gt;Diabetes Care. 2001 Mar;24(3):561-87.&lt;BR&gt;Comment in:&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; ACP J Club. 2001 Sep-Oct;135(2):45.&amp;nbsp;&amp;nbsp;&amp;nbsp; Diabetes Care. 2001 Mar;24(3):421-2.&amp;nbsp;&amp;nbsp;&amp;nbsp; Diabetes Care. 2002 Nov;25(11):2115-6.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/11289485" target="_blank"&gt;[Link to PubMed abstract]&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88924</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.publications.parliament.uk/pa/ld200405/ldselect/ldasdy/86/8602.htm]]&gt;</url>
    <title>Assisted Dying for the Terminally Ill Bill - First Report</title>
    <publicationDate>2005-03-03T00:00:00</publicationDate>
    <publisher>House of Lords</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,EUTHANASIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Assisted Dying for the Terminally Ill Bill seeks to legalise, for people who are terminally ill, who are mentally competent and who are suffering unbearably, medical assistance with suicide or, in cases where the person concerned would be physically incapable of taking the final action to end his or her life, voluntary euthanasia. The authors have examined both the principles underlying the Bill and its practical implications if it were to become law. The authors have also looked at the experience of other countries which have enacted legislation of this nature, and have in addition made some analysis of public opinion in Britain on the subject.]]&gt;</body>
  </document>
  <document>
    <id>123491</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://bereavementupdate.blogspot.com/]]&gt;</url>
    <title>Bereavement</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>St Christopher's Hospice Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,SERVICE PROVISION,SOCIAL &amp; PSYCHOSOCIAL ISSUES,SERVICE TYPE,FUNERALS,WILLS,DEATH RITES &amp; RITUALS,BEREAVEMENT,PLACE OF DEATH,NARRATIVES,POST-DEATH,INFORMATION SERVICES AND LIBRARIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Bereavement 'blog' compiled by Denise Brady, Librarian at St Christopher's Hospice. Provides a brief commentary on&amp;nbsp;a selection of relevant journal articles and&amp;nbsp;other resources.]]&gt;</body>
  </document>
  <document>
    <id>89019</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.biomedcentral.com/1472-684X/3/3]]&gt;</url>
    <title>Bereavement care interventions: a systematic review</title>
    <publicationDate></publicationDate>
    <publisher>Biomedcentral</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,DEATH,BEREAVEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=xfull xmlns:m="http://www.w3.org/1998/Math/MathML"&gt;The authors conducted a systematic review using the terms (bereaved or bereavement) and (grief) combined with (intervention or support or counselling or therapy) and (controlled or trial or design) and also searched citations in published reports for additional pertinent studies. Eligible studies had to evaluate whether the treatment of bereaved individuals reduced bereavement-related symptoms. &lt;/P&gt;
&lt;P class=xfull xmlns:m="http://www.w3.org/1998/Math/MathML"&gt;74 eligible studies evaluated diverse treatments designed to ameliorate a variety of outcomes associated with bereavement. Other than efficacy for pharmacological treatment of bereavement-related depression, the authors could identify no consistent pattern of treatment benefit among the other forms of interventions.&lt;/P&gt;
&lt;P&gt;Due to a paucity of reports on controlled clinical trails, the authors say no rigorous evidence-based recommendation regarding the treatment of bereaved persons is currently possible except for the pharmacologic treatment of depression. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>102153</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.euro.who.int/document/E82933.pdf]]&gt;</url>
    <title>Better palliative care for older people</title>
    <publicationDate></publicationDate>
    <publisher>World Health Organisation</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,LATER LIFE,AGE-RELATED ISSUES,INTERNATIONAL,SERVICE TYPE,ELDERLY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "Older people have traditionally received less palliative care than younger people and services have focused on cancer. This booklet is part of the WHO Regional Office for Europe's work to present evidence for health policy- and decision-makers in a clear and understandable form"]]&gt;</body>
  </document>
  <document>
    <id>88920</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/446/CN-00257446/frame.html]]&gt;</url>
    <title>Biases in how physicians choose to withdraw life support</title>
    <publicationDate></publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,WITHHOLDING &amp; WITHDRAWING TREATMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Authors have investigated biases in physicians' decisions regarding the form of life support to withdraw from critically ill patients in whom the decision to withdraw has already been made.]]&gt;</body>
  </document>
  <document>
    <id>260510</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260510]]&gt;</url>
    <title>BPS 2007 conference highlight. Dr John Williams. Post-surgical pain in breast cancer.</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight. Dr John Williams. Post-surgical pain in breast cancer.&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Introduction and terminology&lt;/H2&gt;
&lt;P&gt;Chronic pain after breast surgery (CPBS) is a major public health problem. It is a common and debilitating problem affecting as many as 30% of patients after breast surgery.&lt;/P&gt;
&lt;P&gt;It is primarily a neuropathic pain syndrome with additional musculoskeletal, physical and emotional components. Its treatment involves a combined approach of neuropathic drugs, physical and psychological therapies and preventative strategies. It is important for patients and health care professionals to recognize the prevalence of the condition, and to be aware of possible risk factors prior to surgery.&lt;/P&gt;
&lt;P&gt;CPBS is the term used to describe a number of different chronic pain conditions. This diagnosis should only be used after excluding all other discrete diagnoses such as recurrent disease or radiation-induced neuropathy. &lt;/P&gt;
&lt;P&gt;Sometimes the term CPBS is only used to indicate neuropathic pain problems after surgery. CPBS was originally referred to as ‘post-mastectomy pain syndrome’. However CPBS has been reported after the new minimally invasive surgical techniques, and therefore the old terminology is inaccurate. In this article I use the term CPBS, but other possible terms include: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;chronic pain after breast cancer treatment (possibly the most accurate term as it recognises the influence of non surgical factors in the aetiology of the pain)&lt;/LI&gt;
&lt;LI&gt;chronic pain in breast cancer survivors (popular terminology in USA)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Alternatively the term should not be used at all, and only the specific more accurate diagnosis of the pain should be used.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Characteristics of the pain&lt;/H2&gt;
&lt;P&gt;CPBS is characterised by persistent pain in the lateral chest wall and along the medial aspect of the upper arm of the affected side. &lt;/P&gt;
&lt;P&gt;The pain is neuropathic in nature, with burning and dysaesthetic components, and with lancinating pain often superimposed over a dull aching pain. Secondary musculoskeletal pain may also exist and contribute to a worsening cycle of pain. Often the pain is made worse by physical activity and may become more severe as the day progresses.&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Prevalence&lt;/H2&gt;
&lt;P&gt;From 1979 to the present day numerous epidemiological studies have consistently demonstrated the prevalence of this condition. Typically it affects approximately up to 30% of women at one year following breast surgery. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Diagnosis of CPBS&lt;/H2&gt;
&lt;P&gt;The diagnosis of CPBS should only be made after other possible causes of pain have been excluded. In particular it is important to exclude recurrent breast cancer.&amp;nbsp; CPBS is a difficult diagnosis to make as there are numerous other potential causes of pain after breast surgery. &lt;/P&gt;
&lt;P&gt;A recent publication (Jung et al, 2003) described 4 different neuropathic pain problems following breast surgery:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Intercostobrachial neuralgia – due to damage to or stretching of the nerve&lt;/LI&gt;
&lt;LI&gt;Phantom breast pain&lt;/LI&gt;
&lt;LI&gt;Neuroma – either macro (palpable) or micro neuromata&lt;/LI&gt;
&lt;LI&gt;Other nerve injury pain&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;&lt;BR&gt;Natural History&lt;/H2&gt;
&lt;P&gt;The natural history of chronic pain after breast surgery is difficult to define.&amp;nbsp; One large follow up study (Macdonald, 2005) showed a prevalence of chronic pain of 43% @ 3 years post surgery and that just over half of these patients had persistent pain at 9 years following surgery.&amp;nbsp; Ivens (1992) indicated some reduction over time.&lt;/P&gt;
&lt;P&gt;Kroner et al (1992) evaluated patients with phantom breast sensations at 3 weeks following surgery and again at 6 years and showed a much reduced incidence at the 6 year point. &lt;/P&gt;
&lt;P&gt;Specific risk factors for development of chronic pain after breast surgery&lt;/P&gt;
&lt;P&gt;Many studies have assessed the impact of specific risk factors in the development of chronic pain.&amp;nbsp; The main risk factors seem to be poorly controlled acute pain, chemotherapy and preoperative stress.&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Treatment&lt;/H2&gt;
&lt;P&gt;CPBS should be regarded as a form of neuropathic pain.&amp;nbsp; Treatment should consist of anti-neuropathic drugs in conjunction with psychological and physical therapies. &lt;/P&gt;
&lt;P&gt;My usual first-line drugs include amitriptyline, gabapentin, tramadol, opioids and 5% lidoderm patch. A number of studies have specifically investigated different treatments for CPBS.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conclusions&lt;/H2&gt;
&lt;OL&gt;
&lt;LI&gt;There is a high incidence of chronic pain after breast surgery. Cancer survivor population is increasing.&lt;/LI&gt;
&lt;LI&gt;CPBS is a neuropathic pain problem, with associated musculoskeletal, physical and emotional components. Treatment is multidisciplinary and involves using anti-neuropathic drugs.&lt;/LI&gt;
&lt;LI&gt;CPBS is a model for acute to chronic pain transition. Preventative strategies include multimodal analgesics, local anaesthetics and aggressive acute pain management.&lt;/LI&gt;&lt;/OL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 8pt"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;
&lt;P&gt;Abdullah TI, Iddon J, Barr L, Baildam AD, Bundred NJ. Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg 1998;85;1443-5. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9782034&amp;amp;query_hl=59&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Dijkstra PU, Rietman JS, Geertzen JH. Phantom breast sensations and phantom breast pain: a 2-year prospective study. Eur J Anaesthesiol, 2007: 23; 136-41. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16487732&amp;amp;query_hl=75&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Archives Neurol 2003: 60; 1524. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14623723&amp;amp;query_hl=65&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Gottrup H, Andersen J, Arendt-Nielsen L, Jensen TS. Psychophysical examination in patients with post mastectomy pain.&amp;nbsp; Pain 2000:87;275-84. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10963907&amp;amp;query_hl=59&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Granek I, Ashikari R, Foley K. The post-mastectomy pain syndrome: Clinical and anatomical correlates. Proceedings of the American Society for Clinical Oncology 3 (1984), p. 122. [not in PubMed]&lt;/P&gt;
&lt;P&gt;Iohom G, Abdalla H, O'Brien J, Szarvas S, Larney V, Buckley E, Butler M, Shorten GD. The associations between severity of early postoperative pain, chronic postsurgical pain and plasma concentration of stable nitric oxide products after breast surgery.&amp;nbsp; Anesth Analg. 2006;103:995-1000. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17000819&amp;amp;query_hl=17&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Jung B, Ahrendt GM, Oaklander AL, Dworkin RH.&amp;nbsp; Neuropathic pain following breast cancer surgery: proposed classification and research update.&amp;nbsp; Pain 2003:104: 1-13. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12855309&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;/P&gt;
&lt;P&gt;Kairaluoma PM, Bachmann MS, Rosenberg PH, Pere PJ. Preincisional Paravertebral Block Reduces the Prevalence of Chronic Pain After Breast Surgery. Anesth Analg 2006;103:703-708. &lt;/P&gt;
&lt;P&gt;Kalso E, Tasmuth T, Neuvonene PJ.&amp;nbsp; Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer.&amp;nbsp; Pain 1996:64; 293-302. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=8740607&amp;amp;query_hl=27&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Kroner K, Knudsen UB, Lundby L, Hvid H.&amp;nbsp;Long-term Phantom Breast syndrome after mastectomy.&amp;nbsp; Cinical Journal of pain 1992:8; 346-350. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=1493345&amp;amp;query_hl=10&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA.&amp;nbsp;Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome.&amp;nbsp; British Journal of Cancer 2005: 92; 225-230. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15655557&amp;amp;query_hl=79&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Macrae WA.&amp;nbsp; Chronic pain after surgery.&amp;nbsp; BJA 2001: 87; 88-98. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11460816&amp;amp;query_hl=14&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;/P&gt;
&lt;P&gt;Paredes JP, Puente JL, Potel J. Variations in sensitivity after sectioning the intercostobrachial nerve. Am J Surg 1990;160;525-8. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=2240388&amp;amp;query_hl=52&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH. Risk factors for chronic pain following breast cancer surgery: a prospective study.&amp;nbsp; Journal of pain 2006: 7; 626-634. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16942948&amp;amp;query_hl=17&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Reuben SS, Makari-Judson G, Lurie SD. Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. Journal of Pain and Symptom Management 2004:27; 133- 139. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15157037&amp;amp;query_hl=17&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Robb KA, Williams JE, Duvivier V, Newham DJ. A pain management programme for chronic cancer-treatment-related pain: a preliminary study. Journal of Pain 2006:7;75-150. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16459273&amp;amp;query_hl=65&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Stevens PE, Dibble SL, Miaskowski C. Prevalence, characteristics and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain 1995: 61: 61-68. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=7644250&amp;amp;query_hl=2&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer.&amp;nbsp; European J of Pain 2002: 6: 17-24. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11888224&amp;amp;query_hl=27&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E.&amp;nbsp; Pain and other symptoms after breast surgery. Ann Oncol 1995: 6; 453-9. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=7669710&amp;amp;query_hl=31&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Vecht CJ. Arm pain in the patient with breast cancer. Journal of Pain and Symptom Management 1990: 5; 109- 117. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=2348086&amp;amp;query_hl=6&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996: 6;195-205. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=8880841&amp;amp;query_hl=31&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wood K.&amp;nbsp; Intercostobrachial nerve entrapment syndrome.&amp;nbsp; South Med J 1978: 71: 662-663. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=663696&amp;amp;query_hl=36&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260508</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260508]]&gt;</url>
    <title>BPS 2007 conference highlight. Dr Paul Farquhar-Smith. Chemotherapy-induced neuropathic pain</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,CHEMOTHERAPY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight. Dr Paul Farquhar-Smith. Chemotherapy-induced neuropathic pain&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Chemotherapy-induced neuropathic pain occurs commonly and is under-recognised and under-treated.&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;It can compromise anti-cancer treatment and adversely affects quality of life and activities of daily living.&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Improvement of assessment and further research into treatment will help patients with this difficult pain.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Attal N, Cruccu G, Haanpaa M et al.&amp;nbsp; EFNS guidelines on pharmacological treatment of neuropathic pain.&amp;nbsp; Eur J Neurol. 2006; 13: 1153-69.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17038030&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Cata JP, Weng HR, Lee BN et al.&amp;nbsp;&amp;nbsp; Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 2006; 72: 151-69 &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16493391&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Cersosimo RJ. Oxaliplatin-associated neuropathy: a review. Ann Pharmacother&amp;nbsp; 2005; 39: 128-35.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15590869&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Eriksson T, Bjorkman S, Hoglund P.&amp;nbsp; Clinical pharmacology of thalidomide.&amp;nbsp; Eur J Clin Pharmacol&amp;nbsp; 2001;&amp;nbsp; 57: 365-76. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11599654&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Flatters SJ, Bennett GJ.&amp;nbsp; Studies of peripheral sensory nerves in paclitaxel-induced painful neuropathy: evidence for mitochondrial dysfunction.&amp;nbsp; Pain 2006; 122: 245-57.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16530964&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Hauscheer FH, Schilsky RL, Bain S et al. Diagnosis, management and evaluation of chemotherapy-induced periperhal neuropathy. Semin Oncol 2006; 33: 15-49:&amp;nbsp; Link to PubMed&amp;nbsp;&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16473643&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Quasthoff S, Hartung HP.&amp;nbsp; Chemotherapy-induced peripheral neuropathy. J Neurol 2002; 249: 9-17.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11954874&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC.&amp;nbsp; Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.&amp;nbsp; E Engl J Med 2005; 352: 2487-98.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15958804&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, Singhal S, Siegel DS, Irwin D, Schuster M, Srkalovic G, Alexanian R, Rajkumar SV, Limentani S, Alsina M, Orlowski RZ, Najarian K, Esseltine D, Anderson KC, Amato AA.&amp;nbsp;Frequency, characteristics and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.&amp;nbsp; J Clin Oncol 2006; 24: 3113-20.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16754936&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Xiao W, Boroujerdi A, Bennett GJ, Luo ZD.&amp;nbsp; Chemotherapy-evoked painful neuropathy: Analgesic effects of gabapentin and effects on expression of the alpha-2-delta type -1 calcium channel subunit.&amp;nbsp; Neuroscience 2007; 144: 714-20.&amp;nbsp; &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17084535&amp;amp;query_hl=88&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&amp;nbsp;abstract&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;Wong GY, Michalak JC, Sloan LA, Loprinzi CL.&amp;nbsp; A phase III double-blinded, placebo-controlled randomised trial of gabapentin in patients with chemotherapy-induced peripheral neuropathy.&amp;nbsp; A North Central Cancer Group Study. J Clin Oncol 2005 23 [729s}, Abstract 8001.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260507</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260507]]&gt;</url>
    <title>BPS 2007 conference highlight: Dr Bill Macrae. Pain in cancer survivors following radiotherapy</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,RADIOTHERAPY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight: Dr Bill Macrae. Pain in cancer survivors following radiotherapy&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Radiotherapy is undoubtedly beneficial in treating patients with breast cancer.&amp;nbsp; However there are both short term and long term side effects.&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Chronic pain is common after treatment for breast cancer: surgery, chemotherapy and radiotherapy can all contribute.&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The effects of radiotherapy can take many years to develop.&amp;nbsp; Modern methods of treatment have reduced the risk of problems significantly.&lt;BR&gt;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, Jung H, Alberti W.&amp;nbsp;Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiotherapy &amp;amp; Oncology 2004; Vol 71: 297-301. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15172145&amp;amp;query_hl=125&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Carpenter JS, Sloan P, Andrykowski MA, McGrath P, Sloan D, Rexford T, Kenady D. Risk factors for pain after mastectomy/lumpectomy. Cancer Pract, 7 (1999) 66-70. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10352063&amp;amp;query_hl=129&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy &amp;amp; of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomised trials. Lancet 2005: 366: 2087-2106. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16360786&amp;amp;query_hl=119&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Johansson S, Svensson H, Larsson LG, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients. Acta Oncologica 2000; Vol 39, 3: 373-82. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10987234&amp;amp;query_hl=125&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain, 7 (2006) 626-34. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16942948&amp;amp;query_hl=17&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Smith WCS, Bourne D, Squair J, Phillips DO, Chambers WA. A retrospective cohort study of post mastectomy pain syndrome. Pain, 83 (1999) 91-95. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10506676&amp;amp;query_hl=119&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tasmuth T, von Smitten K, Hietanen P, Kataja M, Kalso E. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol, 6 (1995) 453-9. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=7669710&amp;amp;query_hl=119&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso, E. Treatment-related factors predisposing to chronic pain in patients with breast cancer - a multivariate approach. Acta Oncol, 36 (1997) 625-30. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9408154&amp;amp;query_hl=111&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tasmuth T, Blomqvist C, Kalso E, Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units, Eur J Surg Oncol, 25 (1999) 38-43. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10188853&amp;amp;query_hl=116&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260464</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260464]]&gt;</url>
    <title>BPS 2007 conference highlight: Professor Henry McQuay. What have systematic reviews told us about managing pain?</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight: Professor Henry McQuay. What have systematic reviews told us about managing pain?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Systematic reviews can provide more or less robust information about the performance, the efficacy and the safety, of our pain interventions. They can only do that for efficacy when proper trials of adequate size, quality and validity have been done. To the extent that our management of pain is guided by evidence, then yes, systematic reviews do tell us things about managing pain. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The guidance they give us, however, is a bit like public health advice - it is about ‘average’ efficacy and safety. The individual clinician and patient have to determine whether or not the patient is a responder to the intervention. The systematic reviews may guide the prescriber to the ‘best’ intervention faster than would have happened before we had such reviews, but the reviews and their products are tools not rules, a help to the clinician rather than mandating treatment. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The lecture covered the strengths and weaknesses of the systematic review approach, including the creation of treatment algorithms from the products of the reviews, and a little bit more about defining and identifying responders.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;Source:&lt;/STRONG&gt; See page 17&amp;nbsp;of the British Pain Society's 2007 Annual Scientific Meeting registration programme - available to download as a pdf &lt;/EM&gt;&lt;A href="http://www.britishpainsociety.org/asm07_rp.pdf" target="_blank"&gt;&lt;EM&gt;here&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Derry CJ, Derry S, McQuay HJ, Moore RA. Systematic review of systematic reviews of acupuncture published 1996-2005. Clin Med 2006 Jul-Aug;6(4):381-6. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16956145&amp;amp;query_hl=98&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004 Dec;112(3):372-80.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15561393&amp;amp;query_hl=106&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;McQuay H, Moore A. Utility of clinical trial results for clinical practice. Eur J Pain 2007 Feb;11(2):123-4.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17067835&amp;amp;query_hl=106&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;/P&gt;
&lt;P&gt;Moore A, McQuay H.&amp;nbsp; Bandolier’s little book of making sense of the medical evidence.&amp;nbsp; Oxford: Oxford University Press. 2006. ISBN: 0198566042.&lt;/P&gt;
&lt;P&gt;McQuay HJ, Moore RA. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7(5):R1046-51.&amp;nbsp;&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16207320&amp;amp;query_hl=106&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005 Jul 20;(3):CD001133.&amp;nbsp;&lt;A href="nelh:236851:0" name=internalLink&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260255</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260255]]&gt;</url>
    <title>BPS 2007 conference highlight: Professor Jürgen Sandkühler. The cellular mechanisms of pain memory</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight: Professor Jürgen Sandkühler. The cellular mechanisms of pain memory&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;Neuropathic and inflammatory pain may be amplified by spinal mechanisms which are triggered by impulses in nociceptive nerve fibres. A potential cellular model for afferent-induced hyperalgesia is the longterm potentiation of synaptic strength (LTP) between primary afferent C-fibres and these lamina I neurons. However, inflammation induces low level activity in primary afferents which typically induces long-lasting depressions rather than LTP. We have now identified a novel form of synaptic LTP at synapses between C-fibres and a group of spinal lamina I neurons. This form of LTP is induced by formalin or capsaicin-injections into a hind-paw or 2 Hz electrical stimulation of the sciatic nerve at C-fibre intensity. Pharmacological profile and signal-transduction pathways of this form of synaptic plasticity and inflammatory pain largely overlap, rendering a LTP a potential synaptic mechanism of pain amplification.&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;EM&gt;&lt;STRONG&gt;Source:&lt;/STRONG&gt; See page 10 of the&amp;nbsp;British Pain Society's 2007 Annual Scientific Meeting registration programme - available to download as a &lt;EM&gt;pdf &lt;/EM&gt;&lt;/EM&gt;&lt;A href="http://www.britishpainsociety.org/asm07_rp.pdf" target="_blank"&gt;&lt;EM&gt;here&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;.&lt;/EM&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;References&lt;/H2&gt;
&lt;P&gt;Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J. Science. 2003 Feb 21;299(5610):1237-40. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12595694&amp;amp;query_hl=2&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Ikeda H, Stark J, Fischer H, Wagner M, Drdla R, Jager T, Sandkuhler J. Science. 2006 Jun 16;312(5780):1659-62. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16778058&amp;amp;query_hl=2&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Corelease of two fast neurotransmitters at a central synapse. Jonas P, Bischofberger J, Sandkuhler J. Science. 1998 Jul 17;281(5375):419-24. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9665886&amp;amp;query_hl=1&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed Abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Nichols ML, Allen BJ, Rogers SD, Ghilardi JR, Honore P, Luger NM, Finke MP, Li J, Lappi DA, Simone DA, Mantyh PW. Science. 1999 Nov 19;286(5444):1558-61. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10567262&amp;amp;query_hl=3&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed Abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260354</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260354]]&gt;</url>
    <title>BPS 2007 conference highlight: Professor Mike Salter. Microglia and pain</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;BPS 2007 conference highlight: Professor Mike Salter. Microglia and pain&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Glial cells were historically considered to serve primarily housekeeping roles in the nervous system. However, this view has changed radically in the last half decade, in particular for the role of microglia in pain resulting from peripheral nerve injury. In the healthy central nervous system microglia are not dormant, as once thought, but act as sentries that react rapidly to various stimuli that threaten physiological homeostasis. A growing body of evidence indicates that microglia in the dorsal horn of the spinal cord play a causal role in neuropathic pain behaviours resulting from peripheral nerve injury and specific neuron-microglia-neuron signalling has been discovered. Thus, suppressing this signalling may represent the basis for new forms of therapy for chronic pain following nerve injury.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;Source:&lt;/STRONG&gt; See page 11&amp;nbsp;of the British Pain Society's 2007 Annual Scientific Meeting registration programme - available to download as a pdf &lt;/EM&gt;&lt;A href="http://www.britishpainsociety.org/asm07_rp.pdf" target="_blank"&gt;&lt;EM&gt;here&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;.&lt;/EM&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A et al.&amp;nbsp; P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.&amp;nbsp; Nature 2003; 424: 778-783. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12917686&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Ikeda H, Tsuda M, Inoue K, Murase K.&amp;nbsp; Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn.&amp;nbsp; Eur K Neuroscience 2007; 25: 1297-1306. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17425556&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Coull JAM, Beggs S, Boudreau D, Boivin D et al.&amp;nbsp; BDNF from microglia causes the shift in neuronal anion gradient underlying Neuropathic pain.&amp;nbsp; Nature 2005; 438: 1017-1021. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16355225&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in ‘small glia’.&amp;nbsp; Trends in Neuroscience 2005; 28: 101-107. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15667933&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260509</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260509]]&gt;</url>
    <title>British Pain Society Cancer Pain Committee</title>
    <publicationDate></publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,POLICY,PAIN MANAGEMENT,UNITED KINGDOM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;British Pain Society Cancer Pain Committee&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN style="FONT-FAMILY: Arial"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt; 
&lt;H2&gt;Dr Jon Raphael (chair)&lt;BR&gt;Dr Joan Hester (BPS)&lt;BR&gt;Prof Sam Ahmedzai (APM)&lt;BR&gt;Dr Martin Johnson (RCGP)&lt;BR&gt;Ms Janette Barrie ( Nursing)&lt;BR&gt;Dr John Williams (Pain Management)&lt;BR&gt;Prof Marie Fallon (Palliative Medicine)&lt;BR&gt;Dr Paul Farqhuar-Smith (Pain Management)&lt;BR&gt;Dr Rebecca Haines (Psychology)&lt;BR&gt;Ms Heather Wallace (Patient representative)&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Assistance from:&lt;BR&gt;Mr Brian Simpson (Neurosurgery)&lt;BR&gt;Dr Peter Hoskins ( Bone oncology)&lt;BR&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;There are several documents/guidelines on cancer pain management; however, these do not help address the place of specialist pain services adequately. It is known that collaboration between palliative care and pain specialist clinics is limited and as a result access to such specialist services is poor. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This led to a plan to prepare a document on behalf of the British Pain Society (BPS) in consultation with the Association of Palliative Medicine (APM) and the Royal College of General Practitioners (RCGP). The document has the aim of producing guidelines on the place of such specialist pain services to aid clinicians in palliative care, pain management, oncology and general practice. It also aims to promote better collaboration between palliative and pain specialists in the treatment of cancer pain to raise standards of practice. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;So as not to reproduce previous guidelines, this document aims specifically to outline areas of practice where pain specialists could be useful in treating patients with cancer pain. Examples of this would include interventions in cancer pain syndromes, acute postoperative pain management in cancer patients, breakthrough&amp;nbsp; pain, non-cancer pain management in patients with cancer and pain management in those dependent on opioids to name a few.&amp;nbsp; The document will also comment upon education and provision of pain specialist services for cancer pain management.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93798</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.whocancerpain.wisc.edu/contents.html]]&gt;</url>
    <title>Cancer Pain Release</title>
    <publicationDate></publicationDate>
    <publisher>World Health Organisation</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,BONE PAIN,NEUROPATHIC PAIN,VISCERAL PAIN,MEDICINES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;"Cancer Pain Release is the publication of the World Health Organization global communications program to improve cancer pain control and palliative and supportive care. Cancer Pain Release is dedicated to keeping a worldwide and multidisciplinary audience in the health professions and government abreast of relevant information and developments in clinical medicine, education and policy."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>271030</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271030]]&gt;</url>
    <title>Chronic heart failure - systematic reviews in 2007</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CARDIOVASCULAR DISEASES,SYMPTOM MANAGEMENT,SERVICE PROVISION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Chronic heart failure - systematic reviews in 2007&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Over the last year some key systematic reviews have been published in the field of supportive care in chronic heart failure.&amp;nbsp; In this evidence update we have included the major systematic reviews, especially those with a meta-analysis covering a range of topics. These have included several reviews from the Cochrane Library. There were several Cochrane Reviews on anthracyclines and how to minimise their effect on cardiac function, thereby decreasing the risk of causing CCF. A key conclusion from this is to give the infusion over at least 6 hours to decrease the peak plasma anthracycline concentration.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There are also several systematic reviews looking at the pharmacological management of heart failure. These confirmed that in heart failure angiotensin-converting enzyme inhibitors are beneficial and that beta-blockers decrease the risk of developing atrial fibrillation. A systematic review of antidiabetic agents in patients with diabetes and heart failure showed metformin to be the safest and most beneficial drug.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A Cochrane Review confirmed that oral anticoagulation decreased mortality in certain groups of patients with heart failure (e.g. atrial fibrillation), but we need to await the results of further studies to see if this is generalisable to heart failure patients who are in sinus rhythm. Another suggests that digitalis is beneficial in patients who have chronic heart failure without atrial fibrillation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The benefits of cardiac resynchronization therapy and left ventricular assist devices have also been systematically reviewed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Other systematic reviews have compared the relationship between diseases, such that worsening renal function leads to a worse prognosis from heart failure, and that heart failure has a negative effect on cognitive function as well as causing an increased risk of strokes.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The full list of 25 reviews is below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;List of reviews&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[Note: Mainly systematic reviews, but the list also includes a few good quality non-systematic reviews]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Amsallem E.&amp;nbsp; Kasparian C.&amp;nbsp; Haddour G.&amp;nbsp; Boissel JP.&amp;nbsp; Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database of Systematic Reviews. 2007; (3): (CD002230).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Barlow J.&amp;nbsp; Singh D.&amp;nbsp; Bayer S.&amp;nbsp; Curry R. A systematic review of the benefits of home telecare for frail elderly people and those with long-term conditions. Journal of Telemedicine and Telecare 2007;13(4):172-9. Abstract&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Chaudhry SI.&amp;nbsp; Phillips CO.&amp;nbsp; Stewart SS.&amp;nbsp; Riegel B.&amp;nbsp; Mattera JA.&amp;nbsp; Jerant AF.&amp;nbsp; Krumholz HM. Telemonitoring for patients with chronic heart failure: a systematic review. Journal of Cardiac Failure.&amp;nbsp; 13(1):56-62, 2007 Feb. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Clark RA.&amp;nbsp; Inglis SC.&amp;nbsp; McAlister FA.&amp;nbsp; Cleland JG.&amp;nbsp; Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis.[see comment]. Comment in: BMJ. 2007 May 5;334(7600):910-1; PMID: 17478790. BMJ.&amp;nbsp; 334(7600):942, 2007 May 5.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Clegg AJ.&amp;nbsp; Scott DA.&amp;nbsp; Loveman E.&amp;nbsp; Colquitt J.&amp;nbsp; Royle P.&amp;nbsp; Bryant J. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation. International Journal of Technology Assessment in Health Care.&amp;nbsp; 23(2):261-8, 2007. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Clerico A.&amp;nbsp; Fontana M.&amp;nbsp; Zyw L.&amp;nbsp; Passino C.&amp;nbsp; Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clinical Chemistry.&amp;nbsp; 53(5):813-22, 2007 May.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Damman K.&amp;nbsp; Navis G.&amp;nbsp; Voors AA.&amp;nbsp; Asselbergs FW.&amp;nbsp; Smilde TD.&amp;nbsp; Cleland JG.&amp;nbsp; van Veldhuisen DJ.&amp;nbsp; Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. Journal of Cardiac Failure.&amp;nbsp; 13(8):599-608, 2007 Oct. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dobre D.&amp;nbsp; van Jaarsveld CH.&amp;nbsp; deJongste MJ.&amp;nbsp; Haaijer Ruskamp FM.&amp;nbsp; Ranchor AV. The effect of beta-blocker therapy on quality of life in heart failure patients: a systematic review and meta-analysis. Pharmacoepidemiology &amp;amp; Drug Safety.&amp;nbsp; 16(2):152-9, 2007 Feb. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dorman S.&amp;nbsp; Byrne A.&amp;nbsp; Edwards A.&amp;nbsp;Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.&amp;nbsp;Palliative Medicine.&amp;nbsp; 21(3):177-91, 2007 Apr.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Eurich DT.&amp;nbsp; McAlister FA.&amp;nbsp; Blackburn DF.&amp;nbsp; Majumdar SR.&amp;nbsp; Tsuyuki RT.&amp;nbsp; Varney J.&amp;nbsp; Johnson JA. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ.&amp;nbsp; 335(7618):497, 2007 Sep 8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Garcia-Lizana F.&amp;nbsp; Sarria-Santamera A.&amp;nbsp; New technologies for chronic disease management and control: a systematic review.&amp;nbsp;Journal of Telemedicine &amp;amp; Telecare.&amp;nbsp; 13(2):62-8, 2007. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Hood WB.&amp;nbsp; Dans AL.&amp;nbsp; Guyatt GH.&amp;nbsp; Jaeschke R.&amp;nbsp; McMurray JJV. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews. 2007; (3): (CD002901).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Katon W.&amp;nbsp; Lin EH.&amp;nbsp; Kroenke K.&amp;nbsp;The association of depression and anxiety with medical symptom burden in patients with chronic medical illness.&amp;nbsp;General Hospital Psychiatry.&amp;nbsp; 29(2):147-55, 2007 Mar-Apr. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lago RM.&amp;nbsp; Singh PP.&amp;nbsp; Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.[see comment].&amp;nbsp; Comments&amp;nbsp; Comment in: Lancet. 2007 Sep 29;370(9593):1101; PMID: 17905143, Comment in: Lancet. 2007 Sep 29;370(9593):1103-4; PMID: 17905146 Lancet.&amp;nbsp; 370(9593):1129-36, 2007 Sep 29.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lip GYH.&amp;nbsp; Chung I. Anticoagulation for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews. 2007; (3): (CD003336).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;McAlister FA.&amp;nbsp; Ezekowitz J.&amp;nbsp; Hooton N.&amp;nbsp; Vandermeer B.&amp;nbsp; Spooner C.&amp;nbsp; Dryden DM.&amp;nbsp; Page RL.&amp;nbsp; Hlatky MA.&amp;nbsp; Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA.&amp;nbsp; 297(22):2502-14, 2007 Jun 13.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Nasr IA.&amp;nbsp; Bouzamondo A.&amp;nbsp; Hulot JS.&amp;nbsp; Dubourg O.&amp;nbsp; Le Heuzey JY.&amp;nbsp; Lechat P. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. European Heart Journal.&amp;nbsp; 28(4):457-62, 2007 Feb.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Saha SA.&amp;nbsp; Molnar J.&amp;nbsp; Arora RR. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials. Journal of Cardiovascular Pharmacology &amp;amp; Therapeutics.&amp;nbsp; 12(3):192-204, 2007 Sep. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Salpeter S.&amp;nbsp; Ormiston T.&amp;nbsp; Salpeter E.&amp;nbsp;Cardioselective beta-blockers for chronic obstructive pulmonary disease.&amp;nbsp;Cochrane Database of Systematic Reviews. 2007; (3): (CD003566).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Singh S.&amp;nbsp; Loke YK.&amp;nbsp; Furberg CD.&amp;nbsp;Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.[see comment]. Comment in: JAMA. 2007 Sep 12;298(10):1216-8;&amp;nbsp; JAMA.&amp;nbsp; 298(10):1189-95, 2007 Sep 12.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;van Dalen EC.&amp;nbsp; Caron HN.&amp;nbsp; Dickinson HO.&amp;nbsp; Kremer LCM. Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database of Systematic Reviews. 2007; (3): (CD003917).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;van Dalen EC.&amp;nbsp; Michiels EMC.&amp;nbsp; Caron HN.&amp;nbsp; Kremer LCM. Different anthracycline derivates for reducing cardiotoxicity in cancer patients. Cochrane Database of Systematic Reviews. 2007; (3): (CD005006) &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;van Dalen EC.&amp;nbsp; van der Pal HJH.&amp;nbsp; Caron HN.&amp;nbsp; Kremer LCM. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database of Systematic Reviews. 2007; (3): (CD005008).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Vogels RL.&amp;nbsp; Scheltens P.&amp;nbsp; Schroeder-Tanka JM.&amp;nbsp; Weinstein HC. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail.&amp;nbsp; 9(5):440-9, 2007 May.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Witt BJ.&amp;nbsp; Gami AS.&amp;nbsp; Ballman KV.&amp;nbsp; Brown RD Jr.&amp;nbsp; Meverden RA.&amp;nbsp; Jacobsen SJ.&amp;nbsp; Roger VL. The incidence of ischemic stroke in chronic heart failure: a meta-analysis. Journal of Cardiac Failure.&amp;nbsp; 13(6):489-96, 2007 Aug. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=NKW2" target="_blank"&gt;Back to the National Knowledge Week contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>102128</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.helpthehospices.org.uk/clip/]]&gt;</url>
    <title>CLIP: Current learning in palliative care - 15 minute tutorials</title>
    <publicationDate></publicationDate>
    <publisher>Help the Hospices</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,RESEARCH,ETHICS &amp; LAW,HUMANITIES,PAIN MANAGEMENT,BONE PAIN,NEUROPATHIC PAIN,VISCERAL PAIN,ALZHEIMER’S DISEASE,LYMPHOEDEMA,DISABILITY,MEDICINES,PROFESSIONS,GASTRO-INTESTINAL,NUTRITION,FATIGUE &amp; ASTHENIA,ANAEMIA,DYSPNOEA,GENITO-URINARY,MOUTH CARE AND DYSPHAGIA,ENDOCRINE &amp; METABOLIC,PSYCHIATRIC,DISEASE MODIFYING MANAGEMENT,COMPLEMENTARY &amp; ALTERNATIVE THERAPIES,SOCIAL &amp; PSYCHOSOCIAL ISSUES,WEIGHT LOSS,FUNERALS,BREAKING DIFFICULT NEWS,WILLS,DEATH RITES &amp; RITUALS,BEREAVEMENT,PLACE OF DEATH,NARRATIVES,COMMUNICATION ISSUES,POST-DEATH,NAUSEA &amp; VOMITING,HAEMATOLOGIC AND LYMPHATIC DISEASES,EDUCATIONALISTS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=main&gt;"The CLIP worksheets grew from the idea of a "coffee update".&amp;nbsp; The principle was to develop a flexible learning material that could be used over a coffee break, but could also be used in a variety of settings.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=main&gt;All the CLIP worksheets have been adapted as online tutorials, with permission, by Help the Hospices from &lt;A href="http://www.radcliffe-oxford.com/books/bookdetail.asp?ISBN=1+85775+964+8" target="_blank"&gt;Helping the Patient with Advanced Disease: a Workbook&lt;/A&gt;, Regnard C, ed. Radcliffe Medical Press 2004."&lt;/SPAN&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>89135</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.jr2.ox.ac.uk/bandolier/booth/Palliative/CATeol.html]]&gt;</url>
    <title>Complementary therapy at the end of life</title>
    <publicationDate></publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,SERVICE PROVISION,PAIN MANAGEMENT,PROFESSIONS,DYSPNOEA,COMPLEMENTARY &amp; ALTERNATIVE THERAPIES,COMPLEMENTARY &amp; ALTERNATIVE THERAPISTS,NAUSEA &amp; VOMITING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H2&gt;Concludes that 'clinical bottom line' is that there is no solid evidence that complementary and alternative therapies have any value for treating pain, dyspnoea or nausea and vomiting at the end of life.There is no solid evidence that complementary and alternative therapies have any value for treating pain, dyspnoea or nausea and vomiting at the end of life.&lt;/H2&gt;]]&gt;</body>
  </document>
  <document>
    <id>284023</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=284023]]&gt;</url>
    <title>Conference highlights: British Pain Society, Annual Scientific Meeting, Liverpool 2008</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Pallliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Conference highlights: British Pain Society, Annual Scientific Meeting, Liverpool 2008&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Professor Anthony Dickenson. Plenary session. &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Top-down processing of pain - pain, the brain and spinal gains&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Pain arises from peripheral and central processes. There is clear evidence from both preclinical and clinical studies that both peripheral and central hyper excitability play important roles in determining the level of pain perceived. Rightly, much emphasis has been put on spinal cord mechanisms in central excitability such as wind-up and long-term potentiation but it is also clear that spinal excitability can be regulated by descending pathways from the brain.&lt;/P&gt;
&lt;P&gt;These originate from predominantly monoamine systems which are additionally implicated in control of emotions, fear, anxiety, thermo-regulation and the sleep cycle and so may mediate these pain induced co-lmorbidities and provide a neuronal link between affective statesand the level of pain. Furthermore, they are likely targets for antidepressants used in pain states.&lt;/P&gt;
&lt;P&gt;Much of the early work in this area concentrated on descending inhibitions, now known to be predominanty noradrenergic , and failure of descending inhibitions has been reported in patients. However, pain could equally be increased by enhanced descending facilitations and data is accumulating in animal models of neuropathy and bone cancer on exactly this. Spinal neurones project through the parabrachial/cuneiform area, an area activated in humans in hyperalgesic states, to the amyglada and hypothalamus where they engage systems related to the affective, autonomic and aversive aspects of pain. The pathways relay on 5HT positive and other neurones in the brainstem rostroventromedial medulla (RVM).&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The final arm is descending serotoninergic facilitory pathway returning back to the spinal cord and then terminating on excitatory 5HT3 receptors in the spinal cord. Interestingly, these 5HT facilitations are not required for either wind-up or long-term potantiation, reinforcing the idea that these are intrinsic spinal events but act alongside them. Interestingly this receptor is the only ion channel out of the &amp;gt;20 receptors for these monoamines.&lt;/P&gt;
&lt;P&gt;Finally, bsed on the changes in these controls after nerve injury and the ability of gabapentin and pregabalin to modulate neuropthic pain, we have shown that the RVM and this 5HT3 mediated descending pathway plays a major role in the state-dpendent actions of this class of drug.&lt;/P&gt;
&lt;P&gt;These excitatory influences are likely to contribute to the development and maintenance of altered excitability in the spinal cord, and furthermore, form a link between emotional states and levels of pain and when dysfunctional, could contribute to many pains including those where there are mood and sleep disturbances such as fibromyalgia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Professor Jeffrey S. Mogil&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;Plenary session. Nature and nurture of chronic pain&lt;/STRONG&gt;&lt;BR&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;Painnoted&amp;nbsp;is asscoaiated with interindividual variability, including in the propensity to develop chronically painful pathologies after injury or infection.Genetic linkage mapping efforts in mice and targeted genetic association studies in humans are beginning to identify thosde genes underlying much of the variability in these traits. In our laboratory, we have recently uncovered a number of genes associated with thermal and inflammatory nociception.&amp;nbsp;These efforts may lead to novel clinical treatments for pain and/or facilitate the patient-centered, individualized treatment of pain using current pharmaceuticals. In addition, we are now paying greater attention to the identification of environmental factors that affect pain behaviour in the mouse. We have very recently observed modulation of pain in the mouse by purely social factors. These data can be interpreted as providing evidence for the existence of empathy for pain in this sub primate species.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Professor Ralf Baron&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Plenary session. Neuropathic Pain&lt;BR&gt;&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Neuropathic pain syndromes, i.e., pain afte a lesion or disease of the peripheral or central nervous system, are clinically characterized by spontaneous pain (ongoing, paroxyms) and evoked pains (hyperalgesia, allodynia). A variety of distinct pathophysiological mechanisms in the peripheral and central nervous system operate in concert: In some patients the nerve lesion triggers molecular changes in nociceptive neurons that become abnormally sensitive and develop pathological spontaneous activity (up-regulation of sodium channels and receptors, e.g., vanilloid TRPV1-, menthol-sensitive TRPM8- or a-receptors. These phenomena may lead to spontaneous pain, shooting pain sensations as well as heat hyperalgesia, cold hyperalgesia and sympathetically maintained pain. Spontaneous activity in damaged non-nociceptive A-fibers may lead to paresthesias. All these changes may also occur in uninjured neurons driven by substances released by adjacent dying cells. The hyperactivity in nociceptors in turn induces secondary changes (hyperexcitability) in processing neurons in the spinal cord and brain. This central sensitization causes input from mechanoreceptive A-fibers to be preceived as pain (mechanical allodynia). Neuroplastic changes in the central descending pain modulating systems (inhibitory or facilitatory)&amp;nbsp;may lead to further hyperexcitability. Other patients have severe spontaneous pain in combination with profound sensory loss but no hyperalgesia or allodynia. The pain is due to spontaneous activity in deafferented central neurons. The medical management of neuropathic pain consists of five main classes of oral medication (antidepressants, (reuptake blockers), anticonvulsants, with Na-blocking action, anticonvulsants with Ca-modulating actions, tramadol and opioids)&amp;nbsp;and several categories of topical medications for patients with cutaneous allodynia and hyperalgesia (capsaicin and local anaesthetics). In many cases an early combination of compunds effecting different mechanisms is useful. At present existing trials only provide general pain relief values for specific aetiologies, which in part may explain the failure to obtain complete pain relief in neuropathic pain conditions. In general, the treatment of neuropathic pain is still unsatisfactory. Therefore, a new hypothetical concept was proposed in which pain is analyzed on the basis of underlying mechanisms. The increased knowledge of pain-generating mechanisms and their translation into symptoms and signs may in the future allow a dissection of the mechanisms that operate in each pateint. If a systematic clinical examination of the neuropathic pain patient and a precise phenotypic characterization is combined with a selection of drugs acting at those particular mechanisms, it should ultimately be possible to design optimal treatments for the individual patient.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Katie Urch,&amp;nbsp;&amp;nbsp;Sam H Ahmedzai, W. &lt;STRONG&gt;Paul Farquhar-Smith&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Workshop: Treating cancer pain - time for a new direction?&lt;/EM&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;22 years of the WHO analgesic ladder: reaching maturity or senility. &lt;EM&gt;Prof Sam H Ahmedzai&lt;/EM&gt;&lt;/LI&gt;
&lt;LI&gt;Developments in the science of cancer pain.&lt;EM&gt; Dr Katie Urch&lt;/EM&gt;&lt;/LI&gt;
&lt;LI&gt;Management of the WHO ladder 'failures' - interventional treatment of cancer pain&lt;EM&gt;. Dr W. Paul Farquhar-Smith&lt;/EM&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>284024</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=284024]]&gt;</url>
    <title>Conference highlights: Palliative Care Congress, Glasgow, 2008</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Pallliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Conference highlights: Palliative Care Congress, Glasgow, 2008&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;See the full programme &lt;A href="http://www.pccongress.org.uk/programme.php" target="_blank"&gt;here&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Tuesday 29th April&lt;/STRONG&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;&lt;STRONG&gt;Time: 1115. Concurrent Symposium. Pain&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;John Welsh - Breakthrough pain - time for a rethink? &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;John Currie - Pain control&lt;/STRONG&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Most pain related to cancer can usually&amp;nbsp;be well&amp;nbsp;controlled with opiates as the final stage of the analgesic ladder. The palliative team really comes into its own when these standard techniques fail and “the drugs don’t work.” The pain may be mediated by different pathways particularly if the pain becomes neuropathic. The main pathway in this process is the N-methyl D-aspartate (NMDA) system. Specific agents are now available to control this type of pain. These drugs are usually combined with the opiate and the doses can be adjusted for optimal pain control and minimum side effects. Some pains require more invasive techniques and this can be co-ordinated by the palliative team. In this way, pain control can be tailored to each particular patient. Regular assessment by the team will also allow forward planning to keep ahead of any exacerbations of pain as the disease progresses. &lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 1630. Concurrent Abstracts. Free Papers 5 - Pain&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Dying without pain: evaluating the impact of nurses prescribing morphine in Uganda - Barbara Jack &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Pain and pain management in older people with cancer - Mike Bennett &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Israel seven years of opioid consumption trends for chronic pain treatment (2000-2006) - Pesach Shvartzman&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;&lt;STRONG&gt;Wed 30th April&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 0800. Masterclass. Opioids for pain control – exploring the molecular basis of their powers&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Elaine Cachia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;George Stefano&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;This Masterclass session will enable one of the leading researchers globally in the molecular biology of opioids, George Stefano, to share his deep insights into the world of opioids and their cellular actions. The session will start with a clinical case presentation by Elaine Cachia, specialist registrar in palliative medicine. She will introduce a case of a lady with sickle cell disease whose recurrent admissions for acute painful crisis led to escalating doses of morphine, fentanyl and other analgesic drugs. As she was spending more and more time in hospital, it emerged that fewer and fewer of her pains could be explained by sickle cell crises. Rather, there was evidence of opioid tolerance, opioid-induced hyperalgesia and spontaneous pain. The situation was brought under control by a regime of ketamine and methadone. Prof Stefano will discuss the actions of opioids from the perspective of his world-class laboratory studies which have clarified their powerful beneficial actions as well as their major adverse effects. Understanding the role of opioids in pain signalling as well as their multiple other biological effects in the body can help us to appreciate the role they should play, alongside other pain targeting mechanisms, in modern pain management. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 0850. Concurrent Workshop. Pain in Children - what is the difference?&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Richard Hain&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The session is an overview of how children in pain differ from adults. It is intended for an audience more used to dealing with adults but who find themselves sometimes having to advise on or to care for children. It will cover physiology, diagnosis, assessment and management of pain in children, briefly outlining some of the myths surrounding the subject and some of the techniques that have now developed in the evolving specialty of paediatric palliative medicine.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 1020. Plenary. Lab to Bedside II. Opioids - ancient mechanisms and modern implications for symptom management&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;George Stefano&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;An evidence-based model of cellular morphine expression and function, including novel µ3 opiate receptor subtype coupling to nitric oxide (NO) production, demonstrates the presence of morphinergic signaling in animal cells. Similar morphinergic processes are found in human and invertebrate tissues, demonstrating conservation during evolution. Furthermore, the µ3 opiate receptor/ NO coupled regulatory pathway exists and is functionally competent in human multi-lineage progenitor cells (MLPC) prepared from umbilical cord blood. Real-time PCR analysis of extracted RNA from undifferentiated human MLPC indicated selective expression of a µ3-like opiate receptor-encoding RNA, in the absence of traditional µ1 material. Complementary microarray analysis of extracted RNA indicated that traditional mu, delta, and kappa opioid receptor gene expression is not detected in both undifferentiated and differentiated MPLC. The data provide compelling evidence in support of both the evolutionary primacy and primordial regulatory role of morphine/µ3 opiate receptor/NO in embryogenesis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Jason Boland&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This paper addresses the clinical features and research on opioid-induced bowel dysfunction (OBD), starting with the epidemiology and symptoms. The current clinical evidence for the inherent constipating effects of different opioids using data from clinical trials show that of all the currently available drugs, fentanyl is associated with the least constipation and also nausea. The poor evidence base for oral laxatives and rectal preparations reveals that these are at best palliative, ie they may increase bowel movements but do not treat the underlying physiological changes. There is now emerging evidence on the latest approach, namely the use of peripherally acting opioid antagonists which attempt to reverse the pathophysiology caused by therapeutic opioids. While early attempts with oral normal release naloxone gave mixed results, modified release naloxone and the new generation of peripherally acting mu-opioid antagonists including alvimopan and methylnaltrexone shows greater promise.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 1750. Symposium. Cancer pain management – update for 2008&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Jon Raphael&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Sam Ahmedzai&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Cancer pain management has made significant strides in the past 20 years since the introduction of the WHO analgesic approach, based on the 3-step ladder. However, cancer pain is still very prevalent and some surveys have shown a worsening, not improving situation even in the UK. Clearly guidelines have to reviewed in the light of advancing science and improvements in treatments available. The British Pain Society has started a review of cancer pain management in conjunction with the Association for Palliative Medicine. The aim is to produce a joint document with a fresh look at this age-old problem. It will include state of the art reviews on pain assessment, cancer pain mechanisms, the role of cancer-directed treatments and palliative treatments and the multidisciplinary approach to treating cancer pain at all stages of the disease. In this session, Jon Raphael who chairs the BPS working group producing the document and Sam Ahmedzai who leads from the APM side, will present the current work. We hope to engage congress participants in discussion about the document and how it could be incorporated into everyday pain and palliative care practice. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Thursday 1st May&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Time: 1130. Concurrent Symposium. Advances in anti-cancer treatment: taking the rough with the smooth&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Noelle O’Rourke&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abstract&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Advances in anti-cancer therapy: taking the rough with the smooth&lt;BR&gt;The past decade has seen incremental improvements in cancer survival across a range of tumour types.&amp;nbsp; More than half of all cancer patients can now achieve long term cure of their disease and the plethora of new treatment options in development promises further improvements.&amp;nbsp; This presentation is in two parts.&lt;/P&gt;
&lt;P&gt;The first section will give a brief overview of major advances in anti-cancer therapy.&amp;nbsp; This includes the evolving technology in radiation treatment enabling image-guided radiotherapy (IGRT), intensity modulated treatment (IMRT), new techniques in brachytherapy (short range radiation) and the wider use of 3D stereotactic techniques.&amp;nbsp; Research in radiobiology and cancer biology has led to innovative scheduling of radiation and chemotherapy with increasing use of concurrent chemoradiation for a number of tumours. Advances in imaging with wider access to PET scanners have improved initial staging and later assessment of tumours on treatment.&amp;nbsp; Interventional radiology offers options for stenting and for radiofrequency ablation of tumours, which can both contribute to improved cancer control even in late stage disease.&amp;nbsp; Novel compounds in development in oncology focus on three major areas: angiogenesis inhibitors, signal transduction inhibitors and cell cycle kinase inhibitors.&amp;nbsp; In all the emphasis is increasingly on targeted therapy with favourable toxicity profiles, often orally available and individualized on the basis of a specific patient’s tumour biology.&lt;/P&gt;
&lt;P&gt;The second section of this presentation is a personal reflection on the objectives of cancer treatment.&amp;nbsp; It will focus on how we measure treatment outcome and how we weigh up the factors of efficacy and toxicity.&amp;nbsp; It will examine the need to individualize therapy based on patient preference and how this can be achieved.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;See the full programme &lt;A href="http://www.pccongress.org.uk/programme.php" target="_blank"&gt;here&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>271039</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271039]]&gt;</url>
    <title>COPD - systematic reviews in 2006-07</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ RESPIRATORY,STAFF USE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RESPIRATORY DISEASES,SYMPTOM MANAGEMENT,SERVICE PROVISION,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;COPD - systematic reviews in 2006-07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;FONT size=2&gt;
&lt;P&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;Over the last 12 months there has been several important systematic reviews published relating to supportive and palliative care in chronic respiratory disease. The scale of the problem is emphasised by a recent systematic review with a meta-analysis showing the global prevalence of COPD to be 7.6% (this percentage was even higher when diagnosis is based on spirometry).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In a review of scales to measure breathlessness the Numeric Rating Scale, Chronic Respiratory Questionnaire dyspnoea subscale, Cancer Dyspnoea Scale and modified Borg seemed most suitable for use in palliative care, although further studies are needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There were several reviews on the management of chronic respiratory disease, including evidence that pulmonary rehabilitation is beneficial for patients with chronic lung diseases. A Cochrane database review showed the benefit (including reduced mortality) of using antibiotics in patients having COPD exacerbations with purulent sputum. There was a Cochrane review of Cochrane systematic reviews assessing the role of systemic corticosteroids in COPD, assessing the risk/benefit ratio in different situations, it concluded that in acute exacerbations, systemic corticosteroids are beneficial, but the optimum dose, route and duration need further studies. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For inhaled corticosteroids the benefit outweighed the risk in the treatment of patients with moderate to severe COPD. Anticholinergics, such as Tiotropium, reduced COPD exacerbations and improved quality of life and symptoms. A review of Heliox in COPD patients receiving non-invasive ventilation showed no change in arterial carbon dioxide or respiratory rate. A systematic review with meta-analysis evaluating the long-term effect of beta&lt;SUB&gt;2&lt;/SUB&gt;-agonists in COPD showed that they increased respiratory deaths. This is thought to be due to the tolerance that develops to their bronchodilator and bronchoprotective effects.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The full list of 20 review articles is below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;List of reviews&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[Note: Mainly systematic reviews, but the list also includes a few good quality non-systematic reviews]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Archives of Internal Medicine.&amp;nbsp; 167(6):551-61, 2007 Mar 26. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Arandjus C,&amp;nbsp; Black PN,&amp;nbsp; Poole PJ, Wood Baker R, Steurer-Stey C.&amp;nbsp;&amp;nbsp; Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.&amp;nbsp;Respiratory Medicine.&amp;nbsp; 100(10):1671-81, 2006 Oct.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Azarpazhooh A,&amp;nbsp; Leake JL, Systematic review of the association between respiratory diseases and oral health. Journal of Periodontology.&amp;nbsp; 77(9):1465-82, 2006 Sep. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Balser E,&amp;nbsp; Neher JO,&amp;nbsp; Safranek S, Taraday J. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations? Journal of Family Practice.&amp;nbsp; 55(12):1079-80, 2006 Dec. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Barr RG, Bourbeau J, Camargo CA,&amp;nbsp; Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax.&amp;nbsp; 61(10):854-62, 2006 Oct.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Bausewein C,&amp;nbsp; Farquhar M,&amp;nbsp; Booth S, Gysels M,&amp;nbsp; Higginson IJ. Measurement of breathlessness in advanced disease: a systematic review. Respiratory Medicine.&amp;nbsp; 101(3):399-410, 2007 Mar.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Colebourn CL,&amp;nbsp; Barber V,&amp;nbsp; Young JD. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review. Anaesthesia.&amp;nbsp; 62(1):34-42, 2007 Jan.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dorman S,&amp;nbsp; Byrne A,&amp;nbsp; Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliative Medicine 2007;21(3):177-91.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Gartlehner G,&amp;nbsp; Hansen RA,&amp;nbsp; Carson SS,&amp;nbsp; Lohr KN. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Comment in: J Fam Pract. 2006 Sep;55(9):756; PMID: 17009435 Annals of Family Medicine.&amp;nbsp; 4(3):253-62, 2006 May-Jun. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Guo R,&amp;nbsp; Pittler MH,&amp;nbsp; Ernst E. Herbal medicines for the treatment of COPD: a systematic review. European Respiratory Journal.&amp;nbsp; 28(2):330-8, 2006 Aug. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Halbert RJ,&amp;nbsp; Natoli JL,&amp;nbsp; Gano A,&amp;nbsp; Badamgarav E,&amp;nbsp; Buist AS.&amp;nbsp; Mannino DM. Global burden of COPD: systematic review and meta-analysis. European Respiratory Journal.&amp;nbsp; 28(3):523-32, 2006 Sep. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Peters J,&amp;nbsp; Pickvance S,&amp;nbsp; Wilford J,&amp;nbsp; MacDonald E,&amp;nbsp; Blank L. Predictors of Delayed Return to Work or Job Loss with Respiratory Ill-Health: A Systematic Review.&amp;nbsp;Journal of Occupational Rehabilitation 2007 Jun;17(2):317-26.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respiratory Research.&amp;nbsp; 8:30, 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Ram FS. Use of theophylline in chronic obstructive pulmonary disease: examining the evidence. Current Opinion in Pulmonary Medicine.&amp;nbsp; 12(2):132-9, 2006 Mar. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Ram FS, Rodriguez-Roisin R,&amp;nbsp; Granados-Navarrete A,&amp;nbsp; Garcia-Aymerich J,&amp;nbsp; Barnes NC, Antibiotics for exacerbations of chronic obstructive pulmonary disease. &lt;A href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004403/frame.html" target="_blank"&gt;Cochrane Database of Systematic Reviews.&amp;nbsp; (2):CD004403, 2006&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Ries AL,&amp;nbsp; Bauldoff GS,&amp;nbsp; Carlin BW,&amp;nbsp; Casaburi R,&amp;nbsp; Emery CF, Mahler DA,&amp;nbsp; Make B,&amp;nbsp; Rochester CL,&amp;nbsp; Zuwallack R,&amp;nbsp; Herrerias C. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007 May;131(5 Suppl):4S-42S.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Salpeter SR,&amp;nbsp; Buckley NS. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clinical Reviews in Allergy &amp;amp; Immunology.&amp;nbsp; 31(2-3):219-30, 2006 Oct-Dec. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Taylor NF,&amp;nbsp; Dodd KJ,&amp;nbsp; Shields N,&amp;nbsp; Bruder A. Therapeutic exercise in physiotherapy practice is beneficial: a summary of systematic reviews 2002-2005. Australian Journal of Physiotherapy.&amp;nbsp; 53(1):7-16, 2007. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?&amp;nbsp;Respirology.&amp;nbsp; 11(6):681-6, 2006 Nov.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Wood-Baker R,&amp;nbsp;Walters J.&amp;nbsp;Walters EH. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews. Respiratory Medicine. 101(3):371-7, 2007 Mar.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=NKW2" target="_blank"&gt;Back to the National Knowledge Week contents page&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>271075</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271075]]&gt;</url>
    <title>Dementia: Some background reading</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,ALZHEIMER’S DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Dementia: Some background reading&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Sharon Scott, Palliative Care Nurse Specialist Dementia Project, at St Christopher’s Hospice Sydenham, London.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Below is some&amp;nbsp;suggested background&amp;nbsp;reading on palliative care and dementia. This is a personal selection which&amp;nbsp;complements the comphrehensive &lt;A href="http://www.library.nhs.uk/laterlife/ViewResource.aspx?resID=262127" target="_blank"&gt;material on dementia in the NLH Later Life Specialist Library&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Documents from the National Council for Palliative Care&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;National Council for Palliative Care &lt;BR&gt;Exploring palliative care for people with dementia. A discussion document. London: NCPC, 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Blight A, Sutton L.&lt;BR&gt;Progress with dementia. Moving forward. Addressing palliative care for people with dementia. London: NCPC, 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncpc.org.uk/palliative_care.html" target="_blank"&gt;http://www.ncpc.org.uk/palliative_care.html&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic review on pain in dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Zwakhalen SMG, Hamers JPH, Abu-Saad HH, Berger MPF.&lt;BR&gt;Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools&lt;BR&gt;BMC Geriatrics 2006 (epub); 6 (3)&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.biomedcentral.com/1471-2318/6/3" target="_blank"&gt;http://www.biomedcentral.com/1471-2318/6/3&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;BMJ review on pain in dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Scherder E, Oosterman J, Swaab D, Herr K, Oooms M, Ribbe M, Sergeant J, Pickering G, Benedetti F.&lt;BR&gt;Clinical review: recent developments in pain in dementia.&lt;BR&gt;BMJ&amp;nbsp; 2005;330&amp;nbsp; (26 February):461-464 (26 February)&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.bmj.com//cgi/content/full/330/7489/461" target="_blank"&gt;http://www.bmj.com//cgi/content/full/330/7489/461&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Portal with useful links to elderly people with dementia&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.cityofhope.org/prc/elderly.asp" target="_blank"&gt;http://www.cityofhope.org/prc/elderly.asp&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;In particular,&amp;nbsp;the following is useful in assessing pain:&lt;/P&gt;
&lt;P&gt;Assessing pain&amp;nbsp;in the nonverbal or cognitively impaired:&lt;BR&gt;&lt;A href="http://www.cityofhope.org/prc/pdf/Assessing%20Pain%209-06.pdf" target="_blank"&gt;http://www.cityofhope.org/prc/pdf/Assessing%20Pain%209-06.pdf&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;End of life assessment for people with dementia and associated disorders&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Volicer L, Hurley AC, Blasi ZV. &lt;BR&gt;Scales for Evaluation of End-of-Life Care in dementia&lt;BR&gt;Alzheimer Disease &amp;amp; Associated Disorders.2001; 15 (4): p194-200&lt;/P&gt;
&lt;P&gt;(This describes a validated&amp;nbsp; tool for end of life care)&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=11723370&amp;amp;dopt=Citation" target="_blank"&gt;http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=11723370&amp;amp;dopt=Citation&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Working with carers&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Silerberg E.&lt;BR&gt;Introducing the 3-A grief intervention model for dementia caregivers: Acknowledge, assess and assist.&lt;BR&gt;Omega&amp;nbsp; 2007;54 (3): p215-235.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Residential care homes&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Volicer L. &lt;BR&gt;End of life for people with advanced dementia in residential care settings. Chicago: Alzheimer’s Association 2005.&lt;BR&gt;&lt;A href="http://www.alz.org/national/documents/endoflifelitreview.pdf" target="_blank"&gt;http://www.alz.org/national/documents/endoflifelitreview.pdf&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;In addition&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Aminoff-Bechor-Zvi, Adunsky, A. &lt;BR&gt;Dying dementia patients: Too much suffering, too little palliation.&lt;BR&gt;American Journal of Hospice &amp;amp; Palliative Medicine,&amp;nbsp; 2005, 22&amp;nbsp; (5)&amp;nbsp; p.344-348. &lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16225356&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;(This journal changed its name from American Journal of Hospice &amp;amp; Palliative Care to American Journal of Hospice &amp;amp; Palliative Medicine in 2005. It could appear under either title that year)&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Dementia Knowledge Week. Palliative Care / End of life Care&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/laterlife/ViewResource.aspx?resID=262127" target="_blank"&gt;http://www.library.nhs.uk/laterlife/ViewResource.aspx?resID=262127&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Author's masters thesis&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Assessment of cognitive impairment in palliative care patients: the utility of the clock drawing test.&amp;nbsp; (Unpublished 2005). An abstract is available: &lt;/P&gt;
&lt;P&gt;Scottt S, Henderson M. Assessing cognitive impairment in palliative care patients: the utility of the clock drawing test (abstract)&lt;BR&gt;Palliative Medicine&amp;nbsp; 2006;20 (3): p271.&lt;/P&gt;
&lt;P&gt;(Palliative Medicine is available via an Athens password provided by the NHS for eligible clinicians) &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>271069</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271069]]&gt;</url>
    <title>Dialysis decision-making and advance planning – an evidence guide for palliative professionals</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SERVICE PROVISION,SYMPTOM MANAGEMENT,RENAL DISEASES,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,HAEMODIALYSIS,PERITONEAL DIALYSIS,STARTING PERITONEAL DIALYSIS,STARTING HAEMODIALYSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Dialysis decision-making and advance planning – an evidence guide for palliative professionals&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Helen Noble, Barts and The London NHS Trust, Whitechapel and City University, London&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;Introduction&lt;/H2&gt;
&lt;P&gt;Palliative care in end-stage renal disease (ESRD) is increasingly important as the numbers with ESRD increase. This increase includes disproportionately more sicker and older patients who may not fare well on dialysis, with adverse impact on their quality of life (1). This article identifies the evidence (and lack of it) on dialysis decision-making; for those who withdraw from dialysis and for the increasing numbers who opt not to have dialysis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Making dialysis decisions - the doctor’s perspective&lt;/H2&gt;
&lt;P&gt;Discontinuation of dialysis is a common cause of death in ESRD patients in the UK and the USA (2-4). Differences in prevalence of dialysis discontinuation may be attributed to differences in referral patterns, dialysis strategies, and variable attitudes of physicians and patients as well as variations in the way dialysis withdrawal is reported (5). Dialysis withdrawal is not always given as the cause of death especially if the patient had high co-morbidity (6), so is under recognised as a cause of death. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A review of dialysis discontinuation by Murtagh et al (7) indicates that discontinuation is an increasingly common event prior to death for those with ESRD. Several studies have attempted to understand how patients are selected for dialysis, their prognosis on dialysis, and subsequent dialysis withdrawal practices (1;8-15). These are primarily quantitative in nature and use questionnaires (9;13;16;17), retrospective data analysis (14;15;18), and surveys (12).&amp;nbsp; All focus on professional practice and add to the evidence on staff decision-making, especially nephrologists. Lambie et al studied the associations between nephrologists’ opinions, availability of dialysis, patient characteristics and comorbidities, and withdrawal rates, in 6 countries including France, Germany, Italy, Spain, UK and the USA. They found wide disagreement over when to start dialysis for patients with advanced age, dementia and other comorbidities, and when to withdraw dialysis for all patients (15). Differences within and across countries probably reflect variations in access to dialysis as well as the practice of withdrawal. Disparities in practice are common, with some nephrologists accepting all patients for dialysis believing that refusal equates to passive euthanasia (13), and some reporting little instruction in medical ethics and management of life sustaining treatments (19), highlighting an obvious need for education in this area.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Making dialysis decisions - the patients’ perspective&lt;/H2&gt;
&lt;P&gt;There is little published evidence on the patient component of decision making. Renal patients have only infrequently had their perspective reported. Withdrawal from dialysis results in death within days, so is a decision with rapid and serious consequences (5). It has been claimed that ‘withholding or withdrawing life-supporting treatment is one of the most ethical issues for medicine in the late 20th century’ (20). Alongside this, palliative care for patients with ESRD is a neglected aspect of nephrology (21). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Calvin highlights the fact that although there is a general lack of knowledge concerning end-of-life treatment preferences of patients undergoing haemodialysis, patients (when prompted) tend to focus on living rather than dying (22). Grounded theory was used to explore decisions among haemodialysis patients and their end-of-life treatment decisions and a substantive theory of ‘personal preservation’ was developed consisting of three phases: knowing the odds for survival, beating the odds and being responsible and taking chances (22).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There are 3 other recent studies (23-25). Ashby et al (23) examined the experiences of patients opting not to have dialysis, or withdrawing from dialysis treatment, taking into account the social and personal impact of this decision. Themes identified included poor quality of life, pain and suffering, a desire not to be a burden, and doctor-patient issues (prognostic uncertainty and a sense of abandonment). The authors recommend a pro-active and open approach towards end of life issues, and suggest that the clinical and health promoting principles of palliative care be integrated into dialysis practice. They also recognize the need for clinical guidelines related to end of life care, advance directives, peer mentoring, and clinical and health promoting palliative care initiatives. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Studies by Fujimaki et al (24) and Chan et al (25), retrospectively reviewed patients who had ‘refused’ the offer of dialysis. Motivation for refusal included not wishing to attend the hospital frequently, feeling ‘too old’ for dialysis, that it would be more ‘natural’ to die without dialysis, and for family reasons. These papers are of interest but the small numbers and retrospective design limit their findings. A review by Germain et al highlights how little we really know about how renal patients die and the urgent need for further study (4). It also promotes the concept of ‘conservative management’ programmes to ensure appropriate support for those who refuse dialysis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Advance planning&lt;/H2&gt;
&lt;P&gt;Most work on advance directives in ESRD originates in the United States (26-30) - it focuses on the role of advance directives in dialysis withdrawal decisions but not on those who have opted not to start dialysis. Evidence indicates that patients prefer to have discussions regarding end of life care with their families/carers rather than health professionals (31).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In a study by Sehgal et al, American, German and Japanese nephrologists were asked for their views on advance directives (32). Family preference to stop dialysis increased the willingness of all 3 groups to stop dialysis, although American nephrologists were more likely to do so than German and Japanese nephrologists. The presence of an advance directive requesting that dialysis be stopped as well as a family preference to stop led to almost all nephrologists saying that they would stop dialysis, although a significant minority of the German and Japanese nephrologists would still continue dialysis. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Practice across countries in relation to advance directives varies considerably. Further study is needed to elucidate this, and to understand patient attitudes towards advance directives. The renal population opting not to embark on dialysis are rarely offered the opportunity for advance planning. We need to know if and how advance planning may be of help to this group as death approaches. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conclusion&lt;/H2&gt;
&lt;P&gt;The treatment of ESRD has raised many ethical concerns. Whether to commence dialysis and when to stop are two questions that are often difficult to answer, and with limited evidence to clarify them. As services offering palliative care to those with ESRD evolve (33;34), these dilemmas will continue. There is considerable need for decision-making and advance planning to be better informed by evidence, so that care to patients and their families can be improved.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;(1) &amp;nbsp;Smith C, Silva-Gane M, Chandra S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clinical Practice 2003;95(2):917-30.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(2) &amp;nbsp;Cohen LM, Germain MJ. The psychiatric landscape of withdrawal. Seminars in Dialysis 2005 Mar;18(2):147-53.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(3) &amp;nbsp;Ikaheimo R, Kervinen M, Karhapaa P, Tryyki R, Lehto S, Ryynanen OP, et al. Discontinuation of dialysis treatment: experience of a single dialysis centre. Scandinavian Journal of Urology &amp;amp; Nephrology 2005;39(5):417-22.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(4) &amp;nbsp;Germain M, Cohen L, Davison S. Withholding and withdrawal from dialysis: What we know about how our patients die. Seminars in Dialysis 2007;20(3):195-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(5) &amp;nbsp;Birmele B, Francois M, Pengloan J, Francais P, Testou D, Brillet G, et al. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population. Nephrol Dial Transplant 2004;19(3):686-91.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(6) &amp;nbsp;Mailloux LU, Bellucci AG, Napolitano B, Mossey RT, Wilkes BM, Bluestone PA. Death by withdrawal from dialysis: a 20-year clinical experience. J Am Soc Nephrol 1993 Mar;3(9):1631-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(7) &amp;nbsp;Murtagh F, Cohen LM, Germain M. Dialysis Discontinuation: Quo Vardis?&amp;nbsp; Advances in Renal Medicine, 2007; 14 (4): 379-401.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(8) &amp;nbsp;Bosshard G, Fischer S, van der HA, Miccinesi G, Faisst K. Intentionally hastening death by withholding or withdrawing treatment. Wiener Klinische Wochenschrift 2006 Jun;118(11-12):322-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(9) &amp;nbsp;Clement R, Chevalet P, Rodat O, Ould-Aoudia V, Berger M. Withholding or withdrawing dialysis in the elderly: the perspective of a western region of France. Nephrology Dialysis Transplantation 2005;20(11):2446-52.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(10) &amp;nbsp;Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M, Grunfeld JP, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003 Apr;14(4):1012-21.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(11) &amp;nbsp;Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. American Journal of Kidney Diseases 1998 Mar;31(3):464-72.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(12) &amp;nbsp;McKenzie J, Moss A, Feest TG, Stocking C, Siegler M. Dialysis decision making in Canada, the United Kingdom and the United States. American Journal of Kidney Diseases 1998;31(1):12-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(13) &amp;nbsp;Pollini J, Teissier M. A difficult dilemma to resolve: aged patients refused for treatment by iterative hemodialysis. Ethical problem or medical choice? Reflections apropos of a questionnaire-inquiry. Nephrologie 1990;11(5):341-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(14) &amp;nbsp;Chandra S, Schulz J, Lawrence C, Greenwood R, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital-based cohort study of factors affecting survival and morbidity. BMJ 1999;318:217-23.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(15) &amp;nbsp;Lambie M, Rayner H, Bragg-Gresham J, Pisoni R, Andreucci V, Canaud B, et al. Starting and withdrawing haemodialysis - associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol Dial Transplant 2006;21:2814-20.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(16) &amp;nbsp;Bosshard G, Fischer S, van der HA, Miccinesi G, Faisst K. Intentionally hastening death by withholding or withdrawing treatment. Wiener Klinische Wochenschrift 2006 Jun;118(11-12):322-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(17) &amp;nbsp;Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. American Journal of Kidney Diseases 1998 Mar;31(3):464-72.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(18) &amp;nbsp;Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M, Grunfeld JP, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003 Apr;14(4):1012-21.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(19) &amp;nbsp;Holley J, Foulks C, Moss A. Nephrologists' reported attitudes about factors influencing recommendations to initiate or withdraw dialysis. J Am Soc Nephrol 1991;1(12):1284-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(20) &amp;nbsp;Neu S, Kjellstrand C. Stopping long-term dialysis. An empirical study of withdrawal of life-supporting treatment. New England Journal of Medicine 1986;314(1):14-20.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(21) &amp;nbsp;Gunda S, Smith S, Thomas M. National Survey of Palliative Care in end-stage renal disease in the UK. Nephrol Dial Transplant 2004;20:392-5.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(22) &amp;nbsp;Calvin A. Haemodialysis patients and end-of-life decisions: a theory of personal preservation. Journal of Advanced Nursing 2004;46(5):558-66.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(23) &amp;nbsp;Ashby M, op't HC, Kellehear A, Kerr PG, Brooks D, Nicholls K, et al. Renal dialysis abatement: lessons from a social study. Palliative Medicine 2005;19(5):389-96.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(24) &amp;nbsp;Fujimaki H, Kasuya Y, Kawaguchi S, Hara S, Koga S, Takahashi T, et al. Refusal of initiation of dialysis by elderly patients with chronic renal failure. Nippon Ronen Igakkai Zasshi 2005;42(4):417-22.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(25) &amp;nbsp;Chan C, Noble H, Lo S, Kwan T, Lee S, Sze W. Palliative care for patients with end-stage renal disease: experiences from Hong Kong. International Journal of Palliative Nursing 2007;13(7):310-4.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(26) &amp;nbsp;Sehgal A, Galbraith A, Chesney M, Schoenfeld P, Charles G, Lo B. How strictly do dialysis patients want their advance directives followed? Jama 1992 Jan 1;267(1):59-63.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(27) &amp;nbsp;Sehgal AR, Weisheit C, Miura Y, Butzlaff M, Kielstein R, Taguchi Y. Advance directives and withdrawal of dialysis in the United States, Germany, and Japan. Jama 1996 Nov 27;276(20):1652-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(28) &amp;nbsp;Rutecki GW, Rodriguez L, Cugino A, Jarjoura D, Hastings F, Whittier FC. End of life issues in ESRD. A study of three decision variables that affect patient attitudes. ASAIO Journal 1994 Jul;40(3):798-802.&lt;/P&gt;
&lt;P&gt;(29) &amp;nbsp;Hines SC, Glover JJ, Babrow AS, Holley JL, Badzek LA, Moss AH. Improving advance care planning by accommodating family preferences. Journal of Palliative Medicine 2001;4(4):481-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(30) &amp;nbsp;Holley JL, Hines SC, Glover JJ, Babrow AS, Badzek LA, Moss AH. Failure of advance care planning to elicit patients' preferences for withdrawal from dialysis. American Journal of Kidney Diseases 1999 Apr;33(4):688-93.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(31) &amp;nbsp;Holley JL. Palliative care in end-stage renal disease: Focus on advance care planning, hospice referral and bereavement. Seminars in Dialysis 2005;18:154-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(32) &amp;nbsp;Sehgal AR, Weisheit C, Miura Y, Butzlaff M, Kielstein R, Taguchi Y. Advance directives and withdrawal of dialysis in the United States, Germany, and Japan. Jama 1996 Nov 27;276(20):1652-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(33) &amp;nbsp;Murtagh F, Murphy E, Shepherd KA, Donohue, Edmonds PM. End-of-life care in end-stage renal disease: renal and palliative care. British Journal of Nursing 2006;15(1):8-11.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(34) &amp;nbsp;Noble H, Chesser A. Developing a Renal Supportive Care Service for patients opting not to dialyse. End of Life Journal in Press 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>280345</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=280345]]&gt;</url>
    <title>Do Once and Share: Pain Assessment. Final documents 2008.</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health Palliative &amp; Supportive Care Specialist Library</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,IMMUNOLOGIC DISEASES,CHILDREN'S CONDITIONS,CANCER,NERVOUS SYSTEM DISEASES,CARDIOVASCULAR DISEASES,RESPIRATORY DISEASES,INFECTIOUS DISEASES,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,MOTOR NEURONE DISEASE,VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD),ALZHEIMER’S DISEASE,LYMPHOEDEMA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),POLYMYOSITIS,CHRONIC FATIGUE SYNDROME (CFS),TUBERCULOSIS (TB),HIV/AIDS,PNEUMONIA,RENAL DISEASES,HAEMATOLOGIC AND LYMPHATIC DISEASES,PARKINSON'S DISEASE,MULTIPLE SCLEROSIS,HUNTINGTON'S DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Do Once and Share: Pain Assessment. Final documents 2008.&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The final project files below are available to download. &lt;/P&gt;
&lt;P&gt;See also the project web page &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=doas" target="_blank"&gt;here&lt;/A&gt;&amp;nbsp;which provides an index to the files as well as other information about the project.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>380942</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.dyingmatters.org/]]&gt;</url>
    <title>Dying Matters</title>
    <publicationDate></publicationDate>
    <publisher>National Council for Palliative Care (NCPC)</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,COMMUNICATION ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>"The Dying Matters coalition is encouraging people to talk about their wishes towards the end of their lives. It’s in everyone’s interest to talk about it, before it’s too late."</description>
    <body>&lt;![CDATA[ &lt;P&gt;"The Dying Matters coalition is encouraging people to talk about their wishes towards the end of their lives. It’s in everyone’s interest to talk about it, before it’s too late."&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.dyingmatters.org/" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>101617</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/723/CN-00139723/frame.html]]&gt;</url>
    <title>Dysgraphia and terminal delirium</title>
    <publicationDate></publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,SYMPTOM MANAGEMENT,ALZHEIMER’S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "The simple clinical task of a request to write 'name and address' revealed overt dysgraphic errors among delirious patients. This examination is clinically acceptable to hospice practice and may be an adequate and accurate bedside test of delirium."]]&gt;</body>
  </document>
  <document>
    <id>177486</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.eapcnet.org/projects/ethics.html]]&gt;</url>
    <title>EAPC Ethics Task Force on Palliative Care and Euthanasia</title>
    <publicationDate></publicationDate>
    <publisher>European Association of Palliative Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POLICY,ETHICS &amp; LAW,INTERNATIONAL,EUTHANASIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Page linking to several EAPC texts.</description>
    <body>&lt;![CDATA[ Page linking to several EAPC texts on euthanasia including the article 'Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force' which represents the official position of the EAPC.]]&gt;</body>
  </document>
  <document>
    <id>94326</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.csp.org.uk/uploads/documents/evidencebrief_palliative_EB04.pdf#search=%22%22Effectiveness%20of%20physiotherapy%20in%20the%20palliative%20care%20of%20older%20people%22%22]]&gt;</url>
    <title>Effectiveness of physiotherapy in the palliative care of older people</title>
    <publicationDate>2002-04-01T00:00:00</publicationDate>
    <publisher>Chartered Society of Physiotherapy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,POPULATIONS AND SETTINGS,AGE-RELATED ISSUES,PHYSICAL THERAPY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Report on the clinical effectiveness of physiotherapy in the palliative care of older people. Word format.]]&gt;</body>
  </document>
  <document>
    <id>381668</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.improvement.nhs.uk/LinkClick.aspx?fileticket=KBUUEsR0mms%3d&amp;tabid=56]]&gt;</url>
    <title>End of life care in heart failure: A framework for implementation</title>
    <publicationDate></publicationDate>
    <publisher>NHS National End of Life Care Programme</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CARDIOVASCULAR DISEASES,SYMPTOM MANAGEMENT,SERVICE PROVISION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Includes sections on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The burden of heart failure 
&lt;LI&gt;The heart failure disease trajectory 
&lt;LI&gt;Advance care planning 
&lt;LI&gt;Multidisciplinary working 
&lt;LI&gt;What is end of life care in heart failure? 
&lt;LI&gt;The end of life care pathway 
&lt;LI&gt;Discussions as end of life approaches 
&lt;LI&gt;Assessment, care planning and review 
&lt;LI&gt;Coordination of care 
&lt;LI&gt;Delivery of high quality services 
&lt;LI&gt;Care in the last days of life 
&lt;LI&gt;Care after death&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>271071</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271071]]&gt;</url>
    <title>Epidemiology and prognosis in advanced chronic kidney disease: Implications for palliative care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ RENAL DISEASES,SYMPTOM MANAGEMENT,SERVICE PROVISION,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,KIDNEY DISEASES,CHRONIC KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Epidemiology and prognosis in advanced chronic kidney disease: Implications for palliative care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Neil Sheerin, Professor of Nephrology, School of Clinical Medical Sciences, Newcastle University.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;The prevalence of diagnosed severe renal disease is increasing rapidly. Chronic Kidney Disease (CKD) stages 3-5 (estimated glomerular filtration rate &amp;lt;60mls/min or less) affects 8.5% of the UK population [1]. Consequently the dialysis population (stage 5 CKD) in the UK is rising by 5% per annum [2]. One major factor is the increasing age of the population as the prevalence of CKD rises dramatically with age [3], 1 in 500 males aged 75-85 years now being on dialysis2. As well as the increasing age of the population, the high prevalence of co-morbidities associated with CKD, for example diabetes mellitus, is also impacting on the epidemiology of CKD [4], [5]. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Availability and impact of dialysis&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;Maintenance dialysis for CKD became available in the UK in the 1960’s.&amp;nbsp; Until the 1980’s availability of dialysis was very limited and older patients or patients with significant co-morbidity were frequently not considered for treatment. Fortunately this has changed and now neither age nor co-morbidity excludes a patient from dialysis. However, nephrologists in the 21st century face a different challenge; how do we best manage incident CKD patients who are now increasingly aged and have greater associated co-morbidity?&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There is a significant treatment burden associated with dialysis. Invasive surgical procedures are required, treatment is usually three times per week for the rest of the patient’s life, and each treatment often takes most of a day. Patients also remain very symptomatic, despite dialysis. So dialysis is often poorly tolerated, particularly in older patients with co-morbidity, the exact patient group with highest prevalence of stage 5 CKD.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Dialysis decision-making&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;Nephrologists therefore need to consider whether dialysis is the correct treatment for all patients with CKD 5 [6]. There are two distinct scenarios. Firstly, the patient who presents acutely with advanced renal failure with life threatening complications such as hyperkalaemia or fluid overload. In this situation (without definite contra-indication such as advanced malignancy, severe co-morbidity, or technical difficulty in delivering dialysis), dialysis should be initiated. If there is uncertainty about appropriateness of treatment, this can be reviewed once the patient’s condition has been stabilised.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The second scenario is of a patient with slowly progressive CKD. GFR falls with age by 1-2 mls per minute per year after the age of 40 years, even in healthy individuals. Many patients with CKD stage 5 may only lose GFR at this or a slightly higher rate. Therefore, a patient with stage 5 CKD (eGFR &amp;lt;15ml/min) may have a dialysis-free life expectancy of several years, ,even though an argument could be made for initiating dialysis at this point. Therefore, a critical question is whether all patients benefit from dialysis, particularly those with a shorter life expectancy due to age and/or significant co-morbidity. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Evidence on survival with or without dialysis&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;There have been no prospective randomised trials assessing the benefit of dialysis in this group and it is the opinion of the author that such a study is unlikely to occur, and we have to rely on observational studies. Smith et al report survival of 38 patients who, after multi-disciplinary assessment, were recommended palliative treatment rather than dialysis [7]. In this cohort, 10 subsequently chose to have dialysis and 18 followed a palliative pathway. Choosing to dialyse did not significantly alter survival. A second study considered all patients over the 75 years with stage 5 CKD managed in specialist nephrology care. 77 patients (60%) were established on a treatment pathway that did not include dialysis [8]. These patients had significantly worse survival than those patients on a pathway that included dialysis, suggesting that overall elderly patients do benefit from dialysis, at least in terms of survival. However, it is impossible to exclude a selection bias, with fitter patients choosing dialysis. Importantly in this study if the patients with higher co-morbidity were considered in isolation choosing dialysis offered no survival benefit, which concurs with the experience of other renal units [9]. As well as co-morbidity predicting survival [10], functional capacity should also be assessed when considering whether a patient will benefit from dialysis, as this is also a good indicator of survival in stage 5 CKD [11].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Implications&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;So what does this mean for nephrologists and palliative care physicians?&amp;nbsp; Older patients with co-morbidity can be given choice whether or not to dialyse without a major adverse effect on survival. Experience suggests that 15-20% of all stage 5 CKD patients will choose not to dialysis. This is patient group with a high symptom burden equivalent or greater than that of patients with malignant disease [12], an unpredictable disease trajectory and therefore needing significant medical and social input.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The suggestion that older patients with significant co-morbidity benefit gain only marginal benefit, if at all, from dialysis identifies a second group of patients that have significant palliative care needs, namely those that do start dialysis. These patients continue to have a large symptom burden because: dialysis will not alleviate all symptoms of renal failure, dialysis itself will add to the symptom burden and many symptoms may relate to other co-morbidities not affected by dialysis [13]. It is vital that we do not ignore palliative needs in this patient group because they are being actively treated and remember that dialysis is itself a palliative treatment for renal failure and not a cure. If we consider all patients over 75 years of age, irrespective of co-morbidity, 40-50% will die in the first year after starting dialysis [14]. With such a high mortality and no robust tool to predict which patients will die, a case could be made for considering the palliative needs, for example symptom control, resuscitation status and preferred place of care, for all older incident dialysis patients. Generally this is not done well by nephrologists with limited expertise and resources allocated to this important element of patient care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Dialysis withdrawal&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;Withdrawal from dialysis is an increasingly common cause of death of our patients [15] and in New England one-in three deaths follow the decision to stop dialysis [16]. This is a complex decision, and patients and carers require support not only in making the decision to stop but in planning the remainder of their life. This is an area where the skills of palliative care teams are critical in ensuring a good death for the patient. It is important that this input is not limited to after any decision is made, but instead palliative care services are involved throughout the process. There are different considerations for those patients who stop dialysis compared to those that do not start. The survival after dialysis withdrawal is much shorter (median survival 8 days[17]). Patients will lose residual renal function whilst on dialysis and therefore become rapidly uraemic on cessation. Although this is a critical and relatively predictable phase of a patient’s management the evidence would suggest that it is phase that is not managed well [16].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Future developments&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;The number of patients who have both nephrology and palliative care needs are increasing and this increase is likely to continue [4]. It is vital that links between these two specialities develop to provide optimum patient care. In addition, it has to be recognised that these patients have very significant medical needs and meeting these needs is not cheap. The system for funding dialysis treatment of stage 5 CKD is well established but no equivalent exists for non-dialysis treatment. As data accumulates to suggest that non-dialysis treatment is a realistic, perhaps more appropriate, option for some patients, this is a situation that must change.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;1. Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney international 2007;72(1):92-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2. Ansell D, Feest T, Hodsman A, et al. UK Renal Registry: The Ninth Annual report; 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;3. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41(1):1-12.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;4. Krishnan M, Lok CE, Jassal SV. Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Seminars in dialysis 2002;15(2):79-83.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;5. Roderick P, Davies R, Jones C, Feest T, Smith S, Farrington K. Simulation model of renal replacement therapy: predicting future demand in England. Nephrol Dial Transplant 2004;19(3):692-701.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;6. Burns A. Conservative management of end-stage renal failure: masterly inactivity or benign neglect? See Smith et al., pp. c40-c46. Nephron Clin Pract 2003;95(2):c37-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;7. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin Pract 2003;95(2):c40-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;8. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22(7):1955-62.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;9. Dasgupta I, Rayner HC. Dialysis versus conservative management of elderly patients with advanced chronic kidney disease. Nature clinical practice 2007;3(9):480-1.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;10. Wong CF, McCarthy M, Howse ML, Williams PS. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Renal failure 2007;29(6):653-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;11. Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (Clinical research ed 1999;318(7178):217-23.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;12. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in chronic kidney disease 2007;14(1):82-99.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;13. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of pain and symptom management 2006;31(1):58-69.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;14. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Annals of internal medicine 2007;146(3):177-83.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;15. US Renal Data System: USRDS annual data report. Am J Kidney Dis 2007;49 (Suppl. 1):s1-s235.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;16. Germain MJ, Cohen LM, Davison SN. Withholding and withdrawal from dialysis: what we know about how our patients die. Seminars in dialysis 2007;20(3):195-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;17. Chambers JE. End of life care. In: Chambers JE, Germain MJ, Brown E, eds. Supportive care for the renal patient. Oxford: Oxford Press; 2004:255-64.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>251350</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://news.bbc.co.uk/hi/english/static/health/euthanasia/basics.stm]]&gt;</url>
    <title>Euthanasia: the basics</title>
    <publicationDate></publicationDate>
    <publisher>BBC</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,EUTHANASIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Report from BBC News. Provides an overview of the issues, the legal position and includes a glossary.]]&gt;</body>
  </document>
  <document>
    <id>304360</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304360]]&gt;</url>
    <title>Family members in end-stage kidney disease in palliative and supportive care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ FAMILIES &amp; CARERS,SYMPTOM MANAGEMENT,DEATH,COMMUNICATION ISSUES,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,RENAL DISEASES,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,END-OF-LIFE CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Family members in end-stage kidney disease in palliative and supportive care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Download the pdf by selecting the link under 'Related Files' below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>177484</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/cgi/content/full/121/10/793?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=%22History+of+Euthanasia+Debates+in+the+United+States+and+Britain%22&amp;searchid=1&amp;FIRSTINDEX=0&amp;resourcetype=HWCIT]]&gt;</url>
    <title>History of euthanasia debates in the United States and Britain</title>
    <publicationDate></publicationDate>
    <publisher>Annals of Internal Medicine</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POLICY,ETHICS &amp; LAW,HUMANITIES,EUTHANASIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Journal article providing a historical perspective on euthanasia.</description>
    <body>&lt;![CDATA[ "The arguments propounded for and against euthanasia in the 19th&lt;SUP&gt; &lt;/SUP&gt;century are identical to contemporary arguments.Such similarities&lt;SUP&gt; &lt;/SUP&gt;suggest four conclusions: Public interest in euthanasia 1) is&lt;SUP&gt; &lt;/SUP&gt;not linked with advances in biomedical technology; 2) it flourishes&lt;SUP&gt; &lt;/SUP&gt;in times of economic recession, in which individualism and social&lt;SUP&gt; &lt;/SUP&gt;Darwinism are invoked to justify public policy; 3) it arises&lt;SUP&gt; &lt;/SUP&gt;when physician authority over medical decision making is challenged;&lt;SUP&gt; &lt;/SUP&gt;and 4) it occurs when terminating life-sustaining medical interventions&lt;SUP&gt; &lt;/SUP&gt;become standard medical practice and interest develops in extending&lt;SUP&gt; &lt;/SUP&gt;such practices to include euthanasia.&lt;SUP&gt;"&lt;/SUP&gt;]]&gt;</body>
  </document>
  <document>
    <id>105641</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.parliament.the-stationery-office.co.uk/pa/cm200304/cmselect/cmhealth/454/45402.htm]]&gt;</url>
    <title>House of Commons Health Select Committee Report on Palliative Care</title>
    <publicationDate>2004-07-22T00:00:00</publicationDate>
    <publisher>United Kingdom Parliament</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES,UNITED KINGDOM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;ADDRESS&gt;&lt;SPAN style="FONT-STYLE: normal"&gt;&lt;/SPAN&gt;&lt;/ADDRESS&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;Includes the following sections:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;1&amp;nbsp; Introduction&lt;/STRONG&gt; &lt;BR&gt;Defining palliative care &lt;BR&gt;The provision of palliative care &lt;BR&gt;&lt;STRONG&gt;2&amp;nbsp; Choice in palliative care&lt;/STRONG&gt; &lt;BR&gt;Support services including domiciliary support and personal care &lt;BR&gt;Personal care &lt;BR&gt;Delayed discharges &lt;BR&gt;&lt;STRONG&gt;3&amp;nbsp; Equity in palliative care&lt;/STRONG&gt;&lt;BR&gt;Inequity by geographical area &lt;BR&gt;Inequity by patient group &lt;BR&gt;Inequity by age group &lt;BR&gt;Inequity by ethnicity &lt;BR&gt;Patients with complex needs &lt;BR&gt;Inequity by disease &lt;BR&gt;&lt;STRONG&gt;4&amp;nbsp; Quality of services&lt;/STRONG&gt; &lt;BR&gt;Communication issues &lt;BR&gt;Governance &lt;BR&gt;&lt;STRONG&gt;5&amp;nbsp; Resources for palliative care&lt;/STRONG&gt; &lt;BR&gt;Staff &lt;BR&gt;Funding issues &lt;BR&gt;&lt;STRONG&gt;6&amp;nbsp; Conclusion: changing attitudes&lt;/STRONG&gt; &lt;BR&gt;Conclusions and recommendations&lt;/EM&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;STRONG&gt;Publication history information:&lt;/STRONG&gt; Published in July 2004&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access:&lt;/STRONG&gt; Available to the general public. &lt;A href="http://www.parliament.the-stationery-office.co.uk/pa/cm200304/cmselect/cmhealth/454/45402.htm" target="_blank"&gt;HTML version (browsable)&lt;/A&gt;&lt;BR&gt;or &lt;A href="http://www.parliament.the-stationery-office.co.uk/pa/cm200304/cmselect/cmhealth/454/454.pdf" target="_blank"&gt;PDF version&lt;/A&gt;&amp;nbsp;requiring &lt;A href="http://www.adobe.com/products/acrobat/readstep2.html" target="_blank"&gt;Adobe Acrobat Reader&lt;/A&gt;.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>394460</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.endoflifecareforadults.nhs.uk/publications/end-of-life-care-in-long-term-neurological-conditions-a-framework]]&gt;</url>
    <title>Improving end of life care in neurological disease: a framework for implementation</title>
    <publicationDate></publicationDate>
    <publisher>NEoLC Programme</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ HEALTH MANAGEMENT,SERVICE SECTORS,QUALITY AND MONITORING,ACUTE SERVICES,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES,QUALITY IMPROVEMENT,INNOVATION AND IMPROVEMENT,CHANGE MANAGEMENT,LEADING IMPROVEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;"This document aims to set out an EoLC framework for implementation that speci?cally meets the needs of those with neurological conditions.&lt;/P&gt;
&lt;P&gt;It covers:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Strategic context &lt;/LI&gt;
&lt;LI&gt;End of life care tools &lt;/LI&gt;
&lt;LI&gt;End of life care in neurological disease &lt;/LI&gt;
&lt;LI&gt;Communication and advance care planning &lt;/LI&gt;
&lt;LI&gt;Co-ordination and multidisciplinary approach to care &lt;/LI&gt;
&lt;LI&gt;Management of physical symptoms &lt;/LI&gt;
&lt;LI&gt;Holistic care – psychosocial and spiritual aspects &lt;/LI&gt;
&lt;LI&gt;Care at the end of life &lt;/LI&gt;
&lt;LI&gt;Carers &lt;/LI&gt;
&lt;LI&gt;Workforce, education and training &lt;/LI&gt;
&lt;LI&gt;Commissioning health and social care services "&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>94301</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://books.nap.edu/books/0309074029/html/R1.html]]&gt;</url>
    <title>Improving palliative care for cancer</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>National Academies Press</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SERVICE PROVISION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Online book/report from the USA's Institute of Medicine. Available&amp;nbsp;in full text - pdf and html format.]]&gt;</body>
  </document>
  <document>
    <id>113152</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/12/39/48/04123948.pdf]]&gt;</url>
    <title>Information for the palliative care sector: Healthcare Resource Groups; Payment by Results; HM Treasury’s Cross Cutting Review (full cost recovery)</title>
    <publicationDate>2005-11-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SERVICE PROVISION,POLICY,PROFESSIONS,UNITED KINGDOM,HOSPICE/HEALTH SERVICE MANAGERS,MULTIDISCIPLINARY/INTERPROFESSIONAL WORKING,AUDIT,OUTCOME MEASURES,SERVICE DEVELOPMENT,ACCESS TO PALLIATIVE AND SUPPORTIVE CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;SPAN lang=EN-GB style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Arial&gt;Produced on behalf of the National Partnership Group for Palliative Care, this information paper provides an overview of Payment by Results and Healthcare Resource Groups.&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;It goes on to explain how these will operate in the specialist palliative care field. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;SPAN lang=EN-GB style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Arial&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;SPAN lang=EN-GB style="FONT-SIZE: 10pt"&gt;&lt;FONT face=Arial&gt;Whilst this briefing is primarily intended for the specialist palliative care voluntary sector, it is of interest to a wider audience including commissioners and NHS specialist palliative care service providers.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>102118</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mndscotland.org.uk/information/library1.php]]&gt;</url>
    <title>Information Service and Library</title>
    <publicationDate></publicationDate>
    <publisher>Scottish Motor Neurone Disease Association</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,SERVICE PROVISION,MOTOR NEURONE DISEASE,SERVICE TYPE,INFORMATION SERVICES AND LIBRARIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>The Association's library pages.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Information Service and Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN class=style28&gt;Includes downloadable reading lists and other resources.&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>270868</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=270868]]&gt;</url>
    <title>Introduction from the National Council for Palliative Care's Policy Unit</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ RESPIRATORY,PUBLICATIONS,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,SERVICE PROVISION,MOTOR NEURONE DISEASE,VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD),ALZHEIMER’S DISEASE,LYMPHOEDEMA,POLICY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),UNITED KINGDOM,SYMPTOM MANAGEMENT,RESPIRATORY DISEASES,NERVOUS SYSTEM DISEASES,CARDIOVASCULAR DISEASES,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RENAL DISEASES,HAEMATOLOGIC AND LYMPHATIC DISEASES,PARKINSON'S DISEASE,MULTIPLE SCLEROSIS,HUNTINGTON'S DISEASE,REPORTS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction from the National Council for Palliative Care's Policy Unit&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Recent years have seen the extension of palliative and end of life care beyond its traditional focus of meeting the needs of people with cancer to covering all conditions and across all settings. This is reflected through all recent national policy such as the &lt;A href="http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Longtermconditions/index.htm" target="_blank"&gt;National Service Framework for Long Term Neurological Conditions&lt;/A&gt; and the &lt;A href="http://www.library.nhs.uk/laterlife/ViewResource.aspx?resID=212221" target="_blank"&gt;NICE Guidance on Dementia&lt;/A&gt;. To therefore support all those involved in palliative care including policy makers, service planners and providers, commissioners, service users and carers address this change in focus the &lt;A href="http://www.ncpc.org.uk/index.html" target="_blank"&gt;National Council for Palliative Care&lt;/A&gt; (NCPC) set up the policy unit.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The NCPC is the umbrella body for all who commission, provide or use palliative care services across all settings in England, Wales and Northern Ireland. The NCPC policy unit provides practical policy solutions and has groups of experts and key partners/ stakeholders looking at:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The needs of older people which is a cross cutting group covering all areas of health and social care including housing and care homes; &lt;/LI&gt;
&lt;UL&gt;
&lt;LI&gt;With a subgroup looking specifically at the needs of people with dementia;&lt;/LI&gt;&lt;/UL&gt;
&lt;LI&gt;The needs of people with neurological conditions;&lt;/LI&gt;
&lt;LI&gt;The needs of people with heart and renal conditions;&lt;/LI&gt;
&lt;LI&gt;The needs of people with chronic respiratory disease;&lt;/LI&gt;
&lt;LI&gt;The needs of people with cancer.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Each group provides guidance, events and solutions/ examples of good practice for addressing palliative care needs. Full details are available at:&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncpc.org.uk/policy_unit/index.html" target="_blank"&gt;http://www.ncpc.org.uk/policy_unit/index.html&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Examples of recent work include:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Focus on Neurology&lt;/LI&gt;
&lt;LI&gt;Progress with Dementia&lt;/LI&gt;
&lt;LI&gt;End of Life Care: A Commissioning Perspective&lt;/LI&gt;
&lt;LI&gt;Population Based Needs Assessment&lt;/LI&gt;
&lt;LI&gt;A Fresh Approach: Palliative Care and Chronic Respiratory Disease Event 4th December 2007&lt;/LI&gt;
&lt;LI&gt;Deactivation of Internal Cardiac Defibrillators&lt;/LI&gt;
&lt;LI&gt;Specialist Palliative Care Workforce Survey&lt;/LI&gt;
&lt;LI&gt;Specialist Palliative Care activity data&lt;/LI&gt;
&lt;LI&gt;Data or Die: Information Needs in the Brand New World of Healthcare Event 22nd November 2007&lt;/LI&gt;
&lt;LI&gt;Artificial Nutrition and Hydration&lt;/LI&gt;
&lt;LI&gt;Changing Gear: Managing the Last Days of Life.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;This work and the importance NCPC places on meeting everyone’s palliative care needs regardless of diagnosis or setting of care mean we are very happy to work with NLH in this week long awareness campaign.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lucy Sutton&lt;BR&gt;National Policy Lead&lt;BR&gt;The National Council for Palliative Care&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>270867</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=270867]]&gt;</url>
    <title>Introduction from the National Library for Palliative and Supportive Care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ SYMPTOM MANAGEMENT,SERVICE PROVISION,POLICY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),ALZHEIMER’S DISEASE,LYMPHOEDEMA,MOTOR NEURONE DISEASE,VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD),PALLIATIVE AND SUPPORTIVE CARE,RESPIRATORY DISEASES,CARDIOVASCULAR DISEASES,NERVOUS SYSTEM DISEASES,CONDITIONS,RENAL DISEASES,PARKINSON'S DISEASE,HAEMATOLOGIC AND LYMPHATIC DISEASES,UNITED KINGDOM,HUNTINGTON'S DISEASE,MULTIPLE SCLEROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction from the National Library for Palliative and Supportive Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Welcome to the second National Knowledge Week run by the National Library for Palliative and Supportive Care. The first NKW was on the subject of 'Pain' and details can be found &lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;here&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The focus of this NKW is on the much broader topic of 'Palliative and supportive care in non-cancer diseases.' There are three main drivers for choosing this subejct. First, as palliative and supportive have developed over the past 20 years in the context of cancer care, a considerable knoweldge base has been accumulated which has clearly benefited enormous number of cancer patients and their&amp;nbsp;carers -&amp;nbsp;albeit, mainly in the more advanced stages of the disease. But in recent years, research and clincial experience have moved apace in many areas of chronic disease management, such as heart failure, chronic respiratory disease, neurological conditions. We have worked with specialists to search and review the literature in these fields, and the results will be presented this week in the form of Annual Evidence Updates. However, it soon became clear to us that the growth of robust evidence, in the form of systematic reviews and meta-analyses, is still limited in these areas. We hope that this resource will direct and inspire others to fill in the gaps of our knowledge.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Second, the National Council for Pallaitive Care has in recent years taken on the challenge of extending the scope of palliative and supportive care beyond cancer very seriously. We are delighted therefore to be working in partnership with NCPC this week on highlighting what progress has occured under their leadership. For more details of NCPC's involvement, &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=270868&amp;amp;tabID=290" target="_blank"&gt;see Lucy Sutton's article&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Third, and probably most importantly, the sheer size of the growing burden of chronic diseases provides a moral and public health imperative for us all to engage more energetically in this issue. The UK Government has shown its committment through the &lt;A href="http://eolc.cbcl.co.uk/eolc" target="_blank"&gt;End of Life Care strategy&lt;/A&gt;, which will be announced later this year. But all those who care for patients suffering the physical, psyschosocial, spiritual and other consequences of chronic and life-limiting diseases need to become more engaged in bringing the benefits of an evidence-based palliative and supportive care approach to these patients and families. We hope that this National Knowledge Week will help more individuals and teams to be more productive and rewarded through this work.&lt;/P&gt;&lt;/FONT&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>126800</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=126800]]&gt;</url>
    <title>Introduction to bereavement services</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health Palliative &amp; Supportive Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,DEATH,SERVICE PROVISION,PROFESSIONS,BEREAVEMENT SERVICE STAFF,SERVICE TYPE,BEREAVEMENT SERVICES,BEREAVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction to bereavement services&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;1.&amp;nbsp;Definition of topic&lt;/H2&gt;
&lt;P&gt;“Most bereavement services are based on the assumption that loss through death challenges coping abilities and that supportive interventions may facilitate&amp;nbsp;post-death adaptation, reduce complicated grief reactions and promote wellbeing”&amp;nbsp; (Field et al. 2004).&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;2.&amp;nbsp;Guidance/Evidence available&amp;nbsp; &lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Guidance&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=35349&amp;amp;tabID=288&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE" target="_blank"&gt;&lt;EM&gt;Improving supportive and palliative care for adults with cancer - the manual&lt;/EM&gt;&lt;/A&gt;&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Chapter 12 covers guidance on services for families and services and carers, including bereavement services. However, it refers to the type of support needed for bereaved people but does not consider the shape of the service. &lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=105471&amp;amp;tabID=288&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE" target="_blank"&gt;&lt;EM&gt;When a patient dies: advice on developing bereavement services in the NHS&lt;/EM&gt;&lt;/A&gt;&lt;/STRONG&gt;&lt;EM&gt; &lt;/EM&gt;
&lt;P&gt;&lt;/P&gt;This outlines services that should be implemented in the immediate aftermath of a death but does not delineate a service which provides a bereavement service providing ongoing support over a number of months or years. 
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Evidence &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=241004&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE" target="_blank"&gt;&lt;STRONG&gt;&lt;EM&gt;A synthesis of psychological interventions for the bereaved&lt;/EM&gt;&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;This study, retrieved from the DARE database, comments on&amp;nbsp;a literature review which looks at bereavement interventions. Authors concluded that, overall the interventions were largely methodologically flawed, rarely specified what theory of bereavement they were testing, and showed surprisingly weak effect sizes.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=89019&amp;amp;tabID=289&amp;amp;summaries=true&amp;amp;resultsPerPage=10&amp;amp;sort=PUBLICATION_DATE" target="_blank"&gt;&lt;EM&gt;Bereavement care interventions: a systematic review&lt;/EM&gt;&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;This literature review published by Biomed Central,&amp;nbsp;comes to a similar conclusion to that above. Due to a paucity of reports on controlled clinical trails, no rigorous evidence-based recommendation regarding the treatment of bereaved persons is currently possible except for the pharmacologic treatment of depression. The authors postulated the following five factors as impeding scientific progress regarding bereavement care interventions: 1) excessive theoretical heterogeneity, 2) stultifying between-study variation, 3) inadequate reporting of intervention procedures, 4) few published replication studies, and 5) methodological flaws of study design.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;A href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000452/frame.html" target="_blank"&gt;&lt;STRONG&gt;Support for women/families after perinatal death&lt;/STRONG&gt;&lt;/A&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This Cochrane review also concludes&amp;nbsp;that no information is available from randomised trials to indicate whether there is or is not a benefit from providing specific psychological support or counselling after perinatal death.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Discussion&lt;/H2&gt;
&lt;P&gt;It is perhaps not surprising that evidence for a benefit from bereavement services is difficult to assess since: (a) the population is very diverse.&amp;nbsp;Bereaved inviduals range from young children to the elderly; (b) bereaved inviduals&amp;nbsp;have a myriad of relationships with the person who has died and with those with whom they grieve; (c) the length of time since bereavement varies considerably, should someone&amp;nbsp;be referred to a service; (d) bereaved people&amp;nbsp;come from every possible cultural, ethnic and religious group. Studies on both child and adult bereavement services in the UK indicate that the type of service provision varies considerably.&amp;nbsp; Evaluation of services is especially problematic as the extent of bereavement support can be provided/integrated into standard care. For example, in the case of perinatal death, hospital ward staff often offer support which is specific to bereavement, but is not regarded per se as a bereavement service.&amp;nbsp;&amp;nbsp;However, surveys of services provide evidence of what is happening in various areas in the UK - examples&amp;nbsp;include the following references. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Rolls L, Payne S. 2003, Childhood bereavement services: a survey of UK provision, &lt;EM&gt;Palliative Medicine&lt;/EM&gt; 17(5):423-432.&amp;nbsp; (Available via NHS Core Content with an Athens password).&lt;/LI&gt;
&lt;LI&gt;Rolls L, Payne S. 2004, Childhood bereavement services: issues in UK service provision &lt;EM&gt;Mortality&lt;/EM&gt; 9(4):300-328.&lt;/LI&gt;
&lt;LI&gt;Field D, Reid D, Payne S, Relf, M. 2004, Survey of UK hospice and specialist palliative care adult bereavement services. &lt;EM&gt;International Journal of Palliative Nursing&lt;/EM&gt; 10(12):569-576.&lt;/LI&gt;
&lt;LI&gt;Reid D, Field D, Payne S, Relf M.&amp;nbsp;2006, Adult bereavement in five English hospices: types of support. &lt;EM&gt;International Journal of Palliative Nursing&lt;/EM&gt; 12(9):430-437.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;STRONG&gt;Standards&lt;/STRONG&gt;&lt;/H2&gt;
&lt;P&gt;There have been other attempts to develop standards for the provision of bereavement services. However, at this stage for the NHS in England users are referred to the Guidance section above. The resources below should be read as an introduction to the subject. &amp;nbsp;&amp;nbsp;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.grief.org.au/projects.html" target="_blank"&gt;http://www.grief.org.au/projects.html&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;(The library at St Christopher’s Hospice has some standards that were created a few years ago. They have not been updated but may be useful as a guide to examining relevant issues in the creation of new ones.&amp;nbsp; Email: &lt;A href="mailto:d.brady@stchristophers.org.uk" target="_blank"&gt;d.brady@stchristophers.org.uk&lt;/A&gt; ) &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conferences&lt;/H2&gt;
&lt;P&gt;Abstracts can be downloaded from these recent conferences:&lt;/P&gt;&lt;FONT face=Arial&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;FONT face=Arial&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;EM&gt;&lt;FONT face=Arial&gt;7&lt;SUP&gt;th&lt;/SUP&gt; International conference on grief and bereavement in contemporary society&lt;/FONT&gt;&lt;FONT face=Arial&gt;&amp;nbsp;12-15 &lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;&lt;st1:place&gt;&lt;st1:PlaceName&gt;July&lt;/st1:PlaceName&gt; 2005, &lt;st1:PlaceName&gt;Kings&lt;/st1:PlaceName&gt; &lt;st1:PlaceType&gt;College,&lt;/st1:PlaceType&gt;&lt;/st1:place&gt; &lt;st1:City&gt;&lt;st1:place&gt;London&lt;/st1:place&gt;&lt;/st1:City&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;/FONT&gt;[&lt;STRONG&gt;To see abstracts arranged by author, see &lt;/STRONG&gt;&lt;A href="http://www.cruse.org.uk/intlconf/index.htm" target="_blank"&gt;&lt;STRONG&gt;this web page&lt;/STRONG&gt;&lt;/A&gt;]&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;&lt;EM&gt;Abstracts from the 9th EAPC conference in Aachen, Germany 2005, 3rd EAPC Research Forum in Stresa, Italy 2004, 8th EAPC conference in The Hague, Netherlands, 2003 and 4th EAPC Research Forum in Venice, Italy, 2006. &lt;/EM&gt;&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt"&gt;[&lt;STRONG&gt;Select the category 'grief, bereavement &amp;amp; support' on &lt;/STRONG&gt;&lt;A href="http://eapc.palliatief.nl/" target="_blank"&gt;&lt;STRONG&gt;this page&lt;/STRONG&gt;&lt;/A&gt;&amp;nbsp;&lt;STRONG&gt;to see all results for this topic from all these conferences&lt;/STRONG&gt;]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;STRONG&gt;Literature search&lt;/STRONG&gt;&lt;/H2&gt;
&lt;P&gt;A search was also conducted on the databases provided by the NLH to its users.&amp;nbsp; It should be noted that here the quality of the research has not yet been critically appraised in detail.&amp;nbsp; However, the results presented provide helpful background to those researching the provision of bereavement services.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The&amp;nbsp;search was conducted using the terms &lt;EM&gt;bereavement &lt;/EM&gt;and &lt;EM&gt;service evaluation&lt;/EM&gt;, using all the databases available on NHS core content.&amp;nbsp; The term &lt;EM&gt;bereavement&lt;/EM&gt;&amp;nbsp;was searched as a subject heading (in PsycInfo the subject heading used was &lt;EM&gt;grief&lt;/EM&gt;). In cases where&amp;nbsp;the term &lt;EM&gt;service evaluation&lt;/EM&gt; was unavailable as a thesaurus term, an appropriate alternative term was used.&amp;nbsp; However, if there did not appear to be any appropriate other term, the term &lt;EM&gt;bereavement service$&lt;/EM&gt; was used.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Excluding services for children and adolescents, 86 items were identified as being of potential use to anyone seeking material on this subject.&amp;nbsp; Most items are post 1996, though a search on one database yielded earlier items.&amp;nbsp; Some of the items below are available in full text to NHS users.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The titles are listed first:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;1. When a patient dies; advice on developing bereavement services in the NHS.&amp;nbsp;Department of Health, (London), 2005, iii,42p. &lt;/P&gt;
&lt;P&gt;2. Spotlight on bereavement services and support. Foss T. &lt;EM&gt;British Journal of Nursing&amp;nbsp;&lt;/EM&gt; 2005 14(20):1053. &lt;/P&gt;
&lt;P&gt;3. Patients who die in hospital. Series: HSG, (97)43, Department of Health, London, 1997, 2p. &lt;/P&gt;
&lt;P&gt;4. Between the idea and the reality: a study of the counselling experiences of bereaved people who sense the presence of the deceased. Taylor S. &lt;EM&gt;Counselling&amp;nbsp;and Psychotherapy Research&amp;nbsp;&lt;/EM&gt; 2005 5(1):53-61. &lt;/P&gt;
&lt;P&gt;5. Bereavement services report.&amp;nbsp;Department of Health, (London) 2001,&amp;nbsp;5p., URL: &amp;lt;&lt;A href="http://www.dh.gov.uk/assetRoot/04/06/93/90/04069390.pdf" target="_blank"&gt;http://www.dh.gov.uk/assetRoot/04/06/93/90/04069390.pdf&lt;/A&gt;&amp;gt;. &lt;/P&gt;
&lt;P&gt;6. Establishing a bereavement service. Duke S. &lt;EM&gt;Nursing Standard&lt;/EM&gt; 1990 5(10):34-37. &lt;/P&gt;
&lt;P&gt;7. Traumatic bereavement and the Asian tsunami perspectives from Tamil Nadu, India. Tharyan P. &lt;EM&gt;Bereavement Care&lt;/EM&gt; 2005&amp;nbsp;24(2):23-6. &lt;/P&gt;
&lt;P&gt;8. Crisis intervention, grief therapy, and the loss of life. McBride J, Johnson ED. Editor(s): Roberts AR. Crisis intervention handbook: Assessment, treatment, and research, 3rd ed, 2005, p. 279-290, pp. xxvi + 845, ISBN: 0-19-517991-9 (hardcover). Publisher: Oxford University Press, New York, NY, US. &lt;/P&gt;
&lt;P&gt;9. Tasks perceived as necessary for hospice and palliative care unit bereavement services in Japan. Saraguchi Y, Tsuneto S, Takayama K. &lt;EM&gt;Journal of Palliative Care&lt;/EM&gt; 2004 20(4):320-323. &lt;/P&gt;
&lt;P&gt;10. The Ohio hospice bereavement study: meeting NHPCO standards. Rathbun A, Denham SA, McCarthy CC. &lt;EM&gt;American Journal of Hospice and Palliative Care&lt;/EM&gt; 2003&amp;nbsp;20(6):448-458. &lt;/P&gt;
&lt;P&gt;11. Setting up and running a bereavement service. Earnshaw-Smith E. p53-64. &lt;/P&gt;
&lt;P&gt;12. Survey of bereavement care and other support services. Department of Health, (London), 2005, 5p., URL: &amp;lt;&lt;A href="http://www.dh.gov.uk/assetRoot/04/06/93/90/04069390.pdf" target="_blank"&gt;http://www.dh.gov.uk/assetRoot/04/06/93/90/04069390.pdf&lt;/A&gt;&amp;gt;. &lt;/P&gt;
&lt;P&gt;13. Developing a multi-agency bereavement service. (For children and their families in York). Wright B, Elvans H, King P. &lt;EM&gt;European Journal of Palliative Care&lt;/EM&gt; 2002&amp;nbsp;9(4):160-163.&lt;/P&gt;
&lt;P&gt;14. Use of a bereavement service among suddenly bereaved families in Hong Kong. (Research in Brief series. Research with people present in A&amp;amp;E when their relative died).&amp;nbsp;Ping S, Chan W, Lee T. &lt;EM&gt;Journal of Clinical Nursing&lt;/EM&gt; 2002&amp;nbsp;11(2):289-90. &lt;/P&gt;
&lt;P&gt;15. The midwife's role in perinatal bereavement. Plagnard N. &lt;EM&gt;INFO Kara: Revue Internationale Francophone de Soins Palliatifs&lt;/EM&gt; 2004 19(3):105-110. [IN FRENCH]&lt;/P&gt;
&lt;P&gt;16. A bereavement service in a critical care unit. Wilkins K, Dalby L. &lt;EM&gt;Nursing Times&lt;/EM&gt; 2000&amp;nbsp;96(45):38-39. &lt;/P&gt;
&lt;P&gt;17. A bereavement care service to address multicultural user needs. Chaplin D. &lt;EM&gt;Nursing Times&lt;/EM&gt; 2003&amp;nbsp;99(39):26-29. &lt;/P&gt;
&lt;P&gt;18. A Group approach to overcome loss. A model for a bereavement service in general practice. Fenner P, Manchershaw A. &lt;EM&gt;Professional Nurse&lt;/EM&gt; 1993 8(10):680,682-684. &lt;/P&gt;
&lt;P&gt;19. Description and evaluation of a bereavement group for people with learning disabilities. Mappin R, Hanlon D. &lt;EM&gt;British Journal of&lt;/EM&gt; &lt;EM&gt;Learning Disabilities&lt;/EM&gt; 2005 33(3):106-12. &lt;/P&gt;
&lt;P&gt;20. Mediating and moderating effects of parental distress on family bereavement program effectiveness. Twohey-Jacobs JL. &lt;EM&gt;Dissertation Abstracts International: Section B: The Sciences and Engineering&lt;/EM&gt;, 2004, vol. 64, no. 10-B, p. 5239, ISSN: 0419-4217. Publisher: Univ Microfilms International, US, &lt;A href="http://www.il.proquest.com/umi/" target="_blank"&gt;http://www.il.proquest.com/umi/&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;21. Art therapy with incarcerated women who have experienced the death of a loved one. Ferszt GG, Hayes PM, DeFedele S, Horn L. &lt;EM&gt;Art Therapy&lt;/EM&gt; 2004&amp;nbsp;21(4):191-199. &lt;/P&gt;
&lt;P&gt;22. Psychological intervention in Madrid March 11 after terrorist attacks. De La Cruz AL, Muñoz PFA, Torres EP, Torres AP, Martín MR, Dávila MP, Val-Espinosa MSD, Olivares AG. &lt;EM&gt;Cliníca y Salud&lt;/EM&gt;, 2004 15, no. Monograph, p. 7-88, ISSN: 1130-5274. Publisher: Colegio Oficial de Psicólogos de Madrid, Spain, &lt;A href="http://www.cop.es/" target="_blank"&gt;http://www.cop.es&lt;/A&gt;. [IN SPANISH]&lt;/P&gt;
&lt;P&gt;23. Effects of an educational bereavement program on health care professionals' perceptions of perinatal loss. Di Marco M, Renker P, Medas J, Bertosa H, Goranitis JL. &lt;EM&gt;Journal of Continuing Education Nursing&lt;/EM&gt; 2002&amp;nbsp;33(4):180-6. &lt;/P&gt;
&lt;P&gt;24. Bereavement care interventions : a systematic review. Forte AL, et-al. &lt;EM&gt;BMC Palliative Care&lt;/EM&gt; 2004&amp;nbsp;3(3) URL: &amp;lt;&lt;A href="http://www.biomedcentral.com/content/pdf/1472-684X-3-3.pdf" target="_blank"&gt;http://www.biomedcentral.com/content/pdf/1472-684X-3-3.pdf&lt;/A&gt;&amp;gt;. &lt;/P&gt;
&lt;P&gt;25. An active postvention program. Campbell FR, Cataldie L, McIntosh J, Millet K. &lt;EM&gt;Crisis: The Journal of Crisis Intervention and Suicide Prevention&lt;/EM&gt; 2004&amp;nbsp;25(1):30-32.&lt;/P&gt;
&lt;P&gt;26. Insights on death &amp;amp; dying. Memorial service: forget me not. Ufema J. &lt;EM&gt;Nursing&lt;/EM&gt; 2005 35(7):26. &lt;/P&gt;
&lt;P&gt;27. The Family Bereavement Program: Efficacy evaluation of a theory-based prevention program for parentally bereaved children and adolescents. Sandler IN, Ayers TS, Wolchik SA, Tein JY, Kwok&amp;nbsp; Oi M, Haine RA, Twohey-Jacobs J, Suter J, Lin K, Padgett-Jones S, Weyer JL, Cole E, Kriege G, Griffin WA. &lt;EM&gt;Journal of Consulting and Clinical Psychology&lt;/EM&gt; Jun 2003&amp;nbsp;71(3):587-600. &lt;/P&gt;
&lt;P&gt;28. What works for therapists conducting family meetings: treatment integrity in family-focused grief therapy during palliative care and bereavement. Chan EKH, O'Neill I, McKenzie M, Love A, Kissane DW. &lt;EM&gt;Journal of Pain and Symptom Management&lt;/EM&gt; 2004&amp;nbsp;27(6):502-512. &lt;/P&gt;
&lt;P&gt;29. Survey of UK hospice and specialist palliative care adult bereavement. Field D, Reid D, Payne S, Relf M. &lt;EM&gt;International Journal of Palliative Nursing&lt;/EM&gt; 2004 10(12):569-576. &lt;/P&gt;
&lt;P&gt;30. The use of research findings in bereavement programs: a case study. Murphy SA. &lt;EM&gt;Death Studies&lt;/EM&gt; 2000&amp;nbsp;24(7):585-602. &lt;/P&gt;
&lt;P&gt;31. Exploring bereavement care in inpatient settings. Street AF, Love AW, Blackford J. &lt;EM&gt;Contemporary Nurse:&amp;nbsp;A Journal for the Australian Nursing Profession&lt;/EM&gt; 2004&amp;nbsp;17(3):240-250. &lt;/P&gt;
&lt;P&gt;32. Outcome evaluation of bereavement groups for adults with intellectual disabilities. Stoddart KP, Burke L, Temple V. &lt;EM&gt;Journal of Applied Research in Intellectual Disabilities&lt;/EM&gt; 2002&amp;nbsp;15(1):28-35.&lt;/P&gt;
&lt;P&gt;33. Acute bereavement care in the emergency department: does the professional-supported volunteers model work? Ting SM, Li P, Lau FL, Chan YC, Chan YK, Lai PW, Choi K, Au A, Cheung B, Tse CY. &lt;EM&gt;European Journal of Emergency Medicine&lt;/EM&gt; 1999 6(3):237-43. &lt;/P&gt;
&lt;P&gt;34. An evaluation of a hospice memorial service. Duncan F, Findlayson R, Wilson P. &lt;EM&gt;Bereavement Care&lt;/EM&gt; 2004&amp;nbsp;23(1):8-10. &lt;/P&gt;
&lt;P&gt;35. A bereavement after-care service for intensive care relatives and staff: the story so far. Williams R, Harris S, Randall L, Nichols R, Brown S. &lt;EM&gt;Nursing in Critical Care&lt;/EM&gt; 2003 8(3):109-15. &lt;/P&gt;
&lt;P&gt;36. Support groups helping women through pregnancies after loss. Côté AD, Freije MM. &lt;EM&gt;Western Journal of Nursing Research&lt;/EM&gt; 2004&amp;nbsp;26(6):650-70. &lt;/P&gt;
&lt;P&gt;37. A year in the life of a bereavement counselling and support service for people with learning disabilities. Read S. &lt;EM&gt;Journal of Learning Disabilities&lt;/EM&gt; 2001 5(1):19-33.&lt;/P&gt;
&lt;P&gt;38. The ABCs of bereavement volunteers: Acquire, build, cherish. Osborne C. &lt;EM&gt;American Journal of Hospice and Palliative Care&lt;/EM&gt; 1999&amp;nbsp;16(1):380-5. &lt;/P&gt;
&lt;P&gt;39. Establishing a bereavement program: caring for bereaved families and staff in the emergency department. LeBrocq P, Charles A, Chan T, Buchanan M. &lt;EM&gt;Accident and Emergency Nursing&lt;/EM&gt; 2003&amp;nbsp;11(2):85-90. &lt;/P&gt;
&lt;P&gt;40. Evaluating a support group for perinatal loss. DiMarco MA, Menke EM, NcNamara T. &lt;EM&gt;MCN: The American Journal of Maternal/Child Nursing&lt;/EM&gt; 2001, 26(3):135-140. &lt;/P&gt;
&lt;P&gt;41. Bereavement support for couples following death of a baby: program development and 14-year exit analysis... reprinted from Death Studies 26:21-37. Reilly-Smorawski B, Armstrong AV, Catlin EA. &lt;EM&gt;Neonatal Intensive Care&lt;/EM&gt; 2002&amp;nbsp;15(7):40-47. &lt;/P&gt;
&lt;P&gt;42. Does grief counseling work? Jordan JR, Neimeyer RA. &lt;EM&gt;Death Studies&lt;/EM&gt; 2003&amp;nbsp;27(9):765-786. &lt;/P&gt;
&lt;P&gt;43. Broad-spectrum group treatment for parents bereaved by the violent deaths of their 12-28 yr old children: a randomized controlled trial. Murphy SA, Johnson C, Cain KC, Gupta AD, Dimond M, Lohan J, Baugher R. &lt;EM&gt;Death Studies&lt;/EM&gt; 1998&amp;nbsp;22(3):209-35. &lt;/P&gt;
&lt;P&gt;44. Developing a multi-agency bereavement service. Wright B, Elvans H, King P, Schneider J, Thompson R, Gillance H. &lt;EM&gt;European Journal of Palliative Care&amp;nbsp;&lt;/EM&gt;2002 9(4):160-163. &lt;/P&gt;
&lt;P&gt;45. Collaboration between hospital social work and pastoral care to help families cope with serious illness and grief. Hart CW, Matorin S. &lt;EM&gt;Psychiatric Services&lt;/EM&gt; 1997&amp;nbsp;48(12):1549-1552. &lt;/P&gt;
&lt;P&gt;46. Palliative care nursing: part 2. Addressing bereavement issues through education. Douglas M, Pemberton S, Hewitt B. &lt;EM&gt;Nursing Times&lt;/EM&gt; 2002&amp;nbsp;98(42):36-37. &lt;/P&gt;
&lt;P&gt;47. Death-related crisis intervention, grief counseling, grief consultation, and death education: A national survey of the role of school psychologists. Seadler KM. &lt;EM&gt;Dissertation Abstracts International Section A: Humanities and Social Sciences&lt;/EM&gt;, Mar 2000, vol. 60, no. 8-A, p. 2816, ISSN: 0419-4209. Publisher: Univ Microfilms International, US, &lt;A href="http://www.il.proquest.com/umi/" target="_blank"&gt;http://www.il.proquest.com/umi/&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;48. Should paediatric units have bereavement support posts? Jennings P. &lt;EM&gt;Archives of Disease in Childhood&lt;/EM&gt; 2002&amp;nbsp;87(1):40-42. &lt;/P&gt;
&lt;P&gt;49. Development of a bereavement program in a tertiary medical center. Snyder D, Ellison NM, Neidig N. &lt;EM&gt;Journal of Palliative Medicine&lt;/EM&gt;&amp;nbsp;2002 5(6):877-882. &lt;/P&gt;
&lt;P&gt;50. Facilitating older spouses' adjustment to widowhood: A preventive intervention program. Raveis VH. &lt;EM&gt;Social Work in Health Care&lt;/EM&gt; 2000 29(4):13-32. &lt;/P&gt;
&lt;P&gt;51. Professional issues. A bereavement counselling service for parents: part 2. Herkes B. &lt;EM&gt;British Journal of Midwifery&lt;/EM&gt; 2002&amp;nbsp;10(3):135-139. &lt;/P&gt;
&lt;P&gt;52. Development of a grief workshop at a community college. Trammell M. &lt;EM&gt;TCA Journal &lt;/EM&gt;1999 27(2):87-9. &lt;/P&gt;
&lt;P&gt;53. Beneficial effects of a hospital bereavement intervention program after traumatic childhood death... including commentary by Jurkovich GJ, Cooper A, Mullins RJ, Rivera FA and Hammond JS with author response. Oliver RC, Sturtevant JP, Scheetz JP, Fallat ME. &lt;EM&gt;Journal of Trauma&lt;/EM&gt; 2001&amp;nbsp;50(3):440-448. &lt;/P&gt;
&lt;P&gt;54. Teaching grief and bereavement. Involving support groups in educating student midwives. Mitchell M, Catron G. &lt;EM&gt;Practising Midwife&lt;/EM&gt; 2002 5(8):26-27. &lt;/P&gt;
&lt;P&gt;55. A bereavement service in a critical care unit. Wilkins K, Dalby L. &lt;EM&gt;Nursing Times&lt;/EM&gt;, 2000 96(45):38-39. &lt;/P&gt;
&lt;P&gt;56. Telephone support groups for HIV-positive mothers whose children have died of AIDS. Wiener LS. &lt;EM&gt;Social Work &lt;/EM&gt;1998 43(3):279-285. &lt;/P&gt;
&lt;P&gt;57. Through grief to healthy parenthood: facilitating the journey through a family pregnancy support programme. Caelli K, Downie J, Knox M. &lt;EM&gt;Birth Issues&lt;/EM&gt;, 1999&amp;nbsp;8(3):85-90. &lt;/P&gt;
&lt;P&gt;58. Evaluation of a pet loss support hotline. Turner WG. &lt;EM&gt;Anthrozoos&lt;/EM&gt;, 1997&amp;nbsp;10(4):225-230. &lt;/P&gt;
&lt;P&gt;59. Bereavement services in acute care settings. Fauri DP, Ettner B, Kovacs PJ. &lt;EM&gt;Death Studies&lt;/EM&gt;, 2000 24(1):51-64. &lt;/P&gt;
&lt;P&gt;60. Bereavement support for couples following death of a baby: program development and 14-year exit analysis. Reilly-Smorawski B, Armstrong AV, Catlin EA.&lt;EM&gt; Death Studies &lt;/EM&gt;2002 26(1):21-37. &lt;/P&gt;
&lt;P&gt;61. Life, loss and living program. Gillmore VL. &lt;EM&gt;Creative Nursing&lt;/EM&gt; 2001&amp;nbsp;&amp;nbsp;7(4):13. &lt;/P&gt;
&lt;P&gt;62. Beneficial effects of a hospital bereavement intervention program after traumatic childhood death. Oliver RC, Sturtevant JP, Scheetz JP, Fallat ME. &lt;EM&gt;Journal of Trauma &lt;/EM&gt;2001 50(3):440-446; discussion 447-448. &lt;/P&gt;
&lt;P&gt;63. A bereavement intervention for parents following the sudden, violent deaths of their 12-28-year-old children: description and applications to clinical practice. Murphy SA. &lt;EM&gt;Canadian Journal of Nursing Research&lt;/EM&gt;, 1997&amp;nbsp;29(4):51-72. &lt;/P&gt;
&lt;P&gt;64. Parenting classes as a part of a hospice bereavement program. Glazer HR, Clark MD. &lt;EM&gt;Hospice Journal&lt;/EM&gt; 1997 12(3):33-40.&lt;/P&gt;
&lt;P&gt;65. Young widows' experience with an Internet self-help group. Bacon ES, Condon EH, Fernsler JI. &lt;EM&gt;Journal of Psychosocial Nursing and Mental Health Services&lt;/EM&gt; 2000&amp;nbsp;38(7):24-33. &lt;/P&gt;
&lt;P&gt;66. Introducing a bereavement support programme in ICU. Tunnicliffe R, Briggs D. &lt;EM&gt;Nursing Standard&lt;/EM&gt; 1997&amp;nbsp;11(47):38-40. &lt;/P&gt;
&lt;P&gt;67. Effects of a program of intervention on parental distress following infant death. Murray JA, Terry DJ, Vance JC, Battistutta D, Connolly Y. &lt;EM&gt;Death Studies&lt;/EM&gt; 2000 24(4):275-305. &lt;/P&gt;
&lt;P&gt;68. Student interns help expand hospice bereavement services. Oman K. &lt;EM&gt;Continuum: An Interdisciplinary Journal on Continuity of Care&lt;/EM&gt; 1997 17(2):16-19. &lt;/P&gt;
&lt;P&gt;69. Weekend courses for families who have lost a child with cancer. Sirkiä K, Ahlgren B, Hovi L, Saarinen-Pihkala UM. &lt;EM&gt;Medical and Pediatric Oncology&lt;/EM&gt; 2000 34(5):352-355. &lt;/P&gt;
&lt;P&gt;70. The Forget-Me-Not Program: incorporating bereavement care into the continuum. Skiba LA, Clark EJ, Kalmer KA. &lt;EM&gt;Continuum: An Interdisciplinary Journal on Continuity of Care&lt;/EM&gt;, 1997 17(2):11-15.&lt;/P&gt;
&lt;P&gt;71. Bereavement follow-up: an opportunity to extend nursing care. Ruden BM. &lt;EM&gt;Journal of Pediatric Oncology Nursing&lt;/EM&gt; 1996&amp;nbsp;13(4):219-225. &lt;/P&gt;
&lt;P&gt;72. A memorial service for renal patients. Ormandy P. &lt;EM&gt;EDTNA/ERCA Journal&lt;/EM&gt; (English ed.) 1998 24(3):22-24. &lt;/P&gt;
&lt;P&gt;73. Acute bereavement services and routine referral as a mechanism to increase donation. Duckworth RM, Sproat GW, Morien M, Jeffrey TB. &lt;EM&gt;Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)&lt;/EM&gt; 1998&amp;nbsp;8(1):16-18. &lt;/P&gt;
&lt;P&gt;74. Efficacy of an educational bereavement program for families of veterans with cancer. Abrahm JL, Cooley M, Ricacho L. &lt;EM&gt;Journal of Cancer Education&lt;/EM&gt; 1995&amp;nbsp;10(4):207-212. &lt;/P&gt;
&lt;P&gt;75. International hospice - Australia. A qualitative evaluation of a bereavement service: an analysis of the experiences of consumers and providers of services in Australia. Marquis R. &lt;EM&gt;American Journal of Hospice and Palliative Care&lt;/EM&gt; 1996&amp;nbsp;13(4):38-43. &lt;/P&gt;
&lt;P&gt;76. Workshops to support the bereavement process. Beem EE, Eurelings-Bontekoe EH, Cleiren MP, Garssen B. &lt;EM&gt;Patient Education and Counseling&lt;/EM&gt; 1998 34(1):53-62. &lt;/P&gt;
&lt;P&gt;77. A memorial service for families of children who died from cancer and blood disorders... with commentary by Cleaveland MJ. Heiney SP, Wells L, Ruffin J. &lt;EM&gt;Journal of Pediatric Oncology Nursing&lt;/EM&gt; 1996&amp;nbsp;13(2):72-80. &lt;/P&gt;
&lt;P&gt;78. Trauma bereavement program: review of development and implementation. Buchanan HLK, Geubtner MD, Snyder CK. &lt;EM&gt;Critical Care Nursing Quarterly&lt;/EM&gt; 1996&amp;nbsp;19(1):35-45. &lt;/P&gt;
&lt;P&gt;79. Perceptions of social work intervention with bereaved clients: some implications for hospital social work practice. Lord B, Pockett R. &lt;EM&gt;Social Work in Health Care&lt;/EM&gt; 1998 27(1):51-66. &lt;/P&gt;
&lt;P&gt;80. Developing strategies to assist sudden-death families: a 10-year perspective. Williams M, Frangesch B. &lt;EM&gt;Death Studies&lt;/EM&gt; 1995&amp;nbsp;19(5):475-487. &lt;/P&gt;
&lt;P&gt;81. The Blue Pages. Current Canadian neonatal research: memories of a gentle presence... the Neonatology Bereavement Program... the family's perspective. Jack A. &lt;EM&gt;Neonatal Network: The Journal of Neonatal Nursing&lt;/EM&gt; 1995&amp;nbsp;14(8):49. &lt;/P&gt;
&lt;P&gt;82. Camp Carousel: a weekend grief retreat. LoCicero JP, Burkhart J, Gray S. &lt;EM&gt;American Journal of Hospice &amp;amp; Palliative Care&lt;/EM&gt; 1998 15(1): 25-27. &lt;/P&gt;
&lt;P&gt;83. Bereavement services development in a rural setting. Wilker HI, Lowell B.&amp;nbsp;Hospice Journal 1996 11(4):25-39. &lt;/P&gt;
&lt;P&gt;84. Parents' evaluation of a preventive intervention following the sudden, violent deaths of their children. Murphy SA, Baugher R, Lohan J, Scheideman J, Heerwagen J, Johnson LC, Tillery L, Grover MC. &lt;EM&gt;Death Studies&lt;/EM&gt; 1996 20(5):453-468. &lt;/P&gt;
&lt;P&gt;85. Parent bereavement stress and preventive intervention following the violent deaths of adolescent or young adult children. Murphy SA. &lt;EM&gt;Death Studies&lt;/EM&gt; 1996 20(5):441-452. &lt;/P&gt;
&lt;P&gt;86. A psychoeducational bereavement-support group for families provided in an outpatient cancer center. Goldstein J, Alter CL, Axelrod R. &lt;EM&gt;Journal of Cancer Education:&amp;nbsp;Official Journal of the American Association for Cancer Education&lt;/EM&gt; 1996&amp;nbsp;11(4):233-237.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>267423</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=267423]]&gt;</url>
    <title>Introduction to end-stage renal disease in palliative and supportive care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health Palliative &amp; Supportive Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ UNITED KINGDOM,SYMPTOM MANAGEMENT,POLICY,SERVICE PROVISION,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,RENAL DISEASES,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,END-OF-LIFE CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction to end-stage renal disease in palliative and supportive care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Definitions&lt;/H2&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;Chronic kidney disease&lt;/STRONG&gt;&lt;/EM&gt; (CKD) differs somewhat from other advanced diseases in that there is a specific measure of disease severity (glomerular filtration rate - GFR) which can be used as an indicator of how advanced the disease is. When estimated GFR falls below 15 mL per minute per 1.73 m body surface area, the CKD patient has reached Stage 5, the most advanced stage of chronic kidney disease [1]. At this point, renal replacement therapy (in the form of dialysis or renal transplant) must be considered if the patient is to survive in the long term, although a small proportion of patients with slow decline in renal function may not develop symptoms of uraemia (and so need renal replacement) for weeks, months or (rarely) years after first reaching Stage 5.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;End-stage renal disease&lt;/STRONG&gt;&lt;/EM&gt; (ESRD) is irreversible decline in kidney function, severe enough to be fatal in the absence of dialysis or transplantation [2] (i.e. it refers to the time when renal replacement is actually needed). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Which renal patients need palliative care?&lt;/H2&gt;
&lt;P&gt;Patients whose palliative and supportive care needs should be considered are those with Stage 5 CKD who:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;•&amp;nbsp;Decline renal replacement therapy (dialysis or transplant) through their own preference &lt;BR&gt;•&amp;nbsp;Are advised against renal replacement therapy because the burden of frequent dialysis is felt to outweigh likely survival and quality of life benefits (a complex and difficult decision likely to apply more often to those with poorer prognoses)&lt;BR&gt;•&amp;nbsp;Have been on dialysis but&amp;nbsp;are now withdrawing or about to withdraw from dialysis&lt;BR&gt;•&amp;nbsp;Are ON dialysis but with a poor prognosis, often because of co-morbid conditions (especially cardiac disease) &lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Context of end of life care in renal disease&lt;/H2&gt;
&lt;P&gt;Renal deaths account for just 1-2% of all deaths [3, 4], although this is an underestimate - other causes of death frequently intervene or co-exist in the final days making death registration an imprecise record. But numbers reaching ESRD are increasing steadily (by between 2-8 % annually [5, 6]), and this increase is projected to continue in parallel with the ageing of the general population and the growing prevalence of diabetes mellitus [7]. Many patients will have one or more co-morbidities [5, 6], and may well die from causes other than their renal disease.&lt;/P&gt;
&lt;P&gt;As with all non-cancer conditions, understanding of survival and illness trajectory (and how these differ from cancer) is important to estimate the best timing for and triggers into palliative care (general, renal and specialist palliative care, as needed), the resources needed for palliative and end-of-life provision, and to facilitate advance care planning. It is also important to understand palliative needs, including symptom prevalence, psychological needs, social and spiritual needs, as well as which interventions are most effective.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Guidance/evidence available&lt;/H2&gt;
&lt;P&gt;Guidance: &lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=10295" target="_blank"&gt;see what is under this tab&amp;nbsp;in the Library&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Evidence: &lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=10295&amp;amp;tabID=289" target="_blank"&gt;see what is under this tab in the Library&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Characteristics of this population:&lt;/EM&gt;&lt;/STRONG&gt; Most patients with ESRD needing palliative care are older people, with high levels of co-morbidity [5,6]; they have variable and often complex needs, with symptoms which are often unaddressed [8]. A systematic literature review of symptom prevalence in ESRD identified evidence mainly from dialysis populations, but illustrates the high prevalence of symptoms experienced by these patients [9]. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Dialysis withdrawal:&lt;/EM&gt;&lt;/STRONG&gt; Recent reviews of the evidence in those withdrawing from dialysis identify mean survival from withdrawal as 8-10 days, with a range of 1-44 days [10, 11],&amp;nbsp; but also highlight the dearth of evidence on palliative needs. Retrospective review suggests palliative needs may be considerable [12]. In one of the few studies prospectively assessing symptoms in those withdrawing from dialysis, Cohen and colleagues show that a significant minority have distressing symptoms in the last 24 hours, although most deaths were viewed as peaceful by relatives [13,14]. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Conservative (non-dialytic) management:&lt;/EM&gt;&lt;/STRONG&gt; Conservative management has only emerged as a specific management option relatively recently, although services are rapidly developing for this group [15]. There has been little evidence about the palliative needs of those managed without dialysis, although this is gradually changing and recent studies are beginning to show that the symptom burden is as high as that of cancer patients [16, 17, 18]. Some preliminary evidence about survival is also emerging, with 1- and 2-year survival (from first reaching stage 5 CKD) of 68% and 47% respectively [19, 20]. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Wider evidence on ESRD:&lt;/EM&gt;&lt;/STRONG&gt; There is a rich seam of research evidence about ESRD that can be usefully extrapolated to palliative and end of life care, although only limited indication of this can be provided here. For instance, the psychological and social impacts of ESRD are known to be considerable, with extensive demands on patient and family, and complex transitions to be negotiated [21, 22, 23]. Communication, especially in relation to dialysis decision-making and advance planning, is key [24, 25], yet presents many challenges [26, 27]. Patients mostly want families to be actively involved in communication, but patient and family preferences may differ [28]. Provision of social and family support is likely to improve outcomes [29, 30], but needs particular resources and models of care. These findings suggest that the patient-centred (rather than disease-centred) approach of palliative care, with attention to psychological, social and spiritual (as well as physical) needs may have much to offer patients with ESRD and their families.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Clinical and policy developments:&lt;/EM&gt;&lt;/STRONG&gt; There is growing recognition within nephrology and palliative circles of the needs of these ESRD patients, with recent publication of the first text book on renal supportive care [31], and national recognition of palliative and end-of-life needs in the National Service Framework for Renal Diseases&amp;nbsp;[32] and the Royal College of Physicians report on the Changing Face of Renal Medicine [33]. A renal version of the Liverpool Care Pathway is under development nationally [34], and clinical guidelines on opioid use in ESRD managed without dialysis have been published [35]. As this is a rapidly changing area of clinical and research practice, resources and evidence are likely to continue to evolve quickly.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;1. &lt;A href="http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm" target="_blank"&gt;http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm&lt;/A&gt; Accessed 6 Aug 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2. Levey AS, Eckhardt K-U, Tsukamoto Y, Levin A et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International (2005) 67, 2089–2100; doi:10.1111/j.1523-1755.2005.00365.x&lt;/P&gt;
&lt;P&gt;3. Heron MP, Smith BL. Deaths: Leading causes for 2003. National Vital Statistics reports; 55 (10). Hyattsville, MD: Center for Health Statistics, 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;4. Mortality statistics – Review of the Registrar General on Deaths in England &amp;amp; Wales, 2004. Series DH1 no 37. Office for National Statistics, London, UK. 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;5. Ansell D, Feest T, Rao R, Williams A, Winearls C. UK Renal Registry Report 2005. Bristol: UK Renal Registry; 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;6. U.S. Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;7. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. The Lancet, 2005; 365: 331-40.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;8. Davison, S. N. Pain in Hemodialysis Patients: Prevalence, Cause, Severity, and Management. American Journal of Kidney Diseases; 2003: 42(6): 1239-47.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;9. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in Chronic Kidney Disease, 2007 January; 14 (1): 82-99.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;10. Germain, M.J, Cohen LM, Davison SN. Withholding and withdrawal from dialysis: what we know about how our patients die. Semin.Dial. 20.3 (2007): 195-99.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;11. Murtagh FEM, Cohen LM, Germain M. Dialysis Discontinuation: Quo Vadis? Advances in Chronic Kidney Disease, 2007 (in press).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;12. Chater, S., et al. "Withdrawal from dialysis: a palliative care perspective." Clin.Nephrol. 66.5 (2006): 364-72.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;13. Cohen, L. M., et al. "Dying well after discontinuing the life-support treatment of dialysis." Archives of Internal Medicine. 160.16 (2000): 2513-18.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;14. Cohen, L. M., et al. "Dialysis discontinuation and palliative care." American Journal of Kidney Diseases. 36.1 (2000): 140-44.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;15. Murtagh FEM, Murphy E, Shepherd KA, Donohoe P, Edmonds PM. End of life care in end stage renal disease: renal and palliative care collaboration. British Journal of Nursing, Jan 2006, 15 (1): 8-11.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;16. Murtagh&amp;nbsp; FEM, Addington-Hall J, Edmonds PM, Donohoe P, Carey I, Jenkins KJ, Higginson IJ. Symptoms in advanced renal disease – a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. Journal of Palliative Medicine, 2007; 10 (6): (in press)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;17. Davison, S. N. "Chronic pain in end-stage renal disease." Adv.Chronic Kidney Dis. 12.3 (2005): 326-34.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;18. Saini T, Murtagh FE, Dupont PJ, McKinnon PM, Hatfield P, Saunders Y. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat Med 2006 September;20(6):631-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;19. Smith C, Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clinical Practice 2003;95 (2):c40-c46.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;20. Murtagh FEM, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with Chronic Kidney Disease Stage 5. Nephrology Dialysis Transplantation, 2007 Access published April 4, 2007, doi:10.1093/ndt/gfm153&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;21. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD. The emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. International Journal of Psychiatry in Medicine 1983;13(4):327-43.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;22. Hutchinson TA. Transitions in the lives of patients with End Stage Renal Disease: a cause of suffering and an opportunity for healing. Palliat Med 2005 June;19(4):270-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;23. White Y, Grenyer BF. The biopsychosocial impact of end-stage renal disease: the experience of dialysis patients and their partners. Journal of Advanced Nursing 1999 December;30(6):1312-20.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;24. Swartz R, Perry E. Advance directives in end-stage renal disease inherently involve family and staff. Advances in Renal Replacement Therapy 5(2):109-19, 1998 Apr (84 ref) 1998 April;(2):109-19.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;25. Perry E, Swartz R, Smith-Wheelock L, Westbrook J, Buck C. Why is it difficult for staff to discuss advance directives with chronic dialysis patients? Journal of the American Society of Nephrology Vol 7(10)()(pp 2160-2168), 1996 1996;(10):2160-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;26. Holley JL, Stackiewicz L, Dacko C, Rault R. Factors influencing dialysis patients' completion of advance directives. Am J Kidney Dis 1997 September;30(3):356-60.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;27. Holley JL, Hines SC, Glover JJ, Babrow AS, Badzek LA, Moss AH. Failure of advance care planning to elicit patients' preferences for withdrawal from dialysis. American Journal of Kidney Diseases 1999 April;33(4):688-93.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;28. Hines SC, Glover JJ, Holley JL, Babrow AS, Badzek LA, Moss AH. Dialysis patients' preferences for family-based advance care planning. Annals of Internal Medicine 1999 May 18;130(10):825-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;29. Devins GM, Hunsley J, Mandin H, Taub KJ, Paul LC. The marital context of end-stage renal disease: illness intrusiveness and perceived changes in family environment. Annals of Behavioral Medicine 1997;19(4):325-32.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;30. Ferrario SR, Zotti AM, Baroni A, Cavagnino A, Fornara R. Emotional reactions and practical problems of the caregivers of hemodialysed patients. Journal of Nephrology 2002 January;15(1):54-60.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;31. Supportive Care for the Renal Patient. Chambers, EJ, Germain M, Brown E (eds). Oxford: Oxford University Press, 2004.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;32. Department of Health. National Service Framework for Renal Services - Part 2. London: Department of Health, 2005.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;33. The Royal College of Physicians. The changing face of renal medicine in the UK: the future of the speciality. Report of a Working Party 2007. London; RCP, 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;34. Douglas C, Murtagh FEM, Ellershaw J et al. Symptom control for the patient dying with ESRD – development of evidence based guidelines based on the LCP. Abstract accepted at the 10th EAPC Conference, 2007. Available at: &lt;A href="http://www.eapcnet.org/budapest2007/pdf/thursday_poster.pdf" target="_blank"&gt;http://www.eapcnet.org/budapest2007/pdf/thursday_poster.pdf&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;35. Murtagh FEM, Chai MO, Donohoe P, Edmonds PM, Higginson IJ. The Use of Opioid Analgesia in End-Stage Renal Disease Patients Managed without Dialysis: Recommendations for Practice. Journal of Pain and Palliative Care Pharmacotherapy, 2007; 21 (2); 5-16.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260256</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260256]]&gt;</url>
    <title>Introduction to policy in palliative and supportive care</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POLICY,SERVICE PROVISION,UNITED KINGDOM,INTERNATIONAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction to policy in palliative and supportive care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;1. Definition of topic &lt;/H2&gt;
&lt;P&gt;Policy is important and should be considered by all involved in the commissioning, provision and delivery of all aspects of palliative and supportive care. Although sometimes it may be difficult to see its relevance to practice, clear examples of the need to keep abreast of policy to inform practice and service development are evident. For example, when considering the recent White Paper Our Health, Our Care, Our Say (England, 2006) this is already leading to the development of an end of life care strategy which will directly affect all involved in palliative care by the formation of end of life care networks, rapid response teams and hospice at home services. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;By the very nature of the field, policy development in palliative and supportive care involves a range of stakeholders from the voluntary sector, NHS, primary care, secondary care, care homes, housing, social care, users, carers. It is important that all of these stakeholders are involved in policy development so policy can truly reflect the complex nature of palliative and supportive care planning, delivery, commissioning and provision. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There are different types of policy documents but typically they are likely to do one or both of the following: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;set out an agreed formal policy position&lt;/LI&gt;
&lt;LI&gt;analyse data and points of view and put forward proposals &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Examples of the former would be National Service Frameworks or guidance from the National Institute for Health and Clinical Excellence. These set out the policy of statutory organisations and, as such, are the basis for practice and service development in public services. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Examples of the latter would include documents from think tanks or pressure groups such as the Kings Fund, DEMOS or the National Council for Palliative Care. These documents are usually intended to influence the development of policy by Government or statutory agencies and may or may not therefore become incorporated into the delivery of public services. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Policy documents in relation to palliative care may cover a wide range of issues including: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;clinical issues&lt;/LI&gt;
&lt;LI&gt;organisational issues &lt;/LI&gt;
&lt;LI&gt;wider social and demographic issues &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Clinical issues relate to practical aspects of how care is delivered, including any protocols or guidance relating to communication, drugs and technologies. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Organisational issues include the funding and commissioning of services and co-ordination between service providers. Palliative care is unusual in the extent to which the voluntary sector provides and funds services. This may be one reason why organisational issues generate significant discussion in the palliative care context. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Wider social and demographic issues may include the implications of changes in society for the delivery of services. For example this might be the ageing population, the increase in chronic illness and co-morbidity or the implications of cultural difference for service provision. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;2. Guidance/Evidence available &lt;/H2&gt;
&lt;P&gt;&lt;BR&gt;Guidance: &lt;BR&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=288" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=288&lt;/A&gt; &lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Evidence: &lt;BR&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=289&amp;amp;" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=289&amp;amp; &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information &lt;/H2&gt;
&lt;P&gt;The National Council for Palliative Care have a policy unit and policy groups formed of all key stakeholders to develop policy. Updates on all key aspects are available at: &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncpc.org.uk/policy_unit/index.html" target="_blank"&gt;http://www.ncpc.org.uk/policy_unit/index.html&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Information on the work of the Policy team at Help the Hospices is available at:&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.helpthehospices.org.uk/policy/index.asp" target="_blank"&gt;http://www.helpthehospices.org.uk/policy/index.asp&lt;/A&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References &lt;/H2&gt;
&lt;P&gt;Dept of Health: &lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/index.htm" target="_blank"&gt;Publications policy and guidance&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;'Reference' section of the Library: &lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=290" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9096&amp;amp;tabID=290&lt;/A&gt; &lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304366</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304366]]&gt;</url>
    <title>Introduction to the 19 Jan 2009 AEU</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,COMMUNICATION ISSUES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Introduction to the 19 Jan 2009 AEU&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The first Annual Evidence Update on 'Patient and carer involvement in chronic disease' was published on 19 January 2009. It collects together the best current knowledge on self care in chronic disease management.&amp;nbsp; Key resources from a small sample of chronic conditions, together with the End of Life Care setting are placed within the general theme of user involvement in health services.&lt;/P&gt;
&lt;P&gt;User involvement in healthcare has become firmly established in the UK and has been actively encouraged by the Department of Health in the care of longterm conditions.&amp;nbsp; The &lt;A href="http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;amp;r=true&amp;amp;o=10893" target="_blank"&gt;NICE guidance (2004) on supportive and palliative care for adults with cancer&lt;/A&gt; helpfully distinguished between “user involvement in decision-making about a person’s own treatment or care and participation in the development of services for all patients.”&amp;nbsp; The guidance further clarified –&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;“User involvement means enabling people who use – or may use – services to voice their experiences and influence broader care.&lt;/P&gt;
&lt;P&gt;They may participate in:&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;service planning to ensure that services meet the needs of patients and carers&lt;/LI&gt;
&lt;LI&gt;the evaluation of services&lt;/LI&gt;
&lt;LI&gt;mutual support with other patients and carers through selfhelp and support groups and individual peer-to-peer support schemes.”&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;The NICE guidance identified the following objectives of user involvement with respect to supportive and palliative care in cancer –&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;“The objectives are to ensure that:&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;user involvement is valued as an integral aspect of service planning and delivery&lt;/LI&gt;
&lt;LI&gt;the views of patients and carers are obtained, taken into account and acted upon by those developing and evaluating cancer services&lt;/LI&gt;
&lt;LI&gt;patient and carer led activity is recognised and supported as an integral part of cancer care.”&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;One area where user involvement has been very active is in cancer research, with the importance attached to the &lt;A href="http://www.ncrn.org.uk/" target="_blank"&gt;National Cancer Research Network&lt;/A&gt; (NCRN) &lt;A href="http://ncrndev.org.uk/index.php?option=com_content&amp;amp;task=view&amp;amp;id=68&amp;amp;Itemid=115" target="_blank"&gt;Consumer Liaison Group &lt;/A&gt;and its representatives in each of the disease-site research groups.&amp;nbsp;In many of the UK cancer networks there are consumer research panels, and probably the well-established one is in &lt;A href="http://www.ntcrp.org.uk/page46.html" target="_blank"&gt;North Trent&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;However, supportive and palliative care now extends far beyond cancer and embraces the patients and families coping with many longterm and progressive conditions including chronic respiratory, cardiac and renal disease; longterm fatal neurological conditions; and most recently, supportive care has acquired a role in the aftercare of patients who are ‘survivors’ of cancer, but have longterm ‘late effects’ of the disease and its treatments. [See &lt;A href="http://www.improvement.nhs.uk/cancer/SurvivorshipLivingWithandBeyondCancer/tabid/65/Default.aspx" target="_blank"&gt;the NHS Cancer Surviorship website&lt;/A&gt;&amp;nbsp;and &lt;A href="http://www.macmillan.org.uk/Get_Involved/Campaigns/Survivorship.aspx" target="_blank"&gt;Macmillan's Survivorship pages&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;In this year’s Annual Evidence Update we are focusing on just a few of these areas but in future updates we will expand the scope and also, given the spurt in research in user involvement, we will bring out evidence for the place of user involvement from clinical studies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>113209</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.kidney.org/professionals/KDOQI/]]&gt;</url>
    <title>Kidney disease outcomes quality initiative</title>
    <publicationDate></publicationDate>
    <publisher>National Kidney Foundation (USA)</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SERVICE PROVISION,AUDIT,OUTCOME MEASURES,SERVICE DEVELOPMENT,RENAL DISEASES,ACCESS TO PALLIATIVE AND SUPPORTIVE CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Kidney Disease Outcomes Quality Initiative or KDOQI provides evidence-based clinical practice guidelines developed by volunteer physicians and health care providers for all stages of chronic kidney disease and related complications, from diagnosis to monitoring and management.&lt;/P&gt;
&lt;P&gt;KDOQI expands the Dialysis Outcomes Quality Initiative or DOQI, a project begun by the US National Kidney Foundation in 1997 and recognized throughout the world for improving the care of dialysis patients.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260250</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260250]]&gt;</url>
    <title>Knowledge outline: Breakthrough pain in cancer patients</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PAIN MANAGEMENT,SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE,CANCER,CONDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge outline: Breakthrough pain in cancer patients&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Definition&lt;/H2&gt;
&lt;P&gt;Breakthrough pain has been defined as “an abrupt, short lived and intense pain that ‘breaks through’ the around the clock analgesia that controls persistent pain.” (Bennett, 2005) It is usually related to background pain and is typically of rapid onset, severe in intensity, and generally self-limiting with an average duration of 30 minutes (Zeppetella 2003). &lt;/P&gt;
&lt;P&gt;Three types of breakthrough pain are described: &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Incident pain:&lt;/STRONG&gt; commonest and related to movement/coughing&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Idiopathic/ spontaneous pain:&lt;/STRONG&gt; no identifiable cause; lasts longer than incident pain&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;End of dose failure:&lt;/STRONG&gt; prior to scheduled dose of analgesia; gradual onset.&amp;nbsp; Often not regarded as true breakthrough pain (Payne, 2007)&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;Prevalence in patients with cancer has been reported as 65% (Caraceni, 1999), but it affects non-cancer and cancer patients. It is a poor prognostic indicator (Bruera 1995) and can have adverse effects such as decreased functioning, increased anxiety and depression and longer stays in hospital. (Portenoy 1999, Fortner 2002) &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Management&lt;/H2&gt;
&lt;P&gt;Portenoy suggested 3 principles for management: implementing primary therapies (surgery, radiotherapy, chemotherapy), optimising around the clock medication, specific pharmacological interventions (Portenoy, 1997). Pharmacological management should be tailored to the type of breakthrough pain: &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;&lt;STRONG&gt;Incident pain:&lt;/STRONG&gt; pre-emptive use of a short acting opioid 30 minutes before activity (McCarberg, 2007). The current European Association for Palliative Care (EAPC) recommendation is to use the same as the four-hourly dose of normal-release morphine (approximately 16% of the daily dose) when necessary (Hanks 2001). A recent Cochrane review of opioids for breakthrough pain concluded that it is appropriate to titrate the dose of rescue medication (Zeppetella, 2006)&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Idiopathic/ spontaneous:&lt;/STRONG&gt; peak intensity can occur in 3-5 minutes and episodes usually last for under 30 minutes, so analgesics with a delayed onset are not helpful for this type of pain. A recent Cochrane review found that oral transmucosal fentanyl citrate (OTFC) was shown to be “an effective treatment for breakthrough pain. When compared to placebo and morphine, participants gave lower pain intensity scores and higher pain relief scores for OTFC at all time points. Global assessment scores also favoured OTFC”. (Zepetella, 2006)&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;End of dose failure:&lt;/STRONG&gt; alter the around the clock medication to increase the dose or shorten the dosing interval ( McCarberg, 2007) &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;More than 4 episodes of breakthrough pain a day should suggest that the current management of the baseline/persistent pain should be reviewed (Coluzzi, 1998).&lt;/P&gt;
&lt;P&gt;Non-pharmacological management includes physical therapy, education about limitations and exacerbating factors and patient counselling to reduce anxiety (McCarberg, 2007). &lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Bennet, D.&amp;nbsp; Consensus panel recommendations for the assessment and management of breakthrough pain. Part 1 assessment. Pharmacy and Therapeutics 2005;30:296-301.&amp;nbsp;[no PubMed abstract]&lt;/P&gt;
&lt;P&gt;Bruera E, Scholler T, Wenk R, MacEachern T, Marcellino S, Hanson J, et al. A prospective multi-center assessment of the Edmonton staging system for cancer pain. Journal of Pain Symptom Management 1995;10:348-355. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=7673767&amp;amp;query_hl=57&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Caraceni A, Portenoy RK.&amp;nbsp;An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International association for the study of pain. Pain 1999; 82:263-74. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10488677&amp;amp;query_hl=59&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Coluzzi PH. Cancer pain management: newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care. 1998 Jan-Feb;15(1):13-22. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9468974&amp;amp;query_hl=86&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001;91(1-2):123-130. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11240084&amp;amp;query_hl=62&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalisations, emergency department visits, and physicians office visits reported by cancer patients with and without history of breakthrough pain. Journal of Pain 2002;3:38-44. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14622852&amp;amp;query_hl=1&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. British Journal of Cancer 2001;84:587-593. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11237376&amp;amp;query_hl=67&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;BR&gt;&lt;/A&gt;&amp;nbsp;&lt;BR&gt;Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical centre. Pain 2003;101:55-64. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12507700&amp;amp;query_hl=71&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;McCarberg, B. The treatment of breakthrough pain. Pain Med 2007 8:S 8-12. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17280601&amp;amp;query_hl=74&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Payne, R. Recognition and diagnosis of breakthrough pain. Pain Med 2007 8: S2-7. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17280600&amp;amp;query_hl=74&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Portenoy RK. Treatment of temporal variations in chronic cancer pain. Seminars in Oncology 1997;24:S16-7-S16-12. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9381227&amp;amp;query_hl=74&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;BR&gt;&amp;nbsp; &lt;BR&gt;Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999;81:129-134. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10353500&amp;amp;query_hl=74&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Zeppetella G, Ribeiro MDC. The pharmacotherapy of cancer-related episodic&amp;nbsp;pain. Expert Opinion in Pharmacotherapy 2003;4(4):493-502. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12667112&amp;amp;query_hl=83&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;BR&gt;&amp;nbsp; &lt;BR&gt;Zeppetella G, Ribeiro MDC. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004311. DOI: 10.1002/14651858.CD004311.pub2. &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=238582&amp;amp;tabID=289" target="_blank"&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259098</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=259098]]&gt;</url>
    <title>Knowledge outline: Mechanisms of pain</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ VISCERAL PAIN,BONE PAIN,NEUROPATHIC PAIN,PAIN MANAGEMENT,SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Produced as part of the National Knowledge Week for 'Pain in palliative and supportive care' Apr-May 2007.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge outline: Mechanisms of pain&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Nociception is normally transmitted by action potentials along unmyelinated C and thinly myelinated A delta fibres in response to a stimulus at receptors in peripheral nerves. These primary pain neurones end centrally in the superficial lamina of the dorsal horn of the spinal cord where they synapse with the second order neurone. The second order neurone which forms the ascending pathway decussates higher up on its way to relay in the thalamus. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Neuroimaging has highlighted several cortical areas critical for different aspects of pain processing. The primary and secondary sensory cortices in the post central gyrus are responsible for the localisation of pain. The amygdala as part of the limbic system convey the emotional response to the stimulus. The anterior cingulate cortex has a role in interpreting the intensity of the input and the pre frontal cortex brings the pain to our consciousness making it a sensation or symptom.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pain has been traditionally divided into nociceptive and neuropathic types, with acute and chronic describing duration rather than the underlying molecular pathophysiology. The entity of “cancer pain” embraces all of these classifications.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Peripheral sensitisation is primarily caused by prostanoid and cytokine release at the site of injury. Peripheral nerve sensitivity and synaptic transmission in the dorsal horn are subject to the excitatory influence of sodium and calcium channels. Inhibitory control is mediated via opioid and GABA&lt;SUB&gt;A&lt;/SUB&gt; receptors, activating potassium and chloride channels respectively. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Central sensitisation is the cumulative response to a sequence of events, starting in the dorsal horn synapses, which leads to the well known clinical picture of hyperalgesia and allodynia. Crucial to this process are the NMDA receptor channels and the generation of nitric oxide. Synaptic transmission is also under the influence of inducible COX. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;It is now clear from both animal and clinical studies that paradoxically opioids, which are heavily used in pain management, can cause hyperalgesia through the same NMDA mechanism. This can explain one of the main limitations of opioids, namely the development of tolerance.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Descending pathways from the PAG can modulate dorsal horn activity via serotonergic and noradrenergic mechanisms which may be inhibitory or excitatory. Another emerging inhibitory control is mediated via cannabinoid CB1 receptors.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Cancer pain has previously been regarded as “unique” but it is possible to understand it in the light of these recently described molecular mechanisms, which are ultimately mediated by the chronic inflammatory response. Most cancer pain may in fact be regarded as mixed inflammatory/neuropathic, regardless of the actual anatomical lesion. For example, the mechanisms underlying malignant bone pain have recently been elucidated. We now know that the central cortex of the bone is heavily innervated and these nerves are activated at a very early stage of metastatic bone disease.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As we further elucidate the mechanisms of pain at molecular, cellular and anatomical levels, we stand to develop more pharmacologically rational treatments with greater efficacy and less toxicity.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short term infusion of the µ-opioid receptor agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003, vol106; 49-57. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14581110&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. European Journal of&amp;nbsp;Pain 2005, vol 9; 463-484. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15979027&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. Journal of&amp;nbsp;Pain 2006, vol 7; 43-48. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16414554&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Fields H. State-dependent opioid control of pain. Nature Reviews Neuroscience 2004, vol 5; 565-575. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15208698&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed (no abstract)&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Gordon-Williams RM, Dickenson AH. Central neuronal mechanisms in cancer-induced bone pain. Current Opinion in Supportive and Palliative Care 2007, vol 1; 6-10. &lt;A href="http://www.co-supportiveandpalliativecare.com/" target="_blank"&gt;Link to journal homepage&lt;/A&gt;&amp;nbsp;[no PubMed entry yet]&lt;/P&gt;
&lt;P&gt;Holdcroft A, Power I. Management of pain. British Medical Journal 2003, vol 326; 635-639. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12649239&amp;amp;query_hl=7&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed (no abstract)&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mach DB, Rogers SD, Sabino MC, Luger NM et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 2002, vol 113; 155-166. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12123694&amp;amp;query_hl=32&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP. Molecular mechanisms of cancer pain. Nature Reviews Cancer 2002, vol 2, 201-209. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11990856&amp;amp;query_hl=32&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Research Reviews 1999, 30; 289-304. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10567729&amp;amp;query_hl=37&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Stahl SM. Mechanisms of action of alpha2delta ligands: voltage sensitive calcium channels (VSCC) modulators. Journal of&amp;nbsp;Clinical Psychiatry 2004, vol 65; 1033-1034. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15323585&amp;amp;query_hl=2&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to&amp;nbsp;PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259099</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=259099]]&gt;</url>
    <title>Knowledge outline: Medical management of cancer and chronic pain</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CANCER,CONDITIONS,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,NEUROPATHIC PAIN,BONE PAIN,VISCERAL PAIN,MEDICINES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Produced for the National Knowledge Week on 'Pain in palliative and supportive care' 30 Apr-6 May 2007</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge outline: Medical management of cancer and chronic pain&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The optimal control of chronic pain in cancer and many non-malignant diseases relies on the understanding of the underlying pathophysiology and molecular mechanisms involved.&amp;nbsp; Thus medical management starts with the diagnosis of the cause of the pain by clinical assessment and imaging.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The ideal mode of palliation (symptom control) is removal or minimisation of the cause, ie disease-directed therapies. For example in malignant bone pain we may use surgery, chemotherapy, radiotherapy and/or bisphosphonates. In infection, antimicrobials or surgical drainage of an abscess could be the first priority.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Alongside disease directed therapy, we now have a host of pharmacological and non-pharmacological medical therapies, which should be used on an individual basis depending on the clinical situation. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Since 1986 the prevailing model for the management of cancer – and latterly some forms of chronic non-malignant – pain has been the WHO 3-step analgesic ladder.&amp;nbsp; This guideline was born of a need for a simple, public health tool, especially for developing countries with little access to opioids.&amp;nbsp; It was not, in the modern sense, evidence-based.&amp;nbsp; The WHO approach relies heavily on the use of opioids, and in particular, oral morphine – with optional use of so-called ‘adjuvants’.&amp;nbsp; Several recent pain surveys and critical reviews have shown that in spite of 21 years of the WHO model, unrelieved cancer pain and ‘opiophobia’ is still as prevalent; and the adjuvant drugs are frequently under-employed. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Used alone and in high doses, opioids are prone to cause multiple troublesome adverse effects and other problems such as tolerance and hyperalgesia.&amp;nbsp; The long-term use of opioids for chronic pain has had mixed reception, when toxicities such as endocrine and immune suppression are included.&amp;nbsp; Indeed, the current trend of ‘opioid switching’ may be, in part, driven by the need to move between incompletely cross-tolerant opioids to minimise their inherent toxicities.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We now understand that opioids differ in terms of receptor binding affinities, pharmacokinetics and their physicochemical properties. This means certain opioids will have advantages over others due to differing side-effect profile, routes of administration, development of tolerance, and propensity for immunomodulation.&amp;nbsp;&amp;nbsp; Modern technologies for administration including transdermal, oral transmucosal and spinal delivery bring advantages in terms of reduced side-effects and/or convenience for many patients.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Endogenous and therapeutic opioids exert their powerful analgesic effect primarily by the activation of G-protein coupled receptors on neurones, which open potassium channels to hyperpolarise their membranes.&amp;nbsp; But these are not the only ‘magic bullets’ to target pain signal transmission.&amp;nbsp; The ‘adjuvants’ are now shown to work via other neuronal and synaptic receptors and ion channels, which may be as important as the opioid ones.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Thus, voltage-gated calcium channels can be blocked by gabapentin or pregabalin.&amp;nbsp; Sodium channels, which in turn activate calcium channels, can be blocked by local anaesthetics and older generation anti-epileptics such as carbamazepine.&amp;nbsp; Other drugs work by modulating noradrenergic and serotonergic transmission and re-uptake, eg tricyclic antidepressants and SNRIs (also tramadol). NSAIDs and COX inhibitors may exert antinociceptic action by dampening down not only peripheral sensitisation of nerve endings but also spinal synaptic transmission.&amp;nbsp; GABA&lt;SUB&gt;A&lt;/SUB&gt; receptors and possibly CB1 receptors reduce neuronal excitability, which can be exploited therapeutically by benzodiazepines, alcohol or cannabinoids.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In most forms of chronic pain, post-synaptic NMDA receptors are opened and these cause calcium influx, nitric oxide induction, neuronal excitability and gene expression leading to neuronal plasticity, central sensitisation, hyperalgesia and allodynia.&amp;nbsp; Specific NMDA channel blockers such as ketamine and dextro-isomers of many opioids, notably methadone, can attenuate these destructive changes.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Depending on the pathophysiology, it may therefore make good pharmacological sense to combine analgesics.&amp;nbsp; Rather than the WHO approach which treats ‘adjuvants’ as optional, there is increasing evidence of the benefit of routinely combining opioids with these other pharmacological agents for synergistic effects, with the prospect of reduced toxicity.&amp;nbsp; There is even emerging evidence that combining different opioids (with differing receptor binding/modulating properties) may lead to similar advantages.&amp;nbsp; The concept of multi-drug regimens working simultaneously on different cellular targets is not new, as the modern management of cancer, rheumatoid arthritis or heart failure show.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The medical management of pain can use non-pharmacological options, eg hypnosis or distraction therapies which act via the pre frontal cortex to decrease perception/sensation of pain.&amp;nbsp; Acupuncture may work by causing release of endogenous opioids.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In summary, modern cancer and chronic pain medical management should be multi-modal, using multiple pharmacological and other neuro-modulating approaches, to achieve analgesia with minimal side-effects and maximal patient convenience.&amp;nbsp; &lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Ahmedzai SH. Window of opportunity for pain control in the terminally ill. Lancet. 2001 Apr 28;357(9265):1304-5. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=11343728&amp;amp;query_hl=1&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt;&amp;nbsp;[no abstract]&lt;/P&gt;
&lt;P&gt;Ahmedzai SH, Boland J.&amp;nbsp; The total challenge of cancer pain in supportive and palliative care. Current Opinion in Supportive and Palliative Care 2007; 1: 3-5.&amp;nbsp;&lt;A href="http://www.co-supportiveandpalliativecare.com/pt/re/spc/pdfhandler.01263393-200704000-00003.pdf;jsessionid=GN8Vp7w0pbJvdPpGBM6RGhX2R0YdnDfTHhq8rLYGp2SXyZ1pQRJm!741375937!-949856145!8091!-1" target="_blank"&gt;Link to full text&lt;/A&gt;&amp;nbsp;[no PubMed entry yet]&lt;/P&gt;
&lt;P&gt;Ballantyne JC, Mao J. Opioid Therapy for Chronic Pain. N Engl J Med 2003;349:1943-53. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14614170&amp;amp;query_hl=1&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;/P&gt;
&lt;P&gt;Bell RF, Wisløff T, Eccleston C and Kalso E. Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review. British Journal of Cancer 2006. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16705312&amp;amp;query_hl=5&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;British Pain Society. Recommendations for the appropriate use of opioids in persistent non-cancer pain. The Pain Society 2004. &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=250460&amp;amp;tabID=288" target="_blank"&gt;Link here&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Clark AJ, Ahmedzai SH, Allan LG, Camacho F, et al. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004 Sep;20(9):1419-28. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15383190&amp;amp;query_hl=5&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Davies PS, Galer BS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64 (9): 937-947. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15101784&amp;amp;query_hl=19&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Davis MP. What is new in neuropathic pain? Support Care Cancer 2007. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17131133&amp;amp;query_hl=21&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Ferreira SL, Kimura M, Teixeira MJ. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer (2006) 14: 1086–1093.&amp;nbsp;&lt;A href="http://www.co-supportiveandpalliativecare.com/" target="_blank"&gt;Link to journal homepage&lt;/A&gt;&amp;nbsp;[no PubMed entry yet]&lt;/P&gt;
&lt;P&gt;Finnerup NB, Ottob M, McQuay H, Jensen TS, Sindrup SH.&lt;BR&gt;Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 118 (2005) 289–305. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16213659&amp;amp;query_hl=23&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Gilron I, Bailey JM, Tu D, Holden RR, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352:1324-1334. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15800228&amp;amp;query_hl=26&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Anita Holdcroft and Ian Power. Recent developments: Management of pain. BMJ 2003;326;635-639. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=12649239&amp;amp;query_hl=34&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed&lt;/A&gt; [no abstract]&lt;/P&gt;
&lt;P&gt;Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer. 2003 Dec 1;89(11):2027-30. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=14647133&amp;amp;query_hl=36&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Martell BA, O’Connor PG, Kerns RD, Becker WC et al. Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116-127. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17227935&amp;amp;query_hl=36&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Meert TF, Vermeirsch HA. A preclinical comparison between different opioids: antinociceptive versus adverse effects. Pharmacol Biol Behav 2005; 80: 309-326. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15680184&amp;amp;query_hl=40&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Meldrum M. The ladder and the clock: cancer pain and public policy at the end of the twentieth century. J Pain Symptom Manage. 2005 Jan;29(1):41-54. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15652438&amp;amp;query_hl=40&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005180. DOI: 10.1002/14651858.CD005180. &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=239015&amp;amp;tabID=289" target="_blank"&gt;Link to Cochrane review&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259348</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=259348]]&gt;</url>
    <title>Knowledge outline: Pain in HIV disease</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,INFECTIOUS DISEASES,PAIN MANAGEMENT,SYMPTOM MANAGEMENT,VISCERAL PAIN,BONE PAIN,NEUROPATHIC PAIN,HIV/AIDS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge outline: Pain in HIV disease&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Mechanisms&lt;/H2&gt;
&lt;P&gt;HIV disease has been transformed from a uniformly fatal illness to that of a chronic illness with antiretroviral therapy.&amp;nbsp; Because of this, peripheral neuropathies have become the most common neurological complications in HIV infection. They may be caused by the HIV itself or by its treatment and may in turn limit future treatment options.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The commonest forms of HIV-associated neuropathies (HIV-N) are the distal sensory polyneuropathies (DSP) and antiretroviral toxic neuropathies (ATN).&amp;nbsp; These are disorders characterized mostly by sensory symptoms that include spontaneous or evoked pain that follow a subacute or chronic course. Combined use of dideoxynucleosides&amp;nbsp; and stavudine (d4T) lead to so called d-type neuropathies which, in association with immune-mediated mechanisms triggered by HIV infection, are critical to the development of distal sensory polyneuropathy. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The neuropathy which HIV itself can cause is a slowly progressive painful neuropathy, whereas the neuropathy in patients receiving nucleoside analog reverse transcriptase inhibitor (NRTI) therapy (AZT, ddC, ddI, and d4T) is a distal symmetric small fibre axonal neuropathy that has a sudden onset of intense burning discomfort in both feet, sparing the hands.&amp;nbsp; NRTIs are associated with a three-fold increase in peripheral neuropathy in AIDS patients. They start at about the 10th week of treatment, and reach severe intensity over a period of days. This is an important source of morbidity in HIV-infected individuals, as the severely debilitating side-effect may force abbreviation or even discontinuation of NRTI therapy&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Mechanisms of toxic and metabolic peripheral neuropathy are usually due to second messenger signaling pathways (i.e. protein kinase A, protein kinase C, extracellular signal-regulated kinases or nitric oxide). However nucleoside analogues principally interfere with Ca &lt;SUP&gt;2+&lt;/SUP&gt;, caspase signaling and mitochondrial electron transport inducing mitochondrial toxicity (rather than the second messenger signaling pathways), with an enhanced risk with pre-existing mitochondrial defects.&amp;nbsp; Newer nucleoside analogues with less interaction with the DNA polymerase may have reduced impact on peripheral nerves and may therefore be associated with less peripheral neuropathy&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Chemokines and their receptors are expressed by neurons and glia throughout the nervous system; they have a variety of roles in addition to their immune function, producing a number of effects on synaptic transmission and on neuronal survival.&amp;nbsp; One of the mechanisms of HIV induced neuropathy is due to gp120 acting directly on nociceptors, activating DRG chemokine receptors which could be responsible for the increased pain sensitivity. Furthermore, an indirect action of gp120 is mediated by spinal microglia and astrocytes also may contribute to the increased pain state. In HIV neuropathy, changes in C-fiber function are restricted to a decrease in conduction velocity changes in ionic currents, especially the voltage gated ion channels.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Pathological changes&lt;/H2&gt;
&lt;P&gt;Markers of neuropathy such as intra-epidermal nerve fibre density from skin biopsies may be valuable tools in the detection and monitoring of distal sensory polyneuropathy. Reduction in fibre density, increased frequency of fibre varicosities and fibre fragmentation are prominent features of skin biopsies from patients with HIV-N.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Virological activity is associated with severity of neuropathic pain in distal sensory polyneuropathy. Enhanced viral suppression from antiretroviral agents may actually improve or decrease the frequency of certain types of neuropathy. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pathological features of DSP and ATN include axonal degeneration of long axons in distal regions, loss of unmyelinated fibers, and macrophage infiltration in peripheral nerves and dorsal root ganglia. Marked activation of macrophages as well as the effect of pro-inflammatory cytokines appears to be the main immunopathogenic factors in DSP. General immune activation, which is a feature of HIV-1 infection, also contributes, as do nutritional defects which can lead to small fibre sensory neuropathy. Immune activation in the gut and subsequent development of AIDS enteropathy can lead to nutritional defects that in turn cause sensory neuropathy.&amp;nbsp; Interference with DNA synthesis and mitochondrial abnormalities produced by nucleoside antiretrovirals have been hypothesized as pathogenic factors involved in ATN.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Opportunisitic infections, mostly associated with cytomegalovirus or herpes zoster virus infection can produce characteristic clinical features such as mononeuritis multiple or radiculopathies. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Common causes in the post-HAART (highly active antiretroviral therapy) era include peripheral neuropathy in association with isoniazid administration for TB; or co-infection with hepatitis B or C which can induce peripheral neuropathy with or without a vasculitis associated with cryoglobulinaemia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Management&lt;/H2&gt;
&lt;P&gt;Increased and improved surveillance for HIV-associated neuropathy will allow earlier interventions to improve quality of life and prevent severe toxicities. If the neuropathy is caused by HIV itself, HAART may help.&amp;nbsp; However, d4T and ddI/ddC should be avoided in the initial regimen.&amp;nbsp; In established neuropathy, specialist opinion should be sought as to altering the drug regimen.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Palliative treatment consists of the reduction of pain with opioids and non-opioid neuro-modulating agents (such as gabapentin and pregabalin). In practice amitriptyline is still often used though it may be less effective.&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, et al.&amp;nbsp;Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain. 2007 Apr 11; [Epub ahead of print] &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17433546&amp;amp;query_hl=89&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C, McGinnis C, White FA. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immun. 2007 Feb 8; [Epub ahead of print] &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17292584&amp;amp;query_hl=89&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Joseph EK, Levine JD. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain. 2006 Mar;121(1-2):105-14. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=16472913&amp;amp;query_hl=89&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Chen X, Levine JD. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat. Mol Pain. 2007 Feb 23;3:5. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17319957&amp;amp;query_hl=96&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Verma S, Estanislao L, Simpson D.&amp;nbsp;&amp;nbsp;HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs. 2005;19(4):325-34. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15813646&amp;amp;query_hl=98&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Kieburtz K, Simpson D, Yiannoutsos C, Max MB et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998 Dec;51(6):1682-8. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=9855523&amp;amp;query_hl=98&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Hahn K, Arendt G, Braun JS, von Giesen HJ et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies J Neurol. 2004 Oct;251(10):1260-6. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15503108&amp;amp;query_hl=98&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowedge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259097</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=259097]]&gt;</url>
    <title>Knowledge outline: The role of the pain clinic</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,SERVICE PROVISION,NEUROPATHIC PAIN,BONE PAIN,VISCERAL PAIN,PAIN CLINICS,PLACE OF CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Produced for the National Knowledge Week on 'Pain in palliative and supportive care' Apr-May 2007.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge outline: The role of the pain clinic&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;It is predicted that the number of people in Britain over 65 years will have grown by 25% from 9.4 million in 1992 to 11.8 million by 2020. Cancer and non-cancer pain is increasingly prevalent in the over-65 age group, and chronic pain is estimated to occur in 70-90% of patients with advanced cancer. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pain clinics, like palliative medicine, embrace a multidisciplinary ethos, which is a prerequisite for the complex and multi-system nature of symptoms that arise. Both disciplines help to manage the character, distress and impact of persistent pain. Both services aim to manage symptoms rather than effect cure. Recognition of this agenda helps specialists, patients and carers focus positively on symptom management.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;UK pain clinics have developed, since the early 1960s, from those run by single-handed enthusiasts to the current multi-disciplinary clinics. Pain management specialists, predominantly anaesthetic-trained, work alongside professions allied to health. The synthesis of the diverse knowledge base of the team members coupled with the interventional skills of anaesthetists has created a wide range of effective treatment modalities in palliative pain management.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Different models of pain-palliative care services exist in the UK, which are influenced by local service organisation, skill mix and historical referral structures.&amp;nbsp; Pain clinics range from those which are fully integrated with palliative medicine - assessing patients simultaneously - to clinics with parallel or separate assessment. It is imperative that patient assessment be linked through established communication mechanisms.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Patients are often referred to a pain clinic with troublesome drug side-effects, or inadequate pain control.&amp;nbsp; Frequently however, there are also unspoken fears of addiction, of reporting pain and anxiety because of their implications as well as fear of loss of control. Professionals provide the environment in which these fears and concerns can be shared. They assess and design acceptable treatments in partnership with patients. Communication is vital, patients should be encouraged to share their fears, feel listened-to and enter agreed treatment strategies with their full understanding.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Good assessment is the key to understanding the cause of the pain and treatment options. Not all pain in cancer is cancer-related. Some pain may have developed because of the primary disease; others are secondary to treatment; or they may arise through unrelated causes. The character, severity and pattern of symptoms help direct the specialist’s examination, investigations and treatment planning. There is increasing evidence for earlier palliative intervention with strong opioids and invasive procedures.&amp;nbsp; For example, good evidence supports neurolytic celiac plexus blocks for pancreatic cancer leading to better symptom control with reduced systemic analgesia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pain clinics aim to be patient-centred, but the structures for dealing with family and carers are less well-developed than in hospice care. The carer’s role is often relegated to that of providing transport and emotional support. However, carers may become a key part of the process - providing reinforcement of advice and information and helping with non-pharmacological strategies of pain control. For them too, the pain clinic offers a calm environment, clear information and a point of reference for future contact. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pain specialists convey rationale for investigations, positive clinical findings, treatment options and possible risks; and help set realistic goals. In partnership with other professionals and with patients and carers, they engender agreed plans, objectives and time frames which build continuity and trust.&amp;nbsp; Barriers still exist in the evaluation of the adequacy of cancer pain management, patient compliance with medication and awareness of the treatment options that a pain clinic can offer. Education about the advances in pain medicine, the need for earlier and individualised treatment regimes, coupled with improved patient information on medication and side-effects may help towards breaking down these barriers.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Imperial Cancer Research Fund. The cancer problem.&amp;nbsp;Imperial Cancer Research Fund. 1999. &lt;/P&gt;
&lt;P&gt;Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353: 1695-1700. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=10335806&amp;amp;query_hl=22&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Marinangeli F et al. J Pain Sypmtom Manage 2004; 22: 1975-1992. [abstract]&lt;/P&gt;
&lt;P&gt;Goudas L,&amp;nbsp;Carr DB, Bloch R, Balk E, Ioannidis JPA, Terrin N, Gialeli-Goudas M, Chew P, Lau J. Management of cancer pain, AHRQ Evidence Reports, No 35. Rockville, MD: AHRQ, 2001. &lt;A href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.49577" target="_blank"&gt;Link to full text&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol. 2007; 102(2): 430-8. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17100960&amp;amp;query_hl=28&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Russell PB, Aveyard SC, Oxenham DR.&amp;nbsp;An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symp Manage. 2006; 32(6): 581-8. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=17157760&amp;amp;query_hl=30&amp;amp;itool=pubmed_docsum" target="_blank"&gt;Link to PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88190</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/153/CN-00123153/frame.html]]&gt;</url>
    <title>Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives</title>
    <publicationDate></publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,WITHHOLDING &amp; WITHDRAWING TREATMENT,ADVANCE DIRECTIVES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The purpose of this study was to describe the life-sustaining treatment preferences of dialysis patients and to compare the acceptability of two generic and a disease-specific advance directive (AD).]]&gt;</body>
  </document>
  <document>
    <id>271125</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271125]]&gt;</url>
    <title>Lymphoedema / chronic oedema – a neglected area?</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SERVICE PROVISION,SYMPTOM MANAGEMENT,LYMPHOEDEMA,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,HAEMATOLOGIC AND LYMPHATIC DISEASES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Lymphoedema / chronic oedema – a neglected area?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Dr Vaughan Keeley, Consultant in Palliative Medicine, Derby Hospitals NHS Foundation Trust.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;Lymphoedema is a chronic incurable condition where there is an accumulation of fluid, fibrosis and fat in the tissues as a result of failure of lymphatic drainage.&amp;nbsp; It has long been thought to be an uncommon and untreatable problem.&amp;nbsp; Therefore, until recently, there has been little investment in the development of lymphoedema services (Lymphoedema Framework, 2007) and relatively little research has been carried out into its aetiology and treatment (Williams et al, 2005).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Prevalence&lt;/H2&gt;
&lt;P&gt;A study of chronic oedema in SW London has recently revealed that it is much more common than previously thought with a prevalence, of 1.33/1000 population similar to that of venous leg ulcers (Moffatt et al, 2003).&amp;nbsp; In addition, prevalence increases with age (5.4 / 1000 in those aged &amp;gt;65 years and 10.3 / 1000 in those &amp;gt;85 years). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Lymphoedema or chronic oedema?&lt;/H2&gt;
&lt;P&gt;Pure lymphoedema can be classified as:&lt;BR&gt;a)&amp;nbsp;Primary&amp;nbsp;&amp;nbsp;-&amp;nbsp;due to an abnormality of development of the lymphatics.&lt;BR&gt;b)&amp;nbsp;Secondary&amp;nbsp;-&amp;nbsp;where the lymphatics are damaged by an extrinsic process e.g. surgery, radiotherapy, trauma or infection. (International Society of Lymphology, 2003)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;P&gt;However, in many clinical situations, the aetiology of the oedema is more complex e.g. in leg oedema arising from immobility in a variety of chronic medical conditions such as neurological weakness, arthritis, respiratory diseases and obesity.&amp;nbsp; In this situation the oedema is both lymphatic and venous in origin (lymphovenous oedema) due to failure of the muscular pump which normally aids lymphatic and venous flow in mobile individuals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Hence, the term “chronic oedema”, which covers the range of aetiologies and describes oedema of at least 3 months duration, is clinically relevant (Moffatt et al, 2003).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;New research in primary lymphoedemas&lt;/H2&gt;
&lt;P&gt;Primary lymphoedemas are relatively uncommon conditions.&amp;nbsp; They may present at birth or shortly afterwards, with another peak of incidence around puberty but some patients do not develop swelling until later on in life.&amp;nbsp; The aetiology of primary lymphoedemas is poorly understood but in recent years new discoveries have identified gene mutations in some inherited forms of primary lymphoedema.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Milroy’s disease, a primary lymphoedema of the lower limbs which presents at or shortly after birth and has an autosomal dominant pattern of inheritance, has been found to be due to a mutation in the gene for Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) (Karkkainen et al, 2000).&amp;nbsp; The pathology is thought to be a distal hypoplasia of the lymphatics (Bollinger et al, 1983) and the phenotype of families with this gene mutation is largely confined to these lymphatic abnormalities (Brice at al, 2005).&lt;/P&gt;
&lt;P&gt;A rarer form of inherited primary lymphoedema, lymphoedema-distichiasis, characterised by pubertal onset of leg oedema together with a double row of eyelashes (distichiasis), has been found to be due to a mutation in the FOXC2 gene.&amp;nbsp; (FOXC2 is a transcription factor involved in a variety of developmental pathways) (Fang et al, 2000).&amp;nbsp; The pathology in this situation seems to be an abnormality in the development of lymphatic (and venous) valves, resulting in reflux (Rosbotham et al, 2000).&amp;nbsp; Patients with lymphoedema-distichiasis may have other abnormalities including varicose veins, ptosis, congenital heart disease and cleft palate (Brice et al, 2002).&amp;nbsp; &lt;/P&gt;
&lt;P&gt;A better understanding of the pathology of primary lymphoedemas may lead to improved treatments in the future.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conclusions&lt;BR&gt;&lt;/H2&gt;
&lt;P&gt;Lymphoedemas and chronic oedemas comprise a variety of conditions with different aetiologies and pathologies.&amp;nbsp; Full assessment and diagnosis can facilitate the choice of appropriate treatment (see next section).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Bollinger A et al (1983).&amp;nbsp; Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphoedema (Milroy’s disease).&amp;nbsp; Lymphology 16: 27-30.&lt;/P&gt;
&lt;P&gt;Brice G et al (2002).&amp;nbsp; Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q 24.&amp;nbsp; J. Med. Genet. 39: 478-483.&lt;/P&gt;
&lt;P&gt;Brice G et al (2005).&amp;nbsp; Milroy disease and the VEGFR-3 mutation phenotype.&amp;nbsp; J. Medical Genetics 42: 98-102.&lt;/P&gt;
&lt;P&gt;Fang J et al (2000).&amp;nbsp; Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphoedema-distichiasis syndrome.&amp;nbsp; Am. J. Hum. Genet. 67: 1382-8.&lt;/P&gt;
&lt;P&gt;International Society of Lymphology (2003).&amp;nbsp; The Diagnosis and Treatment of peripheral lymphoedema: a consensus document.&amp;nbsp; Lymphology 36: 84-91. &lt;/P&gt;
&lt;P&gt;Karkkainen MJ et al (2000).&amp;nbsp; Missense mutations interfere with VEGFR-3 signalling inn primary lymphoedema.&amp;nbsp; Nature Genetics 25: 153-9.&lt;/P&gt;
&lt;P&gt;Lymphoedema Framework (2007).&amp;nbsp; Template for Management: developing a lymphoedema service.&amp;nbsp; London: MEP Ltd.&lt;/P&gt;
&lt;P&gt;Moffatt CJ, Franks PJ, Doherty DC et al (2003).&amp;nbsp; Lymphoedema: an underestimated health problem.&amp;nbsp; Q J Med 96: 731-738.&lt;/P&gt;
&lt;P&gt;Rosbotham JL et al (2000).&amp;nbsp; Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy.&amp;nbsp; Br. J. Dermatol. 142: 148-152.&lt;/P&gt;
&lt;P&gt;Williams AF, Franks PJ, Moffatt CJ (2005).&amp;nbsp; Lymphoedema: estimating the size of the problem.&amp;nbsp; Palliat Med 19: 300-313.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304469</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304469]]&gt;</url>
    <title>Lymphoedema Update for NLH: Information for patient and carer involvement</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Pallliative Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,LYMPHOEDEMA,COMMUNICATION ISSUES,HAEMATOLOGIC AND LYMPHATIC DISEASES,INDIVIDUAL INVOLVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Lymphoedema Update for NLH: Information for patient and carer involvement&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;&lt;FONT size=2&gt;Back to the CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Download the pdf by selecting the link under 'Related Files' below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304475</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304475]]&gt;</url>
    <title>Lymphoedema. List of useful resources (updated Jan 2009)</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,HAEMATOLOGIC AND LYMPHATIC DISEASES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Lymphoedema. List of useful resources (updated Jan 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The following guidance, papers and reviews were all published within the last 12 months and although they are written primarily for healthcare professionals involved in the care of patients with lymphoedema, they may also be of considerable interest to patients and carers themselves.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Guidance&lt;/H2&gt;
&lt;P&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1. Liposuction for Chronic Lymphoedema&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=280968&amp;amp;tabID=288" target="_blank"&gt;NICE Guidance – Interventional Procedure IPG251 February 2008&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Primary Lymphoedema&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;British Journal of Dermatology, June 2008, vol./is. 158/6(1210-5), 1365-2133. Damstra RJ, van Steensel MA, Boomsma JH, Nelemans P, Veraart JC. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18363756" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18363756" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;3. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis&lt;/STRONG&gt; 
&lt;P&gt;British Journal of Dermatology, June 2008, vol./is. 158/6(1350-1353), 0007-0963;1365-2133. Soo J.K., Bicanic T.A., Heenan S., Mortimer P.S. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18241266" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;4. Candidate gene analysis in primary lymphedema&lt;/STRONG&gt; 
&lt;P&gt;Lymphatic Research &amp;amp; Biology, 2008, vol./is. 6/2(69-76), 1539-6851. Ferrell RE, Kimak MA, Lawrence EC, Finegold DN. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18564921" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;5. HGF and MET mutations in primary and secondary lymphedema&lt;/STRONG&gt; 
&lt;P&gt;Lymphatic Research &amp;amp; Biology, 2008, vol./is. 6/2(65-8), 1539-6851. Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18564920" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Secondary Lymphoedema&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;6. Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors&lt;/STRONG&gt; 
&lt;P&gt;Lymphology, March 2008, vol./is. 41/1(18-28), 0024-7766. Hayes S, Janda M, Cornish B, Battistutta D, Newman B. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18581955" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;7. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema&lt;/STRONG&gt; 
&lt;H3&gt;&lt;/H3&gt;
&lt;P&gt;Cancer, June 2008, vol./is. 112/12(2809-19), 0008-543X. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18428212" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;8. Lymphedema in the morbidly obese patient: unique challenges in a unique population&lt;/STRONG&gt; 
&lt;P&gt;Ostomy Wound Management, January 2008, vol./is. 54/1(44-56), 0889-5899. Fife CE, Carter MJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18250486" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;9. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function&lt;/STRONG&gt; 
&lt;P&gt;Journal of Clinical Oncology, July 2008, vol./is. 26/21(3536-42), 1527-7755. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18640935" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;10. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment&lt;/STRONG&gt; 
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=297306&amp;amp;tabID=289" target="_blank"&gt;Moseley A L, Carati C J, Piller N B. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Annals of Oncology, 2007; 18(4): 639-646&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Manual Lymphatic Drainage &amp;amp; Complex Decongestive Physiotherapy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;11. Manipulative therapy of secondary lymphedema in the presence of locoregional tumors&lt;/STRONG&gt; 
&lt;P&gt;Cancer, February 2008, vol./is. 112/4(950-4), 0008-543X. Pinell XA, Kirkpatrick SH, Hawkins K, Mondry TE, Johnstone PA. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18085587" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;12. Effects of complex decongestive physiotherapy on the oedema and the quality of life of lower unilateral lymphoedema following treatment for gynecological cancer&lt;/STRONG&gt; 
&lt;P&gt;European Journal of Cancer Care, 01 September 2008, vol./is. 17/5(463-468), 09615423. Kim S, Park Y. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18637114" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Compression Therapy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;13. Controlled, comparative study of relation between volume changes and interface pressure under short-stretch bandages in leg lymphedema patients&lt;/STRONG&gt; 
&lt;P&gt;Dermatologic Surgery, June 2008, vol./is. 34/6(773-8; discussion 778-9), 1524-4725. Damstra RJ, Brouwer ER, Partsch H. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18336577" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;14. Intermittent pneumatic compression - systems and applications&lt;/STRONG&gt; 
&lt;P&gt;Journal of Medical Engineering &amp;amp; Technology, May 2008, vol./is. 32/3(179-88), 0309-1902. Morris RJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18432465" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Surgical Literature&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;15. Controlled compression and liposuction treatment for lower extremity lymphedema&lt;/STRONG&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18720912" target="_blank"&gt; &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Lymphology, June 2008, vol./is. 41/2(52-63), 0024-7766. Brorson H, Ohlin K, Olsson G, Svensson B, Svensson H. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18720912" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;16. The management of genital lymphoedema&lt;/STRONG&gt; 
&lt;P&gt;BJU International, August 2008, vol./is. 102/4(480-4), 1464-410X. Garaffa G, Christopher N, Ralph DJ. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18325055" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;General Literature&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;17. Diagnosis and management of lymphatic vascular disease&lt;/STRONG&gt; 
&lt;P&gt;Journal of the American College of Cardiology, September 2008, vol./is. 52/10(799-806), 1558-3597. Rockson SG. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18755341" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;18. Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging&lt;/STRONG&gt; 
&lt;P&gt;Lymphology, March 2008, vol./is. 41/1(1-10), 0024-7766. Pecking AP, Alberini JL, Wartski M, Edeline V, Cluzan RV. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18581953" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;STRONG&gt;19. Complete decongestive physiotherapy with and without pneumatic compression for treatment of lipedema: a pilot study&lt;/STRONG&gt; 
&lt;P&gt;Lymphology, March 2008, vol./is. 41/1(40-4), 0024-7766. Szolnoky G, Borsos B, Barsony K, Balogh M, Kemeny L. &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/18581957" target="_blank"&gt;[Link to Pubmed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88918</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/044/CN-00108044/frame.html]]&gt;</url>
    <title>Mediated realism and the representation of a health care controversy</title>
    <publicationDate>1994-01-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,WITHHOLDING &amp; WITHDRAWING TREATMENT,EUTHANASIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Reviews a study designed to investigate the ways in which differing realism conditions (delivered through interactive video) influenced users' understanding of the issue of euthanasia and the case of Dax Cowart. Based on the study's findings, the author raises the issue of a possible trade-off between traditional values of objectivity and authenticity.]]&gt;</body>
  </document>
  <document>
    <id>311189</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=311189]]&gt;</url>
    <title>Message from Joan Hester, President of the British Pain Society</title>
    <publicationDate>2007-04-30T00:00:00</publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Message from Joan Hester, President of the British Pain Society&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;Welcome to this review of the 2007 Annual Scientific Meeting of the British Pain Society, held in Glasgow.&amp;nbsp; The scientific programme, organised by Dr Paul Watson, once again gave us the seamless organisation and variety of content we have come to expect.&lt;/P&gt;
&lt;P&gt;The British Pain Society is the largest multidisciplinary professional organisation in the field of pain within the UK. Our membership comprises medical pain specialists, nurses, physiotherapists, scientists, psychologists, occupational therapists and other healthcare professionals actively engaged in the diagnosis and treatment of pain and in pain research for the benefit of patients.&lt;/P&gt;
&lt;P&gt;The British Pain Society Lecture was given by Professor Henry McQuay, whose infinite originality and clarity of thought, delivered with a modicum of common sense, has inspired and delighted members for many years.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Professor McQuay is the master of systematic reviews.&amp;nbsp; What have they told us about managing pain?&amp;nbsp; They have certainly told us that pain management is difficult; that there are no quick fixes, no easy answers.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Imaging may in the future teach us that chronic pain is a neurodegenerative disorder; but the power of the empathic healthcare professional in helping the pain sufferer should not be underestimated.&lt;/P&gt;
&lt;P&gt;For more information about the British Pain Society and for details of the Annual Scientific Meeting programme in full, &lt;A href="http://www.britishpainsociety.org/" target="_blank"&gt;visit its website&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;FONT size=3&gt;Comment from Specialist Library for Palliative and Supportive Care:&lt;/FONT&gt; &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;On each of the following days of our National Knowledge Update on Pain, we will feature highlights from the Annual Scientific Meeting.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Apart from the thought-provoking lecture on systematic reviews by Professor McQuay (Oxford) referred to by Joan Hester above, we will feature keynote lectures on cellular mechanisms of pain memory (Professor Jürgen Sandkühler – Vienna); and the role of microglia in pain (Professor Mike Salter – Ontario).&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Of the many excellent workshops, we have focused on one reviewing current knowledge on mechanisms and management of pain in cancer survivors, with contributions from Dr John Wiliams (London), Dr Bill Macrae (Dundee) and Dr Paul Farquhar-Smith (London).&amp;nbsp; &lt;/P&gt;
&lt;P&gt;We are also delighted to feature the work of the Expert Patients Programme in the field of chronic pain, through their representatives at the conference, Pete Moore and Dianne Wright.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowedge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>101598</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/433/CN-00422433/frame.html]]&gt;</url>
    <title>Methodologic issues in collecting data from debilitated patients with cancer near the end of life</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,FAMILIES &amp; CARERS,RESEARCH]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "Accruing patients to clinical trials and retaining them when they are critically ill and near death are extraordinarily difficult tasks. The inability to recruit and retain subjects for clinical trials has implications for integrity of data, data analysis, success of the project, and the cost of conducting such projects in the future."]]&gt;</body>
  </document>
  <document>
    <id>271104</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271104]]&gt;</url>
    <title>Methodology - National Knowledge Week 22-26 Oct 2007</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health</publisher>
    <publicationType>EDITORIAL OR OPINION PIECE</publicationType>
    <topics>&lt;![CDATA[ NERVOUS SYSTEM DISEASES,RESPIRATORY DISEASES,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,ALZHEIMER’S DISEASE,LYMPHOEDEMA,MOTOR NEURONE DISEASE,VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD),CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD),SERVICE PROVISION,HAEMATOLOGIC AND LYMPHATIC DISEASES,PARKINSON'S DISEASE,RENAL DISEASES,INFORMATION SERVICES AND LIBRARIES,SERVICE TYPE,HUNTINGTON'S DISEASE,MULTIPLE SCLEROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Methodology - National Knowledge Week 22-26 Oct 2007&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The main aim of this National Knowledge Week was to highlight the best current palliative and supportive care evidence across several 'non-cancer' topics at once. We also sought to&amp;nbsp;engage as many clinicians and other experts in the development of the Library's resources in these areas as possible. The amount and&amp;nbsp;depth of expert participation in this enterprise - developing the 'community of practice' - is, arguably, just as important as the completed information products themselves. Not least because it is these networks of people who will go on to produce the updated versions in the months and years that follow - be that within NLH or in other knowledge services.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For these reasons, we were obviously not able to provide as much detail in each area as we could have done had we been concentrating on a single topic all week. However, we hope that this introduction will be the start of more detailed activity in the Library on each of these topics. The aim is that this&amp;nbsp;would culminate in a more extensive Annual Evidence Update for each topic in 2008.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A mix of methods was used in each topic. The development of the Library is a research exercise in itself, so we are always keen to find the best ways to approach the tasks in hand. Different contributors require different amounts of help or advice from the Library's project team. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The method used to produce the two pieces by Jason Boland is perhaps nearest to the model of how the National Library for Health is encouraging Library teams to proceed. Here, a clinician works closely with an NLH&amp;nbsp;information specialist (me in this case) to search for (i) a list of systematic reviews in a given topic&amp;nbsp;which have been published in a given time period, and then (ii) provides a critical analysis of those results arriving at a final list of useful good quality resources. &amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;However, other approaches - where contributors proceed largely in their own way with little interference from the project team except for the briefest of&amp;nbsp;directions and a small editorial function - can also produce excellent results. In the real world, clinicians and experts work in their own ways, with their own colleagues and in their own workplaces and networks. We sought to facilitate that rather than being too strict about conforming to a single method.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We hope that the exercise was useful in itself and that more experts in the field will be inspired to get involved with the production of Annual Evidence Updates in future. There are many areas we have not yet covered in great detail. The reason for this is often the lack of stimulus from an interested expert in the field. So if you would like to see us cover your area of expertise, do get in touch:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;You can do this by joining the email discussion list. See this page:&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=EMAIL" target="_blank"&gt;http://www.library.nhs.uk/palliative/Page.aspx?pagename=EMAIL&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Or you can email me direct:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Richard Stevens, Information Specialist&lt;/LI&gt;
&lt;LI&gt;email: &lt;A href="mailto:r.j.stevens@sheffield.ac.uk" target="_blank"&gt;r.j.stevens@sheffield.ac.uk&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260231</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260231]]&gt;</url>
    <title>National Knowledge Week on pain in palliative and supportive care 2007: Methodology for the Annual Evidence Update</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Knowledge Week on pain in palliative and supportive care 2007: Methodology for the Annual Evidence Update&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;STRONG&gt;Search strategy&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;To find the resources for this Annual Evidence Update, we used the &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query/static/clinical.shtml#reviews" target="_blank"&gt;PubMed Clinical Queries filter to find systematic reviews&lt;/A&gt; for pain in palliative and supportive care. &lt;/P&gt;
&lt;P&gt;We searched for the articles published in the years 2000-2006 inclusive. 2007 literature will be covered in the 2008 Annual Evidence Update.&lt;/P&gt;
&lt;P&gt;Our detailed search strategy (in the format returned from PubMed via email) was as follows:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;EM&gt;Search (palliative[All Fields] OR supportive[All Fields] OR (("hospices"[TIAB] NOT Medline[SB]) OR "hospices"[MeSH Terms] OR ("hospice care"[TIAB] NOT Medline[SB]) OR "hospice care"[MeSH Terms] OR hospice[Text Word]) OR terminal[All Fields]) AND systematic[sb] AND English[lang] AND "humans"[MeSH Terms] AND "pain" [MeSH Terms] Limits: English, Publication Date from 2000 to 2006, Meta-Analysis, Review, Bibliography, Humans&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Inclusion criteria&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;An article was included in our list if:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;It concerned a topic within the remit of supportive and palliative care.&lt;/LI&gt;
&lt;LI&gt;Its abstract stated explicitly that&amp;nbsp;it was a systematic review, or we judged that it was&amp;nbsp;likely to be one.&lt;/LI&gt;
&lt;LI&gt;It was not an opinion or consensus piece - even when this was from a reputable organisation.&lt;/LI&gt;
&lt;LI&gt;It was the most up to date Cochrane review in PubMed. Previous versions of the same review were not included.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Appraisal&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The clinical members of the team (Jason Boland and Sam H Ahmedzai) appraised the abstracts of each retireved article to decide whether to include them in this Annual Evidence Update. Richard Stevens designed and carried out the search and other information management tasks.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The search produced 93 records. Of these, 37 were included in our list.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260301</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260301]]&gt;</url>
    <title>National Knowledge Week on pain in palliative and supportive care 2007: Other resources on pain</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PAIN MANAGEMENT,SYMPTOM MANAGEMENT,PALLIATIVE AND SUPPORTIVE CARE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Knowledge Week on pain in palliative and supportive care 2007: Other resources on pain&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Books&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;Davis M, Glare P, Hardy J (eds).&amp;nbsp; &lt;STRONG&gt;Opioids in cancer pain&lt;/STRONG&gt;.&amp;nbsp;2005. Oxford: Oxford University Press.&amp;nbsp; (ISBN 0-19-852943-0)&lt;/LI&gt;
&lt;LI&gt;H. Flor, E. Kalso, and J. Dostrovsky (eds) &lt;STRONG&gt;Proceedings of the 11th World Congress on Pain 2006&lt;/STRONG&gt; International Association for Study of Pain (ISBN 0-931092-60-4)&lt;/LI&gt;
&lt;LI&gt;Stephen J. Gibson and Debra K. Weiner&amp;nbsp; &lt;STRONG&gt;Pain in Older Persons&lt;/STRONG&gt; 2005. International Association for Study of Pain (ISBN 0-931092-59-0)&lt;/LI&gt;
&lt;LI&gt;Rober H. Dworkin and William S. Breitbart&amp;nbsp; &lt;STRONG&gt;Psychosocial Aspects of Pain: A Handbook for Health Care Providers&lt;/STRONG&gt; 2003. International Association for Study of Pain&amp;nbsp; (ISBN 0-931092-48-5)&lt;/LI&gt;
&lt;LI&gt;Marcia L. Meldrum &lt;STRONG&gt;Opioids and Pain Relief: A Historical Perspective &lt;/STRONG&gt;2003. International Association for Study of Pain (ISBN 0-931092-47-7)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Journals with significant pain content relevant to supportive and palliative care&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.jr2.ox.ac.uk/Bandolier/" target="_blank"&gt;Bandolier&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.co-supportiveandpalliativecare.com/" target="_blank"&gt;Current Opinion in Supportive and Palliative Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.europeanjournalpain.com/" target="_blank"&gt;European Journal of Pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://journals.elsevierhealth.com/periodicals/jps/home" target="_blank"&gt;Journal of Pain and Symptom Management&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.nature.com/neuro/index.html" target="_blank"&gt;Nature Neuroscience&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.iasp-pain.org//AM/Template.cfm?Section=Home" target="_blank"&gt;Pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.maney.co.uk/search?fwaction=show&amp;amp;fwid=205" target="_blank"&gt;Progress in Palliative Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www2.us.elsevierhealth.com/inst/serve?db=home&amp;amp;id=rapm" target="_blank"&gt;Regional Anesthesia and Pain Medicine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.mascc.org/content/114.html" target="_blank"&gt;Supportive Care in Cancer&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Organisations with significant contribution to improving pain in supportive and palliative care&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.britishpainsociety.org/" target="_blank"&gt;British Pain Society&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.iasp-pain.org/" target="_blank"&gt;International Association for the Study of Pain&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.palliative-medicine.org/" target="_blank"&gt;Association for Palliative Medicine&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.cancerbackup.org.uk/" target="_blank"&gt;Cancer Backup&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.mascc.org/" target="_blank"&gt;Multinational Association for Supportive Care in Cancer&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.ncpc.org.uk/index.html" target="_blank"&gt;National Council for Palliative Care&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.helpthehospices.org.uk/" target="_blank"&gt;Help the Hospices&lt;/A&gt;&lt;BR&gt;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260090</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260090]]&gt;</url>
    <title>National Knowledge Week on pain in palliative and supportive care 2007: Sources of knowledge on pain in palliative and supportive care within the Specialist Library</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Knowledge Week on pain in palliative and supportive care 2007: Sources of knowledge on pain in palliative and supportive care within the Specialist Library&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The NHS National Library for Palliative and Supportive Care contains information covering both supportive care and palliative medicine – the diagnosis and management of symptoms irrespective of the aetiology and prognosis, using a patient-centred model of care. The Library includes evidence for both pharmacological and non-pharmacological methods of pain management.&lt;/P&gt;
&lt;P&gt;When you select 'Pain Management' in the category tree, your search will return different types of resources which are displayed under&amp;nbsp;five different 'tabs' reflecting the level of evidence. Content is displayed for one tab at at time. Click on each tab to display its contents. Note that there may be more than one page of results. Altogether there are over 180 items listed.&lt;/P&gt;
&lt;P&gt;The tabs are as follows:&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Guidance and pathways&lt;/STRONG&gt; - resources from the Dept of Health/NHS/other central government agencies and other reputable specialist organisations to guide diagnostic and management decisions.&lt;/P&gt;
&lt;P&gt;Content here: &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=288" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=288&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Evidence&lt;/STRONG&gt; – best available systematic reviews and research from well established databases which include a level of quality appraisal&amp;nbsp;such as Cochrane and DARE. &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Content here:&lt;/EM&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=289" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=289&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Reference&lt;/STRONG&gt; - websites, expert comment, reports and other resources which may inform and enhance practice/knowledge.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Content here:&lt;/EM&gt; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=290&amp;amp;" target="_blank"&gt;http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=290&amp;amp;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The following two tabs are under development. If you would like to suggest items for inclusion here, please use the &lt;A href="http://www.library.nhs.uk/palliative/ContactUs.aspx" target="_blank"&gt;Contact Us&lt;/A&gt; form.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Education&lt;/STRONG&gt; (this section is in development) - CPD resources include talks/tutorials to aid lifelong professional learning.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Patient information&lt;/STRONG&gt; - (this section is in development).&amp;nbsp;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>284062</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=284062]]&gt;</url>
    <title>National Knowledge Week. Pain in supportive and palliative care. 2008</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Palliative and Supportive Care Specialist Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Knowledge Week. Pain in supportive and palliative care. 2008&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The 2008 knowledge week on pain comprises the following elements:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283525&amp;amp;tabID=289" target="_blank"&gt;Annual Evidence Update 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=283527&amp;amp;tabID=289" target="_blank"&gt;NHS Do Once and Share Programme: Assessment of chronic pain in older children and adults – developing an evidence-based standardised set of measures&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=284023&amp;amp;tabID=290" target="_blank"&gt;Conference highlights: British Pain Society,&amp;nbsp;Annual Scientific Meeting, Liverpool, April 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/viewResource.aspx?resid=284024&amp;amp;code=659f4faa80a4ae3b1e4055187ce42a65" target="_blank"&gt;Conference highlights: Palliative Care Congress, Glasgow, April-May, 2008&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/SearchResults.aspx?catID=9100&amp;amp;tabID=289" target="_blank"&gt;Resources under the Library's "pain management" tag&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>326532</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=326532]]&gt;</url>
    <title>New records added to the Supportive and Palliative Care specialist collection - Monthly lists</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;New records added to the Supportive and Palliative Care specialist collection - Monthly lists&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;New records are added to the collection all the time. Here we list the items that have been added each month:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2011&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;January 2011&lt;/LI&gt;
&lt;LI&gt;February 2011&lt;/LI&gt;
&lt;LI&gt;March 2011&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;2010&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="nelh:341827:0" name=internalLink&gt;January 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:344876:0" name=internalLink&gt;February 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:346837:0" name=internalLink&gt;March 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=372862&amp;amp;tabID=290" target="_blank"&gt;April 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=371617&amp;amp;tabID=289" target="_blank"&gt;May 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="nelh:380475:0" name=internalLink&gt;June 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=377363&amp;amp;tabID=290" target="_blank"&gt;July 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/viewResource.aspx?resid=387220&amp;amp;code=6a7f35a653378885bb78c9dfe7f5e786" target="_blank"&gt;August 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=387534&amp;amp;tabID=290" target="_blank"&gt;September 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=389446&amp;amp;tabID=290" target="_blank"&gt;October 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=396444&amp;amp;tabID=290" target="_blank"&gt;November 2010&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;December 2010&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;2009&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;&lt;FONT color=#000000&gt;
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305740&amp;amp;tabID=290" target="_blank"&gt;December 2008 &amp;amp; January 2009&lt;/A&gt;&lt;/FONT&gt; &lt;/LI&gt;&lt;/FONT&gt;
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=307439&amp;amp;tabID=290" target="_blank"&gt;February 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=310906&amp;amp;tabID=290" target="_blank"&gt;March 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=313873&amp;amp;tabID=290" target="_blank"&gt;April 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=316207&amp;amp;tabID=290" target="_blank"&gt;May 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=318834&amp;amp;tabID=290" target="_blank"&gt;June 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=321667&amp;amp;tabID=290" target="_blank"&gt;July 2009&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=324344&amp;amp;tabID=290" target="_blank"&gt;August 2009&lt;/A&gt; 
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=326298&amp;amp;tabID=290" target="_blank"&gt;September 2009&lt;/A&gt;&amp;nbsp; 
&lt;LI&gt;&lt;A href="nelh:326763:1" name=internalLink&gt;October 2009&lt;/A&gt; 
&lt;LI&gt;&lt;A href="nelh:331459:1" name=internalLink&gt;November 2009&lt;/A&gt; 
&lt;LI&gt;&lt;A href="nelh:333826:1" name=internalLink&gt;December 2009&lt;/A&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;2008&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=288406&amp;amp;tabID=290" target="_blank"&gt;May 2008&lt;/A&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=289548&amp;amp;tabID=290" target="_blank"&gt;June 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=291339&amp;amp;tabID=290" target="_blank"&gt;July 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293405&amp;amp;tabID=290" target="_blank"&gt;August 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=293902&amp;amp;tabID=290" target="_blank"&gt;September 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=297183&amp;amp;tabID=290" target="_blank"&gt;October 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=299881&amp;amp;tabID=290" target="_blank"&gt;November 2008&lt;/A&gt;&lt;/FONT&gt; 
&lt;LI&gt;&lt;FONT color=#000000&gt;&lt;A href="http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=305740&amp;amp;tabID=290" target="_blank"&gt;December 2008 &amp;amp; January 2009&lt;/A&gt;&lt;/FONT&gt; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>283527</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=283527]]&gt;</url>
    <title>NHS Do Once and Share Programme: Assessment of chronic pain in older children and adults – developing an evidence-based standardised set of measures</title>
    <publicationDate></publicationDate>
    <publisher>National LIbrary for Health: Supportive and Palliative Care Specialist Library</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;NHS Do Once and Share Programme: Assessment of chronic pain in older children and adults – developing an evidence-based standardised set of measures&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Introduction&lt;/H2&gt;
&lt;P&gt;The Pain Assessment project is part of the &lt;A href="http://www.connectingforhealth.nhs.uk/engagement/clinical/doas" target="_blank"&gt;NHS Do Once and Share (DOaS) programme&lt;/A&gt; which is working to engage and enable clinicians, healthcare providers and patients to share their knowledge, skills and experience in order to:&lt;/P&gt;
&lt;P&gt;• ensure the best available knowledge is easily accessible&lt;BR&gt;• minimise duplication and wasted time&lt;BR&gt;• provide an agreed, best practice, national approach to care&lt;BR&gt;• make optimum use of new IT systems and services being delivered by NHS Connecting &amp;nbsp;for Health.&lt;/P&gt;
&lt;P&gt;DOaS tries to facilitate the collaboration between clinicians, patient representatives and a large range of stakeholder groups on this complex subject.&amp;nbsp; The end result of the DOaS project is a set of recommendations and sample assessment methods for the whole spectrum of pain assessment in this disparate group.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Background&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a plethora of chronic pain assessment methods and scales that are used across a wide range of care settings. Specialist pain scoring systems are used, for example, in cancer service, pain clinics, arthritis care and nursing homes. There are also different tools for children and older people, including those with dementia. Each service uses different measures which can reduce effective communication. There should be some standardisation so that the best evidence-based measures are used consistently across services. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Aims&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;To describe the best practice in the assessment of chronic pain in adults and older children and to make recommendations for a standardised approach for use in the UK National Health Service. The project was part of an NHS programme to engage and enable clinicians, healthcare providers and patients to share their knowledge, skills, and experiences. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Methods&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A systematic extensive search of the literature was performed. Two national stakeholder events have taken place. The project has sought opinions from a wide range of experts, patient representatives and professional bodies. All key documents and feedback from the events have been posted on the National Library for Palliative and Supportive Care website. An email discussion page was set up to facilitate discussion around this topic. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The literature search and its subsequent sifting have yielded a wealth of measurement tools for the assessment of chronic pain in the target populations. The stakeholder events and the email consultation exercise gave the project team much valuable feedback on choice and appropriateness of the tools. The email consultation with stakeholders also generated several strands of robust discourse about the role of holistic pain assessment in people with chronic pain and the appropriate ways of tapping into the global distress and suffering experienced by them. &lt;/P&gt;
&lt;P&gt;Resulting from these discourses, we have assembled a model or protocol for holistic chronic pain assessment that provides a strategic framework, which is consistent across the whole spectrum of patients, into which specific measures could be placed according to age group, diagnosis group, cognitive functioning level and other patient or environmental variables.&amp;nbsp; The proposed protocol consists of three key stages: Detect – Observe – Longterm.&amp;nbsp; The acronym for this model is DOL, which is the root for the Latin word dolor meaning pain. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The assessment of chronic pain is complex and clearly requires a wide range of measures. &lt;/LI&gt;
&lt;LI&gt;The project has for the first time produced a comprehensive classification and sets of logical recommendations for health and social care professionals, clinicians and researchers. &lt;/LI&gt;
&lt;LI&gt;These now need to be widely consulted and incorporated into clinical data management systems. &lt;/LI&gt;
&lt;LI&gt;The DOL protocol needs to be tested, audited and validated in clinical settings. &lt;/LI&gt;
&lt;LI&gt;Although members of British Pain Society (BPS) worked with the project team during all phases of consultation, it has not officially endorsed this report.&lt;/LI&gt;
&lt;LI&gt;It is hoped that specific parts of this project’s report and recommendations will be taken up by the BPS, as part of its ongoing programme of projects, and further developed and delivered for use in the NHS. &lt;/LI&gt;
&lt;LI&gt;The final report and all the appendices are available to download from the files area of the Palliative and Supportive &amp;nbsp;Care Specialist Library: &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=doas" target="_blank"&gt;http://www.library.nhs.uk/palliative/Page.aspx?pagename=doas&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Acknowledgements:&lt;/STRONG&gt; Helen Hood, Senior Project Manager. Annie McIntosh, Interim Project Manager.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The project team&lt;/H2&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Clinical Lead:&lt;/STRONG&gt; Sam H Ahmedzai, Professor of Palliative Medicine at the University of Sheffield. &lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Project Manager:&lt;/STRONG&gt; Nisar Ahmed, Research Associate, University of Sheffield. Email: &lt;A href="mailto:n.ahmed@sheffield.ac.uk" target="_blank"&gt;n.ahmed@sheffield.ac.uk&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Information Manager:&lt;/STRONG&gt; Richard Stevens, Research Associate, University of Sheffield. Email: &lt;A href="mailto:r.j.stevens@sheffield.ac.uk" target="_blank"&gt;r.j.stevens@sheffield.ac.uk&lt;/A&gt; &lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Project Secretary:&lt;/STRONG&gt; Pauline Hutchinson. Email: &lt;A href="mailto:spcsg-conferences@sheffield.ac.uk" target="_blank"&gt;spcsg-conferences@sheffield.ac.uk&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;'Do Once and Share' Programme Senior Project Manager:&lt;/STRONG&gt; Helen Hood, Service Implementation, NHS Connecting for Health.&lt;/LI&gt;
&lt;LI&gt;&lt;STRONG&gt;Strategic Health Authority Lead:&lt;/STRONG&gt; Rose Hand, Head of Clinical Engagement - NPfIT, NHS Yorkshire &amp;amp; The Humber SHA.&lt;/LI&gt;
&lt;LI&gt;Annie McIntosh, Senior Consultant, Healthlogic Solutions, was Acting Project Manager until August and continues to support the project in an advisory capacity.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;Funding: &lt;/STRONG&gt;The project was commissioned by the National Library for Clinical Rules and Tools (NLCRT) through the ‘Do Once and Share’ Programme.&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>125148</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.ncpc.org.uk/events/outcomes.html]]&gt;</url>
    <title>Outcome measurement in palliative care : Beyond the NICE Guidance</title>
    <publicationDate>2006-03-30T00:00:00</publicationDate>
    <publisher>National Council for Palliative Care (NCPC)</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SERVICE PROVISION,POLICY,RESEARCH,UNITED KINGDOM,AUDIT,OUTCOME MEASURES,NEEDS ASSESSMENT,SERVICE DEVELOPMENT,QUALITY OF LIFE,ACCESS TO PALLIATIVE AND SUPPORTIVE CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Speakers' presentations and other information</description>
    <body>&lt;![CDATA[ &lt;P&gt;Speakers' presentations and full programme details from a one day meeting organised by the National Council for Palliative Care held in London 30 March 2006. Includes pdf files of the following presentations:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;STRONG&gt;Irene Higginson&lt;/STRONG&gt; - &lt;EM&gt;Outcome measurement in palliative care: past, present and future&lt;/EM&gt; 
&lt;LI&gt;&lt;STRONG&gt;Peter Tebbit&lt;/STRONG&gt; - &lt;EM&gt;Outcome measurement in the brave new world of payment by results&lt;/EM&gt; 
&lt;LI&gt;&lt;STRONG&gt;Jane Bradburn and Carolyn Morris&lt;/STRONG&gt; - &lt;EM&gt;Outcomes: what do patients and carers want?&lt;/EM&gt; 
&lt;LI&gt;&lt;STRONG&gt;Alex Baylis&lt;/STRONG&gt; - &lt;EM&gt;Increasing the regulator's focus on patients' outcomes of care&lt;/EM&gt; 
&lt;LI&gt;&lt;STRONG&gt;John Ellershaw&lt;/STRONG&gt; -&lt;EM&gt; Liverpool Care Pathway: can it inform the outcomes agenda?&lt;/EM&gt; 
&lt;LI&gt;&lt;STRONG&gt;Jessica Corner&lt;/STRONG&gt; - &lt;EM&gt;Assessing reach and impact across whole systems&lt;/EM&gt;&lt;/LI&gt;&lt;/UL&gt;]]&gt;</body>
  </document>
  <document>
    <id>260251</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=260251]]&gt;</url>
    <title>Pain in palliative and supportive care: The next 12 months</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Pain in palliative and supportive care: The next 12 months&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This article brings to a conclusion the daily series of knowledge outlines, evidence reviews and conference highlights that together formed the first National Knowledge Week on Pain.&amp;nbsp; In this week from 30 April to 4 May 2007, the Specialist Library for Palliative and Supportive Care has posted up 20 articles, with altogether 147 references from the world literature.&amp;nbsp; Anyone trying to read all of these could easily spend the next few weeks being totally immersed in a world of pain!&amp;nbsp; Given that the 37 systematic reviews we featured on Day 1 only, themselves covered hundreds of original research papers, the reader would emerge as a living encyclopaedia of pain mechanisms and management.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Clearly the purpose of a National Knowledge Week is not to convert people into ‘walking wikipedia’.&amp;nbsp; Rather, the aim of these weeks – and of the Specialist Libraries themselves – is to bring into focus, in a handful of webpages, the doorways to knowledge that the internet can provide.&amp;nbsp; These pages are meant to be dipped into, browsed, and individual papers accessed for detailed information as and when the need occurs.&amp;nbsp; Since nearly all the references have direct PubMed links to abstracts or whole articles, a curious reader can go from puzzlement to enlightenment in seconds. But a repository of knowledge, such as we have compiled on these webpages, would be out of date within months - such is the speed at which internet-based publishing and systematic reviewing proceeds.&amp;nbsp; So we cannot afford to keep the Pain section of the Specialist Library for Palliative and Supportive Care static.&amp;nbsp; We will be regularly appending further articles – systematic reviews, meta-analyses, original research papers, guidelines, consensus documents, educational material and patient information. These webpages representing the National Knowledge Week on Pain will be updated too en bloc, in a year’s time when the accumulated new knowledge is once again sifted, quality-checked and summarised.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We hope to witness important developments in the field of pain in palliative and supportive care in the coming year.&amp;nbsp;Our collaboration with the &lt;A href="http://www.britishpainsociety.org/index.htm" target="_blank"&gt;British Pain Society&lt;/A&gt; will allow us to bring readers up to the minute news of its SIGs, working groups and the documents they publish.&amp;nbsp; We await eagerly, for instance, the Cancer Pain document that Jon Raphael describes &lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=260509&amp;amp;tabID=290" target="_blank"&gt;above&lt;/A&gt;.&amp;nbsp;The next BPS Annual Scientific Meeting will be held in Liverpool on 15-18 April 2008.&amp;nbsp; We will be there again to bring you highlights of the 2008 National Knowledge Week on Pain, which will run in one year’s time.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Other conferences which are coming up this year, from which we will bring breaking news of pain research and reviews, include the congresses of the &lt;A href="http://www.eapcnet.org/budapest2007/" target="_blank"&gt;European Association for Palliative Care in Budapest (6-9 June 2007)&lt;/A&gt; and the &lt;A href="http://www.mascc.org/content/75.html" target="_blank"&gt;Multinational Association for Supportive Care in Cancer in St Gallen (28-30 June 2007)&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;If there are other conferences or events which present new knowledge or reviews of recent research that you would like us to feature, please &lt;A href="http://www.library.nhs.uk/palliative/ContactUs.aspx" target="_blank"&gt;contact us&lt;/A&gt; about them.&amp;nbsp; Also, if you know of high quality educational material or patient information on pain – areas in which our Specialist Library is currently weak - then do let us know.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We are always looking for colleagues to help us with reviewing of the literature – not only of pain, but the dozens of other categories of knowledge in our taxonomy (see navigation bar to the left of this webpage).&amp;nbsp; We issue helpers with guidance on how to rate articles and those who contribute, can become part of our team of ‘Specialist Library for Palliative and Supportive Care editors’. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We hope you have found this in-depth look at pain in palliative and supportive care to be informative and challenging and – most of all – to tempt you to come back for more!&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Sam H Ahmedzai&lt;BR&gt;Jason Boland&lt;BR&gt;Richard Stevens&lt;/STRONG&gt;&lt;BR&gt;&lt;STRONG&gt;The National Knowledge Week on Pain team&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We would like to acknowledge our grateful thanks to the following for their original contributions or BPS conference abstracts:&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;EM&gt;Dr David Dockrell (Sheffield)&lt;BR&gt;Dr Donald Graham (Doncaster)&lt;BR&gt;Dr Paul Farquhar-Smith (London)&lt;BR&gt;Dr Joan Hester (London)&lt;BR&gt;Dr Bill Macrae (Dundee)&lt;BR&gt;Pete Moore (Witham)&lt;BR&gt;Dr Laura McTague (Sheffield)&lt;BR&gt;Prof Henry McQuay (Oxford)&lt;BR&gt;Dr Jon Raphael (London)&lt;BR&gt;Prof Mike Salter (Toronto)&lt;BR&gt;Prof Jürgen Sandkühler (Vienna)&lt;BR&gt;Dr John Williams (London)&lt;BR&gt;Di Wright (Bury St Edmunds)&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/palliative/Page.aspx?pagename=PAIN" target="_blank"&gt;Return to the National Knowledge Week homepage&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>102154</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.euro.who.int/InformationSources/Publications/Catalogue/20050118_2]]&gt;</url>
    <title>Palliative care - the solid facts</title>
    <publicationDate></publicationDate>
    <publisher>World Health Organisation</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POLICY,UNITED KINGDOM,INTERNATIONAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The pdf is available to download free from this web page.&lt;/P&gt;
&lt;P&gt;"Explains why health services should provide good quality palliative care for all people facing serious chronic illness. It provides evidence for the effectiveness of palliative care, shows how it can be improved, and explains the need to ensure full access."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>271212</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271212]]&gt;</url>
    <title>Palliative care for motor neurone disease</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SERVICE PROVISION,SYMPTOM MANAGEMENT,MOTOR NEURONE DISEASE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Palliative care for motor neurone disease&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Nigel Sykes FRCP FRCGP, St Christopher's Hospice, London.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Background&lt;/H2&gt;
&lt;P&gt;Motor Neurone Disease/Amyotrophic Lateral Sclerosis (MND/ALS) is the most common degenerative condition of the motor nervous system occurring in adult life. Nonetheless, its incidence of 2 per 100,000 per year means that it is an unfamiliar entity for most healthcare professionals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The disease causes progressive loss of voluntary motor function throughout the body with a mixed picture of flaccidity and spasticity,although the pattern of progression varies. MND/ALS is not, as originally thought, a purely motor nerve condition but in up to about 30% of cases is associated with cognitive impairment that can amount to a fronto-temporal dementia (1), particularly where bulbar weakness has been present at the disease onset (2). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;MND/ALS is steadily progressive and remains incurable. Overall lifeexpectancy is about three years but is tending gradually to increase. Some 5 to 10% of cases are familial, leaving the vast majority to be idiopathic in origin. The precise mechanism of nerve damage remains elusive, rendering the search for therapies frustrating. Only one drug, riluzole, has so far demonstrated an ability to alter the course of the disease. Riluzole has been approved in the UK by NICE but systematic review evidence indicates that although well tolerated it prolongs survival by only about two months (3) and economic analysis elsewhere has suggested marginal cost-effectiveness (4). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;User experiences&lt;/H2&gt;
&lt;P&gt;All treatment for MND/ALS is palliative. Prompt diagnosis and optimal symptom management improves life quality not only for patients but also their relatives, and may increase survival time (5). News of the diagnosis is a devastating blow and the quality of the communication between professionals, patients and families at this time has a lasting effect on subsequent perceptions of care (6). The needs of people affected by MND/ALS and of those close to them extend well beyond the competence of any one profession or discipline, and a recent cross-sectional study has concluded that a multidisciplinary approach to care enhances the provision of aids and appliances and, quite separately, improves MND/ALS patients' quality of life (7).&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Symptoms&lt;/H2&gt;
&lt;P&gt;MND/ALS causes numerous symptoms. It is not always appreciated that 50-70% will have pain, largely related to the effects of immobility. Alongside physiotherapy the use of drugs, including opioids, in accordance with the WHO analgesic guidelines originally developed for cancer has been recommended (8). Spasticity is a specific cause of pain which will respond to a range of muscle relaxants such as baclofen and tizanidine (9), but careful dose adjustment is necessary to avoid impairing mobility by making the limbs too flaccid. Exercise programmes may also help (10).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dysphagia due to bulbar weakness causes distress in eating and additional muscle weakness through impaired nutrition. A gastrostomy placed early (endoscopically or radiologically) can forestall these problems and is associated with lengthened survival.&amp;nbsp; Early placement is also advisable because the procedure is more hazardous if respiratory function has declined to a FVC under 50% of that expected (11). Together with facial muscle weakness, dysphagia gives rise to drooling. This upsetting symptom usually responds at least partially to an anticholinergic agent, but both irradiation and botulinum toxin injection of the salivary glands have been used successfully in resistant cases. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The predominant cause of death in people with MND/ALS is respiratory failure secondary to progressive weakness of the diaphragm and intercostal muscles. Tracheostomy ventilation can prolong life indefinitely to the point of disease progression that leaves patients 'locked in' and unable to communicate. Non-invasive positive pressure ventilation (NIPPV) can lengthen survival and improve sleep, breathlessness and overall quality of life (12) but is under-used in the UK. NIPPV is less well tolerated by MND/ALS patients with pronounced bulbar symptoms (13) and cannot sustain adequate ventilation beyond a certain point of muscular weakness.&amp;nbsp; Whether or not NIPPV has been used, the appropriate use of opioids, sedatives and anti-secretory medication (for instance as set out in the Motor Neurone Disease Association's Breathing Space Kit (14)) means that the frequent media allegation that MNDALS patients 'choke to death' is without foundation (15).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;1. Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF. Cognitive functioning in sporadic amyotrophic lateral sclerosis: A six month longitudinal study. Journal of Neurology, Neurosurgery &amp;amp; Psychiatry, 2006; 77:668-670.&lt;/P&gt;
&lt;P&gt;2. Gibbons SC, Snowden JS, Thompson JC, Happe F, Richardson A, Neary D. Inferring thought and action in motor neuron disease.&lt;BR&gt;Neuropsychologia, 2007; 45: 1196-1207.&lt;/P&gt;
&lt;P&gt;3. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Systematic Reviews, 2002, no.2, p. CD001447.&lt;/P&gt;
&lt;P&gt;4.&amp;nbsp;Messori A, Trippoli S, Becagli P, Zaccara G. Cost effectiveness of riluzole in amyotrophic lateral sclerosis. PharmacoEconomics, 1999; 16: 153-163.&lt;/P&gt;
&lt;P&gt;5. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. Amyotrophic Lateral Sclerosis. 2007; 8: 195-213.&lt;/P&gt;
&lt;P&gt;6.&amp;nbsp;Hugel H, Grundy N, Rigby S, Young CA. Amyotrophic Lateral Sclerosis. 2006; 7: 161-166.&lt;/P&gt;
&lt;P&gt;7.&amp;nbsp;van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, van der Draaff MM, Wokke JH, van den Berg LH. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology, 2005; 65: 1264-1267.&lt;/P&gt;
&lt;P&gt;8.&amp;nbsp;Miller RG, Rosenberg JA, Gelinas DF, Misumoto H, Newman D, Sufit R. Practice parameter: the care of the patients with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of \neurology: ALS Practice Parameters Task Force. Neurology, 1999; 52: 1311-1323.&lt;/P&gt;
&lt;P&gt;9.&amp;nbsp;Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V, Tomik B. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. European Journal Neurology,2005; 12: 921-938.&lt;/P&gt;
&lt;P&gt;10.&amp;nbsp;Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Systematic Reviews, 2006, no.1, p. CD004156.&lt;/P&gt;
&lt;P&gt;11.&amp;nbsp;Chio A, Finocchiaro E, Meineri P et al. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. Neurology, 1999; 53: 1123-1125.&lt;/P&gt;
&lt;P&gt;12.&amp;nbsp;Piepers S, van den Berg JP, Kalmijn S, van der Pol WL, Wokke JH, Lindeman E, van den Berg LH. Effect of non-invasive ventilation on survival, quality of life, respiratory function and cognition: a review of the literature. Amyotrophic Lateral Sclerosis. 2006; 7: 195-200.&lt;/P&gt;
&lt;P&gt;13.&amp;nbsp;Lo Coco D, Marchese S, Pesco MC, La Bella V, Piccoli F, Lo Coco A. Non-invasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology, 2006; 67: 761-765.&lt;/P&gt;
&lt;P&gt;14. &lt;A href="http://www.mndassociation.org/for_professionals/information/breathing_space.html" target="_blank"&gt;http://www.mndassociation.org/for_professionals/information/breathing_space.html&lt;/A&gt; (accessed 17th October 2007). &lt;/P&gt;
&lt;P&gt;15.&amp;nbsp;Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurology, 2001; 248: 612-616. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;H2&gt;Key texts&lt;/H2&gt;
&lt;P&gt;Mitsumoto H, Przedborski S, Gordon PH (eds.). Amyotrophic Lateral Sclerosis. New York: Taylor and Francis, 2006. &lt;/P&gt;
&lt;P&gt;Oliver D, Borasio GD, Walsh D (eds.). Palliative Care in Amyotrophic Lateral Sclerosis (2nd edition). Oxford: University Press, 2006.&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>266972</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.eapcnet.org/projects/PaedriaticTF.html]]&gt;</url>
    <title>Palliative Care in Children – an EAPC Task Force</title>
    <publicationDate></publicationDate>
    <publisher>European Association for Pallliative Care</publisher>
    <publicationType>CONSENSUS STATEMENT</publicationType>
    <topics>&lt;![CDATA[ CHILD HEALTH,GUIDELINES/EBM,SPECIALTIES,STAFF USE,PALLIATIVE CARE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CHILDREN'S CONDITIONS,POPULATIONS AND SETTINGS,SERVICE PROVISION,CHILDREN &amp; YOUNG PEOPLE,AGE-RELATED ISSUES,SERVICE TYPE,CHILDREN’S SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Website for the EAPC group established in 2006. Includes the document 'IMPaCCT: standards for palliative care in Europe'.]]&gt;</body>
  </document>
  <document>
    <id>113309</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mywhatever.com/cifwriter/content/41/pe3664.html]]&gt;</url>
    <title>Palliative care in end-stage renal disease</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>Robert Wood Johnson Foundation</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CARDIOVASCULAR DISEASES,SYMPTOM MANAGEMENT,DEATH,SERVICE PROVISION,RESEARCH,ETHICS &amp; LAW,PAIN MANAGEMENT,BONE PAIN,NEUROPATHIC PAIN,VISCERAL PAIN,SOCIAL &amp; PSYCHOSOCIAL ISSUES,DEATH RITES &amp; RITUALS,PLACE OF DEATH,WITHHOLDING &amp; WITHDRAWING TREATMENT,ADVANCE DIRECTIVES,COMMUNICATION ISSUES,SERVICE DEVELOPMENT,RENAL DISEASES,QUALITY OF LIFE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Bibliography</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Palliative care in end-stage renal disease&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Bibliography which includes sections on:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Advance care planning 
&lt;LI&gt;Cardiopulmonary resuscitation and Do-Not Resuscitate Orders 
&lt;LI&gt;Stopping dialysis - ethical and legal issues 
&lt;LI&gt;Stopping dialysis - medical management 
&lt;LI&gt;Pain and symptom management 
&lt;LI&gt;Psychosocial and spiritual support 
&lt;LI&gt;Quality of life 
&lt;LI&gt;Communication/Education&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>271215</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271215]]&gt;</url>
    <title>Palliative care input and advance decision making in patients with long-term neurological conditions</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ NERVOUS SYSTEM DISEASES,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,MOTOR NEURONE DISEASE,VARIANT CREUTZFELDT-JAKOB DISEASE (VCJD),ALZHEIMER’S DISEASE,SYMPTOM MANAGEMENT,SERVICE PROVISION,PARKINSON'S DISEASE,HUNTINGTON'S DISEASE,MULTIPLE SCLEROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Palliative care input and advance decision making in patients with long-term neurological conditions&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Patients with rapidly progressing and advanced stages of long-term neurological conditions (LTNC) need access to specialist palliative care services at an appropriate time in their illness and in a location near to their homes. Their care needs to address issues of advance planning for end-of-life problems, counselling and psychological support for patients and families, information giving and appropriate reviews of medication and therapies. A new project aims to address some of the needs of these patients in the day care facility of Barnsley Hospice (The Limes). The year long project will receive funding from St. James’s Place Foundation in association with Help the Hospices’ “Care beyond Cancer” programme and will be evaluated. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Limes currently offers day care facilities to a population of 218,062 [1].&amp;nbsp; The majority of our patients have cancer despite access being open to all on a needs rather than diagnosis basis, although this is gradually changing (6% non cancer in 2005-2006, 16% non cancer in 2006-2007 [2]) .&amp;nbsp; We are keen to extend access further and have concentrated on working with heart failure specialist nurses locally. This new initiative is specifically aimed at those with neurological conditions. There will be funding for medical input in order to fully assess the patients and have the necessary expertise to manage some problems, which may be unfamiliar to those nurses and allied health professionals trained in palliative care mostly for cancer patients. Of course there will be many symptoms common to all patients faced with a life limiting illness and we hope to show that we can manage these effectively, in collaboration with neurological colleagues. We are hoping to reach patients and their carers with motor neurone disease (MND), progressive supra nuclear palsy (PSP), Huntington’s disease (HD), Parkinson’s disease (PD), progressive forms of multiple sclerosis (MS) and multiple system atrophy (MSA).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The need for palliative care in neurological conditions &lt;/H2&gt;
&lt;P&gt;There is much evidence to support a lack of palliative care input for some of these patients. NICE clinical guidelines on Parkinson’s disease state “The needs in the palliative care stage of Parkinson’s disease are not always identified or satisfied. In later stages of PD there may be a need to withdraw dopaminergic drugs …..and increasing sensitivity to unwanted effects…. . Care needs to be supported by good care planning since many problems can be predicted or avoided with appropriate strategies.” Recommendations include “People with PD and their carers should be given the opportunity to discuss end-of-life issues with appropriate healthcare professionals.” [3]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The National Service Framework for Long-term Conditions points out the relevance: “People of all ages who are in the advanced stages of long-term neurological conditions may need specialised palliative care services. Palliative care services take a whole-person centred approach, respect patient autonomy and favour open and sensitive communication. They can also support a person’s family and carers in bereavement.”&amp;nbsp;[4]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A postal survey of consultants working in the fields of neurology, rehabilitation and palliative medicine has explored the interface between the three specialities and highlighted the need for more collaborative working. Although response rates to the survey were low, it demonstrated that 86% of palliative medicine consultants, 68% of neurologists and 72% of rehabilitation consultants perceived gaps in the provision of palliative care services for people with LTNC. Co-ordination between the three areas was also lacking. Commenting on the survey, the authors conclude “There are many exciting opportunities for these three specialities to work together and by doing so to learn from each other in order to improve the experience of patients and their families who live out their lives with a long-term neurological condition”. [5], [6]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The National Council for Palliative Care has established a Neurological Conditions Policy Group to identify the palliative care needs of people with LTNCs, map and assess current provision and identify good practice and service models. The group first met in 2005 and the learning to date has just been published [7].&amp;nbsp; The group has amassed a great deal of information and now intends to be involved in training and to continue to inform and influence the implementation of the End of Life Care Strategy. The key message is about collaborative working between palliative care and other specialists and working alongside primary care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Advance care planning in LTNCs&lt;/H2&gt;
&lt;P&gt;Advance care planning (ACP) does not only include advance decisions about refusal of treatment in anticipation of a time when capacity is lost; it encompasses discussions about preferred place of care, particular personal concerns and wishes, appointment of a lasting power of attorney, artificial hydration and nutrition, resuscitation and hospital admissions. It will inevitably lead to questions about prognosis and likely symptoms at the end of life. Time is needed time to explore fears and address psychological, social and spiritual aspects of the illness. Personal discussions with specialist nurses (working with MND, PSP, HD and PD patients and carers) indicate that there is a great deal of awareness about these issues and a willingness to engage in relevant conversations but a lack of structure to this and often a lack of time or an appropriate quiet environment. The opportunity to use a day hospice environment to specifically address the issues, then document and share them with the other health care professionals concerned will be of great benefit to some patients and carers. An introduction to these ideas and to the hospice itself could occur at any time in the patient’s illness, right from diagnosis. The timing will be very individual and patient or carer centred rather than being dictated by the stage of the disease or prognosis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The aims of ACP include the increase of patient control at the end of life, better use of palliative care and an increased likelihood that death will occur in the place of choice. It should also improve communication within families and take away some of the burden a family feels when having to make decisions at a time of incapacity. Not everyone facing a life limiting illness will wish to consider such discussions and the amount of control and decision making will be very individual. The new Mental Capacity Act has raised the profile of some of these issues in the public arena recently, but there is still a lack of open discussion about death and dying in the United Kingdom. A very useful guide to ACP for health and social care staff is available to download on the NHS end of life care website [8].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There appears to be more general acceptability and research evidence on the use of ACP in North America. A study of 47 bereaved family caregivers of patients with Parkinson’s disease in Oregon demonstrated that difficulty in communication was rated more troublesome by them than difficulties with physical problems (such as eating). 83% of carers recognised the goal of care was comfort in the last month of life, rather than extending life. 48% of the patients were described as unable to make any decisions in the last four weeks. 87% had a health care proxy and 92% had a living will. Pain was very prevalent and perceived as under treated, especially in the 47% not receiving hospice care [9]. This highlights the high prevalence of some form of advance planning in but also demonstrates the need for effective palliative care interventions in PD despite this. A more comprehensive and collaborative approach is needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;There is an excellent discussion of palliative care in Parkinson’s disease in a paper by Lisette Bunting-Perry in the Journal of Neuroscience Nursing. A model for individual patient care is examined from diagnosis to bereavement and there is a much emphasis on advance care planning. She states “Advance care planning is the cornerstone of palliative care. The patient's ability to achieve autonomy in the context of a chronic, progressive neurologic disease is paramount in developing a longitudinal care plan. ACP is a collaborative, continuous process that starts at the time of diagnosis and continues throughout the course of chronic disease. Healthcare providers frequently struggle to determine when to initiate discussions about ACP out of concern for implying that the patient is at the end of life. The ACP process spans the continuum of care for the patient with early, moderate, and advanced PD”. [10]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Overcoming professionals’ reluctance to initiate end of life discussions has long been a problem. Palliative care has always encompassed this area but it can appear more difficult when approaching those with a LTNC such as PD or HD, rather than those with a more predictable illness trajectory such as cancer or MND. An advance care planning interview schedule was developed by a team from Royal Free and University College Medical School in London and its acceptability was qualitatively studied.&amp;nbsp; Twenty two people (patients and carers) were interviewed about the acceptability and structure of the schedule. It was clear that although some had to “face up to things they wouldn’t otherwise discuss”; others acknowledged these issues were there at the back of their minds. A further phase II randomised trial of offering ACP has been undertaken. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As in all aspects of patient care, an individual approach is essential. By carefully collaborating with the general practitioners, neurologists, specialist nurses and therapists who provide the care for patients with long-term neurological conditions in Barnsley, we hope to be able to offer a facility for advance care planning and increase our outreach to non cancer patients in general as a result. Similar approaches are being followed in other areas. More information on the acceptability of this approach and the impact on the outcomes of patient care in this country are needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;1. ONS Census 2001.&lt;/P&gt;
&lt;P&gt;2. Minimum Data Set Project, National Council for Palliative Care&amp;nbsp; National Institute for Clinical Excellence. Clinical Guidance: Parkinson's disease: diagnosis and management in primary and secondary care. NICE June 2006.&lt;/P&gt;
&lt;P&gt;3. Department of Health. The National Service Framework for Long-term Conditions. DH: 2005.&lt;/P&gt;
&lt;P&gt;4.Turner-Stokes L, Sykes N, Silber E, Khatri A, Sutton L and Young E. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions. Clinical Medicine 2007;7:2.&lt;/P&gt;
&lt;P&gt;5. The National Council for Palliative Care: National Survey: Neurological Conditions. NCPC June 2006.&lt;/P&gt;
&lt;P&gt;6. The National Council for Palliative Care: Addressing Palliative Care for People with Neurological Conditions. NCPC October 2007.&lt;/P&gt;
&lt;P&gt;7. Department of Health. Advance Care Planning: A guide for Health and Social Care Staff. DH: February 2007. &lt;A href="http://www.endoflifecare.nhs.uk/" target="_blank"&gt;www.endoflifecare.nhs.uk&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;8. Goy E, Carter J, Ganzini L. Parkinson’s disease at the end of life: caregiver perspectives. Neurology 7 Aug 2007; 69 (6): 611-2.&lt;/P&gt;
&lt;P&gt;9. Bunting-Perry L. Palliative Care in Parkinson ’s Disease: Implications for Neuroscience Nursing. Journal of Neuroscience Nursing. April 2006; 38 (2):106-113.&lt;/P&gt;
&lt;P&gt;10. Barnes K, Jones L, Tookman A, King M: Acceptability of an advance care planning interview schedule: a focus study group. Palliative Medicine 2007; 21: 23-28.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304336</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304336]]&gt;</url>
    <title>Patient and carer involvement in End of Life Care: A literature review</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Patient and carer involvement in End of Life Care: A literature review&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The literature review used selected terms considered pertinent to user involvement. Initially a search in both Cinahl and Medline was conducted and was limited to the years 2005-2008 (see details below). A scoping study had previously captured relevant material up to the end of 2004 (Payne et al) The search was further narrowed by type of publication (slightly different depending on the subject headings used in each database but included meta analysis, review, clinical trials, randomised control trials and systematic reviews). These terms were combined with appropriate terms related to palliative and end of life care. This was conducted on the NLH interface. &lt;/P&gt;
&lt;P&gt;Cochrane and EBM&amp;nbsp;reviews were searched using the Ovid interface and user involvement and consumer participation were used as keywords. In addition the evidence section of the NLH specialist library was searched to provide information on documents that could provide a view of the subject on a broader basis. Material relevant to the broader area of citizenship involvement were also found in this library. The catalogue of the library at St Christopher’s Hospice was also searched.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;David Oliviere (DO) compiled a separate short annotated reference list of particular relevance to his work in user involvement. This is mainly material that could be elusive&amp;nbsp;&amp;nbsp; in the health care database search as it includes book chapters and books and policy documents.&amp;nbsp; These are included in a separate list of references. &lt;/P&gt;
&lt;P&gt;Beyond DO’s reference list, Denise Brady (DB) selected material likely to be of interest to the health professional involved in user involvement from the searches described above and, DO, in turn,&amp;nbsp;selected material that he considered might be useful&amp;nbsp; for palliative care health professionals.&amp;nbsp;He has incorporated some of this material in the following list of references. The following are his comments and his very brief selection from the literature search:&lt;/P&gt;
&lt;P&gt;This literature search underlines the fact that user involvement is a term that can be interpreted in many ways.&amp;nbsp;Themes arising from the literature review included the following: discussion of users as co-researchers (eg Gysels M et al 2008, Perkins P, et al&amp;nbsp;2007); Wright DN et al 2006); patient satisfaction (eg Brumley R et al 2007);&amp;nbsp; involvement in communication about prognosis&amp;nbsp; towards the end of life (eg Clayton JM et al 2007); treatment decisions near the end of life (Schofield P et al 2006); narratives of users’ experiences (eg Bingley et al&amp;nbsp; 2006, Harris FM et al 2008 ); patient information (eg Johnson et al 2008)&amp;nbsp; as well as user involvement (which we have mainly interpreted as service development issues). &lt;/P&gt;
&lt;P&gt;The literature review did not extend to particular illnesses though one item on motor neurone disease indicated how users would wish to be involved in service development and one research article provided insights on the benefits to both users and health professionals on user involvement (Down et al 2005 and Fudge et al 2008).&amp;nbsp; Another study of colon cancer patients indicated that involving users in the provision of written information for patients was helpful to all users (Carney L et al 2006). A further&amp;nbsp; document indicated how users can be involved in guideline development (NICE 2004).&amp;nbsp; These provide further theoretical and clinical knowledge on how user involvement could be developed in palliative care services. &lt;/P&gt;
&lt;P&gt;In addition, user involvement in palliative care can be contextualised by examining literature in social care where it has its roots eg in the mental health and disability fields (Carr 2004, Doel et al 2007, Shaping our lives et al 2007).&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Bingley AF, McDermott E, Thomas C, Payne S, Seymour JE, Clark D (2006) Making sense of dying: a review of narratives written since 1950 by people facing death from cancer and other diseases. Palliative Medicine 20(3):183-195. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Brumley R, Enguidanos S, Jamison P, Seitz R, Morgenstern N, Saito S, McIlwane J, Hillary K, Gonzalez J (2007)&amp;nbsp; Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care Journal of the American Geriatrics Society 55(7): 993-1000.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Carney L, Jones L,&amp;nbsp; Braddon F, Pullyblank AM, Dixon A (2006)&amp;nbsp; A colorectal cancer patient focus group develops an information package. Annals of the Royal College of Surgeons&amp;nbsp; 88(5):447-449.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Carr S (2004) Has service user participation made a difference to social care services? London: Social Care Institute for Excellence &lt;BR&gt;&lt;A href="http://www.scie.org.uk/publications/positionpapers/pp03.pdf" target="_blank"&gt;http://www.scie.org.uk/publications/positionpapers/pp03.pdf&lt;/A&gt; (accessed 8/1/09).&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Clayton JM, Butow PN, Tattersall MHN, Devine RJ, Simpson JM, Aggarwal G, Clark KJ, Currow DC, Elliott LM, Lacey J, Lee PG , Noel MA (2007) Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care&lt;BR&gt;Journal of Clinical Oncology 25(6):715-723.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Doel M, Carrol C, Chambers E, Cooke J, Hollows A, Laurie&amp;nbsp; L, Maskrey L, Nancarrow S. (2007) Participation: finding what difference it makes. Social Care Institute for Excellence.&lt;BR&gt;&lt;A href="http://www.scie.org.uk/publications/resourceguides/rg07/files/rg07.pdf" target="_blank"&gt;http://www.scie.org.uk/publications/resourceguides/rg07/files/rg07.pdf&lt;/A&gt;&lt;BR&gt;(accessed 10/1/08).&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Down K, Hughes R, Sinha A, Higginson IJ, Leigh PN (2005) Involving users in shaping motor neurone disease services. York: Jospeh Rowntree Foundation.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Fudge N, Wolfe CDA, McKevitt, C (2008) Assessing the promise of user involvement in health service development: ethnographic study BMJ 336 (7639 Feb 9):313-317.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Gysels M, Shipman C, Higginson IJ (2008) “I will do it if it will help others” motivations among patients taking part in qualitative studies in palliative care. Journal of Pain and Symptom Management 35(4): 347-355.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Harris FM, Kendall M, Bentley A, Maguire R, Worth A, Murray S, Boyd K, Brown D, Kearney N, Sheikh A (2008) Researching experiences of terminal cancer: a systematic review of methodological issues and approaches European Journal of Cancer Care 17(4): 377-386.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Johnson HM, Nelson A (2008). The acceptability of an information leaflet explaining cardiopulmonary resuscitation policy in the hospice setting: a qualitative study exploring patients’ views. Palliative Medicine&amp;nbsp; 22(5): 647-652.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;NICE (Patient Involvement Unit), Jarrett L&amp;nbsp; (2004) A report on a study to evaluate patient/carer membership of the first NICE guideline development groups. London: NICE.&amp;nbsp; &lt;BR&gt;&lt;A href="http://www.nice.org.uk/niceMedia/pdf/PIU_Evaluation_report_270704.pdf" target="_blank"&gt;http://www.nice.org.uk/niceMedia/pdf/PIU_Evaluation_report_270704.pdf&lt;/A&gt;&lt;BR&gt;(accessed 7/1/09).&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Payne, S, Gott, M, Small, N, Oliviere, D, Sargeant, A, Young, E (2005) User involvement in palliative care: a scoping study. Sheffield: University of Sheffield.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Perkins P, Barclay S, Booth S (2007) What are patients’ priorities for palliative care research? Focus group study. Palliative Medicine 21(3):219-225.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Schofield P, Carey M, Love A, Nehill C, Wein S (2006) 'Would you like to talk about your future treatment options'? Discussing the transition from curative cancer treatment to palliative care Palliative Medicine 20(4): 397-406.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Shaping Our Lives, National Centre for Independent Living and University of Leeds Centre for Disability Studies (2007). Developing social care: service users driving culture change&lt;BR&gt;London: SCIE. &lt;/LI&gt;&lt;/UL&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;A href="http://www.scie.org.uk/publications/knowledgereviews/kr17.pdf" target="_blank"&gt;http://www.scie.org.uk/publications/knowledgereviews/kr17.pdf&lt;/A&gt;&lt;BR&gt;(accessed 8/1/09).&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Wright DN, Hopkinson JB, Corner JL, Foster CL (2006) How to involve cancer patients at the end of life as co-researchers. PalliatIve Medicine 20(8): 821-827.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;CINAHL SEARCH&lt;/H2&gt;
&lt;P&gt;(palliative AND care).ti,ab&lt;BR&gt;exp PALLIATIVE CARE/&lt;BR&gt;(terminal AND care).ti,ab&lt;BR&gt;TERMINAL CARE/ OR HOSPICE CARE/&lt;BR&gt;(terminally AND ill).ti,ab&lt;BR&gt;exp TERMINALLY ILL PATIENTS/&lt;BR&gt;hospices.ti,ab&lt;BR&gt;exp HOSPICES/&lt;BR&gt;(end AND of AND life).ti,ab&lt;BR&gt;1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9&lt;BR&gt;10 [Limit to: Publication Year 2005-2008]&lt;BR&gt;(user AND involvement).ti,ab [Limit to: Publication Year 2005-2008]&lt;BR&gt;exp CONSUMER PARTICIPATION/ OR exp CONSUMER SATISFACTION/&lt;BR&gt;(patient AND education).ti,ab&lt;BR&gt;exp PATIENT EDUCATION/&lt;BR&gt;(patient AND information).ti,ab&lt;BR&gt;(consumer AND information).ti,ab&lt;BR&gt;12 OR 13 OR 14 OR 15 OR 16 OR 17 [Limit to: Publication Year 2005-2008]&lt;BR&gt;10 AND 18 [Limit to: Publication Year 2005-2008]&lt;BR&gt;19 [Limit to: (Publication Type Clinical Trial or Review or Systematic Review) and Publication Year 2005-2008]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;MEDLINE SEARCH&lt;/H2&gt;
&lt;P&gt;1.(palliative AND care).ti,ab&lt;BR&gt;2.exp PALLIATIVE CARE/&lt;BR&gt;3.(terminal AND care).ti,ab&lt;BR&gt;4.TERMINAL CARE/ OR HOSPICE CARE/&lt;BR&gt;5.(terminally AND ill).ti,ab&lt;BR&gt;6.exp TERMINALLY ILL /&lt;BR&gt;7.hospices.ti,ab&lt;BR&gt;8.exp HOSPICES/&lt;BR&gt;9.(end AND of AND life).ti,ab&lt;BR&gt;10.1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9&lt;BR&gt;11. 10 [Limit to: Publication Year 2005-2008&lt;BR&gt;12.(user AND involvement).ti,ab&lt;BR&gt;13.exp CONSUMER PARTICIPATION/ OR exp PATIENT PARTICIPATION/&lt;BR&gt;14.PATIENT EDUCATION AS TOPIC/&lt;BR&gt;15.12 or 13 or 14 &lt;BR&gt;16. 15 AND 29 [Limit to: Publication Year 2005-2008]&lt;BR&gt;17. 16 [Limit to: (Publication Types Clinical Trial, All or Controlled Clinical Trial or Meta Analysis or Randomized Controlled Trial or Review) and Publication Year 2005-2008]&lt;/P&gt;
&lt;P&gt;(Items in capitals are subject headings/MESH headings)&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN lang=EN-GB&gt;&lt;FONT face=Arial&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;EM&gt;Denise Brady (Librarian),&amp;nbsp;David Oliviere (Director of Education and Training), Education Centre, St Christopher’s Hospice&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;January 2008&lt;/EM&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/SPAN&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88916</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/843/CN-00140843/frame.html]]&gt;</url>
    <title>Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment.</title>
    <publicationDate>1997-07-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,ETHICS &amp; LAW,BREAKING DIFFICULT NEWS,WITHHOLDING &amp; WITHDRAWING TREATMENT,COMMUNICATION ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Physicians are frequently unaware of patient preferences for end-of-life care. Identifying and exploring barriers to patient-physician communication about end-of-life issues may help guide physicians and their patients toward more effective discussions.]]&gt;</body>
  </document>
  <document>
    <id>101599</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/358/CN-00380358/frame.html]]&gt;</url>
    <title>Patient-held records in cancer and palliative care: a randomized, prospective trial</title>
    <publicationDate>2002-05-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,COMMUNICATION ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "This study provides no evidence on which to base the widespread promotion of PHRs, although local projects with committed clinicians and patients may well prove popular and effective."]]&gt;</body>
  </document>
  <document>
    <id>125766</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://bmj.bmjjournals.com/cgi/reprint/331/7527/1252?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=ahmedzai&amp;searchid=1&amp;FIRSTINDEX=0&amp;volume=331&amp;issue=7527&amp;resourcetype=HWCIT&amp;eaf]]&gt;</url>
    <title>Pet ownership and human health: a brief review of evidence and issues</title>
    <publicationDate>2005-11-26T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,SOCIAL &amp; PSYCHOSOCIAL ISSUES,ANIMAL-ASSISTED THERAPIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Research into the association between pet ownership and human health has produced intriguing, although frequently contradictory, results often raising uncertainty as to whether pet ownership is advisable on health grounds.</description>
    <body>&lt;![CDATA[ Research into the association between pet ownership and human health has produced intriguing, although frequently contradictory, results often raising uncertainty as to whether pet ownership is advisable on health grounds.]]&gt;</body>
  </document>
  <document>
    <id>102201</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/539/CN-00473539/frame.html]]&gt;</url>
    <title>Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,NEUROPATHIC PAIN,MEDICINES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "Ketamine is known to provide analgesic effects without an anesthetic when administered in a low dose. We previously reported that a tablet containing ketamine had analgesic effects in patients with neuropathic pain. In the present study, we compared the plasma concentration profiles of the enantiomers of ketamine and its active metabolite, norketamine, up to 8 h after the administration of 20 mg of ketamine by injection, after the administration of two tablets containing 25 mg of ketamine, after the administration of two sublingual tablets containing 25 mg of ketamine, after the insertion of a suppository containing 50 mg of ketamine, and after the application of a nasal spray containing 25 mg of ketamine to three healthy volunteers."]]&gt;</body>
  </document>
  <document>
    <id>113216</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mywhatever.com/cifwriter/content/41/pe3647.html]]&gt;</url>
    <title>Promoting excellence: end-stage renal disease workgroup recommendations to the field</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>Robert Wood Johnson Foundation</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,FAMILIES &amp; CARERS,SERVICE PROVISION,AUDIT,OUTCOME MEASURES,SERVICE DEVELOPMENT,RENAL DISEASES,QUALITY OF LIFE,ACCESS TO PALLIATIVE AND SUPPORTIVE CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Promoting excellence: end-stage renal disease workgroup recommendations to the field&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;In 1997, The Robert Wood Johnson Foundation launched a national program &lt;I&gt;Promoting Excellence in End-of-Life Care&lt;/I&gt; with a mission of improving care and quality of life for dying Americans and their families.&lt;/P&gt;
&lt;P&gt;The End-Stage Renal Disease (ESRD) Workgroup worked to improve supportive care and quality of life for dialysis patients from Spring 2000 - Spring 2002. Chaired by Alvin Moss, MD (Director of the West Virginia University Center for Health Ethics and Law), this workgroup consisted of 23 members including nurses, social workers, nephrologists, and kidney transplant recipients. To accomplish its goals, the workgroup divided into three subgroups -- Education, Quality of Life, and Quality of Dying.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259863</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=259863]]&gt;</url>
    <title>Promotional materials and other files to download free</title>
    <publicationDate></publicationDate>
    <publisher>NHS Evidence - supportive and palliative care</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SERVICE PROVISION,SERVICE TYPE,INFORMATION SERVICES AND LIBRARIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Promotional materials and other files to download free&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The files listed below are available for promotional use in libraries, education centres, research units, hospices, staff rooms&amp;nbsp;and other locations as desired.&lt;/P&gt;
&lt;P&gt;Hard copies of these are also available from us&amp;nbsp;whenever we attend a conference, exhibition or other event. &lt;/P&gt;
&lt;P&gt;Please check the content of each file carefully before you print. Some items are longer and/or use more colour than others, so may not be appropriate for your printing facilities or your requirements. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>102276</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/455/CN-00423455/frame.html]]&gt;</url>
    <title>Prostate cancer treated by anti-androgens: Is sexual function preserved?</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,MEDICINES,SEXUAL HEALTH,GENITO-URINARY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "This paper reports on results of the EORTC protocol 30892, an open, prospective, randomized study of 310 patients with previously untreated metastatic prostate cancer with favourable prognostic factors who were treated by either flutamide (FLU) or cyproterone acetate (CPA) monotherapy."]]&gt;</body>
  </document>
  <document>
    <id>105657</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.ncpc.org.uk/publications/index.html]]&gt;</url>
    <title>Publications - National Council for Palliative Care</title>
    <publicationDate></publicationDate>
    <publisher>National Council for Palliative Care (NCPC)</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES,UNITED KINGDOM,INTERNATIONAL,FUNERALS,WILLS,DEATH RITES &amp; RITUALS,BEREAVEMENT,PLACE OF DEATH,NARRATIVES,SERVICE DEVELOPMENT,POST-DEATH]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Comprehensive publications list including commentaries on, and responses to, many key policy documents. Other publications&amp;nbsp;include those which can help develop and implement palliative care strategies, support clinical governance and offer guidance on clinical and ethical issues.]]&gt;</body>
  </document>
  <document>
    <id>102125</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mndassociation.org/life_with_mnd/getting_more_information/publications/index.html]]&gt;</url>
    <title>Publications List</title>
    <publicationDate></publicationDate>
    <publisher>Motor Neurone Disease Association</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,NERVOUS SYSTEM DISEASES,FAMILIES &amp; CARERS,MOTOR NEURONE DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>List of items published by the association.</description>
    <body>&lt;![CDATA[ List of items published by the association.]]&gt;</body>
  </document>
  <document>
    <id>239662</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.britishpainsociety.org/pub_professional.htm#pmp]]&gt;</url>
    <title>Recommended guidelines for pain management programmes for adults - provisional</title>
    <publicationDate>2006-06-01T00:00:00</publicationDate>
    <publisher>British Pain Society</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ PAIN MANAGEMENT,DISEASE MANAGEMENT,MUSCULOSKELETAL,DISEASE MANAGEMENT,TRAUMA AND ORTHOPAEDICS,PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,PAIN MANAGEMENT,VISCERAL PAIN,PAIN MANAGEMENT,NEUROPATHIC PAIN,BONE PAIN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Provisional guidelines launched at the British Pain Society's Annual Scientific Meeting (ASM) in Harrogate on Wednesday 26 April. The publication is now undergoing a year-long consultation process.]]&gt;</body>
  </document>
  <document>
    <id>156472</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mfghc.com/resources/resources_faithindex.htm]]&gt;</url>
    <title>Resources for multi-faith chaplaincy - index by faiths</title>
    <publicationDate></publicationDate>
    <publisher>Multi-Faith Group for Healthcare Chaplaincy</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PROFESSIONS,CHAPLAINS/SPIRITUAL CARE PROFESSIONALS,SERVICE PROVISION,FUNERALS,DEATH RITES &amp; RITUALS,PALLIATIVE AND SUPPORTIVE CARE,DEATH,SYMPTOM MANAGEMENT,ETHNICITY AND HEALTH,SPIRITUAL CARE,RELIGION,CULTURAL COMPETENCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Beliefs and customs of religious faiths including those relevant to health and social care, and relating to death and dying.</description>
    <body>&lt;![CDATA[ Index to beliefs and customs of major religious faiths. Includes many issues relevant to health and social care, and relating to death and dying.]]&gt;</body>
  </document>
  <document>
    <id>95024</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.sach.org.uk/journal/journal.htm]]&gt;</url>
    <title>Scottish Journal of Healthcare Chaplaincy</title>
    <publicationDate></publicationDate>
    <publisher>Scottish Association of Chaplains in Healthcare</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,SERVICE PROVISION,PROFESSIONS,CHAPLAINS/SPIRITUAL CARE PROFESSIONALS,SPIRITUAL CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "The Scottish Journal of Healthcare Chaplaincy aims to assist healthcare chaplains and care workers as they strive to provide effective spiritual, religious and pastoral care within the contemporary healthcare setting.&amp;nbsp; The Journal provides a multi-disciplinary forum for the discussion of a wide range of issues pertaining to healthcare and healthcare chaplaincy in all of its diverse forms."]]&gt;</body>
  </document>
  <document>
    <id>113151</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.worldday.org/EasySiteWeb/GatewayLink.aspx?alId=7548]]&gt;</url>
    <title>Suffering at the end of life: the state of the world</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Help the Hospices</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,HUMANITIES,SOCIAL CLASS &amp; DEPRIVATION,INTERNATIONAL,PLACE OF CARE,HOSPICES &amp; SPECIALIST PALLIATIVE CARE UNITS,OWN HOME,COMMUNITY,HOSPITALS,COMMUNITY HOSPITALS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Suffering at the end of life: the state of the world&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN lang=EN-GB style="FONT-SIZE: 10pt; FONT-FAMILY: Arial; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA"&gt;Produced in partnership with national and pan-national hospice and palliative care associations around the world, this document, published by Help the Hospices, reports on the current situation of hospice and palliative care globally.&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>382764</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.endoflifecareforadults.nhs.uk/assets/downloads/Social_care_framework_again.pdf]]&gt;</url>
    <title>Supporting people to live and die well: a framework for social care at the end of life. Report of the Social Care Advisory Group of the National End of Life Care Programme</title>
    <publicationDate></publicationDate>
    <publisher>NHS National End of Life Care Programme</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,POLICY,SOCIAL &amp; PSYCHOSOCIAL ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "&lt;FONT face=Frutiger-Light&gt;The Department of Health’s End of Life Care Strategy and accompanying implementation programme is intended to change the ‘culture’ and experience of dying on three different levels: wider society’s awareness, service user experience and the professional and service delivery infrastructure. This framework addresses the social care aspect of those changes. It signals a change in the way social care supports people at the end of life.&lt;/FONT&gt;"]]&gt;</body>
  </document>
  <document>
    <id>102155</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk/PALLIATIVE/ViewResource.aspx?resID=102155&amp;tabID=289]]&gt;</url>
    <title>Systematic review of bisphosphonates for hypercalcaemia of malignancy</title>
    <publicationDate></publicationDate>
    <publisher>DARE</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,MEDICINES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Provisional record.&lt;/P&gt;
&lt;P&gt;Original article: &lt;A name=ref1&gt;Saunders Y, Ross J R, Broadley K E, Edmonds P M, Patel S. Systematic review of bisphosphonates for hypercalcaemia of malignancy. Palliative Medicine 2004;18(5):418-431. &lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>102230</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/505/CN-00375505/frame.html]]&gt;</url>
    <title>The effects of single-session music therapy interventions on the observed and self-reported levels of pain control, physical comfort, and relaxation of hospice patients</title>
    <publicationDate>2001-11-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,SERVICE PROVISION,PAIN MANAGEMENT,PROFESSIONS,COMPLEMENTARY &amp; ALTERNATIVE THERAPIES,MUSIC THERAPISTS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ "This article describes the process and results of a three-month music therapy clinical effectiveness study conducted with terminally ill patients. The purpose of this study was to quantify and evaluate the effectiveness of single-session music therapy interventions with hospice patients in three patient problem areas: pain control; physical comfort; and relaxation."]]&gt;</body>
  </document>
  <document>
    <id>372301</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.epcrc.org/publication_listfiles.php?id=mCw3SZ1etExf7tpTvTaW]]&gt;</url>
    <title>The management of depression in palliative care. Draft European guidelines</title>
    <publicationDate></publicationDate>
    <publisher>European Palliative Care Research Collaborative</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,SYMPTOM MANAGEMENT,SERVICE PROVISION,PSYCHIATRIC,SOCIAL &amp; PSYCHOSOCIAL ISSUES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Draft depression guideline open to consultation</description>
    <body>&lt;![CDATA[ "&lt;FONT size=2 face=Tahoma&gt;&lt;FONT size=2 face=Tahoma&gt;Overall objective is t&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=2 face=Tahoma&gt;&lt;FONT size=2 face=Tahoma&gt;o produce an evidence-based clinical guideline for the management of depression in palliative care, on behalf of the European Palliative Care Research Collaborative (EPCRC &lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT color=#0000ff size=2 face=Tahoma&gt;&lt;FONT color=#0000ff size=2 face=Tahoma&gt;&lt;FONT color=#0000ff size=2 face=Tahoma&gt;&lt;A href="http://www.epcrc.org/" target="_blank"&gt;http://www.epcrc.org&lt;/A&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;FONT size=2 face=Tahoma&gt;&lt;FONT size=2 face=Tahoma&gt;). The EPCRC is a project funded by the European Commission’s Sixth Framework Programme, with the overall aim of improving the management of pain, depression and cachexia through translational research."&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>88919</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.mrw.interscience.wiley.com/cochrane/clcentral/articles/795/CN-00080795/frame.html]]&gt;</url>
    <title>The quality of mercy. Caring for patients with 'do not resuscitate' orders.</title>
    <publicationDate>1992-02-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd.</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,ETHICS &amp; LAW,WITHHOLDING &amp; WITHDRAWING TREATMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 1-year randomized, controlled trial which aims to assess (1) the effect of an ethics education intervention for medical house officers on practices surrounding "Do Not Resuscitate" (DNR) orders and (2) the association of DNR care with patient diagnosis and demographic variables.]]&gt;</body>
  </document>
  <document>
    <id>271133</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271133]]&gt;</url>
    <title>The treatment of lymphoedema / chronic oedema</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,LYMPHOEDEMA,SYMPTOM MANAGEMENT,SERVICE PROVISION,HAEMATOLOGIC AND LYMPHATIC DISEASES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The treatment of lymphoedema / chronic oedema&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Dr Vaughan Keeley, Consultant in Palliative Medicine, Derby Hospitals NHS Foundation Trust.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;The evidence base for treatments&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;Physical treatments&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The main treatment for lymphoedema and other chronic oedemas is based upon a combination of physical treatments which include:&lt;/P&gt;
&lt;P&gt;•&amp;nbsp;compression&amp;nbsp;&amp;nbsp;(garments or bandaging)&lt;BR&gt;•&amp;nbsp;massage&amp;nbsp;&amp;nbsp;(manual lymphatic drainage, MLD, and simple lymph &lt;BR&gt;drainage, SLD)&lt;BR&gt;•&amp;nbsp;exercise&lt;BR&gt;•&amp;nbsp;skin care&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Whilst there is evidence that the combination of physical treatments is effective (Ko et al, 1998), there is little evidence to determine which components are more important and whether all elements are needed in all patients.&amp;nbsp; As a result, the Lymphoedema Framework project (a national project in the UK which aims to develop effective service models) has published an international consensus document (Lymphoedema Framework, 2006 a).&amp;nbsp; This is an important source of guidance on management based upon current knowledge.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Further guidance on compression garments and compression bandaging can be found in Lymphoedema Framework (2006 b) and European Wound Management Association (2005).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;Drug therapies&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;i)&amp;nbsp;&lt;STRONG&gt;Diuretics&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Pure lymphoedema does not respond to diuretic therapy (BNF 2007).&amp;nbsp; However, diuretics may have a part to play in the management of more complex oedema where fluid retention or heart failure may contribute.&lt;/P&gt;
&lt;P&gt;ii)&amp;nbsp;&lt;STRONG&gt;Benzopyrones&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Various benzopyrones (e.g. coumarin, oxerutins) have been recommended for the treatment of lymphoedema.&amp;nbsp; There is some evidence for a beneficial effect (Casley-Smith, 1999) but a recent Cochrane review concluded that there was no evidence to support their routine use in the management of lymphoedema (Badger et al, 2003).&amp;nbsp; Unfortunately, there have also been examples of hepatotoxicity with the use of coumarin, so it has been withdrawn in a number of countries including the UK.&lt;/P&gt;
&lt;P&gt;iii)&amp;nbsp;&lt;STRONG&gt;Corticosteroids&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Corticosteroids may play a part in the management of chronic oedema in advanced cancer where there is metastatic lymphadenopathy (Keeley, 2000). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Management of cellulitis / acute inflammatory episodes&lt;/H2&gt;
&lt;P&gt;Patients with lymphoedema are at risk of developing recurrent episodes of cellulitis / acute inflammation as a result of a “local immune deficiency” due to the malfunctioning lymphatic system (Mallon et al,1997).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;There has been debate about whether these episodes are due to infection with Streptococcal or Staphylococcal bacteria.&amp;nbsp; A group of clinicians has recently produced consensus guidelines on the management of cellulitis in lymphoedema (BLS/LSN, 2007).&amp;nbsp; These are based upon the concept that the majority of episodes are caused by ß-haemolytic streptococci.&amp;nbsp; The oral antibiotics recommended for home management are summarised in Table 1.&lt;/P&gt;
&lt;BLOCKQUOTE dir=ltr style="MARGIN-RIGHT: 0px"&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Table 1&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Management of cellulitis in lymphoedema – at home with oral antibiotics&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;1.&amp;nbsp;Amoxicillin 500 mg 8 hourly for at least 14 days.&lt;/P&gt;
&lt;P&gt;2.&amp;nbsp;Add Flucloxacillin 500 mg 6 hourly if Staphylococcus aureus infection is suspected e.g. folliculitis, pus formation or crusted dermatitis is present.&lt;/P&gt;
&lt;P&gt;3.&amp;nbsp;If patient is allergic to Penicillin, use Clindamycin 300 mg 6 hourly for at least 14 days.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;If a patient fails to improve on this regimen or is systemically very unwell, admission to hospital for intravenous antibiotics is recommended.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Prophylactic antibiotics (Penicillin V or Erythromycin) should be considered in patients who develop recurrent episodes of cellulitis (=2 per year).&amp;nbsp; In these patients the management of the lymphoedema is also reviewed, as a reduction in limb volume is associated with a reduced incidence of cellulitis (Ko et al, 1998).&amp;nbsp; Likely causes of infection e.g. ingrowing toenails, eczema, Athlete’s foot are treated appropriately.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Conclusions&lt;/H2&gt;
&lt;P&gt;Treatments are available for chronic oedemas but they are not curative and the evidence for their effectiveness is limited.&amp;nbsp; An international consensus document (Lymphoedema Framework, 2006 a) recommends best practice for management based upon the current evidence.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;Badger C, Preston N, Seers K, Mortimer P (2003).&amp;nbsp; Benzo-pyrones for reducing and controlling lymphoedema of the limbs.&amp;nbsp; Cochrane Database of Systematic Reviews 2003, Issue 4, Art No: CD003143.&lt;/P&gt;
&lt;P&gt;BLS/LSN (2007).&amp;nbsp; Consensus guidelines on the management of cellulitis in lymphoedema available at &lt;A href="http://www.thebls.com/" target="_blank"&gt;www.thebls.com&lt;/A&gt; and &lt;A href="http://www.lymphoedema.org/lsn" target="_blank"&gt;www.lymphoedema.org/lsn&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;British National Formulary (2007).&amp;nbsp; British National Formulary 53.&amp;nbsp; BMJ Publishing Group and RPS Publishing, London.&lt;/P&gt;
&lt;P&gt;Casley-Smith JR (1999).&amp;nbsp; Benzo-pyrones in the treatment of lymphoedema.&amp;nbsp; Int. Angiol. 18(1): 31-41&lt;/P&gt;
&lt;P&gt;European Wound Management Association (EWMA) (2005).&amp;nbsp; Focus Document: Lymphoedema bandaging in practice.&amp;nbsp; London: MEP Ltd.&lt;/P&gt;
&lt;P&gt;Keeley V (2000).&amp;nbsp; Oedema in advanced cancer.&amp;nbsp; In: Twycross R, Jenns K, Todd J, eds. Lymphoedema.&amp;nbsp; Radcliffe Medical Press, Oxford: 338-58.&lt;/P&gt;
&lt;P&gt;Ko DSC, Lerner R, Klose G et al (1998).&amp;nbsp; Effective treatment of lymphoedema of the extremities.&amp;nbsp; Arch. Surg. 133: 452-458.&lt;/P&gt;
&lt;P&gt;Lymphoedema Framework (2006 a).&amp;nbsp; Best Practice for the Management of Lymphoedema.&amp;nbsp; International consensus.&amp;nbsp; London: MEP Ltd.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Lymphoedema Framework (2006 b).&amp;nbsp; Template for Practice: compression hosiery in lymphoedema.&amp;nbsp; London: MEP Ltd.&lt;/P&gt;
&lt;P&gt;Mallon E, Powell S, Mortimer P et al (1997).&amp;nbsp; Evidence of altered cell mediated immunity in post-mastectomy lymphoedema.&amp;nbsp; Br. J. Dermatol. 137: 928-933.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>102232</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.npc.co.uk/ebt/merec/pain/otherback/resources/merec_briefing_no22.pdf]]&gt;</url>
    <title>The use of strong opioids in palliative care</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>MeReC Publications</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,CANCER,SYMPTOM MANAGEMENT,PAIN MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The use of strong opioids in palliative care&lt;/pageTitle&gt;&lt;pageBody&gt;"This briefing focuses on the use of strong opioid analgesics in the management of pain in terminally ill cancer patients, who are the main recipients of palliative care."&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>102248</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.helpthehospices.org.uk/echoices/]]&gt;</url>
    <title>Training - eChoices</title>
    <publicationDate></publicationDate>
    <publisher>hospice information</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,RESEARCH]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 1&lt;/FIRSTPAGE&gt;&lt;FIRSTPAGEID&gt;1&lt;/FIRSTPAGEID&gt;&lt;PAGE&gt;&lt;PAGEID&gt;1&lt;/PAGEID&gt;&lt;PAGESEQUENCE&gt;-1&lt;/PAGESEQUENCE&gt;&lt;PAGETITLE&gt;&lt;/PAGETITLE&gt;&lt;PAGEBODY&gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>320499</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=320499]]&gt;</url>
    <title>Trans-Pennine palliative care research meeting</title>
    <publicationDate></publicationDate>
    <publisher>Trans-Pennine palliative care research meeting</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,POPULATIONS AND SETTINGS,SERVICE PROVISION,POLICY,RESEARCH,ETHICS &amp; LAW,HUMANITIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Trans-Pennine palliative care research meeting&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Network for researchers, and clinical staff in supportive and palliative care.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;"The aim is to provide a platform for discussions with colleagues interested in the field of supportive and palliative care research.&amp;nbsp; The meeting is open to all, whether you are an experienced researcher, a junior colleague or a newcomer in this field, or maybe not yet started on your first project.&amp;nbsp;"&lt;/EM&gt; &lt;/P&gt;
&lt;P&gt;Professor Sam H&amp;nbsp; Ahmedzai&lt;BR&gt;Head of Academic Unit of Supportive Care, University of Sheffield.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The 10th Trans-Pennine palliative care research meeting will be on Thursday 20th May 2010 &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Venue = T&lt;/STRONG&gt;&lt;STRONG&gt;he Source, Meadowhall, Sheffield S9 1EA.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;All enquiries to the conference secretary: &lt;/P&gt;
&lt;P&gt;Pauline Hutchinson&lt;BR&gt;Sykes House&lt;BR&gt;Little Common Lane&lt;BR&gt;Sheffield&amp;nbsp; S11 9NE&lt;BR&gt;Tel: +44 (0) 114 262 0174&lt;BR&gt;Email: &lt;A href="mailto:spcsg-conferences@sheffield.ac.uk" target="_blank"&gt;spcsg-conferences@sheffield.ac.uk&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304323</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304323]]&gt;</url>
    <title>User involvement and End of Life Care. Contextualising User Involvement</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT,COMMISSIONING,MIGRATED RESOURCES (HEALTH MANAGEMENT - COMMISSIONING)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;User involvement and End of Life Care. Contextualising User Involvement&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;“We’re people, we’re not just nuisances”&lt;/H2&gt;
&lt;H2&gt;Patient, User Forum, St Christopher’s, 1 April 2008&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The 55 year-old service user with Parkinson’s Disease who expressed this view as she talked of her local hospital, is not alone. The ‘a person’ not ‘a number’ plea has been expressed repeatedly and yet services struggle still to bring to reality personalised care. The Healthcare Commission’s analysis of the 16,000 complaints it received for independent review between July 2004 and July 2006 revealed that 54% of complaints about hospitals related to care surrounding a death - what better indication is there of the need to get better engaged with and access the views of the people who experience services?&lt;/P&gt;
&lt;P&gt;The challenge to capture the individual voice of service users and carers as well as the collective voice is great in end of life care. Users have increasingly become involved in care, and service delivery, research and education. The statutory requirements for the NHS to consult users and the public is another motivating factor (DH, 2008). For end of life care to be truly person-focused, the first and ultimate partnership needs to be with service users and carers to develop ways to overcome their main criticisms of end of life systems and pathways of care. There needs to be a multiplicity of ways to engage and listen better to individual users and carers and the communities to which they belong.&lt;/P&gt;
&lt;P&gt;The particular challenges for user involvement in end of life care relate to the advanced nature of patients’ illnesses; fluctuating nature of patients’ conditions; patients’ preoccupations with immediate symptoms and other pressing care needs; the difficulties in attending external consultation meetings and forums; the high dependence on carers with a differing sets of views and priorities; the time-consuming nature of effective user engagement; the additional practical support required to enable participation by people with advanced illnesses; and accessing and engaging with the diversity of users and carers.&lt;/P&gt;
&lt;P&gt;Still, experience has shown that providers can start small and provide a ‘mixed economy’ of ways for users and carers to communicate with them. In addition to eliciting feedback through conventional surveys, audits and analysis of complaints, providers of end of life care services have begun by using opportunities to meet users in small groups at out-patients clinics or in day centres, in advertised user forums and by encouraging written or email feedback. &lt;/P&gt;
&lt;P&gt;The National Council for Palliative Care has planned a facility for users and carers to provide online feedback on aspects of care or to contribute ideas for improved user involvement. Even if this facility is only used once or twice by a patient, it can feel empowering and satisfying to have fed back on experiences in the system of care, especially when this contributes to better information for service planners and commissioners. &lt;/P&gt;
&lt;P&gt;Service users and carers are not all passive recipients of care: we need to recognise and harness their own professional competence, life experience and individual skills. &lt;/P&gt;
&lt;P&gt;We need to judge when to facilitate people to use their own resources and means to suggest changes and improvements to services for their own personalised care or at an organisational level. At other times, we are required to be more active advocates for users and carers. However, it is preferable that people are empowered to have their own voice heard. The creation of specific user involvement facilities is one clear way forward.&lt;/P&gt;
&lt;P&gt;The Expert Patients’ and planned Caring with Confidence Programmes build on the empowerment of users and carers and extends it further. The new LINks (Local Involvement Networks) provide another opportunity for local communities to have a voice (Expert Patients’ Programme 2008; Caring with Confidence 2008; National Centre for Involvement 2008).&lt;/P&gt;
&lt;P&gt;For involvement to be real, it will be at all levels in the organisation in order to increase the power base of those who use the services, for example, at the start of a new scheme, as it is being devised and designed, not just after all key decisions have been made. In fact, the use of blogs and other electronic means of communication are perhaps already changing the balance of power between users and providers. It is also important to remember that often users suggest small changes but it can be the smaller changes that create a bigger picture of change over time.&lt;/P&gt;
&lt;P&gt;“It is not just about being a passive ‘data source’. It is a more active process, involving people in speaking for and acting for themselves.”&lt;BR&gt;(Croft and Beresford, 2007)&lt;/P&gt;
&lt;P&gt;Case study – structure of user involvement at St Christopher’s Hospice&lt;/P&gt;
&lt;P&gt;User involvement is concerned with the meaningful and active participation&lt;BR&gt;and consultation of service users (patients, clients and carers), according to their ability and experience and from their unique perspective, in aspects of: &lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Their own care&lt;/LI&gt;
&lt;LI&gt;Service planning&lt;/LI&gt;
&lt;LI&gt;Service delivery&lt;/LI&gt;
&lt;LI&gt;Audit/evaluation/research&lt;/LI&gt;
&lt;LI&gt;Staff training&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;As with many palliative care providers, St Christopher’s facilitates a ‘mixed method economy’ of methods and opportunities to engage the user voice:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;User Forum&lt;/LI&gt;
&lt;LI&gt;Individual feedback and interviews with users&lt;/LI&gt;
&lt;LI&gt;Surveys of users, carers, visitors&lt;/LI&gt;
&lt;LI&gt;Audits&lt;/LI&gt;
&lt;LI&gt;Users’ Education Advisory Group &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;User Forum – Summary. An example of one activity&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Aims to gain insight into the views of home and day care patients&lt;/LI&gt;
&lt;LI&gt;All users and carers are invited, ie self-selection&lt;/LI&gt;
&lt;LI&gt;12-45 patients, including some carers, 3 times per year&lt;/LI&gt;
&lt;LI&gt;11-3pm, including lunch, with&amp;nbsp; short facilitated group sessions&lt;/LI&gt;
&lt;LI&gt;Essential support – transport and nurse on duty&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Feedback to all departments at Clinical Governance meetings&lt;/P&gt;
&lt;P&gt;The primary purpose of the User Forum is to gain insight into the views and experiences of home and day care patients in order to improve service delivery.&amp;nbsp; The proceedings, which run from about 11am to 3pm are facilitated by the Director of Education and the Quality Assurance Adviser, neither of whom are engaged in clinical activity, the idea being that this will make it more likely that participants will feel able to feed back the negatives as well as the positives.&amp;nbsp; Attendees, made up of patients and carers, are invited to form small groups of 5-8 people and to consider their experiences of the care and various services at St Christopher’s.&amp;nbsp; Occasionally the groups will be asked to comment on a new patient information leaflet (a useful jargon-busting exercise). A report to heads of department and a trustee at the Clinical Governance Committee contains recommendations and comments. The Committee decides on any actions arising from these, and changes made as a result of the comments are reported to participants by letter. Typical suggestions have mostly been practical ones such as improved signage around the hospice, more varied menus in day care, better information about help with transport. &lt;/P&gt;
&lt;P&gt;A secondary purpose has been to increase the knowledge and uptake of services, especially new ones. So, for example, our complementary therapists have spoken to&amp;nbsp; the group about a new home-based service for carers and encouraged people to ask questions. We found that the discussion prompted some male patients, who had previously dismissed complementary therapy, to refer themselves.&lt;/P&gt;
&lt;P&gt;There have been, and continue to be, challenges. The biggest of these is to distil, from the personal accounts of individuals, messages for the organisation.&amp;nbsp; For example, patients and carers repeatedly praise the care and services they receive, despite the facilitators’ vigorous attempts at encouraging them to identify areas for improvement. But there is a reason for this:&amp;nbsp; patients’ stories tell us that their expectations on arrival at St Christopher’s are coloured by fear and apprehension, hence their relief at finding that hospices are places where you can laugh and enjoy life.&amp;nbsp; (What they tell us about their expectations has helped us develop our public education activities).&lt;/P&gt;
&lt;P&gt;Another challenge is the uncertainty of who will turn up on the day- inevitably there is a big gap between the number of patients who say they will attend, and the number who make it on the day.&amp;nbsp; Catering and nursing support arrangements have to take this into account.&amp;nbsp; In order to increase numbers, we stopped asking patients’ clinical nurse specialists to identify patients well enough to be invited, and instead requested the names only of those who were too ill to attend. This has resulted in improved attendance (up to 45 patients and carers per event). &lt;/P&gt;
&lt;P&gt;Carer attendance itself has increased to the point where they have requested their own separate discussion groups at the Forum.&amp;nbsp; They say that they gain a strong sense of support from this.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;All the above related to home and day care users. What about patients in the in-patient unit? We tried arranging an in-patient forum, but patients were often too frail for more than a couple to attend.&amp;nbsp; The Quality Assurance Adviser therefore visited patients and asked them about their experiences individually. This has now been superseded by research to develop a tool that will help us to identify patient-generated outcomes, so that we can discover by this means how well we are meeting patients’ objectives.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Caring with Confidence (2008) Introducing Caring with Confidence&lt;BR&gt;Leeds: Caring with Confidence&lt;BR&gt;&lt;A href="http://www.caringwithconfidence.net/publications" target="_blank"&gt;http://www.caringwithconfidence.net/publications&lt;/A&gt; (accessed 9/1/09)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Croft S and Beresford P (2007) Foreword. In Jarrett L (ed) Creative engagement in palliative care. New perspectives on user involvement. Abingdon: Radcliffe Publishing&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Department of Health (2008) Real involvement: working with people to improve services. London:&amp;nbsp; Department of Health &lt;BR&gt;&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089787" target="_blank"&gt;http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_089787&lt;/A&gt;&amp;nbsp;&amp;nbsp; (accessed 8/1/09)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Expert Patients’ Programme (2008)&amp;nbsp; Progress Report. London: Expert Patients Programme. &lt;BR&gt;&lt;A href="http://www.expertpatients.co.uk/public/cms/uploads/ProgressReport08.pdf" target="_blank"&gt;http://www.expertpatients.co.uk/public/cms/uploads/ProgressReport08.pdf&lt;/A&gt;&lt;BR&gt;(accessed 2008) &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;National Centre for Involvement (2008)&amp;nbsp; Local Involvement Networks (LINks). Checking progress. Warwick: NHS Centre for Involvement &lt;BR&gt;&lt;A href="http://www.nhscentreforinvolvement.nhs.uk/docs/Guide%2015%20-%20Checklist.pdf" target="_blank"&gt;http://www.nhscentreforinvolvement.nhs.uk/docs/Guide%2015%20-%20Checklist.pdf&lt;/A&gt;&amp;nbsp; (accessed 6/1/09)&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Denise Brady (Librarian),&amp;nbsp;David Oliviere (Director of Education and Training), Education Centre, St Christopher’s Hospice&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;January 2008&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;Back to the CONTENTS PAGE&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>304351</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=304351]]&gt;</url>
    <title>User involvement in EoLC: how involved can patients/carers be?</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Health: Supportive and Palliative Care Library</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PATIENT AND PUBLIC INVOLVEMENT,PPI IN PRACTICE,PALLIATIVE AND SUPPORTIVE CARE,CONDITIONS,SYMPTOM MANAGEMENT,FAMILIES &amp; CARERS,DEATH,COMMUNICATION ISSUES,INDIVIDUAL INVOLVEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;User involvement in EoLC: how involved can patients/carers be?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Download the pdf by selecting the link under 'Related Files' below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;&lt;A href="http://www.library.nhs.uk/palliative/ViewResource.aspx?resID=304326&amp;amp;tabID=290" target="_blank"&gt;&lt;FONT size=2&gt;Back to the CONTENTS PAGE&lt;/FONT&gt;&lt;/A&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>113487</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.helpthehospices.org.uk/about-hospice-care/user-voices/?locale=en]]&gt;</url>
    <title>Users' voices</title>
    <publicationDate></publicationDate>
    <publisher>Help the Hospices</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PALLIATIVE AND SUPPORTIVE CARE,FAMILIES &amp; CARERS,DEATH,SERVICE PROVISION,HUMANITIES,PLACE OF CARE,HOSPICES &amp; SPECIALIST PALLIATIVE CARE UNITS,NARRATIVES,SERVICE DEVELOPMENT,QUALITY OF LIFE,ACCESS TO PALLIATIVE AND SUPPORTIVE CARE SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Area of the Help the Hospices website which deals with user involvement issues and encourages users to share their experience of illness and the care they receive. Includes transcribed interviews with patients and links to other resources.]]&gt;</body>
  </document>
  <document>
    <id>271068</id>
    <name>&lt;![CDATA[ Palliative and Supportive Care]]&gt;</name>
    <rootDirectory>/palliative</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//palliative/ViewResource.aspx?resID=271068]]&gt;</url>
    <title>Using strong opioids in advanced chronic kidney disease - what is the evidence?</title>
    <publicationDate></publicationDate>
    <publisher>National Library for Palliative and Supportive Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ RENAL DISEASES,MEDICINES,SYMPTOM MANAGEMENT,SERVICE PROVISION,CONDITIONS,PALLIATIVE AND SUPPORTIVE CARE,KIDNEY DISEASES,INTERVENTIONS,OTHERS,CHRONIC KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Using strong opioids in advanced chronic kidney disease - what is the evidence?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;Written by Claire A Douglas, Specialist Registrar in Palliative Medicine, Ninewells Hospital, NHS Tayside, and Fliss Murtagh, Research Training Fellow, Department of Palliative Care, Policy &amp;amp; Rehabilitation, King’s College London.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Introduction &lt;/H2&gt;
&lt;P&gt;A recent systematic literature review has shown that pain is common, both in dialysis patients (1), and in those with stage 5 chronic kidney disease (CKD) managed without dialysis (2). Studies of those dying with advanced CKD also indicate that although most appear to have a ‘good death’, a significant minority experience distressing symptoms, including pain (3) (4) (5). Achieving good pain control for these patients is therefore important.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;What level of renal impairment?&lt;/H2&gt;
&lt;P&gt;The UK CKD guidelines (6) classify CKD into five stages, according to estimated glomerular filtration rate (eGFR). The evidence presented here applies largely to Stages 4 or 5 CKD, when eGFR is = 30 mL per minute. At these levels of renal impairment, drug metabolism is significantly altered and the risk of toxicity from accumulation of renally-excreted drugs is high. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;When to apply this evidence?&lt;/H2&gt;
&lt;P&gt;This evidence applies to those NOT on dialysis, either because they are being managed conservatively (without dialysis) or because they have withdrawn from dialysis, since these are the patients most usually seen by palliative professionals. There are additional considerations for the patient who remains on dialysis (7) (8).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Which strong opioid to use?&lt;/H2&gt;
&lt;P&gt;Certain opioids cause significant toxicity. Evidence for each of the main opioids is provided in turn; much of this evidence is detailed more fully elsewhere (8) (9) (10) (11) (12).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Alfentanil&lt;/EM&gt;&lt;/STRONG&gt; Alfentanil is a very short-acting opioid that undergoes hepatic metabolism to inactive, non-toxic metabolites which are renally cleared. Only 1% of the parent unchanged drug is excreted by the kidneys (13). Small pharmacokinetic studies have shown that in patients with renal failure, there is no change in volume of distribution or elimination half-life, with no reports of adverse effects in renal failure (14). Of all the strong opioids, it has the most evidence to support its safety in severe renal impairment.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Buprenorphine&lt;/EM&gt;&lt;/STRONG&gt; Buprenorphine is a potent partial ?-opioid receptor agonist. It is metabolised in the liver to norbuprenorphine, and buprenorphine-3-glucuronide (B-3-G) (15). These metabolites are excreted via the kidney, while unchanged buprenorphine is excreted principally via the biliary system (11) (15). There has been little evaluation in renal failure to date. In a single-dose study, the pharmacokinetics of the parent drug appeared unchanged in renal failure, but metabolites were not measured (16). Metabolite levels during continuous infusion are significantly higher in severe renal impairment (15) but with wide individual variation. However, norbuprenorphine is 40 times less potent analgesically than buprenorphine, while B-3-G is analgesically inactive (15). Both these studies recorded no adverse effects, but animal studies have identified respiratory depression (17) (18). &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Fentanyl&lt;/EM&gt;&lt;/STRONG&gt; Fentanyl is metabolised to inactive and non-toxic compounds, and the metabolites (and 10% of unchanged fentanyl) are excreted by the kidneys (12). Controversies exist about the influence of renal failure. One study showed that patients with severe renal impairment had normal clearance and distribution of the drug after a single bolus injection (19), but further evidence shows reduction in clearance in renal impairment (20). An increase in half-life and distribution volume has been reported after continuous infusion, but without reports of adverse effects (21). This evidence suggests it is safer in CKD than morphine or diamorphine.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Hydromorphone&lt;/EM&gt;&lt;/STRONG&gt; Hydromorphone is metabolised to hydromorphone-3-glucuronide (H-3-G) which accumulates in renal failure (22).&amp;nbsp; The activity of H-3-G in humans is not fully established although it is known to be neuro-excitatory in rats.&amp;nbsp; One study looked at pain management in patients with cancer and&amp;nbsp; renal impairment (23) and suggests that renally-impaired patients tolerate morphine better than hydromorphone.&amp;nbsp; The study is a retrospective design and the range of creatinine levels reported suggest that the participants had only mild renal failure.&amp;nbsp; There is little or no evidence in more severe renal impairment.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Methadone&lt;/EM&gt;&lt;/STRONG&gt; Methadone is a synthetic opioid with high volume of distribution. It is metabolised primarily by the liver and the main metabolite, 1.5-dimethyl-2-ethyl-3,3-diphenyl-1-pyrroline, is excreted in the faeces, although renal excretion of the unchanged drug is also an important route of methadone elimination. It displays large pharmacodynamic and pharmacokinetic inter-individual variations and considerable difference between acute and chronic phase dosing, with accumulation of methadone on repeated administration in tissues due to its high volume of distribution. There is some evidence which suggests plasma concentrations are no higher than in those with normal renal function (24), suggesting that faecal excretion might compensate in those with renal impairment. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Morphine and diamorphine&lt;/EM&gt;&lt;/STRONG&gt; Morphine and diamorphine are metabolised to morphine-3-glucuronide (M-3-G) (55%), morphine-6-glucuronide (M-6-G) (10%) and normorphine (4%). These metabolites (and approximately 10% of morphine) are excreted unchanged by the kidneys (25). M-6-G is a potent analgesic and central nervous system depressant. Pharmacokinetic studies show that M-6-G and morphine accumulate in ESRD (26). Studies report significant narcosis, toxic agitation and profound respiratory depression following the use of morphine in patients with ESRD (8) (11). Patients with advanced CKD are therefore at significant risk of toxicity if given morphine or diamorphine. Morphine and diamorphine are therefore not recommended, as better alternative opioids are available.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;EM&gt;Oxycodone&lt;/EM&gt;&lt;/STRONG&gt; Oxycodone is metabolised to oxymorphone and noroxycodone; oxymorphone has minimal opioid activity in humans with normal renal function, but 10% of oxycodone is excreted unchanged by the kidneys, so toxicity may occur with regular use (27).&amp;nbsp; In one small study in renal impairment, clearance of oxycodone and its metabolites was delayed, although adverse effects from this were not reported (28). There is little further data on the use of oxycodone in patients with renal failure. The pharmacokinetics of oxycodone suggest that it may be safer than morphine, but as the evidence is currently very limited, oxycodone cannot be recommended.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;General recommendations&lt;/H2&gt;
&lt;P&gt;All strong opioids should be used cautiously, with dose reduction and increased dosing interval. Early review and regular monitoring should be undertaken, since accumulation of opioids and subsequent adverse effects can occur very rapidly. In general, it is best to avoid the longer acting preparations and use short-acting preparations whenever possible. It is beyond the scope of this article to give detailed clinical and dosing information but this can be found elsewhere (9) (10).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Specific recommendations&lt;/H2&gt;
&lt;P&gt;Alfentanil and fentanyl can be cautiously recommended, and are probably the optimum opioids to use at the end of life when an injectable strong opioid is needed. Several clinical and practical considerations (other than safety) need to be taken into consideration; for instance, the short half-life of alfentanil makes it less practical for break-through pain, although it is appropriate for continuous infusion. &lt;/P&gt;
&lt;P&gt;Earlier in the illness trajectory, transdermal fentanyl can be used, provided there is careful titration of dose, and early regular review to watch for accumulation. Transdermal buprenorphine is increasingly widely used clinically, without reports of adverse effects, although the evidence to support this remains very limited. For oral preparations, oxycodone, hydromorphone and buprenorphine all have very limited evidence to indicate whether they are safe or not, although buprenorphine is increasingly used clinically, and both hydromorphone and oxycodone are likely better than morphine or diamorphine. Methadone appears to be safe, and is generally used second line or for neuropathic pain – it should however be used by clinicians who are experienced in its use, given the wide individual variation and late accumulation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In stage 4 and 5 CKD, morphine and diamorphine should be avoided where possible. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;P&gt;(1) &amp;nbsp;Murtagh F, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in Chronic Kidney Disease 2007;14(1):82-99.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(2) &amp;nbsp;Murtagh F, Addington-Hall J, Edmonds P, Donohoe P, Carey I, Jenkins K, et al. Symptoms in advanced renal disease - a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. Journal of Palliative Medicine 2007;10 (6):in press.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(3) &amp;nbsp;Cohen LM, Germain M, Poppel DM, Woods A, Kjellstrand CM. Dialysis discontinuation and palliative care. American Journal of Kidney Diseases 2000 Jul; 36(1):140-4.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(4) &amp;nbsp;Cohen LM, McCue JD, Germain M, Kjellstrand CM. Dialysis discontinuation. A 'good' death? Arch Intern Med 1995 Jan 9;155(1):42-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(5) &amp;nbsp;Arnold RM, Liao S. Editorial: renal palliative care: supporting our colleagues, patients, and family. J Palliat Med 2006 Aug;9(4):975-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(6) &amp;nbsp;Royal College of Physicians, Renal Association. Chronic Kidney Disease in Adults: UK guidelines for identification, management and referral. Renal Association website 2006 Available from: URL: &lt;A href="http://www.renal.org/CKDguide/ckd.html" target="_blank"&gt;http://www.renal.org/CKDguide/ckd.html&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(7) &amp;nbsp;Hardy JR, Herbert AR, Reymond E. Opioids in patients on renal dialysis. J Pain Symptom Manage 2007 Jan;33(1):1-2.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(8) &amp;nbsp;Dean M. Opioids in renal failure and dialysis patients. Journal of Pain &amp;amp; Symptom Management 2004;28(5):497-504.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(9) &amp;nbsp;Murtagh F, Chai MO, Donohoe P, Edmonds P, Higginson I. The Use of Opioid Analgesia in End-Stage Renal Disease Patients Managed without Dialysis: Recommendations for Practice. Journal of Pain and Palliative Care Pharmacotherapy 2007;21(2):5-17.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(10) &amp;nbsp;Broadbent A, Khor K, Heaney A. Palliation and chronic renal failure: Opioid and other palliative medications - Dosage guidelines. Progress in Palliative Care 2003;11(4):183-90.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(11) &amp;nbsp;Mercadante S, Arcuri E. Opioids and renal function. J Pain 2004 Feb;5(1):2-19.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(12) &amp;nbsp;Davies G, Kingswood C, Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 1996 Dec;31(6):410-22.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(13) &amp;nbsp;Meuldermans W, Van Peer A, Hendrickx J, Woestenborghs R, Lauwers W, Heykants J, et al. Alfentanil pharmacokinetics and metabolism in humans. Anesthesiology 1988 Oct;69(4):527-34.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(14) &amp;nbsp;Chauvin M, Lebrault C, Levron JC, Duvaldestin P. Pharmacokinetics of alfentanil in chronic renal failure. Anesth Analg 1987 Jan;66(1):53-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(15) &amp;nbsp;Hand CW, Sear JW, Uppington J, Ball MJ, McQuay HJ, Moore RA. Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites. Br J Anaesth 1990 Mar;64(3):276-82.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(16) &amp;nbsp;Summerfield RJ, Allen MC, Moore RA, Sear JW, McQuay HJ. Buprenorphine in end stage renal failure. Anaesthesia 1985 Sep;40(9):914.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(17) &amp;nbsp;Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. J Pharmacol Exp Ther 1997 Apr;281(1):428-33.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(18) &amp;nbsp;Gueye PN, Borron SW, Risede P, Monier C, Buneaux F, Debray M, et al. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol Sci 2002 Jan;65(1):107-14.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(19) &amp;nbsp;Coral IM, Moore AR, Strunin L. Plasma concentrations of fentanyl in normal surgical patients with severe renal failure. Br J Anaesth 1980;52:101P.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(20) &amp;nbsp;Koehntop DE, Rodman JH. Fentanyl pharmacokinetics in patients undergoing renal transplantation. Pharmacotherapy 1997 Jul;17(4):746-52.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(21) &amp;nbsp;Alazia M, Levron JC. [Pharmacokinetic study of prolonged infusion of fentanyl in intensive care]. Ann Fr Anesth Reanim 1987;6(5):465-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(22) &amp;nbsp;Durnin C, Hind ID, Wickens MM, Yates DB, Molz KH. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with renal impairment. Proc West Pharmacol Soc 2001;44:81-2.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(23) &amp;nbsp;Lee MA, Leng ME, Tiernan EJ. Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med 2001 Jan;15(1):26-34.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;(24) &amp;nbsp;Kreek MJ, Schecter AJ, Gutjahr CL, Hecht M. Methadone use in patients with chronic renal disease. Drug Alcohol Depend 1980 Mar;5(3):197-205.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(25) &amp;nbsp;Aitkenhead AR, Vater M, Achola K, Cooper CM, Smith G. Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. Br J Anaesth 1984 Aug;56(8):813-9.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(26) &amp;nbsp;Angst MS, Buhrer M, Lotsch J. Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action. Anesthesiology 2000 May;92(5):1473-6.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(27) &amp;nbsp;Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996 Jan;59(1):52-61.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;(28) &amp;nbsp;Kirvela M, Lindgren L, Seppala T, Olkkola KT. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. J Clin Anesth 1996 Feb;8(1):13-8.&lt;/P&gt;
&lt;H2&gt;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
</documents>